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Abstract
colourless (els) mutants were isolated in two independent ENU mutagenesis screens for 
recessive zebrafish mutations. All homozygous mutant alleles are embryonic lethal, 
whereas heterozygotes are phenotypically wild-type, els mutants present a lack of all 3 
types of pigment cells, intestinal aganglionosis and a severe reduction in most other 
neurons and glia of the peripheral nervous system, in combination with an inner ear 
defect. The homozygous els phenotype is reminiscent of homozygous Dominant 
megacolon (Dom) mouse mutants, a model for the human congenital Waardenburg- 
Shah Syndrome (WS4). Mutations in the transcription factor SoxlO, a member of the 
highly conserved Sox protein family characterised by their HMG-type DNA binding 
domain, have been identified in Dom (SoxlODom) mice and in some WS4 patients. 
Consequently, we proposed that sox 10 was a good candidate gene for the els locus.
To verify this proposal, we cloned a soxl 0 homologue by RT-PCR and RACE PCR and 
confirmed its true identity by sequence alignment, phylogenetic and in situ 
hybridisation analysis. We demonstrated that soxl 0 expression was disrupted in els 
mutants. Furthermore, we showed that the els locus and sox 10 were tightly linked on the 
distal end of LG 3, and identified mutant lesions in soxlO in 3 of the els mutant alleles. 
Ectopic expression of wild-type sox 10 under the control of a heatshock promoter 
rescued melanophores to a wild-type morphology and migrational behaviour, whereas 
equivalent constructs expressing mutant proteins failed to do so. Taken together, our 
results very strongly support the hypothesis that els encodes soxlO.
Furthermore, we investigated whether the expression patterns of soxlO and its closest 
homologues sox9a and sox9b overlapped and whether either of the Sox9 proteins might 
show functional redundancy with SoxlO, at least in the melanophore lineage.
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Chapter 1 -  Introduction
Zebrafish as a model organism
The zebrafish, Danio rerio (formerly known as Brachydanio rerio), belongs to the 
Super-Order Teleostei (bony fish) and the Family Cyprinidae. It is native to the rivers of 
India and Pakistan where it is found in rather shallow waters of 20-28°C. Zebrafish live 
socially in schools. The adult fish is about 4-5cm long, males tend to be of a slimmer 
build than females and richer in colour with a slight yellowish or reddish undertone 
especially on the anal fin (Riehl and Baensch, 1996).
Adults usually spawn in early morning where females lay up to 300 transparent eggs 
approximately 0.7mm in diameter. Larvae hatch at 2-3 days after fertilisation and start 
to swim and feed freely after 5 days. Maturity is reached after approximately 3 months 
depending on food supply and water temperature.
Zebrafish are widely used for toxicological studies in industrial laboratories.
Only recently have its advantages as a model organism in developmental and genetic 
studies been fully appreciated. Zebrafish breed easily in captivity and can be kept fairly 
cheaply at high densities. The eggs are fertilised externally and their embryos are 
transparent, which enables cell biological studies in the developing embryo such as 
single cell labelling with vital dyes. Likewise, analysis of in situ mRNA hybridisations 
in whole-mount embryos is possible.
The advantages for genetic studies are large family size, the short life cycle of 
approximately 90 days and ease with which recessive mutations can be created by 
placing males into a mutagen solution containing the point mutation inducing substance 
ethylnitrosourea (ENU).
In teleosts, a fairly recent, in evolutionary terms, genome duplication was 
proposed to have taken place more than 100 million years ago (Amores et al., 1998). 
Duplicated genes might have been lost during evolution unless they evolved to develop 
new functions or acquired new regional or temporal specificity. Thus, for every gene in 
mouse one has to consider the possibility of two homologues in zebrafish that have split 
the gene’s original function between themselves. This might be a disadvantage to this 
model organism, since potentially two such paralogues have to be isolated and analysed.
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However, the duplication, degeneration, complementation (DDC) model predicts that 
duplicates may become preserved by degenerative loss of complementary gene 
subfunctions from the duplicate copy (Force et ah, 1999). Hence, a complex mammalian 
gene function might be shared complementarily by two zebrafish homologues. For 
example, in mammalian mutants, a late gene function might be obscured by defects or 
premature death of the embryo caused by the gene’s essential early function. In 
zebrafish however, this might be overcome by the separation of these two functions 
(Postlethwait et al., 1999).
Zebrafish are a particularly suitable model organism to study neural crest 
development. Apart from the general advantages mentioned above like easy access and 
transparency of embryos, the neural crest cells in zebrafish are significantly larger and 
fewer in number compared to neural crest cells in avian or mammalian embryos (Raible 
et al., 1992) facilitating cell biological manipulations.
Large-scale mutagenesis screens in zebrafish for recessive 
mutants
Systematic mutagenesis screens were first carried out in invertebrates such as 
Drosophila (Nuesslein-Volhard et al., 1984; Wieschaus et al., 1984) and C. elegans 
(Kemphues et al., 1988). However, large-scale screens in vertebrate organisms such as 
mouse are difficult due to high costs involved in keeping and breeding such large 
numbers of animals.
In contrast, zebrafish, with its short life cycle, large family size, small space 
requirements and transparent externally fertilised embryos proves to be a very suitable 
vertebrate model system in which a large-scale saturation screen can be attempted. 
Mullins has described in detail the most efficient and reliable method to conduct such a 
mutagenesis screen (Mullins and Nuesslein-Volhard, 1993) using ethylnitrosourea 
(ENU) as the mutagen of choice (Mullins et al., 1994).
To date, two major mutagenesis screens have been reported. One was carried out 
in the Massachusetts General Hospital by W. Driever and his colleagues (Driever et al.,
1996). They screened 2383 mutations affecting embryonic and early larval 
development, resulting in identification of 220 genetic loci. In parallel in Tuebingen, 
Germany, C. Nuesslein-Volhard and her colleagues identified a total of 4264 mutants of 
which 1163 were characterised in more detail. By complementation crosses, 894
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mutants were assigned to 372 genes which were important in various developmental 
processes (Haffter et al., 1996a). Mutant phenotypes identified in the screen were 
organised into many phenotypic groups such as mutations affecting early development, 
formation of body axes, development of organs, pigment cells and mutations with an 
adult phenotype (Haffter et al., 1996a). Most of the mutations isolated were embryonic 
lethal. Since ENU is known to cause mostly point mutations or small deletions, 
embryonic lethality indicated that the function of these genes was indispensable in 
development and thus no other gene was able to fully compensate for the loss.
However, with an average allele frequency of 2.4 it was statistically possible to obtain 
mutations located in various regions of the same gene. Thus, for some loci mutants with 
weaker phenotypes were identified; for others, adult viable phenotypes were created 
making the study of the gene’s role in development a lot easier. The 79 isolated adult 
viable and 19 semiviable mutations were described in more detail in (Haffter et al., 
1996b).
Neural crest development
Although the neural crest is derived from the ectoderm it has often been referred to as 
the fourth germ layer. A discrete set of originally multipotent cells eventually become 
specified and differentiate into an incredibly diverse range of derivatives. The neural 
crest was first described in avian embryos by His (His, 1868 cited in Le Douarin and 
Kalcheim, 1999) as a strip of cells located between the neural tube and the overlying 
dorsal ectoderm, which he called “Zwischenstrang”. Since then, techniques to identify, 
visualise and trace single neural crest cells have led to a better understanding of the 
underlying processes of neural crest development not only in avians, but also in 
amphibians, fish and mammals. Even so, a lot of progress has yet to be made to resolve 
details of the mechanisms controlling neural crest development.
The formation of the neural crest
The neural crest delaminates from the dorsal neural tube in a rostrocaudal manner. 
Neurulation in avians, amphibians and mammals involves the induction of the neural 
plate from the ectoderm, followed by an elevation of the lateral margins of the neural 
plate called neural folds, which finally fuse at the dorsal midline to give rise to the
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neural tube. In contrast, the neural tube in teleosts like the zebrafish and in caudal 
regions of avians is formed by a process called secondary neurulation, whereby a 
ventral thickening of the ectoderm can be observed. This structure, called a neural keel, 
then cavitates to give rise to the neural tube (Lamers et al., 1981). The neural crest cells 
delaminate from the lateral edges of the neural keel and converge towards the dorsal 
midline (Raible et al., 1992; Kimmel et al., 1995; Thisse et al., 1995; Baker and 
Bronner-Fraser, 1997b; Le Douarin and Kalcheim, 1999).
The molecular mechanisms underlying neural induction and the subsequent 
formation of the neural crest are still not fully understood. During neurulation the 
ectoderm gets divided into non-neural ectoderm and neural plate, which give rise to the 
epidermis and the neural tube, respectively. This process is thought to be regulated by a 
gradient of bone morphogenetic protein-4 (BMP-4; an epidermalising factor) 
originating from ectodermal cells, which is generated by a gradient of a BMP inhibitor 
(neuralising factor) such as noggin and chordin (Smith and Harland, 1992; Piccolo et 
al., 1996) secreted by the future axial mesoderm (organizer region). Dorsal ectoderm, 
which by default adopts a neural fate (reviewed in Weinstein and Hemmati-Brivanlou,
1997), would be epidermalised by BMP-4 if factors like noggin and chordin did not 
prevent BMP-4 from binding to its receptor (Piccolo et al., 1996; Zimmerman et al.,
1996). Hence, epidermis is only formed furthest from the organiser (future axial 
mesoderm and notochord), whereas neural tube is formed adjacent to this source of 
noggin and chordin. The neural crest forms at the interface between neural plate and 
non-neural ectoderm.
There are several models of neural crest induction (reviewed by Baker and 
Bronner-Fraser, 1997b).
Albers proposed (Albers, 1987) that a change in ectodermal competence to a signal 
from the organiser could give rise to neural plate, the neural crest and finally epidermis. 
Raven and Kloos were the first scientists to suggest that neural crest induction might 
involve signals from the archenteron roof (paraxial mesoderm) directly underlying the 
prospective neural crest region but, most importantly, that this induction was 
independent from the induction of the neural plate (Raven and Kloos, 1945). They could 
show in grafting experiments that medial archenteron roof was able to induce both 
neural plate and neural crest markers from overlying competent ectoderm, whereas 
lateral archenteron roof induced neural crest markers only. Marchant and colleagues 
further investigated these proposed inducing abilities of mesoderm. They conclude the
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existence of a neural crest inducer originating from the dorsal (axial) mesoderm creating 
a gradient along the dorsolateral (paraxial) mesoderm. In vitro, dorsal mesoderm was 
able to induce neural plate markers like Xsox2 proximally and neural crest markers like 
Xslug at a distance. If dorsal mesoderm was replaced by dorsolateral mesoderm in those 
conjugates, neural crest markers were expressed next to the inducing tissue, whereas 
ablation of dorsolateral mesoderm in early gastrula embryos resulted in loss of the 
neural crest population (Marchant et al., 1998).
A third model suggests that interactions between the neural plate and adjacent non- 
neural ectoderm (future epidermis) induce the neural crest. This has been indicated by 
grafting experiments in amphibians (Rollhauser-ter Horst, 1980; Moury and Jacobson, 
1990) and avians (Selleck and Bronner-Fraser, 1995). Juxtaposed neural plate and 
ventral epidermis were found to be sufficient to generate neural crest derivatives in 
axolotl embryos. Although both tissues contributed to the generation of neural crest 
cells, most neural crest formed from the neural plate gave rise to melanocytes, whereas 
epidermal cells formed neurons of the dorsal root ganglion (Moury and Jacobson,
1990).
Can any of these models fully explain the induction of neural crest? BMP-4 is 
sufficient to repress neural and induce epidermal fates (Wilson and Hemmati-Brivanlou, 
1995). Thus, a role in dorsoventral patterning of the ectoderm was suggested by which 
the neural plate and the non-neural ectoderm could be specified. This is achieved by a 
delicate balance of BMP and BMP antagonist levels such as chordin and the neural crest 
could be induced by intermediate levels of BMP-4. This balance can be manipulated by 
overexpression studies. If BMP-4 is overexpressed in early Xenopus embryos by mRNA 
injection, the neural plate area is reduced, but without affecting actual neural crest 
formation lining the border (LaBonne and Bronner-Fraser, 1998). Prospective neural 
crest cells can be identified by their expression of the zinc finger transcription factor 
XSlug (Mayor et al., 1995; LaBonne and Bronner-Fraser, 1998). Thus, BMP-4 seems to 
be important in defining the location of the neural plate borders. In contrast, 
overexpression of chordin expands the region of Xslug expression laterally at the 
expense of non-neural ectoderm. However, at no concentration of chordin, and thus of 
BMP-4, could wild-type levels of XSlug expression be observed (LaBonne and 
Bronner-Fraser, 1998). Furthermore, LaBonne and her colleagues never observed 
melanocytes being formed in ectodermal explants overexpressing chordin. Taken 
together, this suggests that BMP might provide an initial weak neural crest specification
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at the borders of the lateral neural plate, but additional signals derived from either the 
adjacent non-neural ectoderm and/or underlying mesoderm may then be required to 
enhance and maintain neural crest induction at wild-type levels (LaBonne and Bronner- 
Fraser, 1998).
Members of the Wnt and FGF family have been found to alter the 
anteroposterior characteristics of noggin-induced neural plate tissue (McGrew et al.,
1997). Recently, it has also been shown that there is a direct requirement for Wnt 
signalling in neural crest formation. In contrast to chordin alone, conjugates of chordin- 
expressing and XWnt-8 or eFGF-expressing explants were able to induce wild-type 
expression levels of Xslug. Furthermore, a significant number of melanocytes were 
formed in this chordin-induced neural tissue (LaBonne and Bronner-Fraser, 1998).
Since XWnt-8 is a downstream target of eFGF, it was tested whether the induction of 
neural crest was achieved by eFGF directly and through XWnt-8 signalling. When a 
dominant negative mutant of XWnt-8 was co-expressed, the ability of eFGF to induce 
Xslug expression in chordin-expressing explants was drastically reduced. This 
suggested an indirect role for eFGF in neural crest formation, whereas XWnt-8 was 
shown to have a direct effect on neural crest induction in vitro and in vivo (LaBonne and 
Bronner-Fraser, 1998).
Could the role of XWnt-8 in neural crest and somite formation be connected? Paraxial 
mesoderm (prospective somites) is a potent neural crest inducing tissue. Since a dnWnt 
has been shown to disrupt somite formation, it is possible that the mechanism by which 
XWnt-8 acts on neural crest formation involves disrupting mesoderm, which in turn 
fails to induce neural crest. This hypothesis could be disproved by LaBonne and 
Bronner-Fraser. They demonstrated that neural crest failed to form even when dnWnt 
was exclusively expressed in the ectoderm and that the requirement for XWnt-8 in 
neural crest induction was thus independent of any role it might have in mesoderm 
(LaBonne and Bronner-Fraser, 1998).
A similar role for a member of the Wnt family in patterning the mediolateral polarity 
(dorsoventral axis after formation of the neural tube) has been shown for XWnt7B in 
Xenopus (Chang and Hemmati-Brivanlou, 1998). XWnt7B was able to induce neural 
crest when co-injected with noggin into ectodermal explants. Presumptive neural crest 
was visualised by staining for Xslug and Xtwist. This induction still took place after 
neuralising explants by dissociation and thus even in absence of epidermis. In
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overexpression studies in vivo, XWnt7B also expanded the expression domain of the 
neural crest marker Xtwist.
In summary, the current model suggests a two-signal induction process leading 
to neural crest formation. Firstly, BMP levels have to be decreased sufficiently by 
inhibiting the interaction between BMP and its receptor by neuralising factors like 
chordin or noggin. The induced neural tissue is of anterior character and can then be 
caudalised by factors such as FGF.
This decreased level of BMP signalling also specifies the lateral border regions of the 
neural plate and renders them competent to respond to lateralising (dorsalising) Wnt 
signals that enhance and maintain neural crest induction. Signals involved in the 
patterning of the mediolateral character of the open neural plate (future dorsoventral 
axis of the neural tube) are thought to be derived from the notochord (e.g. hedgehog 
promoting ventral neural fates like floorplate and motor neurons) and from the non- 
neural ectoderm (e.g. Xwnt7B mediating dorsal cell fates like neural crest and 
roofplate).
Overexpression of Slug alone appears insufficient to induce neural crest at wild-type 
levels. However, once Slug is induced by BMP/Wnt like signals it seems to regulate its 
own expression. Thus, Slug appears to have a role in neural crest fate maintenance, 
additionally to a later role in neural crest migration.
This model is broadly consistent with results of studies in zebrafish. The 
zebrafish mutant swirl was shown to encode bmp2b and to be necessary for neural crest 
formation (Nguyen et al., 1998). swirl mutants have a severely dorsalised phenotype, 
whereas chordino mutants, a chordin homologue, are ventralised. This is consistent 
with the interplay of BMP-4 and chordin in dorsoventral patterning of the frog embryo. 
Aside from ventral cell-types, laterally-derived neural crest progenitors, labelled with 
,/fc/d, are severely reduced or absent in swirl mutants. However, this region is enlarged 
in somitabun (smad5) and to a lesser degree in snailhouse (bmp7) mutants, two other 
genes of the BMP pathway. The phenotype of these 3 mutants were explained by the 
activity of a morphogen. Different levels of BMP activity induce differential gene 
expression along the dorsoventral axis (Nguyen et al., 1998; Barth et al., 1999). This 
results in the specification of various cell-types, which is also observed in frogs. Thus, 
to induce neural crest, low levels of BMP (swirl) are necessary at the border between 
the neural plate and the non-neural ectoderm. However, consistent with frogs, it was
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proposed that additional factors apart from BMP may be required for neural crest 
induction (Nguyen et al., 1998).
Neural crest segregation, specification and migration
The neural crest is induced in bilateral bands of cells at the margin of the neural plate 
and is labelled by fkd6  from about 90% epiboly (Odenthal and Nuesslein-Volhard,
1998). Such fkd6  expressing cells are observed posterior to a region stained with 
floating head (flh), which will give rise to the prospective dorsal diencephalon (Masai et 
al., 1997; Barth etal., 1999).
Neural crest segregation, like induction, occurs in a rostrocaudal sequence. At the 
anteroposterior level of somite 8 the neural keel starts to segregate from the overlying 
neuroepithelium at 15hpf and the neural tube has formed from the neural keel by 
cavitation at 17hpf. In contrast to the non-neural ectoderm, the basal lamina covering 
the neural tube is discontinuous at this stage and might thus enable the segregation of 
neural crest cells from the dorsal neural tube. This process is finished by 19hpf and 
neural crest cells are closely associated with the now continuous basal lamina of the 
neural tube (Raible et al., 1992). Neural crest cells in zebrafish are approximately twice 
the size of their avian equivalents and less numerous. In fact, zebrafish on average 
contain 3-5 times fewer premigratory neural crest cells per segment than avians (Raible 
etal., 1992).
Migration o f  neural crest cells
Migration of cranial and trunk neural crest cells show differences in the timing and 
choice of pathway. In avian embryos, cephalic neural crest cells are located anterior to 
somite 5 (Baroffio et al., 1991). The first cranial neural crest cells in birds start to 
migrate as a sheet from above the mesencephalon at the 6 somite stage and follow a 
subectodermal pathway (Baker et al., 1997a). At the hindbrain level, neural crest cell 
migration progresses in distinct bands corresponding to branchial arches (Le Douarin 
andKalcheim, 1999).
Similarly, cranial neural crest cells in zebrafish just caudal to the developing eye, start 
to migrate subectodermally at 15-16hpf. Cells from each axial level contribute to a 
specific pharyngeal segment (Schilling and Kimmel, 1994) and these segment 
restrictions appear to be generated sequentially in a rostrocaudal manner. Thus, all cells
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labelled as early as 12hpf in the rostralmost regions exclusively contribute to the 
mandibular or hyoid arches, but cells labelled more caudally at the same time migrate 
into 3 adjacent segments (Schilling and Kimmel, 1994).
In avians, the neural crest population located above or caudal to somite 5 is 
referred to as the trunk neural crest (Sieber-Blum, 1990). Trunk neural crest cells in 
vertebrates follow two conserved migrational pathways, the medial (ventromedial) and 
the lateral (dorsolateral) pathway.
Neural crest cells first enter the medial pathway at approximately 16-17hpf in zebrafish. 
The onset of neural crest migration in the trunk is linked to the differentiation of the 
somites. Premigratory neural crest cells are not in contact with the dorsal somite 
surface, but begin to probe the latter with long pseudopodia (Raible et al., 1992). As 
somites differentiate they elongate along the dorsoventral axis bringing the dorsal 
somite surface in contact with neural crest cells. This elevation is concomitant with the 
start of neural crest migration ventrally between the neural tube and the somite at 18hpf 
at the level of somite 8 (Raible et al., 1992). In contrast to birds and mammals, cells 
enter the pathway at any axial level along the somite. By the time they reach the ventral 
edge of the neural tube they all seem to have converged towards the middle of the 
somite (Raible et al., 1992). Avian and mammalian neural crest cells however are 
restricted to the rostral part of the somite (Rickmann et al., 1985; Bronner-Fraser, 1986). 
Approximately 4 hours after cells have started migration on the medial pathway in 
zebrafish, some neural crest cells additionally enter the lateral pathway. They disperse 
from the dorsalmost part of the neural tube and migrate dorsolaterally, then ventrally 
between the somite and the overlaying epidermis (Raible et al., 1992). Neural crest cells 
in zebrafish do not seem to be restricted to a region along the somite when they enter 
the lateral pathway, similarly to observations on the medial pathway. Interestingly, 
neural crest cells in mouse seemed to enter both pathways simultaneously (Serbedzija et 
al., 1990), whereas in avians, a 24 hour delay has been reported between the onset of the 
two pathways (Erickson et al., 1992).
Derivatives o f  the cranial and trunk neural crest
Cell lineages derived from cranial and trunk neural crest cells are broadly overlapping. 
However, cartilage precursors are only formed from the cranial neural crest, whereas 
sympathetic neurons for example, are only derived from the trunk neural crest cell 
population.
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The cell-types derived from the cranial neural crest have been extensively 
studied by Schilling and Kimmel. By labelling single neural crest cells with a 
fluorescent dye and recording their fate they were able to construct a fate map of 
cranial neural crest located in the region between the eye and the first somite (Schilling 
and Kimmel, 1994). It was shown that neural crest in the mesencephalic and rostral 
rhombencephalic region consisted of 6 tiers of cells. Whereas the anterioposterior 
position of neural crest cells determined which pharyngeal segment they would 
contribute to, the cell-type could be predicted from the mediolateral position. The most 
lateral tier of cells exclusively gave rise to neurons in cranial ganglia. More medial tiers 
2-5 gave rise to Schwann or satellite glial cells and pigment cells, whereas the most 
dorsally located neural crest cells in tier 4-6 differentiated into cartilage and connective 
tissues forming head structures (ectomesenchymal fates; Schilling and Kimmel, 1994). 
This fate map established for the cranial region in zebrafish seemed to roughly correlate 
to the avian fate map of that region (Noden, 1987). However, a similar study carried out 
by Dorsky, revealed some discrepancies with Schilling’s fate map (Dorsky et al., 1998). 
When Dorsky labelled cranial neural crest cells, neurons were derived exclusively from 
a lateral position in agreement with Schilling’s study. However, pigment cells mostly 
arose from medially located neural crest cells and glia from all positions, although 
slightly fewer from medial positions. Most strikingly, cartilage precursors were labelled 
equally in all mediolateral positions (Dorsky et al., 1998).
The discrepancies between the two studies might be explained, if different cell layers 
had been labelled. Schilling states that he only labelled the most peripheral 20% of 
neural crest cells, whereas Dorsky claims to have labelled representatives of all layers. 
88% of all labelled clones seem to be fate restricted prior to the onset of migration and 
gave rise to a single cell-type. This is very different to data reported for the cranial 
neural crest population in avians (Baker et al., 1997a). Using isochronic isotopic 
transplantation of cranial neural crest cells between quail and chicken embryos they 
showed that all neural crest precursors could give rise to all derivatives regardless of 
when they started their migration. Thus, in contrast to results reported in zebrafish 
(Raible and Eisen, 1994; Schilling and Kimmel, 1994; Raible and Eisen, 1996), she 
concluded that neither early nor late migrating cranial neural crest populations were 
lineage restricted. Furthermore, early neural crest cells contributed equally to dorsal and 
ventral fates, whereas derivatives formed by late neural crest cells were confined to 
dorsal regions and gave rise to fewer ectomesenchymal fates. However, these
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transplants in avians consisted of strips of neural crest cells, 10-15 cells wide and 
spanning the length of the mesencephalon. These grafts likely contained cells of various 
fate-restrictions and thus might have appeared to be multipotent as a group.
In avian and mammalian embryos, neural crest cells in the trunk give rise 
entirely to non-ectomesenchymal derivatives such as neurons of the sensory and 
sympathetic ganglions, Schwann cells and pigment cells. Enteric neurons and glia are 
derived from three locations in avians. The neural crest above somites 1-7, the vagal 
region, forms the majority of the enteric nervous system colonising the gut in a 
rostrocaudal sequence. Neural crest above the lumbosacral spinal cord contributes 
mostly to enteric ganglia in the colorectum whereas some neural crest originating from 
the anterior trunk region colonises the esophagus and anterior part of the stomach 
(Durbec et al., 1996; Bums and Le Douarin, 1998). In zebrafish, trunk neural crest also 
forms fin mesenchyme, an ectomesenchymal fate (Smith et al., 1994).
Most neural crest cells migrating on the medial pathway in zebrafish are fate- 
restricted. They give rise to single cell phenotypes, whereas only 20% produce multiple 
derivative clones (Raible and Eisen, 1994). Labelling single neural crest cells at 
different time points revealed that the number of neural crest precursors producing 
multiple phenotypes decreased with time as those precursor cells undergo progressive 
fate restriction. Sensory and sympathetic neurons are only derived from neural crest 
cells that start migrating before 18hpf, whereas time of migration is less important for 
all other derivatives. Raible and his colleagues could also demonstrate that at least some 
neural crest cells were specified before they reached their final destination. Some neural 
crest cells, like precursors for dorsal root ganglia (DRG) exhibited identifiable and 
reproducible migration patterns; others started to synthesize melanin (melanophores).
Neural crest progeny migrating on the lateral pathway consists of type-restricted 
precursors only and exclusively gives rise to clones of either all melanin-positive 
(melanophores) or all melanin-negative (xanthophores and iridophores) (Raible and 
Eisen, 1994).
How do neural crest cells become specified?
There are two models of neural crest development that attempt to explain how this wide 
variety of different neural crest derivatives is formed. The first one assumes that neural 
crest cells are predetermined to generate specific cell-types. In the second model all 
neural crest cells are equivalent initially and later become fate restricted to give rise to
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various cell-types by localised environmental signals they encounter during their 
migration (Raible and Eisen, 1995). Published results seem to indicate that a 
combination of both, intrinsic differences between cells and environmental cues might 
be involved in neural crest specification.
Some support for the first model is observed by single cell labelling of 
premigratory neural crest cells above the zebrafish trunk with lysinated rhodamine 
dextran. Most trunk neural crest cells on the medial pathway generated derivatives of a 
single phenotype (Raible and Eisen, 1994). Furthermore, all labelled neural crest cells 
on the lateral pathway produced clones of pigment cells that were either all melanin- 
positive or all melanin-negative (Raible and Eisen, 1994). Similarly, 88% of rhodamine 
dextran labelled premigratory cranial neural crest cells generated progeny of single cell- 
types (Schilling and Kimmel, 1994). Although results in these studies clearly 
demonstrate that cells give rise to only a single neural crest fate, they do not show the 
potential of these cells. It was not investigated, whether the same neural crest cells could 
still change their fate, if they were placed in a different environment, for example. In 
fact, there are indications from studies described below that the specification status of 
neural crest cells in vivo is not in agreement with the one predicted by the first model.
The second model proposed a fate restriction for neural crest cells during their 
development in response to intrinsic or extrinsic cues. Evidence supporting this model 
was provided by (Raible and Eisen, 1996). They studied cell-type restrictions of trunk 
neural crest cells migrating on the medial pathway using single cell labelling. They 
asked, whether early and late migrating populations of neural crest cells had different 
fate potential. In their observation, 20% of clones migrating early on the medial 
pathway gave rise to multiple phenotype clones, whereas two hours later, cells 
migrating at the same axial level only produced single phenotype clones (Raible and 
Eisen, 1996). To test, whether these cells had undergone progressive fate-restriction and 
also changed their developmental potential, they used transplantation studies. As an 
example, they specifically investigated a possible change in neuronal potential. They 
found that trunk neural crest cells migrating on the medial pathway early (EMC, in 
segment 7 before 18hpf) gave rise to sensory neurons of the DRG, glia and pigment 
cells. However, late migrating neural crest (LMC, in segment 7 after 18hpf) had lost 
their potential to generate sensory neurons under those environmental conditions.
In their experiments, EMC transplanted into older hosts and thus migrating at the same 
time as endogenous LMC were still able to give rise to DRG neurons, whereas
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transplanted into an even later host (21-23.5hpf) they no longer were able to do so. They 
suggested that a possible change in an environmental signal or a progressive fate- 
restriction might be responsible for the loss of ability to generate DRG neurons. LMC 
transplanted into younger hosts did not gain the ability to produce sensory neurons 
even under the “early” environment, EMC are usually subjected to. However, if such 
LMC were transplanted into those early hosts after ablation of the EMC population they 
migrated ventrolaterally to fill in the EMC positions. They were able to give rise to 
DRG and thus functionally replaced the early neural crest population. Raible and Eisen 
concluded that LMC and EMC still have the same developmental potential although 
they exhibit intrinsic conditional biases towards creating specific fates in their normal 
environment (Raible and Eisen, 1996).
Specification of trunk neural crest derivatives in avians appears to be similar to 
zebrafish. Henion and Weston (Henion and Weston, 1997) asked whether the 
composition of fate-restricted and unrestricted precursors changed within a neural crest 
population over time. They randomly labelled single neural crest cells of a primary 
neural crest cell culture by injection of a lineage tracer. Cells were grown in a medium 
permissive for neuronal, glial and pigment cell fates and identified with cell-type 
specific markers at various time points. They found that the initial neural crest 
population, which had emerged from the neural tube explant and was labelled during the 
first 6 hours consisted of both pluripotent (55.5%) and fate-restricted precursors 
(44.5%). However, 87% of neural crest cells labelled at 30-36 hours after emergence 
were fate-restricted. This progressive fate-restriction had also been reported for 
zebrafish trunk neural crest cells on the medial pathway (Raible and Eisen, 1996).
They further asked in this study, at what stages different cell lineages separated from 
each other. The neurogenic lineage seemed to become specified between 13-16 hours 
and 30-36 hours before the glial and melanogenic lineages and was the first one to start 
migration. Fate-restricted melanogenic precursors emerged last from the neural tube, but 
prior to overt differentiation, which was true for all sublineages. Since these fate- 
restrictions were observed under a presumably uniform cell culture environment, they 
concluded that intrinsic differences between precursor populations or cell-cell 
interactions must be responsible for neural crest diversity rather than environmental 
cues alone. Those distinct subpopulations might then respond to the present 
environment in different ways promoting separate developmental pathways (Henion and 
Weston, 1997).
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In summary, the studies described above seem to fit a model for neural crest 
specification that is a combination between the two extreme original models. In this 
refined model, the initial population of neural crest cells consists of a mixture of fate- 
restricted and multipotent precursors, which become progressively fate-restricted over 
time.
How can two adjacent cells with equivalent potential adopt different fates?
There are two mechanisms described in the literature. The first involves lateral 
inhibition, by which cells to be specified complementarily instruct each other; in the 
second mechanism, cells respond differently to the same signal depending on their 
distance from it.
Cornell and Eisen investigated how cells with apparently equivalent developmental 
potential in the lateral neural plate could be specified to form either neural crest cells or 
Rohon-Beard spinal sensory neurons. They found that cells singled out to be precursors 
for Rohon-Beard neurons expressed deltaA, which bound to the Notch receptor induced 
in the surrounding cells. Notch-Delta signalling was shown to be necessary to prevent 
these surrounding cells from adopting the Rohon-Beard fate and allowing them to 
become neural crest instead (Cornell and Eisen, 2000).
The Wnt signalling pathway on the other hand was shown to be involved in making 
specific fates from the neural crest. Dorsky presented evidence that suggested a role for 
Wnt-1 and/or Wnt-3a in specifying pigment cell fates in the cranial region (Dorsky et 
al., 1998). Wnt-1 and Wnt-3a expressed in the anterior dorsal neural keel seemed to 
promote pigment fates in adjacent neural crest cells at the expense of neurons and glia. 
Interestingly, the formation of ectomesenchymal fates was not affected in any way by 
these Wnt signals further supporting previous data that those fates represented a 
separate neural crest lineage from the non-ectomesenchymal derivatives such as neurons 
and pigment cells (Le Douarin and Teillet, 1974).
Pigmentation mutants and the colourless mutation
A great number of mutations isolated in the Tuebingen screen affect neural crest 
derivatives and especially pigment cells. In total, 285 mutations within 94 distinct genes 
were found, which affect various aspects of embryonic and larval pigment development 
such as pigment specification, distribution and survival (Haffter et al., 1996a). The 
second screen carried out in Boston identified 54 genes (Driever et al., 1996).
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Pigmentation mutants from the Tuebingen screen were described in detail by (Kelsh et 
al., 1996) and mutants were distributed into 7 classes according to their phenotype.
Class I describes mutants such as colourless (els), with no or strongly reduced numbers 
of all 3 types of chromatophores, melanophores, xanthophores and iridophores. Mutants 
in class II show a reduced number of only one chromatophore, e.g. xanthophores or 
iridophores in salz (sal) and shady (shd), respectively, whereas mutants with a reduced 
number of melanophores, like sparse (spa), are listed in class III. Class IV contains 
mutants with altered pigment patterns like choker (cho), which forms morphologically 
normal chromatophores in a pattern different to wild-type larvae. Moonshine (mon) is a 
representative of Class V mutants, which develop a surplus of chromatophores in 
ectopic locations. Class VI contains 10 subgroups each describing a reduced 
chromatophore pigmentation phenotype as can be seen in albino (alb) embryos, 
whereas class VII describes mutants with altered chromatophore morphology such as 
union jack (uni) (Kelsh et al., 1996).
The colourless mutation in zebrafish
The colourless phenotype was initially described by (Kelsh et al., 1996) and (Malicki et 
al., 1996). colourless seemed to have the most dramatic phenotype of all pigment 
mutants, since it lacked all 3 types of chromatophores and thus suggested an important 
role during pigment cell development, els first arose spontaneously within the rose 
stock kept in Tuebingen (clst3). It was defined as having no chromatophores apart from 
a fully pigmented eye and additionally showing an early ear defect. Very few remaining 
chromatophores were observed in some individuals in normal positions although 
melanophores, where present, were unusually small and only found on the dorsal stripe. 
In a more recent study (Kelsh and Eisen, 2000b) it was shown that the pigmentation 
defect resulted from a decrease of actual melanoblast number, not disrupted melanin 
synthesis. Fewer melanoblasts were labelled with dct in els embryos compared to wild- 
type siblings at 27hpf and migration of these dcf-positive cells seemed to be impaired. 
Furthermore, the number of migrating neural crest cells on the lateral pathway (fated to 
become all three types of pigment cells; Raible and Eisen, 1994) was drastically reduced 
in homozygous mutant embryos. However, premigratory neural crest labelled with fkd6  
was formed and maintained in apparently normal numbers in els embryos up to 24hpf.
33
els embryos also show severe defects in other non-ectomesenchymal fates such as 
peripheral neurons and peripheral ganglion glia. The number of enteric neurons was 
severely reduced and enteric glia were either also severely reduced or absent at 7dpf. 
Sensory neurons of the DRG were reduced anteriorly as early as 2dpf, but absent 
posteriorly at 7dpf and sympathetic neurons also could not be detected at 9 dpf. 
Although cranial ganglion neurons appeared normal, satellite glia associated with 
cranial ganglia and Schwann cells around cranial nerves were markedly reduced in els 
embryos at 24hpf.
Ectomesenchymal neural crest derivatives such as craniofacial skeletal structures and 
median fin mesenchyme in head and trunk form normally in els siblings (Kelsh and 
Eisen, 2000b).
In addition to those defects in neural crest derivatives, els has an early effect on 
ear development and morphology first detectable around 36hpf (Kelsh et al., 1996; 
Malicki et al., 1996; Whitfield et al., 1996). By 3dpf the size of the otic capsule is 
slightly smaller and by 5dpf the tiny ear contains two small otoliths and only one 
sensory patch (Malicki et al., 1996; Whitfield et al., 1996).
All els mutant alleles show a recessive phenotype. In the Tuebingen screen 4 
colourless alleles were isolated, called elsty22f, clste275, clstw2 and clslw11.The latter two 
were derived from the same mutagenised family founder male. In the Boston screen two 
els alleles were originally classified as mutants with defective ear morphology 
combined with abnormal pigment pattern. They were named golas (jgos) and the two 
alleles gosm24] and gosm618 (Driever et al., 1996; Malicki et al., 1996). gosm241 was 
described to exhibit a weaker phenotype than gosm618, but unfortunately the stock seems 
to have been lost since.
Mutations affecting els and golas failed to complement each other and thus are allelic. 
As a result, gosm618 was renamed clsm618 (Malicki et al., 1996).
The els gene acts cell-autonomously at least in the pigment cell lineages and 
homozygous mutants, which will be referred to as els embryos hereafter, die at lOdpf 
(Kelsh et al., 1996; Kelsh and Eisen, 2000b).
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Genetic disorders characterised by congenital 
hypopigmentation in mouse and humans
As discussed earlier the neural crest represents an important group of cells responsible 
for the development of many embryonic structures such as craniofacial connective 
tissues, sensory and autonomic ganglia, the enteric nervous system and pigmentation. 
Genetic disorders affecting one or more neural crest derivatives are termed 
neurocristopathies. By far the most commonly observed neurocristopathies are those 
that affect pigment development. These show a wide variety of phenotypes ranging 
from absence of pigmentation due to deficient melanin synthesis to abnormal 
distribution of pigment cells during development. On this basis it is possible to group 
the majority of congenital hypopigmentary disorders into 2 types.
The first type of disorders are caused by mutations in genes that code for proteins 
involved in the formation of the melanosome and melanin pigment at the subcellular 
level such as tyrosinase. Hypopigmented areas in such mutants contain melanocytes, but 
lack the melanin pigment.
The second type of hypomelanoses affect proteins which act at the tissue level and are 
responsible for migration, proliferation, survival or specification of the melanocyte 
lineage. Mutations in these genes result in absence of melanocytes in hypopigmented 
areas.
Human disorders and their mouse models affecting melanin 
synthesis
Oculocutaneous albinism (OCA) represents an example of the first type of pigmentary 
disorders. Ocular and cutaneous melanocytes are distributed normally but are unable to 
synthesise melanin. OCA mutations have been classified by (King et al., 1995) 
depending on the location of the genetic lesion. Mutations in the gene encoding 
tyrosinase results in OCA1 (Barton et al., 1988). Tyrosinase catalyses the first two steps 
of melanin synthesis, the hydroxylation of tyrosine to dihydroxylphenylalanine (DOPA) 
and the oxidation of DOPA to DOPAquinone. The tyrosinase gene is the albino (c) 
locus of the mouse (reviewed in Oetting, 1998). In OCA2, mutations affect the P protein 
(murine pink-eyed dilution locus p) of unknown function, but known to be associated 
with the membrane matrix of melanosomes, whereas OCA3 results from genetic lesions
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in the tyrosinase related protein 1, trp-1 (Gardner et al., 1992; Boissy et al., 1996). 
TRP1, a DHICA oxidase, also has its functions in the melanin synthesis pathway, distal 
to tyrosinase. The brown (b) locus represents the murine TRP1 gene (reviewed in 
Oetting, 1998). Other forms of OCA such as Hermansky-Pudlak syndrome and 
Chediak-Higashi syndrome exhibit defects in addition to those in melanosomes (Boissy 
andNordlund, 1997).
Human disorders and their animal models affecting the distribution 
of melanocytes
The majority of hypomelanoses present with aberrant distribution of melanocytes and 
their underlying molecular defects affect various stages during melanocyte 
development. Animal models help to enlighten the genetic and biological basis of each 
of these human diseases. Table 1.1 summarises the most common human congenital 
pigmentary disorders and their mouse models.
Piebaldism and its murine homologue dominant white spotting (W)
Piebaldism was already recognised by the ancient Romans due to its striking phenotype 
of often symmetrical white patches of skin and hair located on the head, chest and limbs 
of affected individuals (reviewed in Spritz and Ortonne, 1998). Pigmentation of the 
retina and irises is normal and there are no visual or hearing defects in human patients. 
Thus, piebaldism is thought to be a lineage-specific disorder of neural crest derived 
melanoblasts in skin and hair (Murphy et al., 1992; Steel et al., 1992).
Piebaldism is a rare autosomal dominant disorder (1:100 000) and inherited with equal 
frequencies in males and females. It is caused by mutations in KIT, a transmembrane 
type III receptor of the tyrosine kinase family (Giebel and Spritz, 1991). Signalling by 
this receptor requires binding of its ligand, an embryonic growth factor called Steel 
factor, SLF, to the extracellular ligand binding domain. Upon binding SLF, the receptor 
dimerises activating the intracellular tyrosine kinase domain, which then 
autophosphorylates specific tyrosine residues within the kinase domain. This enhances 
the binding of other proteins such as kinases, which mediate activation of downstream 
targets of the KIT-dependent signal transduction pathway (Morrison-Graham and 
Takahashi, 1993).
The dominant phenotypes of human piebaldism show differences in severity depending
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Summary of the most common human congenital pigmentary disorders and their mouse 
models
WS1 WS2 WS3 WS4 rec WS4 dom HSCR2 HSCR Piebald CDHS
Gene j PAX3 MITF PAX3 EDN3, EDNRB SO X 10 EDNRB RET. GDNF PAX3
Locus 2q35 3q12 2q35 20ql3.2 22ql3 13q22 lO qll.l 4ql2 2q35
mode of inheritance { aut. dom. aut. dom. aut. dom. aut. recess. aut. dom. aut. recess. aut. dom. aut. dom. aut. dom.
mouse model splotch mi splotch lethal spotting, Is Dom/.Dom piebald lethal, sl n/k white spotting, W 
1:5000 1:100 000
splotch
Frequency j 1:40 000 1:40 000 1:40 000 very rare 1:40 000 rare n/k
M:F ratio equal equal equal equal 4:1 2 ' \ B 4 : f f  P  equal 4-1
Hypopigmentation j V V V V V occ. V X V
heterochromic irides V ■ 1  - vJi: r * occ. V X
dystopia canthorum j W" x  "  V X X
sensorineural deafness V V V X 
Megacolon j rare V rare V V 






extensive V rare V
more severe V
. . , • ^  i
Table 1.1: A summary of known Waardenburg Syndrome and Hirschsprung Disease like disorders and their mouse models. Description of 
human phenotypes have been taken mainly from (Spritz, 1998 in Nordlund et al., 1998; Spritz and Ortonne, 1998 in Nordlund et al., 1998; 
Boissy and Nordlund, 1997; Pingault et al., 1997; Kuhlbrodt et al., 1998b; Pingault et al., 1998a; Southard-Smith et al., 1999). Phenotypes 
important in defining a particular syndrome are ticked, distinctive missing phenotypes are crossed out. Abbreviations: WS1-4, Waardenburg 
Syndrome 1-4; HSCR, Hirschsprung Disease; CDHS, Craniofacial-Deafness-Hand Syndrome; EDN3, Endothelin 3; EDNRB, Endothelin 
receptor B; GDNF, Glia derived neurothrophic factor; aut. dom./recess., autosomal dominant/recessive; mi, microthalmia; Is, lethal spotting; 
s', piebald lethal; Dom, Dominant megacolon, W, dominant white spotting, occ., occasional; n/k, not known; M, male; F, female.
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on the site of lesion. The most severe phenotypes are observed from some missense 
substitutions within the conserved tyrosine kinase domain. The resulting mutant protein 
acts dominant negatively and thus upon dimerisation, heterozygotes have only 25% of 
the normal amount of functional KIT receptor dimers. In contrast, loss of function 
mutations caused by premature truncations of the protein in the N-terminal ligand 
binding domain result in only a 50% reduction of functional receptors and hence milder 
phenotypes due to haploinsufficiency (reviewed in Spritz, 1998).
Several animal models for piebaldism are known. Heterozygous dominant white 
spotting (W) and Steel (SI) mutant mice display piebald-like phenotypes (Spritz, 1998). 
The W locus encodes the mouse homologue of the c-Kit tyrosine kinase receptor, 
whereas the Steel locus was identified as the c-Kit ligand, Steel factor (SLF). 
Furthermore, the zebrafish locus sparse (spa) encodes a c-kit homologue (Parichy et al., 
1999).
All 3 animal models show depigmented areas reminiscent of the human phenotype. In 
addition, heterozygous W-mutant mice may also show hypoplastic anemia, mast cell 
deficiency and sterility (Spritz, 1998; Spritz and Ortonne, 1998) not yet observed in any 
patients or in the zebrafish mutant spa. Thus, mutations in c-Kit in mouse affect the 
development of melanocytes, hematopoietic precursors and primordial germ cells. 
Occasionally, W mutant mice can show abnormalities in the enteric plexus, known as 
Hirschsprung disease, which has also been described once in a human patient 
(Mahakrishnan and Srinivasan, 1980). Only one patient with a homozygous mutation in 
KIT has been reported. The child had no hair and skin pigmentation, blue irides, 
deafness, hypotonia, severe brachycephaly and was generally developmentally retarded 
(Hulten et al., 1987). This phenotype was reminiscent of viable homozygous Wv/W v 
mutant mice (Spritz, 1998).
By studying the zebrafish mutant allele spab5, a requirement of c-kit for melanophore 
migration and survival was demonstrated and confirmed previous studies in the mouse 
mutants (Parichy et al., 1999). spcf5 is likely a functional null allele, since it lacks the 
tyrosine kinase domain. In spab5 mutants, a greater proportion of melanophores were 
observed closer to their sites of origin compared to wild-types indicating a role for c-kit 
in the migration of this cell-type. By TUNEL staining it was demonstrated that from day 
4 melanophores within the epidermis apoptosed in spab5 mutants providing evidence for 
a role in survival and maintenance of the melanophore lineage. In contrast to mouse, it 
was shown that spa was not essential for melanoblast differentiation since numerous
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melanoblasts were formed from the neural crest in homozygous spab5 mutants. Also, in 
contrast to mouse but not humans, no overt defects in primordial germ cells or 
hematopoietic precursors were observed in zebrafish (Parichy et al., 1999). These 
differences between mammalian and zebrafish c-Kit function might point to a partial 
functional redundancy with an additional Kit-like receptor (Parichy et al., 1999), which 
could have been maintained after the additional genome duplication event in teleosts 
(Postlethwait et al., 1998; Force et al., 1999).
The fam ily o f  Waardenburg Syndromes
The classical Waardenburg syndrome (WS) was first described by Waardenburg, a 
Dutch ophthalmologist in 1951 (Waardenburg, 1951). It is defined as an autosomal 
dominant disorder with piebald-like pigmentation abnormalities of skin and hair in 
combination with pigment abnormalities of the iris (heterochromia irides), lateral 
displacement of the inner canthi of the eyes, which causes a broadening of the base of 
the nose (dystopia canthorum) and absence or reduction of melanocytes in the cochlea 
(sensorineural deafness) (Spritz and Ortonne, 1998). Occasionally, patients also exhibit 
Hirschsprung disease, in which intrinsic ganglion cells of the myenteric (Auerbach) and 
submucosal (Meissner) plexi of the gastrointestinal tract are absent along a variable 
length of the gut. This aganglionosis causes blockage of affected regions and results in 
the formation of an enlarged region proximally, known as megacolon. This phenotype 
was named after Harald Hirschsprung, a Danish physician, who first noted a megacolon 
in newborn babies (Hirschsprung, 1888).
WS has since been subdivided into 4 subtypes, WS1-WS4, on the basis of the 
combination of these phenotypes and will be described individually.
Waardenburg Syndrome type I  (WS1), Waardenburg Syndrome type III (WS3), 
Craniofacial-Deafness-Hand Syndrome (CDHS) and their mouse model 
Splotch (Sp)
WS1 represents the classical WS as described above. It is a rare (1:20 000 - 1:40 000) 
disorder and is inherited in an autosomal dominant manner with equal frequencies in 
males and females (Spritz and Ortonne, 1998).
The phenotype of WS3, also called Klein-Waardenburg Syndrome, is identical to WS1, 
but is associated with additional musculoskeletal abnormalities of the face, limbs and 
upper torso (Spritz and Ortonne, 1998).
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CDHS again bears strong similarities with WS1, but exhibits much more severe 
craniofacial abnormalities and anomalies of the hands (Asher et al., 1996).
Like WS1, both WS3 and CDHS are inherited in an autosomal dominant fashion with 
the same equal male and female frequencies as observed in WS1.
To date, all cases of WS1 are associated with lesions in PAX3, a gene encoding a 
paired-box domain transcription factor which additionally contains a homeobox DNA 
binding domain (Tassabehji et al., 1992). Surprisingly, it was shown that WS1, WS3 
and CDHS are allelic and thus all 3 disorders are associated with mutations in PAX3 
(Hoth et al., 1993; Asher et al., 1996). Lesions have been identified in all 4 structural 
domains, the two DNA binding domains paired-box and homeobox domain, in the 
octapeptide and in the serine-threonine-proline-rich segment. Presumably, the loss of 
distinct regions of PAX3 prevents certain interactions with other transcription factors 
important in the protein’s many roles in development. A correlation between different 
lesions and distinguishable phenotypes such as WS1, WS3 or CDHS could not yet be 
established. However, the majority of mutations in the PAX3 gene result in WS1.
The Splotch (Sp) mouse mutants caused by lesions in Pax3 are reminiscent of 
WS1 patients (Spritz, 1998). Heterozygotes of these semidominant mutations in Pax3 
exhibit white spotting in the most distal region such as the tip of the tail, and/or 
abdomen and feet. Homozygotes have severe neural tube defects (spina bifida and 
overgrowth of neural tissue) and developmental abnormalities in several neural crest 
derived structures such as total lack of body pigmentation and abnormalities in spinal 
ganglia, DRG, sympathetic and enteric ganglia (Auerbach, 1954; Lang et al., 2000). 
Sp/Sp mutant mice die in utero on E l3 (Russell, 1947). Only one child with apparently 
homozygous WS1 has been reported. Its symptoms were more severe than the 
heterozygous phenotype including dysmorphic facial features, almost completely white 
hair and extensive loss of skin pigmentation (Zlotogora et al., 1995).
Pax3 was shown to be expressed early in the embryonic primitive streak, differentiating 
dorsal neuroepithelium, neural crest derived structures and regions of the adult brain 
(Goulding et al., 1991; Goulding et al., 1993). Recently, Pax3 was proposed to be 
required early during neural crest development to expand a pool of fate-restricted 
progenitor neural crest cells such as melanoblasts, but not for their migration (Homyak 
et al., 2001). Thus, even in homozygous Sp/Sp mutants, melanocytes and other neural 
crest derived neural tissues were observed in characteristic locations, but in fewer
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numbers. The phenotype of WS1, WS3 and CDHS patients is also consistent with an 
early role for PAX3 affecting the proliferation of several neural crest derivatives.
Waardenburg Syndrome type II  (WS2)
Waardenburg Syndrome type II is an autosomal dominant disorder that affects 
approximately 1:20 000 -  1:40 000 newborns with equal frequencies in males and 
females. Clinically, the disease is vaguely defined with patients presenting a similar 
phenotype to WS1, but lack dystopia canthorum (reviewed in Spritz, 1998). 
Pigmentation defects in skin, hair and eyes tend to be less severe than in WS1 and 
hearing loss due to a lack of melanocytes in the cochlea is not always present 
(Tassabehji et al., 1994).
At least in some individuals with WS2, a mutation in MITF, a basic helix-loop- 
helix-leucine zipper protein, has been identified. Studies on mutant mouse 
{microphthalmia) and zebrafish {nacre) MITF homologues have been crucial in 
elucidating possible biological mechanisms underlying WS2.
Heterozygous microphthalmia {mi) mice show white spotting on the belly, head and tail 
and reduced pigmentation in the iris. Homozygotes on the other hand have small 
unpigmented eyes, lack all melanocytes in the skin and in the inner ear, rendering them 
deaf. Some strong mi alleles additionally have a deficiency in retinal pigment cells, in 
mast cells and deficiency in secondary bone resorption (osteopetrosis) (Steingrimsson et 
al., 1994). The original mi allele derived from an irradiated male shows semidominance 
and a strong phenotype (Hodgkinson et al., 1993). Other alleles such as eyeless-white 
(mf™) and cloudy-eyed {mfe) are recessive and spotted {misp) has a normal appearance 
(Steingrimsson et al., 1994).
Mi, typically for basic helix-loop-helix-leucine zipper proteins, binds DNA through the 
basic domain and forms homo-and heterodimers utilising the helix-loop-helix and the 
leucine zipper domain (reviewed in Kadesch, 1993). This mode of action also helps to 
explain the differences reported for the various alleles, whereby a mutation severely 
affecting the protein’s function, but retaining its ability to dimerise causes a dominant or 
semidominant appearance due to dominant negative action. A recessive allele is 
predicted to encode a loss of function allele, e.g. a prematurely truncated protein or one 
with a non-fimctional dimerisation domain (Steingrimsson et al., 1994).
Surprisingly, the human alleles in family WS.026 and WS.002 show dominance 
although the mutations affect splice sites in the first few exon boundaries and very
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severely truncate the protein. Surely, this protein then should act as a null allele and thus 
be recessive as observed in various mouse mi alleles (Tassabehji et al., 1994). Two 
possible explanations have been proposed. The MITF gene dosage might be more 
critical in humans than in mouse (haploinsufficiency) or perhaps the altered splice site 
could lead to exon skipping and thus to a protein that can still dimerise and act in a 
dominant negative manner (Tassabehji et al., 1994).
During mouse development, m itf is expressed in presumptive melanoblasts contributing 
later to skin pigmentation and melanocytes in the stria vascularis of the inner ear. 
Furthermore, expression was observed in the embryonic heart and there was weak 
staining in the outer retinal layer of the eye. In adults, m itf was highly expressed in the 
heart and at lower levels in skeletal muscle (Hodgkinson et al., 1993). Mitf acts cell 
autonomously, consistent with coding for a transcription factor. It was shown to be 
required for committed melanoblast survival in premigratory neural crest cells perhaps 
by inducing a set of trophic genes (Homyak et al., 2001). Later during melanocyte 
differentiation Mitf is thought to activate and regulate pigmentation gene expression by 
binding to M-box elements in the promoter of target genes. Such M-box elements were 
found in at least 3 enzymes involved in pigmentation, tyrosinase, tyrosinase-related 
protein 1 and 2, and in in vitro studies, Mitf was able to transcriptionally activate a 
reporter gene driven by an M-box element in conjunction with a TATA box of a 
pigmentation gene promoter (Hemesath et al., 1994).
Fairly recently, the zebrafish orthologue of mzT/'has been cloned, nacre (nac), 
and was shown to be highly important in melanophore development (Lister et al., 1999). 
Homozygous nacw2 fish lack neural crest derived melanophores throughout embryonic 
development. In adults, the pigmentation of the retinal epithelium is normal, but the 
number of xanthophores is slightly reduced and the number of iridophores is increased 
by approximately 40% at day 3. It was shown that nacre functioned early within the 
pigment lineage since early melanoblast markers such as tyrosinase-related protein 2 
(itrp2), now called dopachrome tautomerase (dct; Kelsh et al., 2000c), and spa were 
almost or entirely absent from neural crest cells. Wild-type neural crest cells 
transplanted into nacw2 hosts differentiated into melanophores with wild-type 
morphology indicating cell-autonomy for nacre within this lineage consistent with 
mouse mi. No overt defects in any other neural crest derivatives such as neurons and 
glia of the peripheral nervous system and craniofacial structures were detected. 
Interestingly, it was demonstrated that nacre was able to induce ectopic pigment cells of
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abnormal morphology when misexpressed. This pigmentation was observed 5 hours , 
earlier than in wild-types and in cells of non-crest origin since expression of dct in those 
cells was apparent before the onset of neural crest cell migration. These findings support 
a role for nacre as a melanogenic factor activating the differentiation program possibly 
in cooperation with additional transcription factors (Lister et al., 1999).
The lack of the retinal phenotype in zebrafish observed in humans and mice could be 
explained by the identification of a second mzY/’homologue. Mitfb was shown to act 
redundantly with Mitfa (Nacre) in the retinal pigment epithelium (RPE; Lister et al., 
2001). Mitfb can also explain the recessive phenotype in nacre embryos, since it was 
able to induce ectopic melanophores in nacre embryos.
In summary, both mouse and fish m itf mutants model the human phenotype of 
WS2 very well. During development, Mitf appears to have an early role in melanoblast 
survival and later in differentiating melanocytes by regulating the transcription of 
pigmentation genes such as tyrosinase. MITF itself was shown to be directly regulated 
by PAX3, which would explain the similar phenotypes of WS2 and WS1/WS3. It thus 
suggests that the defects observed in at least some WS1 patients might partially result 
from the inability of PAX3 to regulate MITF (Watanabe et al., 1998).
Recessive Waardenburg Syndrome type 4 (WS4)
Waardenburg syndrome type 4, also known as Waardenburg-Shah Syndrome, combines 
certain phenotypes exhibited in WS3 with Hirschsprung disease, although there is no 
deafness and sometimes the extent of hypopigmentation is more extreme (Gross et al.,
1995). Shah and his colleagues reported studies on 12 babies all of whom had white 
forelocks, eyebrows and eyelashes and intestinal obstruction. At least 8 exhibited 
normal pigmentation of the eyes and at least 6 of them lacked dystopia canthorum or 
white skin patches. None of them had detectable deafness, all of them died 3-38 days 
after birth and the locus seemed inherited in an autosomal recessive manner (Shah et al., 
1981). Lesions in the human endothelin-3 (EDN3) gene have now been discovered in 
patients suffering from the recessively inherited WS4 (Edery et al., 1996; Hofstra et al.,
1996). EDN3 is a 21 amino acid peptide that binds to the endothelin receptor B 
(EDNRB).
The natural mouse mutation, lethal spotting (Is), was mapped to the Edn3 locus 
and serves as a useful animal model for WS4. The Is phenotype is caused by a point
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mutation that prevents the conversion of preproendothelin-3 to its functional form 
(Baynash et al., 1994).
Furthermore, targeted disruption of the endothelin-3 (Edn3) gene in mice also gave rise 
to recessively inherited spotted coat colour and Hirschsprung disease reminiscent of the 
human WS4 phenotype. Homozygous edn3/edn3 mutant mice have black eyes and dark 
coat patches on their head and hips, but 70-80% of their coats lack melanocytes. Their 
ileum and cecum is largely distended, the entire colon is aganglionic and only 
approximately 15% of homozygous mice survive to adulthood.
Studies indicated that EDN3 promoted survival and differentiation of melanoblasts in 
neural tube cultures (Lahav et al., 1996).
Transgenic experiments were employed to enlighten the aganglionic phenotype in mice. 
To label enteric neuroblasts, the dopamine-beta-hydroxylase (DBH) promoter was used 
to drive lacZ expression in this cell-type, but enteric neuroblasts were never observed in 
the distal colon of Is/Is embryos (Kapur et al., 1992; Kapur et al., 1993). Retarded 
colonisation was first evident at the junction of the small and large intestine. This 
suggests a pancolonic defect in Is/Is mice and thus an important role for Edn3 to ensure 
complete colonisation of the gut (Kapur et al., 1993).
Dominant Waardenburg Syndrome type 4/Hirschsprung Disease
This autosomal dominant form of WS4 affects approximately 1:40 000 newborns with 
approximately 4 times higher frequencies in males than in females. WS4 patients 
present with pigmentation anomalies of skin and hair and sensorineural deafness, 
similar to WS1. In addition WS4 patients suffer from aganglionic megacolon, but 
usually lack dystopia canthorum and musculoskeletal malformations (Pingault et al., 
1998a; Southard-Smith et al., 1999).
The mouse mutant dominant megacolon, Dom, arose spontaneously in the 
Mouse Mutant Stock Centre of the Jackson Laboratory, Bar Harbor, ME (Lane and Liu, 
1984). It is a particularly interesting model for WS4 as it mimics well the variable 
penetrance and expressivity of the megacolon phenotype in affected patients (Southard- 
Smith et al., 1999). The heterozygous Dom/+ phenotype, similar to homozygous lesions 
in Edn3 (Is/Is mice) and Ednrb (sl/sl mice), has been described as white belly spot, white 
feet and deficiencies of myenteric ganglion cells. By embryonic day 5 (E5) 
pigmentation anomalies become apparent and by E10 heterozygous mice appear 
malnourished whereas their abdomens look distended due to underlying megacolon
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(Lane and Liu, 1984). Hearing loss in mice is difficult to assess, but circling and 
hyperactivity was observed (Pingault et al., 1998a). This behaviour is known as 
waltzing syndrome and suggestive of inner ear defects (Deol et al., 1986). The life span 
of Dom/+ mice usually ranges from 2 days to 12 months depending on the genetic 
background. Homozygous Dom/Dom mice generally exhibit a more severe phenotype 
and die in utero around E l3 (Lane and Liu, 1984).
Dom was mapped to chromosome 15 (Lane and Liu, 1984) between microsatellite 
markers D15Mit68 and D15Mit2 (Pingault et al., 1997) and found to encode SoxlO, an 
HMG domain type transcription factor (Herbarth et al., 1998; Southard-Smith et al.,
1998). In mice, SoxlO expression is first detected at E8.5 (Southard-Smith et al., 1999), 
is found in newly forming cranial and trunk neural crest cells in wild-type and 
SoxlODom/Dom mice by E9.5 and in melanoblasts on the lateral pathway and all cranial, 
dorsal root, sympathetic and enteric ganglia later in embryonic development. From E9.5 
to El 2.5, SoxlO expression is observed in the epithelium of the otic vesicle, later in the 
developing cochlea and vestibule and in the organ of Corti in adult mice. SoxlO 
expression levels generally decrease over time and by E l3.5 migrating melanoblasts are 
Soxl  ^ -negative including those migrating into the stria vascularis of the inner ear 
(Watanabe et al., 2000).
In homozygous SoxlODom/Dom mice SoxlO levels are drastically reduced in cranial 
ganglia and nerves at E l0.5 and all SoxlO expression is lost by El 1.5 apart from in the 
most caudal neural crest. Thus, in contrast to wild-types, no Soxl 0-positive cells can be 
detected in homozygote gut sections at E14.5 (Herbarth et al., 1998; Southard-Smith et 
al., 1998). Heterozygous SoxlO1Dom/+ mice exhibit the same expression patterns as wild- 
types, but levels are overall reduced. Enteric neuron number is decreased and 
colonisation is somewhat retarded from El 1.0 over the entire length of the gut, not just 
in the large intestine as described for Is/Is and sl/sl mice. Even so, growth and rotation of 
the intestine proceeds normally (Kapur et al., 1996). In one study, 14 out of 22 
SoxlODom,+ mice had extensive aganglionosis at E l4 varying between being localised 
only in the distal part of the rectum and as proximal as the ileocaecal junction (Puliti et 
al., 1996). In Northern blot hybridisations SoxlO transcripts were detected in heart, 
brain, lung, skeletal muscle and testes in adult mice (Southard-Smith et al., 1999).
After SoxlO was shown to cause the Dom phenotype, heterozygous lesions were also 
detected in the human SOX10 homologue in previously unidentified WS4 patients 
(Pingault et al., 1998a; Southard-Smith et al., 1999). Like in mice, patients also show a
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variable phenotype even within a family, which has been hypothesised to be due to 
modifier loci. Mice show a fully penetrant phenotype on a mixed C3HHeB:FeJLe- 
axC57BL/6JLeB6 (C3xB6) background, whereas lethality is higher (70% versus 18%) 
and head spotting is lower (3% versus 50%) on a B6 background compared to a C3 
background (Southard-Smith et al., 1999). Similarly, all SoxlODoml+ mice completely 
lack enteric ganglion cells in the distal large intestine on a B6 background in 
comparison to only one third on C3 (Kapur et al., 1996). One such locus modifying the 
pigmentation and loss of hearing phenotype in humans has been mapped to 
chromosome 21 (Puffenberger et al., 1994a). A similar modifier locus has been found 
on mouse chromosome 10, which segregates with the mast cell growth factor (MGF), a 
c-Kit ligand, and thus makes a good candidate gene (Southard-Smith et al., 1999).
In human embryos, SOX10 is expressed in the neural crest at 4 weeks, in all 
cranial ganglia, DRG, cranial and spinal nerves, the otic vesicle and in the entire 
sympathetic and parasympathetic ganglion chain by 5-6 weeks. At 6 weeks of age, also 
enteric ganglia, cranial foregut, oesophagus, stomach and lungs, but not yet the CNS are 
SOX10-positive. Later on, at 17-25 weeks, SOXIO is mostly observed in several parts of 
the brain, in lung and kidneys (Bondurand et al., 1998a). In adults, transcripts were 
detected in Northern Blot hybridisations in the heart, brain, colon, small intestine, lung, 
skeletal muscle, testes, ovary, pancreas, bladder, prostate, stomach, spinal cord, trachea 
and adrenal gland (Bondurand et al., 1998a; Southard-Smith et al., 1999). These high 
transcript levels in brain and spinal cord in humans is consistent with SoxlO expression 
observed in rodent glial cells (Kuhlbrodt et al., 1998a). Also, like in mice, expression 
seen in the entire intestinal tract, stomach, small intestine and colon corresponds to the 
developing enteric nervous system (Southard-Smith et al., 1999).
Mouse and human expression patterns are very similar albeit not identical. Only humans 
show expression in the cephalic neural crest giving rise to cartilaginous structures in 
nasal bones, in the fetal and adult cerebral cortex, in major brain nuclei, heart, prostate 
and testis (Bondurand et al., 1998a).
Inoue and colleagues recently identified a novel SOXIO mutant allele in a patient with 
myelination deficiencies in the CNS and PNS in addition to hypopigmentation, long- 
segment HSCR, heterochromic irides, deafness, dystopia canthorum and nystagmus 
(Inoue et al., 1999). This finding was quite surprising since long-segment HSCR and 
facial malformations are usually associated with mutations in RET and PAX3, 
respectively. Also, such myelination defects have not yet been reported for SoxlO in any
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model organism (Inoue et al., 1999). They can be accredited to a role for SoxlO in 
myelin development and maintenance though since SoxlO is expressed in Schwann cells 
and oligodendrocytes known to produce myelin. SoxlO also interacts with myelin- 
related transcription factors such as Oct6, Pax3 and EGR2 (Kuhlbrodt et al., 1998a). 
Furthermore, a child diagnosed with Yemenite Deaf-Blind Syndrome was found to 
exhibit a heterozygous SOXIO mutation. The girl presented patches of hypo-and 
hyperpigmentation on trunk and extremities, grey hair, white eyebrows and eyelashes, 
severe hearing loss, nystagmus and dental abnormalities, but no dystopia canthorum or 
HSCR (Bondurand et al., 1999).
Several roles for SoxlO during neural crest development have been suggested 
such as involvement in survival, migration and differentiation. Recent studies have 
demonstrated synergistic activation of several target genes by SoxlO with partner 
factors. For example, Pax3 and SoxlO bind to enhancer elements in the cRet (Lang et 
al., 2000) and in the M itf promoter (Bondurand et al., 2000; Potterf et al., 2000) and 
SoxlO also interacts synergistically with Tst-l/Oct6/SCIP (Kuhlbrodt et al., 1998a). 
However, further studies will be required to fully elucidate SoxlO’s complex 
involvement during neural crest development.
Hirschsprung Disease/Waardenburg Syndrome (HSCR2)
Puffenberger and his colleagues studied a large Mennonite pedigree in which 6.3% of 
affected individuals had bicoloured irides, 2.5% were hypopigmented, 5.1% showed 
hearing loss and 7.6% had a white forelock additional to the HSCR phenotype. This 
autosomal recessive disease was named Hirschsprung Disease/Waardenburg Syndrome 
or Hirschsprung disease type 2 (HSCR2) and mapped to chromosome 13q22, as did 
endothelin receptor B (EDNRB) encoding a G protein-coupled receptor (Puffenberger et 
al., 1994a; Puffenberger et al., 1994b).
HSCR2 is distinguished from WS4 by the presence of bicoloured irides. However, in 
contrast to WS1 and WS3, dystopia canthorum is absent in both WS4 and HSCR2. It 
was estimated that approximately 95% of HSCR2 caused by mutations in EDNRB 
resulted in short-segment aganglionosis (Chakravarti, 1996).
Its mouse model, the piebald-lethal (sl) mouse, also exhibits a white colour coat 
in addition to megacolon (Hosoda et al., 1994). The hypomorphic allele piebald (s) only 
shows 20% white coat spotting and almost never enteric aganglionosis even in 
homozygous s/s mutants. Heterozygous sl mice appear to be normal, whereas in the
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homozygous state, over 90% of the coat pigmentation is lost apart from very small dark 
asymmetrical regions on the head and hips, eyes are black and pups never survive to 
adulthood. Abnormalities in the inner ear were also described (Hosoda et al., 1994). The 
intestinal region distal to the sigmoid colon usually lacks myenteric ganglion neurons 
causing distension and sometimes even perforations in more proximal regions. The 
melanoblast marker trp-2 (dct) is lost by E l0.5 in Ednrb/Ednrb mice, whereas it is still 
present in W and Sl mutant mice at El 1 indicating that EDNRB may function upstream 
of c-kit and Steel factor in melanoblast development (Hosoda et al., 1994). Gariepy and 
colleagues (1998) were able to show that EDNRB was needed in the enterics lineage 
after the latter had segregated from the melanocyte precursors. With transgenic sl/sl rats 
containing the Ednrb gene under the control of a human dopamine-beta-hydroxylase 
(DBH) promoter, which directs Ednrb expression to the enteric nervous system 
precursors, the megacolon phenotype was rescued, but not the coat pigmentation defect. 
Kapur demonstrated in sl/sl <-> wild-type aggregation chimeras that EDNRB although 
being a receptor had a non-cell autonomous effect on melanoblasts and neuroblasts 
indicating that inter-cellular signals downstream of EDNRB influence colonisation. 
Hence, wild-type neuroblasts were able to rescue migration of sl mutant neural crest 
cells in some chimeric embryos (Kapur et al., 1995).
Shin and his colleagues could further show a temporal requirement of EDNRB between 
E10 and El 2.5 for the migration of both melanoblasts and enteric neuroblasts (Shin et 
al., 1999).
Although the severity of defects in Ednrb and Edn3 mutant mice are similar as 
one might expect since they act as receptor and its ligand during development it is 
interesting to note that the Edn3 phenotype appears to be milder. This could be 
explained by slight redundancy with closely related endothelins, Ednl and Edn2, which 
are known to be able to bind to EDNRB albeit with lower affinity (Hosoda et al., 1994).
Lethal white foal syndrome (LWFS) also represents a homologous congenital 
disorder to HSCR2 in horses. In its homozygous state it is characterised by white coat 
colour and aganglionosis of the bowel. Heterozygotes exhibit a specific coat colour 
pattern known as overo, but no intestinal defects. The location of the mutant lesion was 
placed in the EDNRB gene (Yang et al., 1998).
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Dominant Hirschsprung Disease without pigmentation defects
An autosomal dominantly inherited form of Hirschsprung disease was found to be 
caused by mutant lesions in the proto-oncogene RET (REarranged during Transfection; 
Edery, Lyonnet et al. 1994; Romeo, Ronchetto et al. 1994). Apart from Hirschsprung 
disease, RET, a receptor tyrosine kinase, has previously been implicated in multiple 
endocrine neoplasia type 2A and B (MEN2A, B) and medullary thyroid carcinoma, but 
never in pigmentation anomalies (Spritz, 1998). It was estimated that mutations in RET 
account for approximately 50% of HSCR cases, of which 75% involve long-segment 
aganglionosis (Chakravarti, 1996). The latter is defined by the extent of the 
aganglionotic tract reaching proximal to the splenic flexure (Romeo et al., 1994).
In zebrafish, the orthologue of c-ret is expressed in spinal motoneurons, 
pronephric ducts, cranial ganglia, pharyngeal arches and the enteric nervous system 
(Bisgrove et al., 1997).
During mouse development, c-ret is expressed in sensory, autonomic and enteric 
ganglia, the Wolffian duct and in the ureteric bud epithelium. Mice with a targeted 
homozygous mutation in c-ret exhibit defects in kidney development, total 
aganglionosis posterior to the proximal stomach, lack the superior cervical ganglia 
(SCG) and die soon after birth (Romeo et al., 1994; Schuchardt et al., 1994). In contrast 
to humans, c-ret in mice behaves in an autosomal recessive manner.
Homozygous targeted mutations in one of c-Ref s ligands, Glial cell-line derived 
neurotrophic factor (GDNF), results in a very similar and equally severe phenotype 
(Schuchardt et al., 1994). It was demonstrated in vitro that RET signalling via GDNF is 
necessary and sufficient (together with the GPI-linked co-receptors) for development of 
cultured neuronal cells, whereby GDNF promotes survival, proliferation and 
differentiation of c-ret positive enteric neural crest cells during E12.5-E13.5. This is 
consistent with increased programmed cell death observed by TUNEL staining in 
enteric neural crest cells in homozygous c-ret mutant mice (Taraviras et al., 1999). 
Mutations in Pcdc3, Sox 10 and c-ret can result in an aganglionic phenotype. Consistent 
with this, results indicated that Pax3 and Sox 10 together might be required to activate a 
c-ret enhancer element (Lang et al., 2000). Thus, the failure of dysfunctional SoxlO or 
Pax3 to activate c-ret expression sufficiently might account for the enteric phenotype 
observed in these mutants.
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Sox10 as a candidate gene for the colourless mutation
As described in the previous section, there are numerous neurocristopathies reported in 
mice and humans affecting pigmentation in combination with defects in other neural 
crest derivatives (Table 1.1). Most of those loci present with similar combinations of 
phenotypes to els embryos, but can be excluded as candidate genes for els after more 
careful analysis of their defects.
The extent and severity of aganglionosis in els embryos is most reminiscent of c- 
ret mutations in mice. Like els, c-ret behaves in an autosomal recessive manner and 
homozygous mice exhibit total aganglionosis posterior to the proximal stomach (Romeo 
et al., 1994; Schuchardt et al., 1994). In humans, RET mutations are dominant, but still 
present long-segment aganglionosis in 75% of all cases (Chakravarti, 1996). However, 
neither in mice nor humans pigmentation anomalies are associated with the c-ret/RET 
locus and this makes RET an unlikely candidate for els.
The PAX3 locus associated with WS1, WS3 and CDHS can be excluded for 
similar reasons. All three human disorders involve craniofacial defects like dystopia 
canthorum (reviewed in Spritz, 1998), whereas ectomesenchymal derivatives are 
unaffected in els embryos. Furthermore, megacolon associated with aganglionosis is 
only very rarely observed in patients with PAX3 mutations and is not present in the one 
patient reported with homozygous WS1 (Zlotogora et al., 1995) or homozygous splotch 
mice (Russell, 1947; Auerbach, 1954).
Likewise, mutations in KIT and MITF mostly cause pigmentation defects and 
again, megacolon is only very rarely observed (Mahakrishnan and Srinivasan, 1980). 
Although the phenotype of homozygous mice and humans is aggravated, there are no 
reports of aganglionosis.
Mutations in EDN3 and EDNRB are both recessively inherited in mice and men 
and combine defects in pigmentation and enteric nervous system. The homozygous 
enteric ganglion phenotype appears to be milder compared to homozygous els embryos, 
since even s/s and Is/Is mutant mice only lack enteric ganglia in the posterior gut (Kapur 
et al., 1992; Kapur et al., 1993; Hosoda et al., 1994). However, this could be caused by 
the genetic background or species specific differences.
els embryos exhibit a grossly abnormal ear morphology (Kelsh et al., 1996; Malicki et 
al., 1996; Whitfield et al., 1996). However, deafness has not been reported in WS4
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patients with lesions in EDN3 and only in 5.1% of HSCR2 patients suffering from 
lesions in EDNRB (Puffenberger et al., 1994a).
Furthermore, Ednrb/Ednrb mouse mutants lack the extensive defects in the peripheral 
nervous system such as cranial ganglia and DRG observed in els embryos (Southard- 
Smith et al., 1998).
The pigmentation defect in els embryos is caused by a severely reduced number 
of melanoblasts. Similarly, in homozygous Sox 10Dom/Dom mice melanoblasts are absent 
from El 0.5 (Southard-Smith et al., 1998). The extent and severity of the enteric ganglia 
phenotype of els mutants is strongly reminiscent of homozygous Sox 10Dom/Dom mice.
The latter exhibit extensive aganglionosis over the entire length of the gut by E l 4.5 
(Southard-Smith et al., 1998). Furthermore, Soxl(Pom/Dom mice and els embryos have 
extensive peripheral nervous system defects outside the enteric lineage, for example in 
cranial ganglia and DRG (Herbarth et al., 1998; Southard-Smith et al., 1998). 
els embryos exhibit inner ear defects, since only a single sensory patch and 2 small 
otoliths are formed (Whitfield et al., 1996). In mice, Sox 10 is expressed in the 
developing ear and although hearing loss has not yet been conclusively demonstrated, 
circling and hyperactivity has been observed in Soxl(Potn heterozygotes suggesting inner 
ear defects (Pingault et al., 1998b). Lastly, ectomesenchymal neural crest derivatives 
contributing to the craniofacial skeleton for example are unaffected in both els and 
SoxlODom mutants.
In summary, of all the known pigmentation loci, homozygous els embryos 
appear to be most reminiscent of homozygous Soxl(Pom/Dom mouse mutants and thus, 
Sox 10 was chosen as the most promising candidate gene for the zebrafish colourless 
mutation.
The Sox gene family of transcription factors and their role in 
development
There are a number of different groups of DNA binding proteins, each of which are 
characterised by their DNA binding domain. The latter consists of conserved structural 
motifs such as the basic helix-loop-helix motif, leucine zippers or zinc fingers. In 1990, 
Tjian and his coworkers (Jantzen et al., 1990) discovered a novel DNA binding domain 
in the gene for the RNA polymerase I transcription factor UBF. This region is repeated 
six times in UBF and each of them shows high homology to two domains of High
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Mobility Group 1 (HMG1) proteins, which gave this new binding domain its name. 
Genes that were found to contain such an HMG domain were classified as members of 
the HMG box superfamily. Since Tjian and his colleagues first recognised the HMG 
box as a binding domain, many more members have been isolated from organisms as 
diverse as mammals, insects, plants and fungi. This indicates that a putative ancestral 
gene giving rise to the HMG box superfamily predates the separation of animal and 
fungal kingdoms at least 1000 million years ago (Laudet et al., 1993).
Separation of HMG box proteins into two major subfamilies based 
on the properties of their DNA binding domain
Several groups have attempted to partition this superfamily into smaller subfamilies by 
comparing the identity of the most conserved HMG domain between members. On 
average, the HMG domains are comprised of 80 amino acids and show approximately 
25% sequence identity between different homologues. There are only 3 residues 
conserved in >80% of all members, P at position 8, W at position 45 and K at position 
53 of the alignment published by (Laudet et al., 1993). Based on this sequence 
alignment an unrooted phylogenetic Fitch tree was calculated dividing the HMG box 
superfamily into two distinct subfamilies, the HMG/UBF and the TCF/SOX subfamily.
Members of the HMG/UBF subfamily such as HMG-1, UBF-1, ABF2, 
TETHMG and CCG1 contain two or more HMG domains (Laudet et al., 1993) and 
references therein). HMG-1 like proteins are ubiquitously present in all eukaryotes and 
roles have been suggested in DNA replication and nucleosome assembly. They bind 
DNA in a manner that is independent of sequence, but instead recognise certain DNA 
structures in vitro like four-way junction DNA and (CA)n repeats forming the latter 
(Ferrari et al., 1992; Peters et al., 1995). Such four-way junction DNA structures can be 
generated in vivo by recombination events and by intrastrand base pairing of inverted 
repeats (Bianchi et al., 1989).
The TCF/SOX subfamily includes transcription factors like TCF-1, LEF-1, 
MATA1 and SRY-like Sox genes (Laudet et al., 1993 and references therein). 
Interestingly, with their single HMG domains they recognise both particular DNA 
structures like four-way junctions and also specific heptameric consensus sequences on 
target genes based on the motif 5’ (A/T A/T C A A A/T G) 3’ (Harley et al., 1994). The 
human SRY binding domain was reported to exhibit a greater affinity for junction DNA
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in vitro than for the specific DNA binding site. The interaction between SRY and DNA 
which is already distorted, closely mimics the final structure that is formed after specific 
binding and conformational bending of the DNA, but is much less costly energetically. 
However, once bound to the consensus motif, the interaction between DNA and protein 
is much stronger. Ferrari and her coworkers proposed a model to explain how this 
subfamily of HMG domain proteins were still able to act through sequence specificity 
even though binding to kinked unspecific DNA is favoured. They suggested that the 
concentration of HMG 1-like proteins recognising distorted DNA with great affinity was 
much higher than of transcription factors like SRY and so would bind with higher 
probability. Statistically, SRY would get displaced from these sites and restricted to its 
DNA specific, undistorted binding sites, which HMG 1-like proteins were unable to bind 
(Ferrari et al., 1992).
The 3 dimensional structure of the HMG domain with and without being bound to 
consensus target DNA was solved with the use of NMR by 2 separate groups (van 
Houte et al., 1995; Werner et al., 1995). Irrespective of the presence of DNA the domain 
forms three a-helices, with helix I antiparallel to helix II forming the long arm of a 
twisted L-shape, and with helix III forming the short arm. A hydrophobic core supports 
this concave structure.
In the TCF/SOX subfamily this L-shape recognises the heptameric consensus 
motif as described above and binds to the minor groove of target DNA. This is an 
unusual mode of action as most other transcription factors bind to the major groove of 
DNA. As a result, a bend of up to 130° is induced in the target DNA which slightly 
unwinds the helix and thus functions to organise the local chromatin structure (Pevny 
and LovellBadge, 1997). Furthermore, close proximity to other transcription factors that 
bind to the major groove becomes physically possible and facilitates the formation of 
transcriptionally active multiprotein complexes (Wolffe, 1994; Wemer and Burley,
1997). Because of their ability to bend DNA, members of this gene family have also 
been known as architectural transcription factors (Grosschedl et al., 1994). To initiate 
the widening of the minor groove, it was demonstrated that Ile-168 in human SRY (can 
be replaced by Met or Phe in other sequence-specific HMG box proteins) disrupts the 
base pair stacking at the site of insertion by intercalating between two AT basepairs. 
(Love et al., 1995; Peters et al., 1995; Wemer et al., 1995). In one of the many human 
46X,Y sex reversal mutations, Ile-168 is replaced by Thr resulting in a diminished DNA
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binding affinity by two orders of magnitude compared to wild-type SRY (Wemer et al., 
1995).
Subdivision of the SOX family based on overall sequence and 
structural homologies
Within the TCF/SOX family, the SRY-type SOX proteins are the best characterised 
group of transcription factors. Until recently, a SOX protein was distinguished from 
TCF/LEF proteins by its high amino acid identity (>50%) within its HMG domain to 
that of the founding member of this group, mouse SRY. Thus, genes containing such an 
SRY-type HMG box were called Sox genes (Pevny and LovellBadge, 1997).
Koopman and his colleagues have proposed a new method to identify members 
of the SOX protein subfamily (Bowles et al., 2000). They suggest using the 
conservation of key motifs within the HMG domain as an alternative criterion to define 
Sox genes. They argue that SRY is not the most suitable representative for the SOX 
protein family as it is the only member which has no homologues outside the 
mammalian lineage. Additionally, most likely because of their location on the Y 
chromosome, the rate of evolution for SRY homologues is a lot faster and hence the 
subgroup of SRY genes is clearly more divergent than others . If the homology to the 
SRY HMG domain was to be used to identify SOX proteins, >50% amino acid identity 
was a too stringent criterion. Their argument is backed up by the recently isolated 
huSOX30 and ceSOXJ proteins, which only show 48% and 46% sequence identity to hu 
SRY, respectively. However, their latest alignment of HMG domain sequences revealed 
that the motif RPMNAFMVW is common to all non-SRY SOX protein members and 
they suggest this as the most reliable signature to distinguish SOX proteins in future 
(Bowles et al., 2000).
SOX proteins were thus divided into 10 subgroups A-J (Figure 1.1). The subdivisions 
based on the phylogenetic alignment of HMG domain sequences are consistent with the 
grouping of SOX proteins based on overall structural and functional motifs of the entire 
protein sequence. Such structural motifs include the conservation of intron positions, 
whereas functional motifs refer to additional domains characteristic for the subgroup. 
Members of the subgroup D for example (Sox5, Sox6, Soxl3 and Sox23), are 
characterised by a leucine zipper domain, which was shown to be capable of 
homodimerization (Lefebvre et al., 1998). This dimerization only indirectly interferes
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with DNA binding in that it reduces the affinity of the dimer for single Sox consensus 
binding sites. For the long variant of Sox5,L-Sox5 heterodimerization with Sox6 has 
also been demonstrated (Lefebvre et al., 1998). Whereas most members of subgroups 
B1 (Soxl, Sox2, Sox3 and Soxl9), C (Sox4, Soxl 1, Sox22 and Sox24), E (Sox8, Sox9 
and SoxlO) and F (Sox7, Soxl7 and Soxl8) have one or two transactivation domains, 
subgroup B2 proteins (Soxl4 and Sox21) contain a repression domain (Uchikawa et al., 
1999; Bowles et al., 2000).
Sox proteins exhibit very high sequence conservation within the DNA binding domain, 
especially between members of the same subgroup. Furthermore, Sox proteins often 
show overlapping regions of expression and thus, the question of how they can still 
regulate the transcription of target genes in a cell-type specific manner arises.
How Sox genes exhibit cell-specific transcriptional regulation and 
their role in development
Several mechanisms might be expected to contribute to this specificity such as 
additional specific flanking nucleotides to each side of the consensus binding motif and 
other functional domains in addition to the DNA binding domain. Furthermore, 
synergistic activity with other cell-type specific transcription factors might increase the 
specificity dramatically in some cases.
The recognition motifs to which SOX proteins have been shown to bind vary 
very little in sequence both in vivo and in vitro (Kamachi et al., 1999; Mertin et al.,
1999). The binding affinity might be increased slightly by specific flanking nucleotides 
to each side of the core element AACAAT, as was demonstrated for the human SOX9 
and SRY protein in vivo (Mertin et al., 1999).
The angle SOX proteins introduce by binding to DNA depends largely on the 
binding site and thus is also fairly similar. Hence, the specificity cannot be explained 
solely by selective binding to downstream targets or by introducing the correct degree 
of bending. For example, both HMG domains of SOX1 and SOX9 from chicken were 
able to bind equally well to the Sox binding site in the Col2al minimal enhancer 
element, which is only a target of SOX9 in vivo (Kamachi et al., 1999).
There are indication that other domains might contribute significantly to 
specificity apart from the DNA binding domain and the C-terminal transactivation 
domain. Cell-type specificity of SOX1, SOX2 and SOX9 is observed in vivo, despite of
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Figure 1.1: Alignment of HMG domain sequences, modified from (Bowles et al., 2000)
HMG domains of Sox protein representatives for each subgroup from zebrafish, Danio rerio (ZF), chicken, Gallus gallus (C), mouse, Mus 
musculus (M), human, Homo sapiens (H), Xenopus laevis (X) and Caenorhabditis elegans (Ce) were aligned with ClustalW. The subgroups are 
labelled A-J and the accession numbers for each gene are shown (Acc. No.). Identical amino acids to the consensus sequence (top) are 
represented by dashes. Amino acids conserved across all Sox genes are underlined in the consensus sequence, whereas residues which form the 3 
a-helices are bracketed. Mouse LEF1 and TCF1 sequences are included as outgroups.
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that all 3 C-terminal domains by themselves show strong transactivation of 
Chloramphenicol Acetyl Transferase (CAT) regardless of cell-types when fused to the 
GAL4 DNA binding domain (Ng et al., 1997; Kamachi et al., 1999; Kamachi et al.,
2000). The N-terminal synergy domain of some Sox proteins such as SoxlO was shown 
to be required for interaction with partner factors (Kuhlbrodt et al., 1998a), but in 
addition, the region just C-terminal to the HMG domain also makes a minor 
contribution (Kamachi et al., 1999). Partner transcription factors might then confer 
tissue specificity of transcriptional regulation by their restricted expression. 
Furthermore, specificity might be improved by stabilising the binding of the SOX 
protein to its DNA target site by the partner factor. Such binding sites for SOX proteins 
and partner factors have been identified on the 8-crystallin enhancer for SOX2 and 
8EF3 (Kamachi et al., 1995; Kamachi et al., 1999); SOX2 and Oct3/4 on the FGF4 
enhancer (Dailey et al., 1994; Ambrosetti et al., 1997); SOX9, SF1, GATA and WT1 on 
the anti-Muellerian hormone (AMH) enhancer (Marshall and Harley, 2000); SOX9, L- 
SOX5 and SOX6 on the Col2al minimal enhancer (Lefebvre et al., 1998); and SOXIO 
and PAX3 on the MITF promoter (Bondurand et al., 2000; Potterf et al., 2000).
Aims of the project
The neural crest has been recognised as a highly important embryonic structure that 
gives rise to a great number of various derivatives such as neurons and glia of the 
peripheral nervous system (PNS), the enteric nervous system (ENS), craniofacial 
cartilage structures and pigment cells. The underlying processes and timing involved in 
specifying those different cell fates from multipotent precursors is still largely 
unknown. Not surprisingly, there are numerous human congenital diseases, generally 
termed neurocristopathies, in which either specification, survival, proliferation or 
differentiation of one or more neural crest derivatives has been disrupted.
Waardenburg Shah Syndrome (WS4) patients and their mouse model, the Dominant 
megacolon mouse (Dom), present with defects in most neural crest derivatives and are 
caused by lesions in the transcription factor SOXIO (Herbarth et al., 1998; Pingault et 
al., 1998a; Southard-Smith et al., 1998). As a result, SOXIO was suggested to be a key 
factor in neural crest development (Pevny and LovellBadge, 1997).
The phenotype of the zebrafish pigment mutant colourless (els; Kelsh et al., 1996; 
Malicki et al., 1996) is highly reminiscent of these mammalian SoxlO mutants
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(described in detail in a previous section of this chapter) and thus, sox 10 was proposed 
to be a promising candidate gene for the els locus.
The aim of this project is to investigate whether els encodes a zebrafish sox 10 
orthologue. This was attempted by
i) Cloning a soxlO homologue from zebrafish embryos
ii) Testing whether soxl 0 maps to the same locus on LG3 as els
iii) Testing for mutant lesions in at least one of the soxl 0 alleles
iv) Attempting to rescue the colourless mutant phenotype by injecting wild-type
soxlO cDNA inducible by a heatshock promoter
v) Analysis of the embryonic expression pattern of wild-type and els mutants
knowing that els acts cell-autonomously at least within the pigment lineage 
(Kelsh and Eisen, 2000b).
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Chapter 2 -  Materials and Methods
Fish husbandry
Wild-type and mutant embryos were obtained from the University of Oregon. Crosses 
were set up as described in Westerfield (1995), eggs were collected from successful 
matings on the following morning with the use of a tea-strainer. After rinsing with RO 
water, eggs were transferred to a Petri-dish containing embryo medium (5mM NaCl,
0.17mM KC1, 0.33mM CaCb, 0.33mM MgS04 ,10 ‘5% methylene blue to suppress 
fungal growth). The embryos were raised at 28.5°C and staged according to Kimmel et 
al. (1995). Embryos to be live mounted or sorted were anaesthetised in a 0.2% solution 
of 3-aminobenzoic acid ethyl ester (“Tricaine”, Sigma) prior to analysis.
Primer design and sequences
Primers were designed with the use of two programs. First, suitable primer pairs for 
PCR amplifications were suggested by Primer3
(http://waldo.wi.mit.edu/cgi-bin/primer/primer3.cgi/primer3 www.cgi).
Primer pairs, each containing at least 1-2 GC clamps at the 3’end were then analysed for 
hairpins, dimers, crossdimers and melting temperature (Tm) with a second program, 
NetPrimer (http://www.premierbiosoft.com/netprimer/netprimer.html).
Only primers with a rating of at least 80 (out of 100; NetPrimer) were selected. 
Sequencing primers were directly designed and analysed with NetPrimer. Primers S21, 
S22 and S23 were obtained from MWG-Biotech AG, lOnmol scale of synthesis and 
HPSF purification. All other primers were ordered from Gibco BRL Lifetechnologies 
with standard purification and 50nmol synthesis scale. Primers used for site-directed 
mutagenesis were additionally PAGE purified.
Primers used to clone and map soxlO
5'SOX 10*: 5' AAG GCC GGA TCC ATG AAY GCN TTY ATG GTN TGG 3 ’
3'SOX 10*: 5' AAG GCC GGA TCC GGY TGR TAY TTR TAR TCN GG 3'
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5GSP: 5’ TCC GTC TCG TTC AGC AGT CTC CAC AGC 3’
N5GSP: 5’ GGC GTT GTG CAG GTG CGG ATA TTG ATC C 3’
3GSP: 5’ AAG CTG TGG AGA CTG CTG AAC GAG ACG G 3’
N3GSP: 5’ TAT CGA GGA GGC CGA GCG CTT GAG G 3’
S9: 5’ AGG TCT GGC TGG AGT GGG CGT AGT AGG 3’
S10: 5’ CGA TGA TTT TTA GCA CAC ACA CAC ACC 3’
SI 1: 5’ ACC GTG ACA CAC TCT ACC AAG ATG ACC 3’
SI2: 5’ AAA ATC ATC GAA ACA CTC GCC TGC ACC 3’
S13: 5’ CAT GAT AAA ATT TGC ACC CTG AAA AGG 3’
S14: 5’ GTA TTT ATT TAC TTA CCC AAT GTT AGG 3’
*.. .In those degenerate primers, the letter “Y” stands for C or T, “R” for A or G, 
“N” could be either A, C, G or T.
Primers used to search for mutant lesions
S19: 5’ GCA GCA AGA GCA AAC CGC ACG 3’
S20: 5’ TGG TAG GGG GCG TTG GAG GGC 3’
S21: 5 ’ ACC TAC CGA AGT CAC CTG TGG 3 ’
S22: 5’ GAT ATT GAT CCG CCA GTT TCC 3’
S24: 5’ AAT CGC ATT ACA AGA GCC TGC 3’
S25: 5 ’ CCA GGG AAG TGT GTT TCA CTC 3 ’
S26: 5’ TAT ACA TAC GGC ATC TCC AGC 3’
S27: 5’ AGT TTG TGT CGA TTG TGG TGC 3’
Primers used to make the soxlO heatshock construct
Cla I-S21: 5’ CCA TCG ATA CCT ACC GAA GTC ACC TGT GG 3’
S21-Xba I: 5’ GCT CTA GAG TTT GTG TCG ATT GTG GTG C 3’
Primers used to make the sox9a and sox9b heatshock constructs
S9A-1: 5’ GGA TCC AAG CTT ATC GAT TTC G 3’
S9A-2: 5’ GCT CTA GAG CTT TTT CAG TGC ACA TTC AGG C 3’
S9B-1: 5 ’ CCA TCG ATG GAT CTG TGT GTG TTT CAG CAG C 3 ’
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S9B-2: 5’ GCT CTA GAG CTG CTG ATA GTG ATT CAG GCG 3’
Primers used to sequence the sox9a and sox9b constructs
9A/B19: 5’ GTG CTG AAG GGY TAC GAC TGG 3’
9A20: 5’ GGT GGT GGG AGG AGT GGG CGG 3’
9A22: 5’ CCT GCG CCC ACA CCA TAA ACG 3’
9A24: 5’ ACC CAC ATC TCG CCC AAC GCC 3’
9A25: 5’ GCT CGT TGT AAT GGC TCG GGC 3’
9A26: 5’ CAA AAC GGC AGC CCT CAA AGC 3’
9B20: 5’ GGT GGT GGG TGG TGT GGG GGG 3’
9B22: 5’ CTT GAG CCC AAA CCA TAA ACG 3’
9B24: 5’ ATG CGC TGT TCA GAG CCC TGC 3’
9B25: 5’ CCT CTG CTG GTG CTG CTC GCC 3’
9B26: 5’ AGT ACC TGC CTC CGC ACG GGG 3’
Primers used for site-directed mutagenesis
m618-»WTl: 5’ GCT CAG CAA AAC ACT GGG GAA GCT GTG GAG ACT GC 3’ 
m618—»WT2: 5’ GCA GTC TCC ACA GCT TCC CCA GTG TTT TGC TGA GC 3’ 
WT1—»tw2: 5’ GGGCGC AGA TGG CGG GTA AAC GCA GAT AAA GAG 3’
WT2->tw2: 5 ’ CTC TTT ATC TGC GTT TAC CCG CCA TCT GCG CCC 3 ’
WT1-*Y83X: 5’ AGG TGC TGA ACG GGT AAG ACT GGA CGC TCG TGC 3’ 
WT2-»Y83X: 5’ GCA CGA GCG TCC AGT CTT ACC CGT TCA GCA CCT 3’ 
WT1->E189X: 5’ AGC TCA GAG GCC TAG GCC CAC TCT GAG GGT GAG G 3’ 
WT2-»E189X:5’ CCT CAC CCT CAG AGT GGG CCT AGG CCT CTG AGC T 3’
Polymerase Chain Reactions (PCR)
PCR conditions (MgCh, dNTP and primer concentrations) were optimised with a 
scheme of 12 reactions varying all parameters in combinations (Figure 2.1). The Tm 
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Figure 2.1: This PCR optimisation scheme (designed by Stone Elworthy, University of Bath) varies 3 concentrations of magnesium chloride 
combination with 2 concentrations each of dNTPs and primers. The molarities noted in this scheme represent the concentrations of stock 
solutions of MgCl2, dNTP and primers. The resulting final test conditions used in each of the 12 reactions were as follows:
111 112 211 212 511 512 521 522 711 712 721 722
MgCl2 ImM ImM ImM ImM 1.5mM 1.5mM 1.5mM 1.5mM 2mM 2mM 2mM 2mM
dNTPs 20jiM 20gM 200gM 200|iM 20jiM 20gM 200(iM 200gM 20^M 20\iM 200|iM 200(iM
primers 0.2nM l(xM 0.2(iM ljiM 0.2nM l|iM 0.2nM l^ iM 0.2|iM lpM 0.2|iM lpM
RT-PCR Protocols
Isolation o f  total RNA using Tri Reagent
Approximately 200-300 embryos of the desired stage were dechorionated using 
watchmaker forceps, killed by an overdose of the anaesthetic Tricaine and homogenised 
thoroughly in 1ml Tri Reagent (Sigma). Homogenates were spun at 13000rpm for 10 
minutes at 4°C, the supernatant was removed to a fresh tube and the sample allowed to 
stand for 5 minutes at room temperature. 0.2ml chloroform was added, the tube shaken 
vigorously and left to stand for 2-15 minutes at room temperature. After centrifugation 
at 13000rpm for 15 minutes at 4°C the aqueous phase containing RNA was transferred 
to a fresh tube, 1/10 volume of isopropanol was added, the tube was inverted a few 
times and allowed to stand at room temperature for 5 minutes. The sample was spun 
again at 13000rpm for 10 minutes at 4°C and an equal volume of isopropanol added to 
the transferred supernatant. After the tube was inverted again and left to stand for 5-10 
minutes at room temperature the precipitated total RNA was pelleted at 13000rpm for 
10 minutes at 4°C. The supernatant was removed, the pellet washed with 1ml 75% 
ethanol by vortexing and the sample respun at 13000rpm for 5 minutes at 4°C. After 
removal of all the ethanol, the pellet was dried at room temperature for approximately 5 
minutes and redissolved in a suitable volume (approximately 50pl) of fresh milliQ 
water. The quality of the total RNA preparation was assessed by analysing 1 pi of the 
sample on a standard 1%TBE gel.
Reverse transcription using random hexamers or an oligo dTprimer
3-6pg of total RNA was combined with lOOng random hexamers or 500ng oligo dT and 
the volume made up to 12pl with fresh milliQ water. The sample was heated to 70°C 
for 10 minutes, chilled on ice, then 4pl 5x reaction buffer (Gibco BRL), 2pl 0.1M DTT 
and lp l lOmM dNTPs were added. After mixing the reaction, samples were incubated 
at 25 °C (or 42°C for oligo dT reactions) for 2 minutes and 1 pi (200u) Superscript II 
(Gibco BRL) was added. When using random hexamers, tubes were incubated for 
another 10 minutes at 25°C. All reactions were transferred to 42°C for 50 minutes 
followed by 15 minutes at 70°C to inactivate the reverse transcriptase. Then 2u RNAse 
H (Promega) was added and reactions incubated at 37°C for 20 minutes. The reactions
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were diluted to a 1:50 final concentration directly into PCR reactions (i.e. lp l cDNA 
used in a 50pl PCR reaction).
PCR protocols for primer combinations used to clone soxlO
Degenerate primers 5 ’SoxlO and 3 ’SoxlO to clone the HMG box
These primers and the PCR protocol were first published by Yuan et al. (1995). A 50pi 
PCR reaction included 4pl 25mM (2mM final) MgCL, 5pl 2.5mM (250pM final) 
dNTP, 5 pi lOpM (lpM  final) of each primer, lp l (5u) Taq DNA polymerase 
(Promega), 5pl lOx reaction buffer and 2pl cDNA. Reactions were subjected to 1 
minute at 94°C, 25 cycles of 1 minute at 94°C, 1 minute at 45°C and 1 minute of 72°C 
followed by a final extension step of 10 minutes at 72°C.
RACE-PCR protocol
RACE-PCR (Rapid Amplification of cDNA Ends-Polymerase Chain Reaction) was 
carried out using the Clontech SMART (Switching Mechanism At 5’ end of RNA 
Transcript) RACE cDNA Amplification Kit. First, 5’RACE cDNA and 3’RACE cDNA 
were synthesised by combining lpg of total RNA from 19hpf embryos with lp l 5’-CDS 
primer or 3’-CDS primer respectively and lpl SMART II (5’RACE cDNA reaction 
only). Supplied sterile water was added to the final volume of 5pl, the reactions 
incubated at 70°C for 2 minutes and cooled on ice for 2 minutes. After spinning the 
tubes briefly to collect the contents, 2pl 5x First-Strand buffer, lp l 20mM DTT, lp l 
lOmM dNTP mix and lp l (200u) Superscript II (Gibco BRL) reverse transcriptase were 
added. Reactions were incubated at 42°C for 90 minutes, diluted with lOOpl Tricine- 
EDTA buffer supplied with the kit and heat treated at 72°C for 7 minutes.
RACE PCR reactions were set up by combining 2.5pl 5’RACE or 3’RACE cDNA with 
5pl lOx UPM (universal primer mix), lp l lOpM 5GSP (5’gene specific primer, for 
sequence see primer design and sequence section of Materials and Methods) or 3GSP 
(3’ gene specific primer), 5pl lOx Reaction Buffer, lp l lOmM dNTP mix, lp l 50x 
Advantage 2 Polymerase Mix (Clontech) and 34.5pi PCR-grade water. In a MJ 
Research PTC-DNA Engine PCR reactions were subjected to 5 cycles of 94°C for 10 
seconds, 72°C for 3 minutes, then 5 cycles of 94°C for 10 seconds, 70°C for 10 seconds,
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72°C for 3 minutes, then 30 cycles of 94°C for 10 seconds, 68°C for 10 seconds, 72°C 
for 3 minutes followed by a final extension step at 72°C for 10 minutes. 5pl of each 
reaction were run out on a 1% agarose/ethidium bromide gel and examined using an 
ultraviolet light source.
To test for product specificity nested PCR reactions were carried out by diluting 5 pi of 
the primary PCR products into 245pl of Tricine-EDTA buffer. PCR reactions were set 
up as before, but replacing the 2.5pi cDNA with 5pi of the diluted primary PCR product 
and lp l lOpM 5GSP or 3GSP with either lpl 10pMN5GSP orN3GSP, respectively. 
For primer sequences see primer design and sequence section of Materials and Methods. 
The nested PCR reactions were subjected to 25 cycles of 94°C for 10 seconds, 68°C for 
10 seconds and 72°C for 3 minutes followed by a final extension of 72°C for 10 
minutes. As before, 5pl of each reaction were run out on a 1% agarose/ethidium 
bromide gel (TBE) and examined on an ultraviolet light source.
PCR protocol fo r amplification between primers 5*SoxlO, 3GSP or N3GSP and 
S13 (clone 15 and 20)
Since the 3’RACE product did not span the entire region 3’ to the HMG box, an 
overlapping fragment was amplified between primers 5’Sox 10 and SI3. A 20pl PCR 
reaction included 2pl cDNA, 2pl lOpM (lpM  final) of each primer, 0.3pl (1.5u) 
Thermoprime Taq DNA polymerase (Advanced Biotechnologies), 1.8pl 1 lx  reaction 
buffer [167pl 2M TrisHCl pH8.8, 83pl 1M Ammonium sulphate, 33.5pl 1M 
Magnesium chloride, 3.4pl lOmM EDTA pH8, 3.6pl P-mercaptoethanol, 75pl of each 
lOOmM dNTP stock and 85pl lOmg/ml BSA (DNAse free, Pharmacia), recipe kindly 
provided by Dr. Diane Hird, University of Bath] and 11.9pl milli-Q water to make up to 
20pl. Reactions were subjected to 1 minute at 94°C, 35 cycles of 30 seconds at 94°C, 1 
minute at 60°C and 3 minutes 30 seconds of 72°C followed by a final extension step of 
10 minutes at 72°C.
Subsequent nested PCRs involved amplification between primers 3GSP or N3GSP and 
S I3. The PCR reaction were set up like described in the previous section for the 
5’Soxl 0/S 13 amplification replacing the 2pl cDNA with equal volume of 1:10 diluted 
first round PCR template. Reactions were subjected to 1 minute at 94°C, 25 cycles of 30 
seconds at 94°C, 1 minute at 66°C and 3 minutes 30 seconds of 72°C followed by a
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final extension step of 10 minutes at 72°C. Products obtained from this amplification 
were cloned into pGEM-T Easy vector and sequenced.
PCR protocols involved in mapping soxlO on the radiation hybrid 
panel LN54
The LN54 collection of radiation hybrids (zebrafish in a mouse background) was kindly 
provided by Marc Ekker from the Loeb Research Institute in Ottawa, Canada (Hukriede 
et al., 1999). It contains 93 radiation hybrid DNA samples (100ng/pl each), DNA from 
the two parental cell lines (zebrafish AB9 and mouse B78) and a 1:10 mixture of the 
latter two.
For mapping soxlO on the panel, a PCR reaction with primers SI 1 and S13 was used. 
For primer sequences see primer design and sequence section of Materials and Methods, 
lp l of each of the 96 DNA samples was combined with 2pl lOpM SI 1 primer, 2pl 
lOpM S13 primer, 1.8pl 1 lx  PCR buffer (recipe see previous section), 0.3pl 
Thermoprime Taq DNA polymerase (Advanced Biotechnologies) and 12.9pl milliQ 
water.
PCR reactions were denatured at 94°C for 1 minute, then cycled at 94°C for 30 seconds, 
66°C for 1 minute, 72°C for 3 minutes for 30 cycles, followed by a final extension of 
72°C for 10 minutes. To increase the intensity and specificity of the obtained products, 
those first PCR products were diluted 1:10 and lpl was then included in a nested PCR 
reaction. The reaction set up and PCR program was identical to the one outlined above 
with the exception that 2pl lOpM primer SI 1 were replaced by 2pl lOpM of the nested 
primer SI 2. All 20pl of nested PCR reactions were loaded on a 1% agarose/ethidium 
bromide gel and location of the products of the expected 850bp size was recorded. This 
assay was carried out in duplicate and the resulting data submitted to the mapping 
program at http://mgchdl.nichd.nih.gov:8000/zfrh/beta.cgi.
PCR protocols for primer pairs used to screen for mutant lesions
The sequence of mutant els alleles was compared to wild-type soxl 0 by sequencing 4 
overlapping PCR fragments spanning the entire coding region. Those fragments were 
amplified between primer pairs S19-S20, S21-S22, S24-S25 and S26-S27. The optimum
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conditions were determined by setting up a PCR optimisation scheme (Figure 2.1) for 
each primer pair. S19-S20 and S21-22 gave cleanest products with condition “122”, the 
other primer pairs worked optimally in condition “121” (see Figure legend 2.1).
A 50pl “122” reaction contained 5pi mutant or wild-type cDNA, 5pi lOx reaction 
buffer, lp l 50mM (ImM final) MgCl2, lp l lOmM (200pM final) dNTP, 5pl lOpM 
(lpM  final) of each primer, lp l (5u) Taq DNA polymerase (GibcoBRL) and milli-Q 
water to make up to 50pl.
A 50pl “121” reaction contained 5pl mutant or wild-type cDNA, 5pl lOx reaction 
buffer, lp l 50mM (ImM final) MgCl2, lpl lOmM (200pM final) dNTP, lp l lOpM 
(0.2pM final) of each primer, lp l (5u) Taq DNA polymerase (GibcoBRL) and milli-Q 
water to make up to 50pl.
The PCR program identical for all primer pairs apart from the annealing temperature 
involved 1 minute at 94°C, 35 cycles of 30 seconds at 94°C, 1 minute at 68°C for SI 9- 
S20, 58°C for S21-S22, 56°C for S24-S25 or 55°C for S26-S27 and 1 minute at 72°C 
followed by a final extension step of 10 minutes at 72°C.
PCR protocol for primers used to make the soxlO heatshock 
construct
soxlO coding regions were amplified from wild-type and els mutant cDNAs using 
primers Cla I-S21 and S21-Xba I.
In a 20pl reaction, 0.4pl undiluted wild-type cDNA from 38hpf total RNA was 
combined with 0.4pl (2u) Taq DNA polymerase (TaqPlus Precision PCR System, 
Stratagene), 2pl lOx reaction buffer, 2pl 2mM (200pM final) dNTPs, 2pl of each 2pM 
(0.2pM final) primer and 11.2pl milli-Q water.
Mutant coding regions of alleles clsm618 and clstw2 were amplified in lOpl reactions 
containing lp l 1:5 diluted mutant cDNA, 0.2pl lOmM (200pM final) dNTPs, lp l 2pM 
(0.2pM final) of each primer, 0.2pl (lu) Herculase (Herculase enhanced DNA 
Polymerase, Stratagene), lpl lOx reaction buffer and 5.6pl milli-Q water.
All PCR reactions were denatured at 92°C for 1 minute, then subjected to 10 cycles of 
92°C for 10 seconds, 67°C to 57°C (l°C/cycle) for 45 seconds, 72°C for 2 minutes
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followed by 30 cycles of 92°C for 10 seconds, 57°C for 45 seconds and 72°C for 2 
minutes followed by a final extension of 72°C for 10 minutes.
PCR protocol for primers used to make the sox9a and sox9b 
heatshock constructs
sox9a and sox9b coding regions were amplified using primers S9A-1 and S9A-2 or 
S9B-1 and S9B-2, respectively.
lOpl reactions were set up with 200pg of each plasmid miniprep containing the full 
length sox9a and sox9b clones, 0.2pl lOmM (200pM final) dNTPs, lp l lOpM (lpM  
final) of each primer, 0.2pl (lu) Herculase (Herculase enhanced DNA Polymerase, 
Stratagene), lp l lOx reaction buffer and 5.6pl milli-Q water.
PCR reactions amplifying the sox9a coding region were denatured at 92°C for 1 minute, 
then subjected to 10 cycles of 92°C for 10 seconds, 68°C to 58°C (l°C/cycle) for 45 
seconds, 72°C for 2 minutes followed by 25 cycles of 92°C for 10 seconds, 58°C for 45 
seconds and 72°C for 2 minutes followed by a final extension of 72°C for 10 minutes. 
PCR reactions amplifying the sox9b coding region were denatured at 92°C for 1 minute, 
then subjected to 10 cycles of 92°C for 10 seconds, 60°C to 48°C (1.2°C/cycle) for 45 
seconds, 72°C for 2 minutes 30 seconds followed by 25 cycles of 92°C for 10 seconds, 
48°C for 45 seconds and 72°C for 2 minutes and 30 seconds followed by a final 
extension of 72°C for 10 minutes.
Protocol for primers used for site-directed mutagenesis
To create a wild-type soxlO heatshock construct from the clsm618 mutant heatshock 
construct, primers m618->-WTl (forward primer) and m618->WT2 (reverse primer) 
were used. The clstw2 mutant heatshock construct was then created from the wild-type 
construct using primers WT1—»tw2 (forward primer) and WT2->tw2 (reverse primer). 
Four 50pl reactions were set up, each containing either 5ng, lOng, 20ng or 50ng of 
template (clsm618 mutant heatshock construct to make the wild-type construct and wild- 
type to make the clstw2 mutant heatshock construct), lp l 125ng/pl of each primer, 
m618-»WTl and m618->WT2 or WTl->tw2 and WT2->tw2, lp l 20mM (400pM 
final) dNTPs, lpl (2.5u) Pfu Turbo DNA Polymerase (Stratagene), 5pl lOx reaction
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buffer and milli-Q water to make the reaction volume up to 50pl. A “no primer” control 
reaction was included containing 20ng of template, but no primers.
Reactions were subjected to 95°C for 30 seconds and 12 cycles of 95°C for 30 seconds, 
55°C for 1 minute and 68°C for 12 minutes and 30 seconds. 
lOpl of each reaction were analysed on a standard agarose gel for successful 
amplification. To the remaining 40pl reaction, lp l Dpn I restriction enzyme (NEB) was 
added directly into the PCR tubes and samples incubated at 37°C for 60 minutes to 
digest the parental methylated strands. 1.5pl of those double-stranded nicked open 
circular plasmids containing the mutated site were transformed into Epicurian Gold 
Supercompetent cells (Stratagene) and colonies tested for successful mutagenesis by 
either restriction digest with TspRI or by sequencing across the mutated region. If the 
wild-type construct was created successfully, a TspRl restriction was gained compared 
to the clsm618 mutant allele. To test this, a 20pl restriction digest with 2.5pi putative 
wild-type construct miniprep, 0.2pl BSA, lp l 7spRI (NEB), 2pl lOx NEB4 reaction 
buffer and 14.3pl milli-Q water was set up and incubated at 65°C for 3 hours. Positive 
clones were sequenced to ensure successful mutagenesis.
Since there was no similar test based on a change of restriction digest pattern available 
for the clstw2 heatshock construct, 350ng of several minipreps were directly sequenced 
across the mutagenesis site.
Molecular Cloning Techniques 
Agarose gel electrophoresis
To prepare a 1% agarose gel, 0.5g agarose was weighed into 50ml lxTBE buffer [per 
litre 10.8g Tris base, 5.5g boric acid, 4ml 0.5M EDTA pH8.0] and heated in a 
microwave at full power for 2 minutes to dissolve the agarose. The evaporated liquid 
was replenished with RO water, the gel solution briefly cooled under tap water, 3 pi 
(lOmg/ml) ethidium bromide added and the gel poured. Gels were run at 80-100V for 
approximately 1 hour in lx  TBE buffer with additional 5pi ethidium bromide added to 
the cationic compartment of the gel tank, examined using an ultraviolet light source and 




Approximately lp.g of plasmid DNA or 200-300ng of a PCR product were digested in a 
total reaction volume of usually lOpl containing lp l 1 Ox restriction enzyme buffer and 
10 units of restriction enzyme. Incubation was carried out at the enzyme’s specific 
reaction temperature (usually 37°C) for at least 2 hours and up to overnight. The 
majority of enzymes were purchased from Promega or New England Biolabs (NEB).
Ligation of PCR products
50-100ng of PCR product was directly ligated into 25ng of pGEM-T Easy vector 
(Promega) in a total reaction volume of 20pl containing 3units T4 DNA ligase 
(Promega) and supplied ligation buffer. The reaction was carried out at 16°C at least 
overnight or preferably for the duration of 2 days.
Preparation of CaCI2 competent cells
DH5a cells from a glycerol stock were plated on a fresh LB agar plate [LB medium 
contains lOg bacto-tryptone, 5g bacto-yeast extract, lOg NaCl per litre with pH adjusted 
to 7.0 with 5N NaOH; for LB-agar plates 15g bacto-agar is added] and incubated at 
37°C overnight. 50ml LB medium was then inoculated with one colony and again 
incubated at 37°C in a shaking incubator overnight. 2ml of overnight culture were 
diluted into 50ml fresh LB medium and incubated at 37°C in a shaking incubator until 
A6oo = 0.4-0.6. The culture was pelleted at 4000rpm for 10 minutes at 4°C and the 
supernatant discarded. The well drained cell pellet was resuspended in 20ml ice cold 
50mM CaCl2 and left on ice for at least 20 minutes. The cells were centrifuged again at 
4000rpm for 10 minutes at 4°C, the supernatant discarded and the cells resuspended in a 
solution of 4.25ml ice cold 50mM CaCb and 0.75ml sterile glycerol. Aliquots of 200pl 
were snap-frozen in a dry ice/acetone bath and stored at -80°C.
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Transformation of competent E.coli by heatshock
Transformation o f  competent D H 5a cells prepared with the CaCl2 method
A 2 0 0 jli1 aliquot of competent DH5a cells was thawed on ice, 20pl ligation reaction 
was added and gently mixed with a pipette tip. The tube was kept on ice for 30 minutes 
followed by heatshock in a waterbath at 42°C for exactly 90 seconds and returned to ice 
for another 2 minutes. 800pl LB medium was added and the cells left to recover at 37°C 
for an hour. The cells were pelleted at 5000rpm for 3 minutes, resuspended in 
approximately 50pl LB medium and spread onto an LB agar plate containing 50pg/ml 
ampicillin (Sigma), 20pg/ml X-gal and 20pg/ml IPTG.
Transformation o f  Gold Super-competent Epicurian Coli cells
Constructs created by site-directed mutagenesis were transformed into Gold Super- 
competent Epicurian Coli cells (Stratagene) according to the manufacturers instructions. 
Cells were slowly thawed on ice, gently swirled to mix cells and lp l XL 10-Gold p- 
mercaptoethanol was added. During the following 10 minute incubation on ice the cells 
were gently swirled every 2 minutes and then 1.5-2.0pl ligation reaction was added. 
After incubating the cells on ice for 30 minutes, they were heatshocked at 54°C for 60 
seconds, returned to ice for 2 minutes and 150pl LB medium was added. The cells were 
allowed to recover at 37°C for an hour and were then spread onto an LB agar plate 
containing 50pg/ml ampicillin (Sigma).
Plasmid preparations
Plasmid minipreps using alkaline lysis
The protocol for Lysis by Alkali described in Sambrook et al. (1989) was followed with 
a few alterations. Single colonies were picked from transformation plates and grown 
overnight in a 37°C shaking incubator in 2.5ml LB medium containing 50pg/ml 
ampicillin (Sigma). The culture was centrifuged at 13000rpm for 3 minutes, the pellet 
drained well, resuspended in lOOpl resuspension buffer [5mM glucose, lOmM EDTA 
pH 8.0 and lOOmM Tris/HCl pH 8.0] by vortexing and left to stand at room temperature 
for 10 minutes. Then 200pl of freshly prepared lysis mix [0.2M NaOH, 1% SDS] was
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added and the tubes sharply inverted until the solution was clear and viscous. After 5 
minutes incubation on ice, 150pl neutralisation solution [3M NaOAc pH 4.8] was 
added, the tubes inverted as before and stored on ice again for 5 minutes. Samples were 
centrifuged at 13000rpm for 10 minutes, the clear supernatant was transferred to a fresh 
Eppendorf tube, the plasmid DNA was precipitated with 1ml 100% ethanol for at least 
20 minutes at -20°C and collected by centrifuging at 13000rpm for 10 minutes. The 
pellet was resuspended in lOOpl 0.1M NaOAc pH 4.8 and reprecipitated for at least 20 
minutes at -20°C by adding 200pl 100% ethanol. The DNA was pelleted again by 
spinning at 13000rpm for 10 minutes, the ethanol removed and finally, the dried DNA 
pellet was taken up in a solution of 36pl milliQ water and RNAse (4pl lmg/ml). The 
sample was incubated at 37°C for 30 minutes and then stored at -20°C until needed.
Plasmid minipreps using the Wizard Plus SVMiniprep DNA Purification 
System (Promega)
Single colonies were picked from transformation plates and grown overnight in a 37°C 
shaking incubator in 5ml LB medium containing 50pg/ml ampicillin (Sigma). The 
culture was centrifuged at 13000rpm for 5 minutes, the pellet drained well and 
completely resuspended in 250pl Wizard Plus Cell Resuspension Solution by vortexing 
thoroughly. 250pl Wizard Plus Cell Lysis Solution was added and mixed by inverting 
the tube until lysis was complete. lOpl Alkaline Protease Solution was added, the tube 
mixed by inverting it 4 times and incubated at room temperature for 5 minutes. Then 
350pl Wizard Plus Neutralisation Solution was added, the tube inverted 4 times and 
spun at 13000rpm for 10 minutes at room temperature. The cleared lysate was 
transferred into a Wizard Spin Column and centrifuged at 13000rpm for 1 minute at 
room temperature. The flow through was discarded, 750pl Wizard Plus Column Wash 
Solution was added to the column and respun at 13000rpm for 1 minute at room 
temperature. The last step was repeated with 250pl Wash Solution and the column spun 
at 13000rpm for 2 minutes at room temperature. The column was then transferred to a 
fresh Eppendorf tube, the plasmid eluted with 100pl Nuclease-Free Water and collected 
by centrifuging at 13000rpm for 1 minute at room temperature.
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Plasmid midipreparations using the Wizard Plus Midipreps DNA Purification 
System (Promega)
Single colonies were picked from transformation plates and grown overnight in a 37°C 
shaking incubator in 100ml LB medium containing 50pg/ml ampicillin (Sigma). The 
culture was centrifuged at 6000rpm for 15 minutes in a Sanyo Harrier 18/80 benchtop 
centrifuge, the pellet drained well and completely resuspended in 3ml Cell 
Resuspension Solution by vortexing thoroughly. 3ml Cell Lysis Solution was added and 
mixed by inverting the tube until lysis was complete. Then 3ml Neutralisation Solution 
was added, the tube inverted 4 times, the sample split into 6 Eppendorf tubes and spun 
at 13000rpm for 15 minutes at 4°C. The cleared lysate was mixed with 10ml of 
resuspended Wizard Midipreps DNA Purification Resin, transferred to a Midicolumn 
and the resin/DNA mix bound to the column by applying a vacuum. To wash the DNA 
2x15ml of Column Wash Solution was applied and drawn through by a vacuum. The 
resin was dried briefly by continuing the vacuum for 30 seconds after the solution had 
been pulled through. The column tip was spun at 13000rpm for 2 minutes at room 
temperature to remove any residual Wash Solution, 300pl preheated 65°C milliQ water 
was added, the column left to stand for 1 minute and the eluted DNA was collected by 
centrifuging at 13000rpm for 20 seconds at room temperature. To remove any residual 
resin fines the sample was spun at 13000rpm for 5 minutes, the supernatant transferred 
to a fresh tube and stored at -20°C.
Gel extraction using QIAquick Gel Extraction Kit (Qiagen)
DNA fragments of 70bp-10kb were purified using the QIAquick Gel Extraction Kit 
(Qiagen).
The DNA band was excised from a 1% agarose gel with a razor blade, weighed and 3 
volumes of Buffer QG per 1 volume of gel was added (100mg~100pl). The gel was 
dissolved by heating in a 50°C waterbath, 1 gel volume isopropanol added (unnecessary 
if DNA band was between 500bp and 4kb) and the sample transferred to a QIAquick 
spin column. After spinning the column at 13000rpm for 1 minute at room temperature, 
the flow through was discarded and the DNA washed with 750pl Buffer PE. After 
centrifugation at 13000rpm for 1 minute at room temperature, the flow through was 
discarded, the column respun for 1 minute and transferred to a fresh Eppendorf tube. To
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elute the DNA 30jal of Nuclease-Free Water was added to the centre of the column, left 
to stand for 1 minute and the DNA finally collected by centrifugation at 13000rpm for 1 
minute at room temperature.
PCR purification using QIAquick PCR Purification Kit (Qiagen)
Single or double stranded DNA of lOObp-lOkb from PCR and other enzymatic reactions 
were purified using the QIAquick PCR Purification Kit (Qiagen).
To 1 volume of PCR reaction 5 volumes of Buffer PB were added, the sample mixed, 
applied to a QIAquick spin column and spun at 13000rpm for 1 minute at room 
temperature. After the flow through was discarded, the DNA was washed with 750pl 
Buffer PE, the column centrifuged at 13000rpm for 1 minute at room temperature, the 
flow through discarded again and the column respun for 1 minute. Then the latter was 
transferred to a fresh Eppendorf tube, 30pl Nuclease-Free Water was applied to the 
centre of the column, left to stand for 1 minute and the eluted DNA collected by 
centrifuging at 13000rpm for 1 minute at room temperature.
DNA sequencing
Sequencing by the Sanger Dideoxy-mediated chain termination method
To sequence cloned HMG boxes the T7 Sequenase version 2.0 DNA sequencing kit 
(Amersham) was used according to the manufacturer’s instructions.
Approximately 5pg of template DNA in 20pl milliQ water was denatured for 10 
minutes at room temperature with 5 pi freshly prepared 2M NaOH and purified with a 
minispin column (Pharmacia). 7pi of the denatured template was annealed to lpM of 
either -40 M l3 forward primer (supplied by the kit) or M l3 reverse primer (Gibco 
BRL) and labelled with 5pCi 35S following the manufacturer’s instructions.
A 5% polyacrylamide gel (7.5M urea) was poured with the use of the Sequagel “Ultra 
Pure” Sequencing System (National Diagnostics), the entire lOpl sequencing reaction 
was loaded and run on a Sequi-Gen GT Nucleic Acid Electrophoresis Cell (BioRad) 
sequencing rig at 95-130W until the Xylene Cyanol dye front (light blue) reached about 
10cm above the bottom of the plates. The gel was fixed for 15 minutes in a solution of 
10%methanol, 10% glacial acetic acid, transferred to Whatman filter paper and dried on
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a flatbed dryer using a BioRad Hydro Tech Vacuum Pump. An X-ray film was placed 
above the dried gel and exposed for several days at room temperature.
Automated sequencing using BigDye terminator chemistry
The sequencing of plasmid constructs and PCR products to find mutant lesions in soxlO 
were carried out by Dr. Paul Jones (Sequencing Core Facility, University of Bath) on an 
ABI DNA sequencer using BigDye terminator chemistry. For sequencing, typically 
300-500ng plasmids were combined with lOpmoles of primer or alternatively, 3-1 Ong 
PCR product (approximately 500bp) with 5pmoles of primer in 6pi total volume. The 
resulting sequence files were viewed with the Chromas viewing programme.
Plasmids
Cloning the full length sox 10 and parts thereof was accomplished using the pGEM-T 
vector (Promega) or pGEM-T Easy vector (Promega). Both T-vectors are based on the 
pGEM -5Zf(+) plasmid (Promega). pGEM-T was created by digesting the pGEM -  
5Zf(+) plasmid with EcoRV and adding a 3’-terminal thymidine to both ends, whereas 
for pGEM-T Easy, the MCS (multiple cloning site) was modified by adding additional 
Not I and EcoRl restriction sites flanking the T-overhangs on each end.
Heatshock constructs were created in the pCSHSP vector (Halloran et al., 2000). It was 
created from the pCS2+ plasmid by replacing the sCMV promoter region with the 
heatshock promoter HSP70/4 (for a plasmid map see chapter 7, Figure 7.1).
Site-directed mutagenesis
Site-directed mutagenesis was carried out following the instructions published in the 
online manual to the QuikChange Site-Directed Mutagenesis Kit (Stratagene, 
http://www.stratagene.com/manuals/200518.PDF).
Mutagenesis primers each complementary to opposite strands of the vector were 
designed according to the recommended guidelines to be 25-45 bases long with a Tm 
greater or equal to 78°C. The desired mutation site was located in the middle of the 
primers with 10-15 basepairs of correct flanking sequence to each side. The primers 
have a GC content of at least 40%, terminate with one or more GC clamps and were
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PAGE purified. (For primer sequences see Primer design and sequence section in 
Materials and Methods).
Four 50pl reactions were set up, each containing either 5ng, lOng, 20ng or 50ng of 
template (clsm618 mutant heatshock construct to make the wild-type construct, wild-type 
to make the clstw2, clsY83x and c l^ 189x mutant heatshock constructs), lp l 125ng/pl of 
each primer (m618-*WTl and m618-»WT2 or W Tl-»tw2 and WT2—»tw2,
WT1—>Y83X and WT2->Y83X, WT1->E189X and WT2->E189X), lp l 20mM (400pM 
final) dNTPs, lp l (2.5u) Pfu Turbo DNA Polymerase (Stratagene), 5pi lOx reaction 
buffer and milli-Q water to make the reaction volume up to 50pl. A “no primer” control 
reaction was included containing 20ng of template, but no primers.
In an MJ Research PTC-DNA Engine reactions were subjected to 95°C for 30 seconds 
followed by 12 cycles 95°C for 30 seconds, 55°C for 1 minute and 68°C for 12 minutes 
30 seconds (2 minutes/kb of plasmid length) if a point mutation was to be introduced 
{clsm6I8->WT, WT—»c//w2, WT-^clsY83X). Alternatively, 16 cycles were employed when 
changing a single amino acid residue to create the c l f 189X allele. lOpl of each reaction 
were analysed on a standard agarose gel for successful amplification. To the remaining 
40pl reaction including the “no primer” control, lp l (lOu) Dpn I restriction enzyme 
(NEB) was added directly into the PCR tubes and samples incubated at 37°C for 60 
minutes to digest the parental methylated strands. 1.5pl of those double-stranded nicked 
open circular plasmids containing the mutated site which gave the most and cleanest 
product and 1.5 pi of the “no primer” control were transformed into Epicurian Gold 
Super-Competent cells (Stratagene) as described in the appropriate Material and Method 
section. Colonies were tested for successful mutagenesis by either restriction digest with 
T^R I or by sequencing across the mutated region. If the wild-type construct was 
created successfully, a TspRl restriction was gained compared to the clsm618 mutant 
allele. To test this, a 20pl restriction digest with 2.5pl putative wild-type construct 
miniprep, 0.2pl BSA, lp l 7j/?RI (NEB), 2pl lOx NEB4 reaction buffer and 14.3pl milli- 
Q water was set up and incubated at 65°C for 3 hours. Positive clones were sequenced 
to ensure successful mutagenesis.
Since there was no similar test based on a change of restriction digest pattern available 
for the clstw2 heatshock construct, 350ng of several minipreps were directly sequenced 
across the mutagenesis site.
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In situ protocols
Preparation of Dig and Flu labelled RNA in situ probes
Approximately 10pg of plasmid containing the gene of interest was linearised with 70- 
lOOu of restriction enzyme cutting 5’ to the probe fragment in a large volume, typically 
1 OOjlxL An aliquot of the reaction was loaded on a 1% agarose gel to check for complete 
digestion. The remaining sample was purified using the QIAquick PCR Purification Kit 
(Qiagen) and the concentration of the purified linearised plasmid estimated by 
comparison to a quantitative ladder (lkb ladder, NEB) on a 1% agarose gel. Probes 
were synthesised using the Dig RNA Labelling Kit (Boehringer/Roche). In a 20pl 
reaction l-2pg of linearised plasmid was combined with lp l 20x Dig-NTP or 2pl lOx 
Flu-NTP labelling mixture, 2pl lOx transcription buffer, lp l RNAse inhibitor and 2pl 
RNA polymerase. Depending on the orientation of the cloned fragments T7 or SP6 
RNA polymerase was used to create an antisense RNA probe. After incubation at 37°C 
for 2 hours, a lp l aliquot was kept at -20°C. To the remaining reaction lp l RNAse-free 
DNAse was added, the sample incubated at 37°C for 15 minutes, then 15pl 5M 
Ammonium acetate, 75pi absolute ethanol and 1.5pi seeDNA (Amersham) were added. 
The RNA was precipitated on ice briefly, spun at 13000rpm for 15 minutes at 4°C, the 
pellet washed with 500pl 70% ethanol, air dried for 1 minute after carefully removing 
all traces of ethanol and redissolved in 20pl fresh milliQ water. Again, a lp l aliquot was 
removed and compared to the one kept earlier before DNAse treatment on a 1% agarose 
gel. Before storing the RNA probe at -80°C 80pl formamide (Sigma) were added. 
Typically, the in situ probes were used at a 1:200 working dilution made up in 
hybridisation mix.
In situ hybridisation on whole mount zebrafish embryos
Digoxigenin or Fluorescein labelled RNA was detected with alkaline phosphatase 
conjugated anti-Dig or anti-Flu antibodies, respectively. To visualise labelled transcripts 
NBT/BCIP (Boehringer/Roche) or Fast Red (Boehringer/Roche) were used as colour 
substrates in the alkaline phosphatase reaction.
Embryos were staged according to Kimmel et al. (1995), dechorionated if  they were 
older than 24hpf, anaesthetised and fixed in 4% paraformaldehyde/PBS [0.8% NaCl,
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0.02% KC1, 0.02M P0 4 pH7 .3] for at least 24 hours at 4°C. Embryos up to 24hpf were 
dechorionated after fixation. All further procedures were carried out at room 
temperature and using 1ml of solution at any time unless stated otherwise.
Embryos were dehydrated by washing 3x5 minutes in methanol, 1x10 minutes in 
methanol and then stored at -20°C for a minimum of 2 hours or until needed. Embryos 
were rehydrated by washing 5 minutes in 75% methanol/25% PBS, 5 minutes in 50% 
methanol/50% PBS, 5 minutes in 25% methanol/75% PBS and finally 4x5 minutes in 
PBT [0.1% Tween20 in PBS].
To improve the penetration of the probe, embryos between 18-somite and 22-somite 
stages were digested in a solution containing 10pg/ml proteinase K in PBT for 5 
minutes, 24hpf embryos were treated for 15 minutes, 30hpf-48hpf embryos for 30 
minutes and embryos up to 72hpf for 1 hour. Embryos were then refixed in 4% 
paraformaldehyde/ PBS for 20 minutes, washed 5x5 minutes in PBT and prehybridised 
at 65°C for 2-5 hours in hybridisation mix [50ml hyb mix contains 25ml formamide, 
12.5ml 20xSSC, 0.5ml 5mg/ml heparin, 0.5ml 50mg/ml tRNA, 0.25ml 20% Tween20, 
0.46ml 1M citric acid and 10.7ml milliQ water].
Embryos were hybridised in 200pl of a 1:200 dilution of the probe and incubated at 
65°C overnight. The probe was saved and stored at -20°C for re-usage. To wash away 
non-specifically bound probe, embryos were first rinsed in hybridisation mix (HM), 
followed by 10 minute washes at 65°C with each of 75% HM/25% 2xSSC, 50% 
HM/50% 2xSSC, 25% HM/75% 2xSSC and 2xSSC in turn. Two high stringency 
washes at 65°C in 0.2xSSC for 30 minutes each were performed, followed by 10 minute 
washes at room temperature in each of 75% 0.2xSSC/ 25% PBT, 50% 0.2xSSC/50% 
PBT, 25% 0.2xSSC/75% PBT and PBT.
Embryos were blocked at room temperature in PBT/2% sheep serum/2mg/ml BSA for 
2-5 hours and incubated with the appropriate antibody (anti-Dig or anti-Flu diluted 
1:5000 in block solution) overnight at 4°C. The antiserum was discarded and the 
embryos rinsed once in PBT, then washed 6x15 minutes in PBT and 3x5 minutes in 
NBT/BCIP buffer [lOOmM TrisHCl pH 9.5, 50mM MgC12, lOOmM NaCl, 0.1% 
Tween20 in milliQ water] or Fast Red buffer [0.1M Tris pH8.0] depending on the 
colour substrate to be used in the detection step. NBT/BCIP stain solution was freshly 
prepared by dissolving one NBT/BCIP tablet (Boehringer/Roche) in 10ml milliQ water, 
whereas one Fast Red tablet (Boehringer/Roche) was crushed and dissolved in 2ml Fast
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Red buffer. Embryos were stained in the dark up to 48 hours and the reaction then 
stopped by washing the embryos in PBT several times. To improve the optical clarity of 
stained embryos they were transferred to 50% glycerol/50% PBS a few hours prior to 
inspection under an MZ12 dissecting microscope (Leica). For a more detailed analysis 
and for documentation an Eclipse E800 microscope (Nikon) and DIC or fluorescence 
optics were used.
Double in situ protocol
To detect expression of sox 10 and another gene of interest simultaneously a sox 10 
antisense RNA probe was labelled with fluorescein and detected with an anti-Flu 
antibody coupled to alkaline phosphatase using Fast Red (Boehringer/Roche) as a 
colour substrate. Antisense RNA probes against sox9a and sox9b (kind gift of Bon-chu 
Chung, Institute of Molecular Biology, Taipei, Taiwan), crestin (kind gift of Paul 
Henion, Department of Neuroscience, Ohio State University, USA),forkhead 6 (Jkd6) 
and dlx2 (kind gift of Craig Miller, Institute of Neuroscience, University of Oregon, 
USA) were labelled with digoxygenin, detected with an anti-Dig antibody also coupled 
to alkaline phosphatase, but using NBT/BCIP (Boehringer/Roche) as a purple colour 
substrate.
Preabsorption o f  anti-Flu antibody
The anti-Flu antibody was found to give much less background when preabsorbed prior 
to usage. To preabsorb the antibody approximately 300 3-5dpf embryos were fixed in 
4% paraformaldehyde in PBS at least overnight at 4°C, dehydrated in methanol as 
described in the single in situ protocol and kept at -20°C until needed. At the start of the 
double in situ protocol those embryos for preabsorption were treated alongside the 
experimental ones with the following modifications. Proteinase K treatment was carried 
out for 1 hour and instead of prehybridisation solution they were incubated in 1ml 
blocking solution containing 2pl anti-Flu antibody (1:500) at 
least overnight at 4°C.
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Double in situ hybridisation on whole mount zebrafish embryos
The protocol described previously for single in situ hybridisations was employed with 
the following modifications: The prehybridisation and hybridisation step was carried 
out at 66°C. The hybridisation mix contained both probes at a 1:200 dilution.
The blocking solution was modified to contain 5% sheep serum, 2mg/ml BSA and 1% 
DMSO in PBT. soxlO was detected first with a 1:5000 dilution of preabsorbed anti-Flu 
antibody in blocking solution overnight at 4°C. The Fast Red colour reaction was 
stopped by 2 fast washes in PBT followed by 4x3 minute washes at room temperature in 
PBT. After developing the first colour reaction, bound anti-Flu antibody was removed 
by washing embryos 6x15 minutes in lOOmM glycine, pH 2.2, 0.1% Tween20 at room 
temperature, rinsing 5x5 minutes in PBT, refixing in 4% paraformaldehyde/PBS for 30 
minutes at room temperature and washing again 3x5 minutes in PBT before repeating 
the blocking step with the anti-Dig antibody. After the second colour reaction was 
stopped as described before for the first colour reaction, embryos were stored in 4% 
paraformaldehyde/PBS at 4°C.
Antibody staining protocols 
Antibody staining with DAB as a substrate
Embryos up to 60hpf were stained using this protocol. Embryos to be antibody stained 
were dechorionated and fixed in 4% paraformaldehyde/PBS overnight at 4°C and then 
kept in PBSX at 4°C until needed. They were washed 2x5 minutes with PBSX [0.5% 
Triton-X (Sigma) in PBS], 4x30 minutes (2x30 minutes after in situs) in milliQ water, 
incubated in acetone for 7 minutes at -20°C and blocked for at least one hour in 
PBSDX [50ml 2xPBS pH7.3, lg BSA (Sigma), 1ml DMSO (Sigma), 0.5ml 10% Triton 
X-100 and milliQ water up to 100ml] containing 15pl/ml horse serum (Sigma) block. 
Primary antibody, anti-Hu (Monoclonal antibody facility, University of Oregon) was 
diluted 1:5000 in PBSDX containing 15pl/ml horse serum and the embryos incubated 
overnight at 4°C. On the following day embryos were washed 4x30 minutes in PBSDX, 
the biotinylated secondary horse anti-mouse/rabbit antibody diluted 1:5000 in PBSDX 
with 15pl/ml horse serum and the embryos incubated overnight at 4°C.
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The antibody was discarded, the embryos washed 4x30 minutes in PBSDX, incubated 
45 minutes in the diluted ABC reagent (Vectastain ABC Elite kit), washed 3x30 
minutes in PBSDX and 30 minutes in PBSX. The DAB substrate diluted in PBSX 
(14pl/ml) and the embryos incubated for 15 minutes. After transferring the embryos to a 
glass well plate 7pl hydrogen peroxide (Sigma) were added per 1ml diluted DAB 
solution. The stain was developed in the dark for 5 minutes up to a few hours. For long 
incubations it was necessary to add more hydrogen peroxide approximately every 10 to 
15 minutes. The development was finally stopped by rinsing the embryos several times 
in PBSX and embryos were kept at 4°C.
Antibody staining with a fluorescently labelled secondary antibody
This protocol was used for embryos older than 60hpf since the sensitivity of detection 
of structures deep within the tissue is greater with the fluorescent signal than with the 
DAB substrate.
Embryos were washed 3x5 minutes at room temperature in PBSX, 3x1 hour in milliQ 
water, preincubated in 0.75ml block [0.5% Triton X-100, 1% DMSO, 5% horse serum 
in PBSX] and incubated at room temperature overnight with the primary anti-Hu mouse 
antibody diluted 1:1100 in 0.75ml block.
The antibody was discarded, embryos rinsed in PBSX as described in the previous 
protocol, washed for 3x1 hour in PBSX and incubated at room temperature overnight 
with the secondary antibody, Alexa Fluor 546 rabbit anti mouse IgG (Molecular probes, 
Oregon), diluted 1:800 in 0.75ml block.
The antibody was discarded, embryos rinsed in PBSX, washed for 3x30 minutes in 
PBSX, transferred into 50% glycerol/PBS and incubated for 15 minutes. Embryos were 
analysed with an Eclipse E800 microscope (Nikon) using fluorescence microscopy 
(TRITC filter).
Antibody staining as a secondary stain after a standard in situ 
hybridisation
If an antibody stain was to be carried out as a secondary stain after an in situ 
hybridisation, the following procedures of the in situ protocol described above were 
modified. Dechorionated embryos were fixed in 4% paraformaldehyde/PBS at 4°C for a
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maximum of 24 hours. The duration of the proteinase K treatment on those embryos in 
the course of the in situ hybridisation was decreased to 15 minutes for 24hpf embryos,
25 minutes for up to 48hpf and 45 minutes for older stages). The in situ colour reaction 
product was slightly underdeveloped, so as not to mask any areas of weak antibody 
stain. At the end of the in situ protocol embryos were stored in PBT at 4°C ready for the 
antibody stain using either one of the two protocols described above.
Heatshock cDNA injection and rescue protocol
Plasmid DNA to be injected was isolated in a midiprep using the Wizard Plus 
Midipreps DNA Purification System (Promega) and further cleaned by adding an equal 
volume of phenol:chloroform (1:1) and then, to the supernatant an equal volume of 
chloroform. A third of the volume 7.5M Ammonium acetate and 2.5 volumes absolute 
ethanol were added to precipitate the plasmid DNA followed by 1.5pl seeDNA 
(Amersham) to facilitate the pellet’s visibility and tubes spun immediately at 13000 rpm 
at 4°C for 30 minutes. The pellet was washed with 1ml 70% ethanol, resuspended in 
50pl milli-Q water and the concentration estimated by comparing several dilutions of 
the plasmid construct to a quantitative DNA ladder (NEB). Embryos from crosses of 
heterozygous clsm618 were injected with 2-5nl 13ng/pl of the appropriate heatshock 
construct dissolved in milli-Q water at the 1-4 cell stage using a Nanojet II injector 
(Drummond Scientific Co.), incubated at 28.5°C at low density to recover and dead 
embryos removed after 6-8 hours. The injected volume was estimated by comparing the 
diameter of the bead of injected liquid with the diameter of a 1-cell stage embryo 
(approximately 700pm; Kimmel et al., 1995). Embryos were then heatshocked at 15-16 
hpf by incubating embryos at 37°C for 1 hour. They were scored for rescue at 48 hpf 
using a MZ12 dissecting microscope (Leica). Melanophore rescue was defined as the 
presence of at least one melanophore of wild-type morphology.
Data analysis
Interpretation of sequencing data
The most likely identity of isolated HMG box sequences and RACE PCR clones was 
determined by a BLAST search on http://www.ncbi.nlm.nih.gov/BLAST/. Direct
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comparison of the nucleotide or peptide sequence of two fragments was carried out with 
the use of the Pairwise BLAST analysis on
http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html. Multiple sequence alignments were 
performed using the multiple sequence alignment program of the GCG package 
(Genetics Computer Group, Wisconsin package, Version 8.0-Unix, September 1994). 
Overlapping sequence fragments were put together in contigs using the following 
programs of the GCG package: gelstart, gelenter, gelmerge, gelassemble and 
geldisassemble. A consensus sequence was created using gelview.
Statistical analysis of rescue experiments
The injection of heatshock cDNAs seemed to cause malformations in embryos of 
varying degree depending on the concentration of DNA injected and the time of 
heatshock. To determine the optimum amount of cDNA (13ng/pl) that could rescue the 
els phenotype to the highest degree possible whilst giving the least malformations a 
range of different concentrations (6ng/|_il, 13ng/pl, 25ng/pl and 60ng/pl each in 0.1% 
phenol red) of hs>c/^WTcDNA were injected, each heatshocked at 2 different time
points (early at 15-16hpf and late at 18-18.5hpf). The number of malformed wild-type
* • *and els embryos was recorded at 48hpf and statistically analysed. First, a % test (using
the Yates’ correction formula and one degree of freedom) was carried out on individual 
clsfWT pair datasets to determine whether the genotype influenced the degree of 
malformations. Since no significant difference was found at either 5%, 1% nor 0.1% 
level malformations did not vary with the genotype and hence for all subsequent 
analyses no distinction between els and WT malformations were made.
A single factor anovar analysis with two levels was used to determine whether there 
was a difference in malformation when the hs>cA^T or the equivalent amount of control 
plasmid pCS (without soxlO cDNA) was injected, whether malformation varied 
depending on the amount of cDNA injected, whether a heatshock increased 
malformations in general and whether the time of the heatshock was important. Finally, 
to test whether the presence of malformations had any effect on the probability of els 
embryos being rescued, a % test (using the Yates’ correction formula and one degree of 
freedom) was employed.
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Chapter 3 -  Cloning of a zebrafish sox10 homologue
Introduction
There are principally two approaches to identify the gene encoded by a mutant locus. 
Firstly by positional cloning which involves mapping the mutation to a critical interval 
on a chromosome followed by screening of Yeast artificial chromosome (YAC), 
Bacterial artificial chromosome (BAC) or PI-derived artificial chromosome (PAC) 
clones for open reading frames. The gene encoding the mutant locus can then be 
identified, for example by rescue experiments.
Alternatively, a candidate gene approach represents a more direct and potentially much 
faster method if a likely candidate gene is available. Here, this gene is cloned and tested 
by means of rescue experiments or presence of causative mutant lesions.
Since, as described in the Introduction chapter, a sox 10 homologue was considered a 
strong candidate for the els gene, the candidate gene approach was chosen.
Methods for cloning candidate genes
There are two approaches to clone such a candidate gene, by screening a cDNA library 
or by RT-PCR. Originally, both methods seemed equally suitable and hence were 
attempted in parallel.
At the time, there were only a few libraries available for zebrafish, but they 
included a XLAP cDNA library prepared from 19hpf zebrafish embryos (Appel and 
Eisen, 1998). This library has successfully been used to clone genes from zebrafish such 
as nacre (Lister et al., 1999). At 19hpf during zebrafish development, neural crest cells 
in the head and anterior trunk have entered the medial migration pathway, whereas crest 
cells in more caudal regions are still residing in a premigratory position. Both 
populations of cells in mouse embryos of equivalent stage would express Sox 10 
(Herbarth et al., 1998; Southard-Smith et al., 1998). Furthermore, expression would also 
be expected at this stage in the developing otic vesicle in concordance with mouse and 
chick data (Southard-Smith et al., 1998; Cheng et al., 2000; Watanabe et al., 2000). 
Thus, we attempted to identify a sox 10 homologue from the 19hpf cDNA library using a
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1.45kb fragment of mouse Sox 10 as a probe, kindly provided by Michelle Southard- 
Smith. This fragment has previously been used for a low stringency hybridisation 
demonstrating conservation of Sox 10 amongst multiple vertebrate species (Zooblot; 
Southard-Smith et a l, 1999). The protocol is based on a hybridisation in Church buffer 
at 50-55°C overnight and 3x5 minutes washes in 2xSSC, 1%SDS at 55°C (Southard- 
Smith, M., personal communication).
Initially, this approach was attempted using the published Zooblot protocol. Since 
technical problems persisted even after thorough optimisation of conditions this method 
proved unsatisfactory in our hands and will not be considered further here.
The RT-PCR approach carried out in parallel by then appeared to be a more 
promising method and hence efforts were focused on this second approach. We took 
advantage of the high degree of conservation of Sox genes to attempt to clone at least a 
fragment of a zebrafish sox 10 by RT-PCR. Success with this approach required 
consideration of three major factors, the primer sequences, the PCR protocol and the 
stage of embryonic tissue as a source of mRNA.
A fragment of Sox 10 was first cloned from mouse using degenerate primers against 
conserved regions located just within the 5’ and 3’ boundaries of the HMG box (Wright 
et al., 1993). Michael Wegner’s group then cloned a rat SoxlO homologue using primers 
designed against almost identical sites first published by Yuan et al. (1995). 69% of 
HMG box fragments isolated from a primary rat Schwann cell culture showed high 
identity to SoxlO (Kuhlbrodt et al., 1998a). Hence, we decided to attempt to isolate a 
zebrafish sox 10 homologue by RT-PCR using those degenerate primers and PCR 
protocol previously employed by Kuhlbrodt.
To prepare total RNA, we chose several stages during zebrafish development including 
19hpf, 24hpf, 5dpf and adult head and skin. The rationale behind choosing those stages 
was based on the mouse SoxlO expression pattern. In mouse, both premigratory and 
migrating neural crest cells express SoxlO (Herbarth et al., 1998; Southard-Smith et al., 
1998). In zebrafish embryos, cranial crest cells just caudal to the developing eye start to 
migrate subectodermally at 15-16hpf (Schilling and Kimmel, 1994). At 18hpf, some 
crest cells above somites 1-7 and anterior trunk crest cells have entered the medial 
migration pathway, whereas caudal to somite 9, the neural crest is in a premigratory 
stage. More posteriorly still, crest cells are still segregating from the neural keel (Raible 
et al., 1992). Thus, since neural crest cells of all premigratory and migratory phases are 
present, the 19hpf stage seemed an appropriate stage to use.
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At 24hpf, neural crest cells are still entering the medial pathway along almost the entire 
length of the axis, whereas some crest cells in the region above somites 1-5 have started 
migrating on the lateral pathway (Raible et al., 1992). This stage appeared suitable since 
premigratory neural crest and crest cells migrating on both pathways were present. Cells 
on the lateral pathway give exclusively rise to pigment cells (Raible and Eisen, 1994), a 
cell-type severely affected in els mutant embryos. Furthermore, counts of neural crest 
cells on the lateral pathway in els mutant embryos show a 95% reduction in number 
compared to wild-type siblings indicative that els is functioning by this stage (Kelsh et 
al., 1996).
Finally, since in mouse SoxlO is maintained in certain crest derivatives and the 
developing ear during later stages, we chose two later stages as sources for RNA.
The 5dpf larval stage was chosen, because it represents the latest ethically acceptable 
larval stage to use, since larvae now start to actively feed and thus are protected under 
UK law.
In adult mice and humans, SoxlO/SOXlO is known to be expressed in Schwann cells in 
the peripheral nervous system (PNS) and in oligodendrocytes in the brain (Kuhlbrodt et 
al., 1998a; Kuhlbrodt et al., 1998b; Pusch et al., 1998). Hence, total RNA from adult 
brains was prepared. Finally, it was reported that melanocytes in mice express SoxlO 
(Southard-Smith et al., 1998) and hence, adult zebrafish skin containing pigment cells 
was included.
The chosen strategy aimed to isolate the HMG box of zebrafish soxlO, since this 
region is the most highly conserved. However, this general conservation across all Sox 
genes might make it very difficult to reliably identify a particular homologue across 
species. The sequence differences between two members of the same subgroup are very 
limited and hence, it would be unreliable to distinguish a sox 10 homologue from other 
subgroup E members based on the HMG sequence alone.
Thus, to confirm the identity of a suspected sox 10 fragment, we anticipated having to 
obtain a larger fragment outside the HMG box region employing the RACE-PCR 
(Rapid Amplification of cDNA Ends-Polymerase Chain Reaction) technique. Even with 
the full length clone in hand one would have to be careful in assigning an identity. Since 
fewer Sox gene sequences were available for comparison, a fair number of homologues 
published in Genbank were misclassified and only recently reassigned correctly. For 
example, the mouse gene originally published as a Sox21 homologue (Tani et al., 1997) 
has now been confirmed to be a misnamed SoxlO (Pusch et al., 1998). Likewise, trout
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SoxPl reliably clusters with other known Sox8 homologues. Thus, extensive 
phylogenetic analysis would be necessary to assign confidently an identity to any 
cloned Sox gene homologue.
Results
Cloning of a sox10-\\ke HMG box from zebrafish by RT-PCR
Two RT-PCR strategies were considered to clone a soxl0-like HMG box. Firstly, soxlO 
specific primers could be designed. At the time, only mammalian SoxlO homologues 
from human, mouse and rat were published in Genbank (Herbarth et al., 1998; 
Kuhlbrodt et al., 1998a; Pingault et al., 1998a; Southard-Smith et al., 1998). Conserved 
regions identified between the above mammalian genes might not necessarily show the 
same degree of conservation in fish. Hence, choosing suitable sites for primers with 
acceptable degeneracy was expected to be very unreliable and difficult.
The second strategy would involve amplification with primers in regions conserved 
across all Sox genes and subsequently identify a sox 10 homologue from the mixture. 
The use of such generic Sox gene primers had proven successful before in isolating 
SoxlO homologues from mouse and rat. Thus, this strategy seemed more promising and 
hence was chosen to clone a soxl 0-like HMG box from zebrafish by RT-PCR.
These primers, 5’ SoxlO and 3’Sox 10, (for sequences see Materials and Methods; Yuan 
et al., 1995) amplify a mixture of HMG box sequences from cDNA corresponding to 
Sox genes expressed at any particular stage during development (Figure 3.1). Fragments 
were then cloned, sequenced and aligned with previously characterised members of this 
gene family to identify a likely soxlO homologue.
Isolation o f  HMG box sequences cloned by RT-PCR from  cDNA o f  4 different 
developmental stages
Total RNA was prepared from 19hpf, 24hpf, 5dpf and adult brain and skin of AB wild- 
type zebrafish. The rationale behind choosing these stages has been described in detail 
in the Introduction to this chapter. RNA samples of each stage were quantified 
spectrophotometrically by measuring the absorption of a diluted aliquot of RNA at 




HMG box #   AAA A 3’
V 3’SoxlO V
5’UTR 3’UTR
Figure 3.1: The general structure o f a SoxlO homologue.
Start (ATG) and Stop (TGA) codons mark the beginning and the end of the coding 
region. The latter is preceeded by a 5’ untranslated region (5’UTR) and followed by a 3’ 
untranslated region (3’UTR). The degenerate primers, 5’Sox 10 and 3’Sox 10, are located 
just within the HMG box and were used to amplify HMG box sequences from various 
stages by RT-PCR.
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Stage 19hpf 24hpf 5dpf Adult tissues
■^260nm 0.062 0.156 0.258 0.019
A-280nm 0.042 0.076 0.111 0.011
i^ 260nm/i^ 280nm 1.48 2.05 2.32 1.73
RNA conc. 740ng/pl 1.87pg/pl 3.10pg/pl 760ng/pl
Hg RNA used 
per RT reaction
Ipg Ipg 2pg Ipg
pi cDNA used 
in PCR
2 pi 2 pi 2pl 2pl
ng PCR product 
cloned
~200ng ~100ng ~100ng ~350ng
Total white 
colonies
64 -150 -100 83
Colonies grown 
up
19 (29.7%) 18 (-10%) 20 (-20%) 29 (34.9%)
Positive clones 18(94.7%) 15(83.3%) 13 (65.0%) 29 (100%)
Clones
sequenced
10 (55.6%) 12 (80%) 12 (92.3%) 13 (44.8%)
Sox genes 9 (90%) 10 (83.3%) 6 (50%) 11 (84.6%)
No homol. to 
Sox genes
1 (10%) 2(16.7%) 6 (50%) 2(15.4%)
Table 3.1: Summary of results from cloning of HMG boxes by RT-PCR using generic 
Sox gene primers
For each developmental stage, this table lists spectrophotometric measurements of 
absorption of 260nm and 280nm wavelength light by total RNA samples. The 
concentration of each sample was calculated using the A260nm reading. The ratio 
A^ omr/A^ sonm* ideally close to 2.0, provides an estimate for purity of the RNA sample. 
The amounts of pg total RNA included in each reverse transcription (RT) reaction, the 
numbers of pi cDNA reaction out of a total of 200pl used per PCR reaction and the 
amount of PCR product in ng, estimated by agarose gel electrophoresis, which was 
ligated into 25ng pGEM-T vector, are listed. In each case, the entire ligation reaction 
was transformed. The table summarises the number of white colonies obtained from 
each cloning experiment and how many of those were chosen for plasmid 
minipreparations. It also lists the number of constructs which contained inserts of the 
expected size (positive clones), how many of those were sequenced and the proportion 
of HMG box sequences identified from each stage, conc., concentration; homol., 
homology.
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wavelength gave an estimation of protein contamination. When comparing the two 
readings A260/A280 the ratio was usually close to 2.0, typical for RNA of high purity. 
(Table 3.1). Gel electrophoresis further showed that the RNA was of good quality. This 
was judged by two criteria, presence of three strong bands corresponding to the 3 
ribosomal rRNA types (23 S, 16S and 5S) and a slight smear indicative of mRNA 
transcripts (Figure 3.2A, 3.4A and B). Total RNA isolated from adult tissues contained 
a lot more genomic DNA compared to the other stages (Figure 3.4A). Nevertheless, this 
RNA was used, because the short extension time during the amplification reaction 
would likely bias against a longer genomic product, if an intron disrupted the HMG 
box. Even if such a product was obtained it could be distinguished by its larger size due 
to the intronic insertion. To control for amplification from genomic DNA, a reverse 
transcription reaction without the reverse transcriptase was set up alongside (“-RT”). 
Indeed, no product was obtained in the subsequent RT-PCR reaction even with 2pl of 
the “-RT” control reaction (Figure 3.4C).
From each stage, l-2pg of total RNA (Table 3.1) were reverse transcribed as described 
in the Materials and Methods. Six equivalent RT-PCR reactions were set up with a 
suitable amount of cDNA, usually 2pl, previously determined by a pilot RT-PCR. 
Increasing the amount of cDNA also increased the amount of RT-PCR product (Figure 
3.3 A and 3.4C). The rationale behind setting up 6 reactions was to allow pooling of the 
PCR product so as to have sufficient purified product for cloning. All experimental 
reactions amplified the expected single product of 204bp, which was never observed in 
the "no cDNA" control (-ve lane) for 24hpf and 5dpf stages (Figure 3.2B, 3.3A). A 
barely visible band was observed in the “no cDNA” control for the 19hpf stage and 
adult tissues (Figure 3.4C). Most likely this indicates a DNA contamination whilst 
setting up this control reaction or a very slight DNA contamination of one or both 
primers. However, bands derived from experimental reactions were much stronger in 
comparison. Control reactions containing only one of the primers (“5s SoxlO only” and 
“3’Sox 10 only”) or none of the primers (“no primers”) were included in RT-PCRs from 
adult tissues and 19hpf stage. As expected, no product was amplified in these control 
reactions (Figure 3.4C).
The remainder of all PCR reactions were pooled, purified using the QIAquick PCR 
Purification Kit (Qiagen) and directly ligated into the pGEM-T vector. Constructs were 









Figure 3.2: RT-PCR from 5dpf zebrafish embryos using generic Sox primers 
(A) The quality o f total RNA from 5dpf larvae and 24hpf zebrafish embryos was good 
as judged by the presence o f the 3 ribosomal RNA bands, 23S, 16S and 5S (asterisk), in 
combination with a slight background smear corresponding to mRNA transcripts. lOObp 
M, lOObp marker (Promega). (B) Samples o f the RT-PCR reactions are shown. A single 
specific product (arrowhead) o f the expected size (204bp) was obtained in all 
experimental reactions (lanes 1-6), but not in the “no cDNA” control (-ve lane). These 
204bp products corresponded to HMG box sequences. Sizes were judged by 
comparison to a lOObp marker (lOObp M, Promega). Concentration and purity was 
estimated by spectrophotometric determination of absorption at 260nm and 280nm. (C) 
Samples o f plasmid DNA minipreparations were digested with BamHl to test the size of  
the insert. Here, 9 such digests are shown (lane 1-9), together with a lOObp marker 
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Figure 3.3: RT-PCR from 24hpf zebrafish embryos using generic Sox primers 
(A) The amounts o f cDNA were tested in RT-PCR reactions with 2pl cDNA (lane 2) 
producing a stronger band of the correct size (arrowhead) than with lp l cDNA (lane 1). 
No such band was observed in the “no cDNA” control (-ve lane). To judge band sizes, a 
lOObp marker (lOObp M, Promega) was run alongside experimental samples. Lanes 
marked with a dash, /, are irrelevant to this experiment. (B) Plasmid minipreparations 
were digested with BamHl to test for presence and size o f inserts. All, but clone 7 and 
13 contain inserts o f the expected 204bp size (arrowhead). The size o f the vector 
(asterisk) and insert bands were judged by comparison to a lOObp marker (lOObp M, 
Promega).
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Figure 3.4: RT-PCR from 19hpf zebrafish embryo and adult tissues using generic Sox 
primers
(A, B) The quality of total RNA from heads and skins of 9 adults (A) and 19hpf stage 
embryos (B) was good as judged by the presence of the 3 ribosomal RNA bands, 23 S, 
16S and 5S (asterisk), in combination with a slight background smear corresponding to 
mRNA transcripts. A large amount of genomic DNA (arrowhead) was present in the 
RNA preparation from adult tissues (A). The lane marked with a dash, /, is irrelevant to 
this experiment (A). A rough size estimate was provided by a lOObp marker (lOObp M, 
Promega). (C) Samples of RT-PCR reactions and controls are shown alongside a lOObp 
marker (lOObp M, Promega). RT reactions were set up with RNA from 19hpf embryos 
and adult tissues. RT-PCR reactions (+RT lanes) using 2pl cDNA (lanes “2”) instead of 
lp l cDNA (lanes “1”) produced stronger bands of the expected 204bp size (arrowhead). 
Control reactions for the reverse transcription step are labelled “-RT”, because no RT 
enzyme had been included. As expected, no band was observed in the “-RT” control 
reaction from adult tissues (adult, -RT). However, a strong product was obtained in the 
equivalent control reaction from the 19hpf stage (19hpf, -RT), which is most likely 
derived from an amplification off genomic DNA. Control reactions for the RT-PCR 
amplification included reactions with only one of the primers (lanes “5’SoxlO only” and 
“3’Sox 10 only”), none of the primers (lane “no primers”) and no cDNA (lane “no 
cDNA”). As expected, no products were observed in single primer only and no primer 
controls. However, a faint band was seen in the “no cDNA” control, which might be 
due to slight contamination of a primer solution or any other PCR reagent. (D) Samples 
of plasmid DNA minipreparations were digested with Pvull to test the size of the 
inserts. Here, 4 such digests from the 19hpf stage and 7 from the adult tissue cloning are 
shown. All but clone 11 contain an insert of the expected 650bp size (arrowhead) 
compared to a 1 kb marker (lkb M, Promega). Clone 4, renamed SoxS4, was later shown 
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plated on LB plates containing ampicillin, isopropylthiogalactoside (IPTG) and 5- 
Bromo-4-chloro-3-indolyl p-D-galactopyranoside (X-gal) for blue/white selection. The’ 
pGEM-T vector contains a gene conferring ampicillin resistance to cells harbouring the 
plasmid and thus enabling them to grow on ampicillin plates. Usually, 60-150 white 
colonies likely to contain plasmids with inserts were obtained per transformation and a 
convenient number (10-20 colonies) picked for plasmid minipreparations using the 
alkaline lysis method (Materials and Methods, Table 3.1). Preference was given to those 
colonies growing amongst blue ones indicating that the blue/white selection was 
working in that area of the plate. Furthermore, very small white colonies grown at high 
densities were avoided since they might represent satellite colonies. These false 
positives do not contain the plasmid and can only grow in ampicillin depleted zones 
found in close proximity to ampicillin resistant clones.
Plasmid constructs derived from 24hpf and 5dpf stage RNA were analysed by 
restriction digestion with BamRl (Promega). There are BamHl recognition sequences 
engineered into each primer, 5’Sox 10 and 3’Sox 10. Digestion of a positive clone with 
this enzyme releases the ligated HMG box fragment, which is recognised as a band of 
204bp on an agarose gel together with a 3018bp band, corresponding to the remaining 
vector (Figure 3.2C and 3.3B). Of 18 white colonies grown up from the 24hpf stage, 15 
(83.3%) contained an insert of the correct size. This was also true for 13 out of 20 
(65%) white colonies derived from the 5dpf stage.
Analysis of clones from the 19hpf and adult stage was performed in a similar way, 
except that, for trivial reasons, an alternative restriction enzyme, PvuII (Promega), was 
used to excise the insert. PvwII recognition sites are located more distantly from the 
integration site and thus release an insert 436bp bigger than the cloned fragment. Thus, 
positive clones are recognised by a 640bp band in combination with a 2560bp band 
corresponding to the remaining vector (Figure 3.4D). All of 29 (100%) constructs 
derived from adult tissues and 18 out of 19 (94.7%) from the 19hpf stage contained an 
insert of the correct size.
12 positive clones from each of the 24hpf and 5dpf stages, plus 10 from 19hpf and 13 
from adult stages were manually sequenced. Preference was given to clones digested to 
completion, which might indicate a cleaner plasmid minipreparation. Furthermore, 
constructs releasing additional bands were avoided. Preliminary assignment of sequence 
homologies of positive clones to published Sox genes were determined by a BLASTN 
search of the Genbank database (Table 3.2). Vector and primer sequences were removed
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prior to the alignment. The quality of sequence of one insert cloned from the 5dpf stage 
was insufficient for analysis and 5 additional clones did not show any homology to Sox 
genes outside the primer sites. Two clones from adult tissues and the 24hpf stage and 
one clone from the 19hpf stage were also discarded for the same reason. One clone 
including its primer sites isolated from the 19hpf stage showed a high percentage 
nucleotide identity (119 out of 146bp, 81.5%) to rat SoxlO. This clone, SoxS4, was thus 
resequenced 3 times to improve sequence quality. The consensus sequence was then 
used for further investigations.
Sequence analysis o f  the putative soxlO-like HMG box clone SoxS4
Although very similar to SoxlO, we wanted to examine whether SoxS4 might be a sox9 
or sox8 homologue. This concern is justified, since all 3 genes show high similarities 
throughout the HMG box. To address this question we made sequence comparisons 
based on the nucleotide sequence using BLASTN and based on the predicted protein 
sequence using BLASTX (Figure 3.5). Both results were suggestive of a soxlO identity, 
since SoxS4 matched SoxlO homologues slightly better than Sox9 homologues, Soxl O's 
closest relative. In sequence alignments with HMG domains of known members of the 
subgroup E, SoxS4 was 94.1% identical to SoxlO, but only 92.6% identical to Sox9 and 
91.2% identical to Sox8 homologues (Figure 3.6). The HMG domain has been defined 
by convention as the stretch of 80 amino acids starting with the highly conserved 
residues PHVKRP and ending with residues RRRKNG in SoxlO homologues and 
RRRKSV in Sox8 and Sox9 homologues (Kuhlbrodt et al., 1998a; Pusch et al., 1998; 
Bowles et al., 2000). The amino acid identities in the alignments with clone SoxS4 and 
other known Sox proteins were calculated in the overlapping region. Primer sequences 
(MNAFMVW and PDYKYQP) used to identify SoxS4 were included in the alignment 
since the amino acid sequence they encode is fully conserved across SoxlO proteins and 
very highly conserved in all known Sox proteins (Bowles et al., 2000). This assumption 
was later confirmed to be true for SoxS4 when the full cDNA had been cloned and 
sequenced (Figure 3.17). Hence, amino acid identities were calculated between residue 
7 (M, methionine) and 74 (P, proline) (Figure 3.6).
To further test the identity of clone SoxS4, its sequence was aligned with the HMG 
domains of the two zebrafish paralogues sox9a and sox9b, which were available to us 
prior to publication (Chiang et al., 2001; Figure 3.6). This analysis clearly showed 
that SoxS4 was equally similar to both zebrafish Sox9 sequences, and less related to
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Table 3.2: Composition of Sox HMG box sequences derived from different stages by 
RT-PCR reactions using generic Sox primers.
The table summarises tentative identities of isolated Sox-like sequences. RT-PCR 
reactions were set up from total RNA derived from 19hpf and 24hpf whole zebrafish 
embryos, whole 5dpf larvae and adult tissues (brain and skin). The first two columns 
describe the number of sequenced clones showing homologies to Sox genes and their 
proportion of total Sox-like clones. Column 3 and 4 describe the best matching sequence 
to the isolated HMG box fragment obtained from a BLAST search and the extent of 
sequence identity. Numbers in brackets represent the length of the isolated fragment 
after vector and primer sequences were removed. The ratio corresponds to the number 
of nucleotides of the isolated clone which are identical to the best matching sequence. 
For example, one 178bp clone isolated from adult tissue exhibited 155 nucleotides 
identical to zebrafish soxllb  over a region of 161bp of the soxllb  sequence. The E 
value in column 5 decreases exponentially with the significance of a match. Hence, with 
an E value of 1 assigned to a BLAST result, one might expect to see one sequence 
match with a similar score just by chance. It thus represents a probability that the 
tentative identity assigned in column 3 is a true match. Finally, the last column assigns 
the most likely identity of the isolated clone to a zebrafish homologue.
LG27, an Eublepharis macularius (leopard gecko) derived Sry-related sequence, and the 
SoxB2 from Strongylocentrotus purpuratus (sea urchin) have not been renamed 
according to the Sox gene nomenclature. However, LG27 shows similarities to 
mammalian Sox4 homologues and SoxB2 to Xenopus Sox2.
One clone derived from the 19hpf stage showed high similarity to Sox 10 homologues. It 
was renamed SoxS4 and investigated further.
Chelydra serpentina (Chelydra), Snapping turtle; Danio rerio (D. rerio), zebrafish; Ovis 
aries (O. aries), sheep; Strongylocentrotus purpuratus (S. purpuratus), sea urchin; 






























1 11.1% D. rerio sox llb 155/161 (178) 3c-64 S ox llb
1 11.1% mouse Soxl3 75/84(190) l e 17 Soxl3
1 11.1% human SOX4 25/27(135) 1.4 Sox4
1 11.1% LG27 45/54(141) 0.37 Sox4?







1 16.7% human SOX4 99/115(115) 2e*°8 Sox4
1 16.7% human SOX6 43/44 (202) 6e-lj Sox6
1 16.7% D. rerio sox31 18/18(188) 9.1 Sox 31





















S o x ll
1 10% O. aries Sox2* 123/148 (219) 4e*>* . Sox2
1 10% D. rerio sox31 132/136(181) 6e'56 Sox 31





2 22 .2% mouse Soxl3 112/134(192)
92/110(197)
2e'16 Sox/3
1 11.1% rat Sox 10 119/146(198) l e 27 SoxlO
1 11.1% D. rerio soxl lb 146/152(151) 4e-63 S ox llb
1 11.1% Chelydra Sox5 32/35 (125) 1.3 Sox5
1 11.1% Human SOX6 32/33 (148) 2c-06 Sox6
1 11.1% S. purpuratus SoxB2* 22/23 (126) 1.3 SoxB2
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Sequences producing significant alignments: Score
sp|009141|SX21 MOUSE TRANSCRIPTION FACTOR Sox-21 (TRANSCRIPTION... 120
embICAA04 4 85| (AJ001029) SoxlO protein [Rattus norvegicus] 120
gi13264586 (AF047043) Sox-10 protein [Mus musculus] 120
emb|CAA04576 1 (AJ001183) SOX10 protein [Homo sapiens] 120
qi|3264588 (AF047389) Dominant megacolon mutant Sox-10 protein ... 120
gi|2826523 (AF017182) putative transcription factor; SoxlO [Mus... 120
sp|P48434|SOX9 CHICK TRANSCRIPTION FACTOR Sox-9 gi11589736 (Ul... 118
dbj1BAA252961 (AB012236) Sox9 [Gallus gallus] 118
sp|018896[SOX9 PIG TRANSCRIPTION FACTOR Sox-9 gi|2554931 (AF02... 118
sp|P48436ISOX9 HUMAN TRANSCRIPTION FACTOR SOX-9 gi|1082721|pir... 118
gb[AAD17974I (AF106572) Sox9 [Alligator mississippiensis] 118
pir| |S52469 Sox9 protein - mouse 118
dbjIBAA24 365| (AB006448) Sox9 [Oncorhynchus mykiss] 116
gi13126870 (AF061784) Sox9 homolog [Calotes versicolor] 116
pir| |S68425 SoxPl protein - rainbow trout gi11199770|dbj|BAAll... 115
sp|Q04888|SX10 MOUSE Sox-10 PROTEIN gi|423573|pir||S30242 soxl... 99
gi11575717 (U70441) SoxlO [Mus musculus] 99
sp|Q04887|SOX9 MOUSE TRANSCRIPTION FACTOR Sox-9 gi|423577|pir|... 96
sp|Q04 886|SOX8 MOUSE Sox-8 PROTEIN gi|423576|pir||S30246 sox8 ... 94
sp|009141|SX21 MOUSE TRANSCRIPTION FACTOR Sox-21, TRANSCRIPTION FACTOR Sox-M
gi11872475 (U66141) transcription factor Sox-M [Mus 
musculus] Length = 533 
Score = 120 bits (298), Expect = le-27
Identities = 59/66 (89%), Positives = 62/66 (93%), Gaps = 2/66 (3%)
Frame = +1
SoxS4: 1 MNAFM-FGQAGR-KLRDQYPHLHNAELSKTLGKLWRLLNETDKRPFIEEAERLRKQHKKD 174 
MNAFM + QA R KL DQYPHLHNAELSKTLGKLWRLLNE+DKRPFIEEAERLR QHKKD 
Sox21: 202 MNAFMVWAQAARRKLADQYPHLHNAELSKTLGKLWRLLNESDKRPFIEEAERLRMQHKKD 261
SoxS4: 175 YPDYKYQP 198 
+PDYKYQP 
Sox21: 262 HPDYKYQP 269
Figure 3.5: The preliminary SoxS4 sequence aligns with subgroup E Sox proteins in a 
BLASTX search.
BLASTX compares the given nucleotide sequence in all six reading frames to peptide 
sequences in the database. Even the preliminary SoxS4 sequence obtained from the first 
read shows higher amino acid identities to known SoxlO than Sox9 or Sox8 
homologues. The mouse Sox21 sequence is homologous to and now recognised as a 
mislabelled SoxlO (Pusch et al., 1998). Subsequently, the SoxS4 fragment was 
resequenced several times on both strands, which resolved all mismatches to mouse 
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Figure 3.6: Alignments o f the 
confirmed SoxS4 sequence with 
published members o f subgroup E
Multiple sequence alignments were 
produced with Pileup (gcg Package, 
see Materials and Methods) and 
regions o f identity shaded in black 
(Genedoc). Amino acid identities 
were calculated between residues 7- 
74.(A) Pileup o f SoxlO homologues 
reveals slightly higher identity o f  
SoxS4 to this group (94.1%) than 
other closely related Sox genes. (B) 
Pileup o f SoxS4 with Sox9 
homologues (92.6% identity). (C) 
Pileup o f SoxS4 with Sox8 
homologues (91.2% identity). (D) 
Pileup o f SoxS4 with zebrafish 
sox9a and sox9b (92.6% identity) 
showing that SoxS4 is indeed not a 
zebrafish sox9, the closest relative 
to soxlO. It is noteworthy that the 
tentative identity o f clone SoxS4 as 
a soxlO homologue rests on the 
conserved residue D at position 48. 
c, chicken; h, human; m, mouse; r, 
rat; t, trout.
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either of them than they were to each other. Thus, this result argued against the 
possibility that SoxS4 was a sox9 homologue and further supported the identity of SoxS4 
as a soxlO clone.
Cloning of a full length soxlO homologue by RACE PCR
SoxS4 showed great promise as a true soxlO homologue, but it was necessary to extend 
the analysis to a full length cDNA. It was important to demonstrate a high degree of 
conservation outside the DNA binding domain. Furthermore, this larger fragment could 
also be used as an in situ hybridisation probe. If the cloned gene represented a sox 10 
homologue, its expression pattern would be expected to be reminiscent of mouse SoxlO 
(Chapter 4).
RACE-PCR cloning strategy
The common approaches to cloning a full length cDNA are either screening a cDNA 
library or extending a previously cloned fragment of the gene of interest by RACE PCR 
(Rapid Amplification of cDNA Ends-Polymerase Chain Reaction). The RACE PCR 
approach was chosen, since difficulties were experienced previously with library 
screens.
We chose the widely used SMART RACE PCR Kit (Clontech), which uses the 
following strategy to clone a 5’RACE product (Figure 3.7). First strand synthesis is 
primed using an oligo(dT) based primer (5’cDNA Synthesis Primer, 5’CDS). After 
extending this primer, the Superscript II reverse transcriptase adds a short sequence of 
cytosines (dC) to the 3’ end of the first cDNA strand. The SMART oligo supplied in the 
kit anneals to this region and thus serves as an extended template for the reverse 
transcriptase during its subsequent synthesis of the antisense cDNA strand. This is 
important, because DNA polymerases in PCR reactions require a primer presenting a 3’ 
hydroxyl group for DNA synthesis. Without the SMART oligo extension, the far 5’end 
of the gene would be lost in subsequent cycles of PCR amplification.
During the first round of 5’ RACE PCR, the RNA/DNA hybrid is denatured and the 3’ 
end of the Long Universal Primer (Long UP) anneals to the SMART oligo sequence 
incorporated into the first cDNA strand. This results in a double stranded cDNA 
template. Subsequent gene specific rounds of 5’RACE PCR amplify the region between 
a Short Universal Primer (Short UP), which binds to the 5’ end of the Long UP and a 5’
103
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SMART first-strand synthesis
SMART oligo 
5’- h m  GGG............ .
c c c  —
RNA/DNA hybrid 
5’- — m  GGQ...........





First round of gene specific PCR
5’-
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Second round of gene specific PCR
Short UP
















Figure 3.7: Flow Chart o f the 5’RACE PCR reaction, modified from the Clontech 
SMART RACE cDNA Amplification Kit User Manual.
The strategy behind the 5’RACE PCR reaction is explained in the text. 5GSP, 5’gene 
specific primer; Long UP, Long universal primer; Short UP, Short universal primer
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Gene Specific Primer (5GSP).
The strategy to clone a 3’ RACE product is based on a similar principle (Figure 
3.8). The 3’RACE cDNA population is synthesised by reverse transcribing mRNA 
using the 3’ cDNA Synthesis primer (3’CDS). It represents an oligo(dT) primer with the 
SMART oligo sequence linked to its 5’end. During the first round of gene specific 
3’RACE PCR, a fragment is amplified between the 3’ Gene Specific Primer (3GSP) and 
a Long UP, which recognises the SMART oligo sequence. Again, this enables the 
isolation of a full length 3’RACE clone by extending the mRNA sequence past the 
polyA-tail. During subsequent rounds of gene specific synthesis, amplification occurs 
between the 3GSP and a Short UP, which anneals to the 5’ end of the Long UP.
The SMART RACE PCR Kit contains all primers apart from the 5’ and 3’ Gene 
Specific Primers (5GSP and 3GSP). Thus, two gene specific and two nested gene 
specific primers located within the SoxS4 HMG box (Figure 3.9) were designed with the 
help of the primer design program Netprimer. Parameters in the program were adjusted 
according to guidelines in the Clontech RACE PCR manual, which included length of 
primer, melting temperature Tm, %GC content and number of GC clamps at the 3’end. 
%GC content is the percentage of guanines (dG) and cytosines (dC) in the primer 
sequence. Adenine forms 2 hydrogen bonds with thymine, whereas guanine forms 3 . 
hydrogen bonds with cytosine. Hence, a high %GC content increases the stability of the 
primer bound to the template and thus raises the Tm of the primer. The rationale for 
designing primers with at least 1 GC pair at the 3’end is based on the same principle. A 
GC clamp increases the strength of bonding of the primer to the DNA template at its 
3’end. This is important since the DNA polymerase can only synthesise the 
complementary strand once the primer’s 3’end has annealed.
The sequence of the primers can be found in the Materials and Methods and location of 
the primers is shown in Figure 3.9.
Control reactions supplied in the kit were set up to optimise the PCR program for our 
samples and PCR machine. They involved synthesis of control 5’ and 3’RACE cDNA 
populations and amplification of control products using supplied gene specific primers. 
Bands of the expected size were amplified from the control cDNAs (data not shown), 
but products were faint. As a result, the cycle number in the PCR program (Materials 
and Methods) was increased by 5 cycles as suggested in the kit’s guidelines.
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Figure 3.8: Flow Chart o f the 3’RACE PCR reaction, modified from the Clontech 
SMART RACE cDNA Amplification Kit User Manual.
The strategy behind the 3’RACE PCR reaction is explained in the text. 3’ GSP, 3’ gene 







5 ' S o x lO
1 ATGGAACGCG TTCATGGTGT GGGCGCAGGC CGCGCGCAGG AAACTGGCGG
N5GSP
51 ATCAATATCC GCACCTGCAC AACGCCGAGC TCAGCAAAAC ACTGGGGAAG
________ 3GSP__________ 5GSP_________ I
1 0 1  CTGTGGAGAC TGCTGAACGA GACGGATAAG CGGCCGTTTA TCGAGGAGGC 
N3GSP 3 ' S o x lO
1 5 1  CGAGCGCTTG AGGAAGCAGC ATAAGAAAGA TTATCCCGAG TACAAGTACC
2 0 1  AGCC
Figure 3.9: Location of gene specific primers used in the RACE PCR.
The figure shows the general structure of a SoxlO homologue including the DNA 
binding domain (HMG domain). Start and Stop mark the ends of the coding region, 
which is preceeded by a 5’untranslated region (5’UTR) and followed by a 3’untranslated 
region (3’UTR). The degenerate primers 5’Sox 10 and 3’Sox 10 in black were used to 
amplify the HMG box clone SoxS4 by RT-PCR. The 5’ gene specific primer (5GSP) and 
the nested 5’ gene specific primer (N5GSP) in red located towards the N-terminal of the 
HMG box clone SoxS4 were used to amplify a 5’RACE fragment. Similarly, the 3’ gene 
specific primer (3GSP) and nested 3’ gene specific primer (N3GSP) in blue towards the 
C-terminal end of SoxS4 were used to amplify a 3’RACE product.
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Cloning o f  the region 3 ’ to the HMG box by 3 ’RACE PCR
A schematic of the 3’RACE PCR Flow Chart is depicted in Figure 3.8.
The same total RNA sample as for the RT-PCR of the HMG box fragment was used to 
synthesise the 3’ RACE cDNA population. The integrity of the 19hpf stage total RNA 
was confirmed by gel electrophoresis beforehand (data not shown).
PCR and single primer control reactions were set up and examined by gel 
electrophoresis. Two very faint bands of approximately 1.2kb and 500bp length were 
observed, but none in the single primer control reactions (data not shown).
To test, whether these bands were specific products or just PCR artefacts, a nested PCR 
was set up with 1:25 diluted 3’RACE fragment. The nested PCR protocol amplified a 
product of approximately 1.8kb as expected (Figure 3.10) between the nested gene 
specific primer (N3GSP, Figure 3.9) and the universal primer mix (UPM) containing 
the Short and the Long UP. Bands of 1.2kb and 500bp were also observed again, but 
were thought to be too short to be full length products based on comparisons of human 
and mouse SOX10/Sox 10 sequences (Pingault et al., 1998a; Pusch et al., 1998).
This nested 3’PCR product was directly cloned into the pGEM-T vector and plasmids 
prepared from white colonies. Pvull digests were used to screen for clones with the 
expected insert of 2.25kb. Of 24 clones tested, 2 (clone B2 and C2) showed the correct 
sized insert (Figure 3.10). A full sequence was obtained using the automated sequencing 
facility provided in the Department of Biology and Biochemistry. The sequence of 
clones B2 and C2 were identical. A BLASTN search revealed homologies of the 
3’RACE clones to SoxlO genes. However, surprisingly, they aligned to a different 
region within the mouse SoxlO sequence than expected. Thus, the forward primer 
(N3GSP) had bound to a similar, but not identical, site approximately lOOObp further 
downstream in the corresponding mouse sequence (Figure 3.11). This finding also 
indicated that the 3’UTR (3’ untranslated region) in zebrafish was approximately 
lOOObp larger than in mice or humans. As expected, no significant sequence homology 
was observed in 3’UTRs between mammalian and zebrafish soxlO.
New gene specific reverse primers were designed within the 3’UTR (S9 and 
SI3, Figure 3.11) to clone the missing fragment linking the HMG box to the 3’RACE 
clone (B2 or C2). Fresh RT reactions were set up using 19hpf total RNA and either 
random hexamer primers or oligo(dT). PCR reactions with different combinations of 
primers and both cDNA populations were investigated including 5’SoxlO-S9, 5’SoxlO- 
S10, 5’Soxl0-S13, 3GSP-S9 andN3GSP-S9 (Materials and Methods). Generally, RT-
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Nested 3'RACE constructs
Figure 3.10: Cloning of the 3’ RACE product
(A) Agarose gel electrophoresis of nested 3’RACE PCR products. Nested PCR 
amplification was carried out between primers N3GSP (nested 3’ gene specific primer) 
and UPM (universal primer mix) (lane N l) and between primers N3GSP and NUPM 
(nested universal primer mix) (lane N2). In lane N l, a product of the expected 1.8kb 
size (arrow) was observed additionally to two non-specific products. The size was 
judged by comparison to a lkb marker (lkb M, Promega). No such band was observed 
in lane N2. Single primer control reactions were set up with UPM only (lane U), 
NUPM only (lane NU) and N3GSP only (lane N3). As expected, no products were 
obtained in these control reactions. (B) Samples of plasmid DNA minipreparation were 
digested with Pvull to test for inserts. A positive clone was expected to show bands of 
2.25kb (insert, arrowhead) and 3kb (linearised vector, asterisk). Two positives (lane B 
and C) out of a total of 24 digests were identified. Sizes were estimated by comparison 
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Figure 3.11: BLAST alignment of clone B2 and mouse SoxlO
(A) The schematic shows mouse SoxlO and the region of high homology to the 3’RACE 
PCR clone B2 (dashed box) corresponding to the C-terminus of the coding region. The 
B2 3’RACE clone did not overlap with the HMG box clone SoxS4. To clone the 
missing fragment, PCR amplifications were set up between primers 5’Sox 10, 3GSP (3’ 
gene specific primer) and N3GSP (nested 3’ gene specific primer) located within the 
HMG box and newly designed gene specific reverse primers S9 and SI3. Numbers refer 
to nucleotide positions in the mouse SoxlO gene. 5’UTR, 5’ untranslated region;
3’UTR, 3’ untranslated region. (B) Alignment of the homologous region ((TTT]) between 
3’RACE clone B2 and mouse SoxlO created with BLAST (Alignment of two 
Sequences, Materials and Methods). The region extends between nucleotide positions in 
mouse SoxlO 1565 and 1746, close to the stop codon at position 1748. This corresponds 
to the C-terminal coding region and, as anticipated, no significant identity was observed 
in the 3’UTR. Note that although the 3’RACE reaction was meant to amplify between 
3GSP and the 3’CDS (an oligo (dT) supplied in the SMART RACE Kit, Figure 3.8), the 
3GSP must have bound further downstream and produced an approximately lOOObp 
shorter product.
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PCR reactions from oligo(dT) cDNA populations produced fewer non-specific products 
and curiously the bands derived were consistently slightly larger than equivalent 
products amplified from random hexamer derived cDNA (Figure 3.12A). Reactions 
with 3GSP and N3GSP primers in combination with S9 produced a strong band of 
approximately 800bp. This was consistent with the size expected for this fragment from 
the equivalent SoxlO region in mouse or human (Pingault et al., 1998a; Pusch et al., 
1998). Furthermore, as expected, the 5’SoxlO-S9 product was approximately lOObp 
longer. This corresponds to the distance between the 5’GSP and the N3GSP primer 
within the HMG box. However, in all those reactions non-specific products were 
abundant. A second round of amplification was used to bias the reaction towards 
amplifying a specific product. Thus, nested PCR reactions were set up using the first 
round PCR reaction that contained the least number of non-specific products,
5’Soxl OS 13 (oligodT), and either 3GSP or N3GSP and SI 3 as nested primers. The 
same PCR program was used, but the annealing temperature was raised to 66°C. The 
size of the expected product was estimated to be approximately 1.5-2kb. When PCR 
reaction were analysed by gel electrophoresis, 3-4 products ranging between 1.5 and 
2.0kb were observed (Figure 3.12B). Since all 4 were equally strong products it was 
hypothesised that they might all represent specific products, maybe even different 
splicing variants. The entire reactions N3GSP-S9, 3GSP-S9, N3GSP-S13 and 3GSP- 
S13 were shotgun cloned into pGEM-T Easy vector. Five white colonies from each of 
the 4 transformations were chosen using criteria described in section 3.1. Plasmids were 
prepared using the Wizard Plus SV Miniprep DNA Purification System (Promega). 
After digestion with £coRI, 3 constructs, 15,19 and 20, contained inserts of 
approximately the correct size. Only clones 15 and 20 were sent off for automated 
sequencing (Figure 3.12C). Apart from a 109bp insertion in the 3’UTR of clone 15, 
which is not present in clone 20, they were identical to each other. Both clones showed 
high homology within the coding region to other SoxlO genes (for example, 88 out of 
104 nucleotides identical to chicken SoxlO). Only 51 out of 60 nucleotides were 
identical to the best matching Sox9 homologue from chicken. No homologies were 
observed to Sox8 homologues in a BLAST search.
With the help of the gelassemble program, clones SoxS4, 20 and B2 were assembled 
into a single contig (Figure 3.13).
I l l
Figure 3.12: Cloning of a fragment linking the HMG box region to the 3’RACE clone
(A) RT-PCRs with various primer combinations were tested by agarose gel 
electrophoresis for amplification of expected-sized fragments. Generally, reactions from 
oligo(dT) derived cDNA (“dT” lanes) gave cleaner products with less non-specific 
smear with all primer combinations than reactions from random hexamer derived cDNA 
(“Hex” lanes). Bands of approximately 800bp (arrowhead) in reactions containing 
primer S9 (lanes 3G-S9 and N3-S9) correspond to the estimated size of an expected 
product compared to a lkb marker (lkb M, Promega). Hex, Random Hexamers; dT, 
oligo(dT); 5’S, 5’SoxlO; 3G, 3GSP; N3, N3GSP. (B) Second round PCR amplification 
from the diluted 5’SoxlO-S13 first round PCR reaction (lane 5’S-S13) with nested 
primers 3GSP/N3GSP and S13 produced 4 equally strong bands (arrowheads), which 
all might represent specific products. (C) Samples of plasmid DNA minipreparations 
were digested with iscoRI to test for inserts. Here, 9 such digests are shown (lanes 12-15 
derived from the N3GSP-S13 PCR, lanes 16-20 derived from the 3GSP-S13 PCR), 
together with a lkb marker (lkb M, Promega). A positive clone was expected to show 
bands of 1.5-2.0kb (insert, arrowhead) and 3kb (linearised vector, asterisk). Clones 15, 
19 and 20 containing inserts of the expected size, but only clones 15 and 20 were 
sequenced.
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Cloning o f  the region 5 ’ to the HMG box by 5 fRACE PCR
A separate 5’RACE cDNA population was synthesised according to the manufacturer’s 
instructions (see Materials and Methods). This was necessary since the SMART oligo 
sequence was not incorporated into the 3’CDS primer (Figure 3.8), but used as a 
separate primer in the 5’RACE PCR extending the 5’end of the cDNA (Figure 3.7). 
RACE PCR reactions were set up amplifying the region between the SMART oligo 
supplied in the kit and the 5’gene specific primer (5GSP). Initial attempts failed to 
produce any bands. There are several possible reasons that could explain such a result. 
For example, the 5GSP primer might be poorly designed. The latter might cause 
mispriming to several locations on the template, to the SMART oligo primer or to the 
Long Universal Primer. However, it seemed more likely that the quality of the 5’RACE 
cDNA was insufficient. This could be due to difficulties of the reverse transcriptase to 
synthesise full length transcripts in the presence of high secondary RNA structures such 
as hairpins or GC rich regions.
Thus, it was decided to resynthesise the 5’RACE cDNA (“new”) with standard random 
hexamer primers instead of the 5’CDS (“old”). Both cDNA populations were then 
tested in RT-PCR reactions, whether RNAseH treatment and/or addition of 
dimethylsulphoxide (DMSO) to the PCR reaction would improve the amplification. 
RNAseH digests RNA in RNA/DNA hybrids and thus might improve primer binding 
conditions. Addition of DMSO might lead to a decrease in cDNA secondary structures 
and hence facilitate primer access to binding sites.
A product of the expected size was obtained from both “old” and “new” cDNAs when 
treated with RNAseH alone (see Figure 3.14A). Surprisingly, a similar product was 
obtained from the “old” cDNA population that had not been treated with either 
RNAseH or DMSO. To avoid non-specific by-products, nested PCR reactions were set 
up with 1:25 diluted first round PCR products and primers N5GSP and UPM. Agarose 
gel electrophoresis of samples showed clean products of approximately 850bp and 
800bp (Figure 3.14B). PCR products derived from one of each cDNA reaction, “-R-D, 
o” and “+R-D, n” were cloned into pGEM-T Easy vector. 5 out of 10 plasmid 
minipreparations tested contained an EccRl fragment of the correct size (Figure 3.14C). 
Two constructs (32 and 62) were sequenced and their sequences matched perfectly, 
although clone 32 had a 26bp 5’extension compared with clone 62. When assessed in a 
BLAST search, clones 32 and 62 showed high identity to regions of human SOXIO 
(161/183bp identical) and human SOX9 (160/183bp identical) corresponding to the
114
Figure 3.13: Schematic diagram showing the overlap of soxlO-like fragments of clones 
32, SoxS4, 20 and B2
(A) Schematic diagram of overlapping fragments. Numbering refers to nucleotide 
positions in individual clones. Clone 15 and 20 were identical apart from a 109bp insert 
in clone 15. The site of insertion in clone 20 is indicated. (B) The three regions of 
overlap are shown. Clone 32 overlaps with clone SoxS4 over a region of 73bp in the N- 
terminal region of the HMG box ( m ), whereas clone SoxS4 overlaps with clone 20 in 
the 108bp C-terminal region of the HMG box (£2). Clones 20 and B2 align completely 
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Figure 3.14: Cloning of the 5’RACE PCR fragment
(A) Multiple RT-PCR reaction conditions were evaluated for amplification of expected 
5’ sox 10 fragments. RT-PCR were set up with 5’RACE cDNA (old, o) and cDNA made 
with Random Hexamer primers (new, n), with or without RNAseH (+R, -R) and with or 
without DMSO (+D, -D) treatment. A band of approximately the expected size (900bp) 
was observed in reaction lanes “-R-D, o” and “+R-D, o” (arrowhead), whereas in lane 
“+R-D, n” the product appeared to be slightly smaller (asterisk) compared to a lkb 
marker (lkb M, Promega). Two non-specific products were also observed in reaction 
“+R-D, o”. (B) Second round PCR amplification from “-R-D, o” and “+R-D, n” with 
nested primers N5GSP (5’ nested gene specific primer) and UPM (universal primer 
mix) obtained single products of the correct size. The nested product of reaction “-R-D, 
o” (arrowhead) was approximately 850bp, the band from “+R-D, n” approximately 
800bp (asterisk). As expected, no product was obtained in the control reaction without a 
DNA template (lane “-ve Ctrl”). A lOObp marker (lOObp, Promega) was used to judge 
sizes. A nested reaction from reaction “+R-D, o” was omitted due to presence of strong 
non-specific products. (C) Samples of plasmid DNA minipreparations were digested 
with EcoRl to test for inserts. Here, 10 such digests are shown (lanes 31-35 derived 
from “-R-D, o” PCR and lanes 61-65 derived from “+R-D, n” PCR), together with a 
lOObp marker (lOObp, Promega). Positive clones were expected to show bands of 
approximately 850bp (inserts, arrowhead) and 3kb (linearised vector, asterisk). Clones 
32, 33, 34, 35 and 62 were identified as likely positives and clones 32 and 62 were 
sequenced.
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HMG box region and the sequence just upstream. In comparison, only 79/91 bp were 
identical to human SOX8.
The sequence of the slightly longer 32 clone was used to assemble a consensus 
sequence of the full length cDNA (Figure 3.13 A).
Assembly o f  a fu ll length soxlO-//Atf cDNA
All sequences were assembled into a single 3231bp contig (Figure 3.13A) and the 
consensus sequence, called sox/0-like, deduced using the GCG package. The sequence 
of the 109bp insertion of clone 15 in the 3’UTR was included in the consensus sequence 
since its presence had been confirmed in the genomic sequence (T. Carney, pers. 
comm.). All sequence ambiguities were solved by sequencing both strands of all clones, 
32, 62, S4, 15, 20, B2 and C2 several times and where necessary, using internal primers 
to resolve persistently ambiguous bases. As will be described in chapter 6, the wild-type 
coding region, 1455bp (485 residues) in length, was additionally confirmed by 
sequencing 4 overlapping PCR fragments multiple times in the search for mutant 
lesions. The consensus sequence submitted to Genbank (accession number AF402677) 
is shown in Figure 3.15. A 5’UTR of 375bp preceeds the predicted open reading frame 
which is followed by a 3’UTR of 1398bp.
Sequence alignment with other soxlO homologues and phylogenetic 
analysis
To assign a definite identity to the soxl 0-like gene we used BLAST searches, multiple 
sequence alignments with closest homologues of the same subgroup and phylogenetic 
analysis.
Firstly, a BLASTX search with the complete predicted protein sequence reveals high 
amino acid identities to mouse SoxlO protein (266/435 residues) and less to mouse 
Sox9 (217/466 residues) and mouse Sox8 (192/437 residues).
ClustalW alignment of the full length predicted proteins and calculation of a sequence 
identity matrix (BioEdit program) shows that the isolated Soxl0-like clone shows 61% 
and 60% amino acid identity to mammalian and chicken SoxlO, respectively, but only 
about 40% identity to zebrafish Sox9 paralogues, mammalian Sox9 and trout and 
mammalian Sox8 homologues (Table 3.3).
Secondly, the Soxl 0-like predicted open reading frame appears to have all domains
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Figure 3.15: The cDNA sequence of a zebrafish soxlO-like homologue as published in 
Genbank, accession number AF402677 
The predicted 485 residue coding region extends between nucleotides 376 and 1833. The 
highly conserved DNA binding domain (HMG box) is found between nucleotides 691 and 
930. These 80 residues are marked in red. A 375bp 5’ untranslated region (5’UTR) is 
located N-terminal to the start of translation between nucleotides 1 and 375, whereas a 
1398bp 3’ untranslated region (3’UTR) at the C-terminus is found between 1834-3231. 
Although no attempt was made to investigate whether the cDNA was full length at the N- 
terminal end, the C-terminal end appears complete with a 28bp polyA-tail.
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1 GTTTTTTCTC GCTCTTCACA CAACGGGGCT CTTTAAGCCT CGACGCGCGA CACAGAGCAG GCATTCAGAG
7 1 CGCGAGCGAG GGGGCTGAAC CGACGGACTC TCGCGCTGGG CGGGCGACCT GCTGCACTGT AAAGTTTCCA
1 4 1 TCAGATCTAT ATTCTGAGGA AGACGGCGGA AGGATTCCTT CTGACAGAGT CGAGTCGTTT GAAAAGAACT
2 1 1 GTTAAAGTTT CACTGGATGA TCTTAAATAA TAAACAAAAG CACAATTATT TTACAAGAAA AAAACATTTG
2 8 1 AGAAGTATAA ATTAATACAT TTATATTTAA AATAAAATTT AAGTGAGGAA ATTAAACCTA CCGAAGTCAC
3 5 1 CTGTGGCCGC AGAACTAGTG GACCGATGTC GGCGGAGGAG CACAGCATGT CGGAGGTGGA AATGAGTCCC
1 M S A E E H S M S E V E M S P
4 2 1 GGGGTGTCGG ACGATGGGCA CTCCATGTCC CCTGGTCACT CGTCGGGCGC TCCCGGTGGC GCGGACTCCC
16 G V S D D G H S M S P G H S S G A P G G A D S
4 9 1 CTCTGCCCGG TCAGCAGTCT CAGATGTCCG GGATCGGGGA TGATGGAGCC GGTGTCTCCG GCGGGGTCTC
39 P L P G Q Q S Q M S G I G D D G A G V S G G V
5 6 1 GGTGAAGTCC GACGAGGAAG ATGACCGGTT CCCCATCGGC ATCCGCGAGG CGGTCAGTCA GGTGCTGAAC
62 S V K S D E E D D R F P I  G I R E A V S Q V L N
6 3 1 GGGTACGACT GGACGCTCGT GCCCATGCCC GTGCGCGTGA ACTCGGGCAG CAAGAGCAAA CCGCACGTCA
86 G Y D W T L V P M P V R V N S G S K S K P H V
7 0 1 AGCGGCCGAT GAACGCGTTC ATGGTGTGGG CGCAGGCCGC GCGCAGGAAA CTGGCGGATC AATATCCGCA
1 0 9 K R P M N A  F M V W A Q A A R R K L A D Q Y P
7 7 1 CCTGCACAAC GCCGAGCTCA GCAAAACACT GGGGAAGCTG TGGAGACTGC TGAACGAGAC GGATAAGCGG
1 3 2 H L H N A E L S K T L G K L W R L L N E T D K R
8 4 1 CCGTTTATCG AGGAGGCCGA GCGCTTGAGG AAGCAGCATA AGAAAGATTA TCCCGAGTAC AAGTACCAGC
1 5 6 P F I E E A E R L R K Q H K K D Y P E Y K Y Q
9 1 1 CACGTCGACG CAAGAACGGC AAACCGGGTT CCAGCTCAGA GGCCGACGCC CACTCTGAGG GTGAGGTCAG
1 7 9 P R R R K N G K P G S S S E A D A H S E G E V
9 8 1 CCACAGCCAA TCGCATTACA AGAGCCTGCA CCTGGAGGTG GCGCACGGCG GGGCTGCAGG GTCACCATTG
2 0 2 S H S Q S H Y K S L H L E V A H G G A A G S P L
1 0 5 1 GGTGATGGAC ACCACCCTCA CGCTACAGGT CAGAGTCACA GCCCTCCAAC GCCCCCTACC ACCCCCAAGA
2 2 6 G D G H H P H A T G Q S H S P P T P P T T P K
1 1 2 1 CGGAACTGCA GGGAGGAAAA TCAGGCGAGG GCAAGCGTGA GGGCGGAGCC TCTCGGAGTG GACTGGGGGT
2 4 9 T E L Q G G K S G E G K R E G G A S R S G L G
1 1 9 1 GGGAGCAGAT GGAAGCTCCG CCTCATCGTC TGCCAGCGGG AAACCGCACA TCGACTTCGG TAACGTGGAC
2 7 2 V G A D G S S A S S S A S G K P H I D F G N V D
1 2 6 1 ATTGGCGAAA TCAGCCATGA CGTGATGGCC AACATGGAGC CGTTCGACGT GAACGAGTTC GACCAGTATC
2 9 6 I  G E I  S H D V M A N M E P F D V N E F D Q Y
1 3 3 1 TCCCACCCAA TGGCCACCCG CAGGCGTCCG CCACTGCCAG CGCAGGATCT GCAGCGCCAT CGTATACATA
3 1 9 L P P N G H P Q A S A T A S A G S A A P S Y T
1 4 0 1 CGGCATCTCC AGCGCGCTAG CGGCCGCTAG TGGCCACTCC ACCGCATGGC TGTCCAAGCA GCAACTGCCG
3 4 2 Y G I  S S A L A A A S G H S T A W L S K Q Q L P
1 4 7 1 TCCCAGCAGC ATTTGGGCGC AGATGGCGGG AAAACGCAGA TAAAGAGTGA AACACACTTC CCTGGGGATA
3 6 6 S Q Q H L G A D G G K T Q I K S E T H F P G D
1 5 4 1 CAGCGGCGAG CGGTTCACAC GTCACATACA CGCCGCTAAC ACTGCCGCAC TACAGCTCCG CCTTCCCCTC
3 8 9 T A A S G S H V T Y T P L T L P H Y S S A F P
1 6 1 1 GCTGGCGTCC CGCGCACAAT TCGCCGAATA CGCCGAGCAC CAGGCCTCGG GATCCTACTA CGCCCACTCC
4 1 2 S L A S R A Q F A E Y A E H Q A S G S Y Y A H S
1 6 8 1 AGCCAGACCT CAGGCCTCTA CTCCGCCTTC TCCTACATGG GCCCCTCACA GCGGCCCCTG TACACCGCCA
4 3 6 S Q T S G L Y S A F S Y M G P S Q R P L Y T A
1 7 5 1 TTCCGGATCC GGGATCCGTG CCGCAGTCAC ACAGCCCTAC GCATTGGGAG CAGCCCGTAT ACACCACACT
4 5 9 I  P D P G S V P Q S H S P T H W E Q P V Y T T
1 8 2 1 GTCTCGACCG TGACACACTC TACCAAGATG ACCAGTCACT AAAGGTCCAA CCGTAAGGTG TGTGTGTGTG
4 8 2 L S R P *
1 8 9 1 TGCTAAAAAT CATCGAAACA CTCGCCTGCA CCACAATCGA CACAAACTGA GATCTGAGAA ACGAGTGTGT
1 9 6 1 GTGTGTGTGT GAGATCTGCA GGGAAATATT CTCACGTGCC TCAGACGACC ACCGTCCAGA CCTGCTCCCT
2 0 3 1 CAACGCCAAT TTGACACCAG TAGTATTTTC GAAAAAGACG TAGTACCAAA GTACCGAGAC CAAAACATTA
2 1 0 1 CAGAAATACG AGAGTGCATC CATCCTTCCT GAACTCCGGA TATCAGATCA CACACAGACT TCAACACATG
2 1 7 1 ATGCTAGTAC CAGTGCATCC GCATTTTTTA TCTGTATTTG TATGAATGAA TAATCTTTTT ATTAACCAAA
2 2 4 1 ATAAGGCCAT ATTGTTTTTA AAAAAATAAT GAGGTGTTTT TCGTTGTTGT AATCTCTTGT GTTGTCGTTA
2 3 1 1 CTGTTGTTAT TTGTGTTGCC ATAACTACAC TGAAAAGTCT TCACCACTGT CTAGTGTTTG TTAATGACAT
2 3 8 1 TTGTGTTTTA TGACTTTCAG CGTGTGTAAA TATCAGTGCC AGGACGCCAT ACACACATGT CTCCACCCAA
2 4 5 1 TTAAGGTGCG CTCACAGTGA CGTTAATTAA ATTGAGGAAT TCCCAACCAT GCAAATTCCT CTAGAAATGG
2 5 2 1 CTATATTTCG TGAAAGCAGT AAATGTGAGC GCACCTTTAT TTCACACAAG CAGTACTGTA AAGGTAATAT
2 5 9 1 ATTTTTGCCA GATTGGAAAT GGTGGACGTA ATTACGAATT TTTAATAATA AATGACTATT TTTAGAGAAT
2 6 6 1 ACCGCTAGTG CCTCAAGTCC ATCACAAACG AATTGTCGTT TCTGATAAAT TCAATTTTGA TGATGTAAAA
2 7 3 1 TCCTTTTCAG GGTGCAAATT TTATCATGCG TTAACCGATG TGATTATACA TCGAATATGC ATATGCAAAT
2 8 0 1 TAATAAGTGC CATTTTTATA ATTAAAAATA CATCAACTAT CTGAAGACCT TCCTAACATT GGGTAAGTAA
2 8 7 1 ATAAATACAT TTATTTCATT GTATTATTTT TGGTAAATAC AATATTTAGC TATTCTATGT TTTGTCTCCC
2 9 4 1 TTTGGTACTT TATAGTTTTG TTTTTGCCCT CTTTATTATT TAGTATTATT CAGAAACAAA CAAACTCTTT
3 0 1 1 TTATATATTA CAGAATATTA TTTATATTTG TTGTTGTTTT TTTTTATCAG TAGCGTTTTA TTCTGTTTGT
3 0 8 1 CGTAAACCTC TGTCGTGTGC TGTTGTGGTG GGTTAAAGTG CTGTTGTTTT TCTCTGTCGG TGTAAATAGA
3 1 5 1 ACTGAGAGCA GTGACTAACT TTCCTCACTC TAAATAAAGC TGCAGTCTTT ACTAAAAAAA AAAAAAAAAA





characteristic for SoxlO homologues. An amino acid alignment with known SoxlO 
proteins and the percentage identities within distinct domains between homologues is 
depicted in Figure 3.16. Preliminary studies of a zebrafish SoxlO genomic clone show 
conservation of intron sites (T. Carney, unpubl. data).
Finally, Professor Laurence D Hurst, University of Bath, calculated a 
phylogenetic tree containing Sox gene members of subgroup E. Nucleotide sequences 
were translated and the coding regions aligned using ClustalX (Thompson et al., 1997) 
to improve the reliability of the pileup. The actual nucleotide alignment was 
subsequently reconstructed from the protein alignment using MRTRANS (Materials and 
Methods). From this sequence alignment an unrooted phylogenetic tree was constructed 
using PUZZLE (v 4.0.2) (Strimmer, 1996; Figure 3.17). This program calculates the 
probability of relatedness for each included Sox gene homologue by maximum 
likelihood. The number for each branch represents a bootstrap value, which is the 
percentage of times this branch is placed on the tree in this specific location (Figure 
3.17). The soxl 0-like homologue clearly clustered with other Soxl Os. The bootstrap 
values for each branch of SoxlO homologues were close to the maximum of 100 
indicating high support for each branch and thus a very reliable cluster.
Discussion
We have described the successful cloning of a zebrafish soxlO homologue.
Each of two possible strategies to clone soxlO were begun, but screening a cDNA 
library was not successful in our hands. The problem was high background, despite 
attempting to closely mimic the conditions used by Southard-Smith and colleagues 
(Southard-Smith et al., 1999). There are at least two possibilities that could explain the 
differences in results. Although the fish species included in their zooblot was not 
specified in their publication, it was different to zebrafish (M. Southard-Smith, person, 
comm.). Secondly, the genomic blots used by SouthardSmith were commercially 
obtained and thus, it was impossible to mimic the exact procedures used to prepare the 
genomic blot. Thus, we could not confirm the band observed in fish.
Meanwhile, the second approach involving RT-PCR with generic Sox gene 
primers was successful. These degenerate primers 5'SoxlO and 3’SoxlO were located in 
regions very conserved in Sox genes. They had originally been used to amplify a Sox2
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G e n e csoxlO csox8 csox9 hsoxlO hsox8 hsox9 msoxlO ms ox 8 ms ox 9 rsoxlO tsox9 tsoxpl zsoxlO zsox9a zsox9b
csoxlO 100 42.9 48.2 81.9 42.8 48.0 82.1 41.4 47.6 81.4 48. 9 43.5 5 9 . 8 47.2 43.3
csox8 --- 100 47.5 43.8 68. 4 46.0 44.0 73.5 45.4 44.0 47. 9 71. 6 4 1 . 5 47.6 45.1
csox9 --- --- 100 46.8 43.3 81.3 47.1 45.7 81.0 47.1 70. 4 46.0 4 2 . 8 68.2 55.0
hsoxlO ---- --- ---- 100 43.8 46.9 98.4 42.2 46.6 97.4 48.3 42.7 6 0 . 9 46.8 43.0
hsox8 --- ---- --- --- 100 42.4 43.8 80.3 41.8 43. 6 43.7 62.5 4 1 . 1 44 . 6 43.1
hsox9 ---- ---- --- --- ---- 100 47.3 43. 6 95.8 47.5 70.2 44.8 4 2 . 7 68.6 53.9
msoxlO ---- ---- ---- --- ---- --- 100 42.4 46.9 98.9 48.9 43.1 6 0 . 9 47.2 43.2
msox8 --- ---- ---- ---- ---- ---- ---- 100 43.2 42.2 46.7 66.3 4 0 . 6 45.3 42.7
ms ox 9 ---- ---- --- --- ---- ---- --- --- 100 47.1 69.5 44.0 4 2 . 7 67.9 52.8
rsoxlO ---- ---- — --- ---- --- — --- --- 100 48.7 42.9 6 0 . 7 47.2 43.0
tsox9 --- --- ---- ---- ---- --- --- --- --- ---- 100 47.2 4 4 . 7 76.2 57.5
tsoxpl ---- ---- --- ---- ---- ---- --- --- --- --- ---- 100 4 1 . 8 46.1 45.0
zsoxlO ---- --- ---- ---- ---- ---- ---- --- --- ---- --- ---- 100 4 2 . 6 4 0 . 0
zsox9a ---- ---- ---- --- ---- ---- ---- --- --- ---- --- ---- ---- 100 59.6
zsox9b ---- --- ---- ---- ---- ---- ---- --- --- --- --- ---- ---- ---- 100
Table 3.3: Sequence Identity Matrix of members of subgroup E
Numbers represent % amino acid identity between two Sox genes, c, chicken; h, human; m, mouse; r, rat; t, trout; z, zebrafish.
Although homologues of different species usually show 70-80% identity, zebrafish SoxlO only shows approximately 60% overall sequence 
identity to other Soxl Os, but even less, around 40%, to Sox8s and Sox9s including both zebrafish Sox9 paralogues.
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Figure 3.16: Amino acid identities within distinct domains between SoxlO homologues 
(A) The multiple sequence alignment of published SoxlO proteins was created with 
Pileup (gcg package, Materials and Methods). Regions of identity are shaded in black 
(Genedoc). The highly conserved HMG domain is underlined red (residues 106-185 in 
zebrafish SoxlO). The synergy domain (blue) and the transactivation (TA) domain 
(green) are poorly defined. However, the regions underlined in blue and green show 
high sequence homologies particularly between mammalian SoxlO proteins and 
exhibited synergistic and transactivational properties in in vitro studies (Kuhlbrodt et 
al., 1998b; Pusch et al., 1998). (B) Amino acid identities within functional regions are 
shown. Zebrafish SoxlO (zSoxlO) was compared to mammalian (hSOXlO, human 
SOXIO; mSoxlO, mouse SoxlO) and chicken (cSoxlO, chicken SoxlO) SoxlO proteins. 
The HMG domain (red) is the most conserved region with up to 95% identity. The 
transactivation domain (green) and the region just upstream of the HMG box with 
unknown function both show approximately 75% identity. However surprisingly, the 
synergy domain does not appear to be as highly conserved as the other domains in this 
zebrafish SoxlO homologue. Accession numbers of sequences are as follows: human 
SOXIO (hSOXlO) (NM_006941); mouse SoxlO (mSoxlO) (AF047389); chicken SoxlO 
(cSoxlO) (AF152356); zebrafish SoxlO (zSoxlO) (AF402677).
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Figure 3.17: Maximum likelihood phylogenetic tree of subgroup E Sox genes 
generated by Prof. Laurence D Hurst, University of Bath.
Nucleotide sequences were translated and then aligned using ClustalX. The nucleotide 
alignments were reconstructed from the protein alignments using MRTRANS. By 
Maximum Likelihood an unrooted neighbour joining tree was calculated. As expected 
zebrafish soxlO clearly clusters within the SoxlO clade of vertebrate Sox genes. 
Bootstrap values close to 100 on each of the SoxlO branches present high support for 
this cluster. The accession numbers for the sequences are as follows: chicken Sox8 
(AF228664); trout SoxPl (D83256); mouse Sox8 (AF191325); human Sox8 
(AF226675); rana frog Sox9a (AB035887); alligator Sox9 (AF106572); trout Sox9 
(AB006448); zebrafish sox9a (AF277096); zebrafish sox9b (AF277097); chicken Sox9 
(ABO 12236); pig Sox9 (AF029696); human Sox9 (Z46629); zebrafish soxlO 
(AF402677); chicken SoxlO (AF152356); mouse SoxlO (AF047389); rat SoxlO 
(AJ001029); human SoxlO (NM_006941).
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gene (Yuan et al., 1995), but also led to successful cloning of rat SoxlO (Kuhlbrodt et 
al., 1998a). In the latter study, Kuhlbrodt and her colleagues used cDNA derived from a 
primary rat Schwann cell culture to clone Sox proteins involved in the development of 
Schwann cells. This cDNA might have been enriched with SoxlO transcripts, since 69% 
of isolated clones showed high identity to SoxlO homologues. Unfortunately, an 
equivalent source of cultured zebrafish cells was not available. Thus, to identify a soxlO 
homologue, we anticipated having to screen a large number of clones. Perhaps cloning 
chances could have been improved by dissecting whole zebrafish embryos to obtain 
tissues expected to express high levels of sox 10 such as premigratory neural crest or the 
gut. Due to the small size of zebrafish embryos this was not attempted in this study. 
However, we hoped to enrich for sox 10 transcripts by including adult tissues (brain and 
skin). If the cloning of HMG boxes from 19hpf stage carried out in parallel had not been 
successful, more HMG box clones derived from adult tissues would have been screened 
and might have also led to success.
A total of 61 HMG box clones were manually sequenced. As expected, HMG 
boxes with homology to various Sox genes were cloned from all stages. Their identities 
were tentatively assigned to the closest match in a BLASTN search. This was necessary, 
because clones were only sequenced once and thus are prone to PCR and sequencing 
errors. These are the likely explanation for mismatches between the sequences obtained 
here and published sequences of zebrafish genes (Table 3.2).
Although the sample number was small and the cloned Sox gene homologues might not 
be representative, it was interesting that at least some could correspond to 
developmental processes during the stages used. Thus, 5 out of 9 HMG boxes (55.6%) 
cloned from adult tissue and 6 out of 10 (60%) cloned from 24hpf stage appeared to be 
zebrafish soxl9. Zebrafish sox 19 was first isolated from a cDNA library prepared from 
late gastrulation embryos and is classified as a member of subfamily B1 (Vriz and 
LovellBadge, 1995). Expression studies are still unavailable, but the abundance of 
soxl 9-like HMG boxes observed here in adult brain might indicate a role in the CNS. It 
could be speculated that the high representation of soxl 9-like clones at 24hpf is also 
derived from expression in the developing CNS.
Two soxl 1-like homologues (subfamily C) were cloned from the 24hpf stage, one of 
which clearly matched the soxl la  paralogue. This is consistent with expression of 
soxl la  in the fore-, mid- and hindbrain at 24hpf (Rimini et al., 1999). One of 9 clones 
isolated from the 19hpf stage, 3 out of 6 clones from the 5dpf and 1 clone out of 9 from
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the adult stage showed high homologies to zebrafish soxl lb. The latter result is 
surprising, since Rimini reported that expression levels of soxl lb  at 36hpf were already 
fainter and from 48hpf no expression could be detected. This does not exclude that 
soxl lb  might be required again later and thus, our result might point to an unknown late 
function of soxl lb.
Another two Sox genes, similar to sox31 and sox2, also involved in the development of 
the CNS, were isolated. Zebrafish sox31 was identified from the 24hpf stage. Consistent 
with our observations, it is expressed in the developing CNS (forebrain, midbrain, 
hindbrain and dorsal spinal cord) up to at least 36hpf (Girard et al., 2001). One clone 
isolated from the 5dpf stage showed very low sequence similarity (18bp outside the 
primer sequences) to sox31. With an Expect value (E) of 9.1 it is most likely a cloning 
artefact. It means that by chance, one might expect to see 9.1 sequences from the 
database to show a similar extent of identity.
From the 24hpf stage, a sox2-like homologue was isolated, which has not been 
described yet in zebrafish. It belongs to subgroup B l, like soxl, sox3 and soxl9. In 
chicken, Sox2 is expressed primarily in the CNS, but also in spinal, sympathetic and 
cephalic ganglia, Schwann cells, putative parasympathetic nerves, branchial arches, 
nasal epithelium and both neural retina and lens (Uwanogho et al., 1995; Uchikawa et 
al., 1999).
An HMG box with high nucleotide identity to Sox4 homologues (subgroup C) was 
cloned once from the 5dpf stage and twice from the adult stage. Again, a zebrafish sox4 
has not been published yet and the time and place of function is unknown. Three likely 
members of subfamily D were identified, which showed similarities to sox5 (19hpf 
stage), sox6 (19hpf embryos and 5dpf larvae) and soxl3 (19hpf and adult tissues). All 
three genes represent novel zebrafish homologues. In mice, Sox5 and Sox6 are involved 
in spermatogenesis and chondrogenesis (Lefebvre et al., 1998). Soxl3 is expressed in 
mouse embryos in developing arterial walls, inner ear and thymus and also in the 
thymus of adult mice (Roose et al., 1998). Consistent with this, we isolated a soxl3-Yiks 
homologue from 19hpf stage zebrafish embryos and adult tissue.
An HMG box with similarities only to a sea urchin SoxB2 (Genbank accession number 
AF157388) was isolated from the 19hpf stage. The region of identity was small (23bp 
outside primer sequences) and no similarities to other Sox genes were found. SoxB2 
clusters with members of subgroup B2 and thus might represent either a Sox 14 or Sox21
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orthologue (Bowles et al., 2000). However, with an Expect value E of 1.3, this fragment 
might only represent a cloning artefact.
Finally, we identified the soxl 0-like HMG box only once, from cDNA prepared from 
19hpf zebrafish embryos. As described earlier, at the equivalent stage in mouse, SoxlO 
is expressed widely in premigratory and migrating neural crest cells and the otic vesicle 
(Herbarth et al., 1998; Southard-Smith et al., 1998). Thus, it was not surprising to 
isolate it from tissue of this stage.
In conclusion, the HMG box clones obtained by RT-PCR generally fitted the available 
expression data of those Sox genes in the stages investigated.
Although unnecessary for the progress of this study at the time, it would indeed 
be interesting to continue this experiment with the aim of looking for a second soxlO 
homologue, derived from the fairly recent genome duplication in ray-finned fish 
(Amores et al., 1998; Postlethwait et al., 1998). Any duplicated gene would have had to 
diverge in order to be maintained in the genome. Under the classical model for the 
evolution of duplicated genes, a duplicate is only preserved if a mutation creates a new 
function. Since this event is likely to be much rarer than any deleterious mutation, this 
model could not explain the high number of duplicates observed. An alternative model, 
called the Duplication-Degeneration-Complementation model (DDC), may explain the 
frequent maintenance of both duplicates (Force et al., 1999). It hypothesises that a 
member of the duplicated pair may undergo Nonfunctionalisation, in which it acquires a 
null mutation; Neofunctionalisation, in which a mutation gives rise to a new gene 
function; or Subfunctionalisation, in which the duplicates accumulate degenerative 
mutations in different regulatory elements. By complementing each others function, 
both duplicates are maintained. This in turn might even increase the chances of 
acquiring a novel gene function in either of them. Indeed, what is often observed is that 
the original role of the ancestral gene is temporally or spatially shared by the two 
paralogues. The zebrafish duplicates engrailedl (engl) and engrailedlb (englb) are 
presented as one of the examples illustrating this subfunctionalisation. Engrailedl 
(EN1) in mouse and chicken is expressed in the pectoral appendage bud and in certain 
neurons of the hindbrain and spinal cord (Joyner and Martin, 1987 cited in Force et al., 
1999). In zebrafish these two regions of expression are split between engl and englb , 
with engl expressed in the pectoral appendage bud and englb in neurons of the 
hindbrain (Force et al., 1999). Mammalian Sox9 is expressed in testes and is involved in 
sex determination (Foster et al., 1994; Wagner et al., 1994; Kent, 1996). In zebrafish,
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sox9a is expressed in testes, whereas sox9b is found in ovaries (Chiang et al., 2001). 
This change of expression pattern could indicate a new role adopted by the second 
paralogue.
It is impossible to predict, which subfunction a second soxlO paralogue might have 
developed during evolution.
It remains untested whether the alternative cloning strategy involving the design 
of soxl  ^ -specific primers might have been a better method to use. Potentially, this 
specificity for sox 10 could have lead to the successful cloning of a soxl 0-like HMG box 
in even shorter time. However, the design of such primers might have been difficult 
since only sequences of mammalian SoxlO homologues were available at the time. With 
the addition of a recently published chicken SoxlO and a likely fish soxlO homologue, 
the design of such degenerate sox 10 specific primers in highly conserved regions would 
be the cloning strategy of choice, if the procedure were to be performed now.
Isolation of a full length soxlO homologue
Once the HMG box had been cloned, extension of the sequence with the SMART 
RACE PCR Amplification Kit (Clontech) proved straightforward.
A 3’RACE product, clone B2 or C2, was obtained at the first attempt, although primer 
N3GSP had misprimed within the sox 10 sequence approximately lOOObp further 
downstream. It might be that the PCR conditions were not appropriate to amplify a 
product spanning the entire region 3’ to the HMG box (about 2.8kb). In any case, 
shorter products are usually favoured. Alternatively, the cDNA population might have 
contained a lot of truncated reverse transcripts. With the specific annealing site missing, 
the primer might have been forced to bind to a location with lower sequence homology 
further downstream. Thus, an additional round of gene specific amplification was 
required to complete the 3’ sequence. This overlapping fragment, represented by clones 
15 and 20, linked the HMG box clone SoxS4 to the 3’RACE product, clone B2.
Clone 15 differed from clone 20 only by an insertion of 109bp within the 3’UTR. This 
insertion might represent a splicing variant or less likely a PCR artefact. A PAC clone 
containing the equivalent genomic region was sequenced and confirmed the presence of 
this 109bp insert in the soxl 0 gene (T. Carney, unpubl. data). Thus, the insertion was 
included in the soxlO-like cDNA.
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Some perseverance was necessary to establish conditions to clone the 5’RACE 
fragment. Two clones, 32 and 62, were isolated, which were identical to each other 
apart from the N-terminal 26bp extension in clone 32. This might have been caused by 
mispriming of the SMART oligo on a series of cytosines further downstream in the 
soxl 0 sequence.
Both the results from the BLASTX search and an unrooted maximum-likelihood 
tree consistently suggested that the soxlO-\ikQ cDNA represented a true sox 10 
homologue. As was demonstrated in Figure 3.17, the newly isolated member of the Sox 
gene family clearly clustered with other Soxl Os instead of Sox9 or Sox8s. In fact, an 
alignment with the two zebrafish sox9 paralogues, both closely related to soxlO, only 
exhibit an overall amino acid identity of 40 and 42.6%, respectively, whereas they show 
59.6% identity to each other (Table 3.3)
The zebrafish Soxl0-like predicted protein sequence also shows consistently higher 
identity to all published Soxl Os (approximately 60%) than to Sox9s (approximately 
43%) and even less homology to Sox8s (approximately 41%). Together these results 
strongly support the hypothesis that the cDNA indeed represents a true soxlO 
homologue. In accordance with the zebrafish gene nomenclature it will be referred to as 
soxlO (protein as SoxlO) in subsequent chapters of this thesis.
We made no attempt to test whether the cloned soxlO cDNA represented a full length 
clone. The SMART RACE PCR kit is designed to isolate full length 5’ and 3’RACE 
fragments. Indeed, the presence of a 28 nucleotide poly-A tail strongly indicates a 
complete 3’end. However, to investigate the true 5’ end of the mRNA transcript, a 
primer extension experiment is necessary, whereby the beginning of the 5’UTR is 
reverse transcribed with a labelled, gene specific primer. Once the genomic sequence 
(PAC clone) of that region and the length of the labelled product is known, the first 
nucleotide of the transcript can be determined. However, for the purposes of this study, 
a full length coding region was most important and thus, such primer extension studies 
were omitted.
The start of translation was determined by sequence alignment with other SoxlO 
proteins. The first 30 residues show significant conservation in all known SoxlO 
proteins and thus the corresponding initiator methionine in zebrafish was easily 
identified (Figure 3.16). Also, no alternative in frame methionine codon is present 
further upstream. Southard-Smith investigated an alternative methionine in mouse 
further upstream as a potential start of translation by aligning the mouse, human and rat
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sequences (Southard-Smith et al., 1999). The region exhibited 90% nucleotide identity 
between mouse and human 5’UTR indicative of structural relevance. However, a 
frameshift present in the human sequence introduced a stop codon between the two 
possible initiator sites, thus eliminating the possibility of usage of alternative 
methionine further upstream.
The 485 residues representing the coding region of the soxl 0 cDNA extend from 
nucleotides 376 to 1833 (Figure 3.15). The only significant difference from other SoxlO 
homologues C-terminal to the HMG domain is the insertion of 15 amino acids rich in 
Glycine, G (5 out of 15) and Serine, S (4 out of 15) (see Figure 3.16). The function of 
this region is unknown. The HMG domain (residues 106-185) is the most conserved 
region showing 95% amino acid identity to mammalian SoxlO homologues (Figure 
3.16). It is preceeded by 38 residues that are highly conserved within members of the 
subgroup E. Zebrafish SoxlO, for example, shows 83.8% amino acid identity to all 
known SoxlO homologues in this region. Their function still requires investigation.
An N-terminal domain, called the synergy domain, is poorly defined. Kuhlbrodt and 
colleagues (1998a) tested rat SoxlO deletion constructs in in vitro luciferase reporter 
assays and concluded that both the HMG domain and the first 89 residues were required 
for synergistic interaction of SoxlO with other partner transcription factors such as Tst- 
l/Oct6/SCIP. The N-terminal domain of SoxlO shows a low degree of conservation 
compared to mammalian SoxlO proteins. Thus, residues 1-89 exhibit 42.5% amino acid 
identity between zebrafish and mouse, but 100% identity between human and mouse 
synergy domains (Figure 3.16).
The transactivation domain (TA domain) is also not well defined. Deletion constructs 
fusing various parts of the SOXIO 3’ end to the GAL4 DNA binding domain were tested 
for in vitro ability to transactivate a GAL4-dependent CAT-reporter plasmid (Pusch et 
al., 1998). Only the region between residues 377-466 produced a 29-fold CAT induction 
and thus exhibited transactivational abilities. This region is highly conserved in 
mammals (Figure 3.16) and also corresponded approximately to the transactivation 
domain previously identified in SOX9 (Suedbeck et al., 1996). The same region in 
zebrafish SoxlO, residues 395-485, is not as highly conserved between zebrafish and 
human or chicken SoxlO (75% amino acid identity to either of them, Figure 3.16B). 
However, the high identity of 87.2% within the last 47 residues in all SoxlO 
homologues might point to a functionally important part of this domain.
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A region rich in prolines (P, 5/13 residues) and threonines (T, 4/13 residues) and 
completely conserved across all subgroup E homologues is located between residues 
240-252. Bondurand et al. (2000) have also mentioned such a domain in approximately 
the correct location and it would be interesting to investigate its function.
In conclusion, we were able to show the cloning of a true soxlO homologue from 
zebrafish by RT-PCR and RACE-PCR and confirm its identity by phylogenetic analysis 
and sequence alignments. In the following chapter we will ask whether soxlO is 
expressed in the neural crest, and whether expression in els mutant embryos is 
disrupted, as might be expected if els encodes soxlO.
133
Chapter 4 -  Expression of soxlO in wild-type and els 
mutant embryos
Introduction
In the previous chapter we have described the cloning of a soxl 0-like homologue. We 
could further show by sequence alignment and phylogenetic analysis that this Sox gene 
was a true soxlO homologue in zebrafish.
We next asked whether this soxlO homologue was expressed in the correct places to be 
a strong candidate for the els gene. Cell autonomy studies of the els phenotype indicated 
that els would be expressed in the premigratory neural crest (Kelsh and Eisen, 2000b). 
Likewise, the strong ear phenotype in els mutants would be consistent with expression 
in the otic vesicle. These aspects are observed in mammalian SoxlO expression patterns. 
Furthermore, the expression pattern of soxl 0 was expected to be disrupted in 
homozygous els mutant embryos.
SoxlO expression during mouse, human and chicken development
The SoxlO HMG box was first isolated from a mouse embryo cDNA library by 
degenerate PCR amplification (Wright et al., 1993). In the course of identifying the 
product of the Dom locus by a positional cloning approach, the full cDNA sequence in 
mouse was isolated by two independent research groups (Herbarth et al., 1998; 
Southard-Smith et al., 1998). Based on amino acid similarities within the conserved 
HMG domain and characteristics outside such as the presence of specific functional 
domains and conservation of intronic sites, SoxlO was classified as a member of 
subgroup E together with Sox9 and Sox8 (Bowles et al., 2000). At the same time, rat 
SoxlO was partially cloned by RT-PCR and this HMG box fragment used to isolate the 
full length clone from a Schwann cell cDNA library (Kuhlbrodt et al., 1998a). 
Phenotypic similarities between the SoxlO00"11+ mouse and patients with Waardenburg 
Shah Syndrome (WS4) led to the proposal that WS4 might result from SOXIO 
mutations. Consequently, SOXIO was isolated from a human brain cDNA library using 
the rat SoxlO cDNA as a probe (Pingault et al., 1998a). Only a year later, the cloning of 
a chicken SoxlO homologue was reported (Schneider et al., 1999; Cheng et al., 2000).
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SoxlO expression in the neural crest and its derivatives
Although there are small species-specific differences in SoxlO expression, the overall 
pattern appears largely conserved. Thus, in mammals and chicken, SoxlO is strongly 
expressed in premigratory neural crest cells soon after emergence from the neural tube. 
In mouse and humans, the onset of SoxlO (SOXIO) expression has not been studied in 
detail. SoxlO transcripts were first detected in E8.5 mice (5-12 somites) in a region 
corresponding to the edges of the neural plate, adjacent to areas which have just closed 
to form a neural tube. These cells most likely represent neural crest cells emerging from 
the neural tube (Kuhlbrodt et al., 1998a). In expression studies in chicken, SoxlO 
transcripts were first detected just after Slug at HH (Hamburger & Hamilton) stage 7/8 
(3 somites) in the folding neural plate, but not in the lateral region from which the 
neural crest delaminates. However, consistent with the mouse data, strong expression 
was observed in cranial and trunk neural crest slightly later, from HH stage 9 (-6-7 
somites; Cheng, Cheung et al. 2000). The earliest stage investigated in human embryos 
was 4 weeks, the equivalent to mouse E10. SOXIO expression was seen in the 
premigratory crest area (Bondurand et al., 1998a).
Furthermore, SoxlO appears to be expressed in at least some migrating neural 
crest cells on either pathway and is maintained predominantly in glial-type cells of the 
PNS and CNS, whereas SoxlO is down regulated in differentiating neuronal derivatives. 
In mouse, SoxlO expressing neural crest cells were seen to migrate on both the medial 
pathway at E9.5 (Pusch et al., 1998) and on the lateral pathway until at least E l2.5. The 
latter cells correspond to pigment cell precursors (Southard-Smith et al., 1998). Some 
migrating SOX10-positive neural crest cells were observed in 4 week human embryos 
(mouse E10) in the region of forming glosso-pharyngeal ganglia.
In contrast to mouse and chicken, SOXIO was also detected in some derivatives 
of the cephalic neural crest in 6 week human embryos (mouse El 4), which later form 
cartilaginous rudiments of several nasal bones (Bondurand et al., 1998a). Maintenance 
of SoxlO expression in such ectomesenchymal fates was not observed in mouse 
(Kuhlbrodt et al., 1998a).
SoxlO expression in the mouse peripheral nervous system was seen at E9.5 in DRG, 
trigeminal and the cochlear-vestibular ganglion (Kuhlbrodt et al., 1998a). By E10.5, 
SoxlO staining was associated with all cranial ganglia, cranial and spinal nerves (motor 
and sensory nerves) and sympathetic ganglia (Pusch et al., 1998; Southard-Smith et al.,
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1998). Furthermore, from E l2.5 enteric ganglia in the trunk exhibited hybridisation 
signals (Kuhlbrodt et al., 1998a; Southard-Smith et al., 1998). All these crest derivatives 
were also strongly labelled by SOXIO in human embryos (Bondurand et al., 1998a).
In chicken, it was shown that SoxlO expression was not maintained in neural crest cells 
undergoing neuronal differentiation as judged by expression of the Hu epitope, for 
example in the centre of peripheral ganglia in head and trunk (Cheng et al., 2000). This 
is consistent with findings of non-overlapping SoxlO signals and the neuronal marker 
SorLA in the developing trigeminal ganglion in mouse (Kuhlbrodt et al., 1998a). Since 
high expression levels of SoxlO were found in cultured Schwann cells, these SoxlO- 
positive cells surrounding peripheral ganglia and along cranial and peripheral nerves 
most likely corresponded to satellite glia cells and Schwann cells, respectively 
(Kuhlbrodt et al., 1998a). It was suggested that some of these Sox/0-positive cells in 
DRG might also represent undifferentiated neural crest cells since they did not express 
glial markers and as differentiated neurons would have turned off SoxlO (Britsch et al., 
2001).
SoxlO expression outside the neural crest
Aside from the neural crest, it was suggested that SoxlO in chicken was expressed in 
neuronal and glial precursors during early CNS development. Thus, the entire 
ventricular zone was labelled at HH26 (~5 days), which contains mostly neuronal 
precursors. At later stages expression was absent in Hu-expressing neuronal cells and 
became restricted to oligodendrocytes (Cheng et al., 2000). In mice, labelling intensities 
in the CNS increased from E12.5toE18.5 drastically. Expression was observed 
throughout the brain corresponding to forming oligodendrocytes, but never in brain 
nuclei (Kuhlbrodt et al., 1998a). This was interesting since in contrast to mice, SOXIO 
was also observed in major brain nuclei and in the cerebral cortex in both fetal and adult 
human CNS (Bondurand et al., 1998a).
High levels of SoxlO are noted in the otic vesicle from E9.5 in mouse (Pusch et 
al., 1998; Southard-Smith et al., 1998) and between the 5th (corresponding to ~E11 in
thmouse) and 6 week (~E14) during human development (Bondurand et al., 1998a). The 
otic placode in chicken is labelled very early from HH stage 9 (~6-7 somites) and 
expression there is maintained strongly at least up to HH stage 27 (~5.5 days) in non­
neuronal cells as shown in double labelling with anti-Hu antibody.
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SoxlO transcripts were also observed in the developing pineal gland of chicken 
at HH stage 26 (~5 days; Cheng et al., 2000).
SoxlO mutant mice have altered SoxlO expression patterns
The Dom mouse was the first SoxlO mutant to be identified. An insertion of a single 
guanine residue at nucleotide 929 causes a frameshift, which leads to the generation of 
99 novel amino acids before premature truncation of the protein (Southard-Smith et al., 
1998). Its phenotype has been described in the Introduction chapter.
SoxlO expression patterns in Dom mutants in the neural crest
In situ hybridisation with SoxlO in SoxlODom/Dom mice revealed that expression was 
present in premigratory neural crest cells at E9.5 in a wild-type pattern. Expression 
persisted in migrating neural crest cells in caudal regions until E l0.5 although these 
neural crest cells were delayed in their migration. By E l0.5, cranial ganglia and cells 
associated with their projections showed strongly reduced SoxlO levels. Soxl  ^ -positive 
cells in the gut were absent and were reduced in the sympathetic primordium (Britsch et 
al., 2001). Melanoblasts, normally expressing SoxlO and Dct, an early melanoblast 
marker, were absent. At El 1.5, SoxlO transcripts were only detectable in the caudal- 
most neural crest cells, which, in developmental terms, are the youngest. At the same 
time, cells in DRG and in a location consistent with migrating neural crest were 
undergoing significant apoptosis as seen by TUNEL staining (Terminal 
deoxynucleotidyl transferase-mediated dUTP nick end-labelling) (Southard-Smith et al., 
1998). In contrast to wild-type embryos, in situ hybridisation on sections of E14.5 
SoxlODom/Dom mutant embryos demonstrated a lack of enteric precursors in their 
intestines and a reduction in SoxlODoml+ siblings (Herbarth et al., 1998).
These results demonstrate disrupted SoxlO expression in SoxlODom/Dom mutants and are 
consistent with the defects in neural crest cell lineages observed in the SoxlODoml+ 
mouse. Apoptosis of neural crest cells in hetero- and homozygous SoxlO00"1 mutants 
appears to cause a reduction of pigment cells and enteric ganglia (Southard-Smith et al., 
1998).
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SoxlO expression patterns in Soxl(Pom mutants outside the neural crest
In contrast to that in neural crest derivatives, expression in the otic vesicle, the CNS and 
cells associated with developing cartilage persisted in SoxlODomlDom mutants (Britsch et 
al., 2001).
Results 
The soxlO expression pattern in wild-type zebrafish
We asked whether the expression pattern of zebrafish soxlO was equivalent to the one 
reported for mammalian and chicken SoxlO. To study the cloned gene's expression 
pattern in wild-type zebrafish, we performed mRNA in situ hybridisations on whole 
mount embryos of various developmental stages.
Thus, we synthesised an antisense mRNA in situ probe against the sox 10 
sequence C-terminal to the HMG box (Materials and Methods). The 1913bp 3’RACE 
clone 20 was used as a template. It contained 988bp of coding sequence beginning with 
the 85bp 3’end of the HMG box domain and including 925bp of the 3’ untranslated 
region (3’UTR). Prior to RNA synthesis with RNA polymerase T7, the plasmid 
containing clone 20 was linearised with Sal I, which also removed the 3’end of the 
HMG box sequence. This was considered important in order to prevent possible cross­
hybridisation due to the high degree of sequence conservation within this domain 
between different Sox genes (Figure 4.1).
Zebrafish embryos were collected from heterozygous clsm618 crosses, staged 
according to (Kimmel et al., 1995) and fixed at appropriate stages for a timecourse. In 
situ hybridisations on batches of 20-30 embryos per staining reaction were carried out 
with 1:200 dilutions of the sox 10 in situ probe (Materials and Methods).
soxlO expression in the neural crest and its derivatives
We asked whether soxlO expression was maternally transmitted. However, no 
expression was detected at the 4 cell stage, sphere stage (4hpf), shield stage (6hpf) and 
at 90% epiboly (9.5hpf).
First expression of soxlO was observed in 2 somite stage embryos (approximately 10.5 
hpf) at the lateral edges of the neural plate (Figure 4.2A). This region corresponded to 




Figure 4.1: Preparation of the sox 10 in situ hybridisation probe 
Clone 20 was used as a template for antisense RNA transcription. The clone contains 
the soxlO cDNA fragment 3’ to the HMG box ( Hill), including 85bp of HMG box 
sequence and 925bp of 3’UTR. Prior to probe synthesis, the plasmid was linearised with 
Sal I at the 5’ end of the cDNA, which also removed the HMG box sequence. This was 
thought to be necessary to prevent possible cross hybridisation to other HMG box 
containing genes. RNA polymerase T7 was then used to synthesise 1825bp antisense 
mRNA transcripts.
Figure 4.2: soxlO expression in wild-type and els embryos up to the 18 somite stage 
Expression patterns in els mutant embryos were indistinguishable from wild-type 
siblings up to the 18 somite stage. (A) soxlO expression was first observed in emerging 
neural crest cells in the lateral neural plate from the 1-2 somite stage. By the 5 somite 
stage, cranial crest cells had formed two broad stripes of cells (B). In the example of a 
transverse (C) and longitudinal (D) section shown (plane of section indicated in (B), all 
neural crest cells seemed to express soxlO. However, very occasionally, a single soxlO 
negative cell amongst labelled cells was observed (black arrow, E). Premigratory trunk 
neural crest cells expressed soxl 0 in 14 somite stage embryos (F) and in 18 somite stage 
embryos (black arrow, G). Furthermore, strong expression was maintained in cranial 
neural crest cells (black arrow head, G) and migratory trunk neural crest cells (asterisk, 
G). The otic placode (o) was stained strongly from the 11 somite stage (data not shown), 
in 14 and 18 somite embryos (F, G). In transverse sections (A, C, E) dorsal is up and in 
the longitudinal section (D) dorsal is up and anterior to the left. Wholemount (B) is 
shown in a dorsal view with anterior to the left, whereas wholemounts (F, G) are lateral 
views with anterior to the left (F) and anterior up (G). e, eye; nc, neural crest; o, otic 








and neural crest cells appeared to have started to converge dorsally (Figure 4.2B, C).
We asked whether all neural crest cells were sox/0-positive and thus prepared sections 
of 2 somite and 5 somite embryos. Transverse and longitudinal sections through the 
neural keel showed that most, if not all, neural crest cells were labelled with soxlO 
(Figure 4.2C, D).
The strong expression o f soxl 0 in premigratory neural crest cells was maintained and 
extended caudally during later stages of somitogenesis. At approximately 12-14 somite 
stage (15-16hpf), cranial neural crest cells just caudal to the eye start to migrate away 
from their premigratory positions (Schilling and Kimmel, 1994). Trunk neural crest 
cells start to enter the medial pathway at approximately the 14-16 somite stage (16- 
17hpf) and the lateral pathway approximately 4 hours after the first cells started to 
migrate medially at this axial level (Raible et al., 1992). Consistent with the literature, 
trunk neural crest cells remained in the migration staging area above the somites until at 
least the 14 somite stage (16hpf, Figure 4.2F). By the 18 somite stage (18hpf) more 
caudally located neural crest cells still remained premigratory, but at least some soxlO- 
positive neural crest cells were seen to migrate on the medial pathway in the anterior 
trunk region (Figure 4.2G). At 24hpf, anterior trunk neural crest cells labelled with 
sox 10 were seen on the medial and lateral pathway (Figure 4.30).
Melanophores were the first neural crest derivatives of the pigment cell lineage 
to differentiate. We asked whether soxlO expression was maintained in differentiated 
melanophores. By 30hpf, migrating melanophores were visible on the medial and lateral 
pathway, but sox 10 expression in these cells was not readily detectable. Occasionally, a 
melanophore dorsal to the neural tube was seen to weakly express sox 10 (Figure 4.3G). 
Since only pigment cell precursors are known to migrate on the lateral pathway (Raible 
and Eisen, 1994), this finding indicated that sox 10 was turned off rapidly in 
differentiating pigment cells. Consistent with this, expression in pigmented 
xanthophores was never observed.
Derivatives of the peripheral nervous system were first seen around 24hpf. Cells 
expressing high levels of soxlO accumulated in the region of forming cranial ganglia 
and extended caudally from the posterior lateral line ganglion by 24hpf (Figure 4.3A). 
By 36hpf, soxl0-positive cells were observed to be clustered around the trigeminal, 
anterior and posterior lateral line ganglia (Figure 4.3 J). We asked whether these soxlO- 
positive cells were glial and/or neuronal derivatives. The expression patterns observed 
were reminiscent of in situ hybridisation labelling studies with fkd6 , a glial marker
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Figure 4.3: soxlO expression in wild-type and els mutant embryos at 24-36hpf stages 
From 24hpf, some differences between the wild-type (WT) and els expression patterns are 
observed.
(A) In 24hpf WT strong sox 10 expression is seen in cranial ganglia (white arrowheads) and 
along the posterior lateral line nerve (PLLn, A, black arrowhead, enlarged in inset; in transverse 
section in O), in premigratory (A, black arrow) and migrating crest cells (A, black asterisk) on 
both medial (O, black arrowhead) and lateral pathways (O, black arrow). Cells marked by an 
asterisk in O might also migrate laterally or be Schwann cells on the PLLn. Strong expression is 
seen in the otic vesicle (o) in the epithelial layer (I). Note the forming acoustic ganglion (black 
arrowhead, I). (B) In contrast, 24hpf els embryos show much reduced labelling in the cranial 
ganglia (white arrowheads) and on the PLLn (black arrowhead, enlarged in inset). Crest cells in 
the head are clustered (white asterisk). The expression in the ear is comparable to WT. soxlO- 
positive cells migrate normally in the rostral trunk (black asterisk), but some cells tend to cluster 
in premigratory positions (black arrows). (C, D) Double labelling with soxlO (purple) and the 
pan-neuronal anti-Hu antibody (orange) shows strong expression associated with cranial ganglia 
(g) in WT, which is reduced in els (D). Sections through the posterior lateral line ganglion 
(approximate position indicated by white line in C, D) in WT (E) and els mutants (F) shows that 
soxlO expression is restricted to satellite glia (purple) surrounding the neuronal (orange) centre 
of the ganglion. (G) soxlO is down regulated rapidly in differentiating melanophores. At 31hpf 
some still show weak expression in the dorsal stripe (black arrowheads). (H) Weak soxl 0 
staining is seen in the ventricular layer of the hindbrain (black arrowhead) at 24hpf. (J, M, N) In 
36hpf (J) and 40hpf (M, N) WT embryos, expression is maintained in satellite glia of all cranial 
ganglia (trigeminal, black arrowhead; anterior lateral line ganglion, black arrow), the otic 
vesicle (o) and in the ventricular layer in the brain (J, asterisk; M and N, black arrowheads). (K, 
L) Double in situ hybridisation with dlx2 (K, purple) and sox 10 (L, green) in 29hpf stage 
embryos shows absence of soxlO expression in developing branchial arches (1-5). (P, Q) In 
35hpf WT and els embryos, segmentally arranged clumps of 3-4 sox 10 positive cells (black 
arrows) are observed along the entire trunk and tail, adjacent to the dorsal notochord, 
presumably glia of dorsal root ganglia or Schwann cells on segmental nerves. The soxlO 
expression pattern in this region of els embryos is very similar to wild-types (Q).
Anterior is to the left in all lateral views (A-D, K, L, P, Q) and in dorsal views (G, J). In the 
dorsal view (M), anterior is up and in all transverse sections (E, F, H, I, N, O), dorsal is up. e, 
eye; g, posterior lateral line ganglion; no, notochord; o, otic vesicle. Scale bar: 165pm in A-B, 
P-Q; 50pm in C-D; 80pm in E-F, M-N; 90pm in G; 60pm in H-I, O; 110pm in J; 70pm in K-L.
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(Kelsh et al., 2000a). Thus, soxl0 expressing cells were thought to be developing 
satellite glial cells surrounding all cranial ganglia and Schwann cells associated with the 
posterior lateral line nerve. In accordance with this, soxl 0-positive cells in ganglia were 
not double-labelled with the pan-neuronal marker anti-Hu antibody, thus confirming 
their glial, not neuronal, identity (Figure 4.3C, E, H, J). However, without further tests 
we cannot exclude the possibility that some of these soxl 0-positive cells might also 
represent undifferentiated neural crest cells as suggested in mouse (Britsch et al., 2001). 
Furthermore, we could show in a double in situ hybridisation that soxl 0-positive cells 
on the lateral line nerve also expressed Jkd6 at 24hpf confirming their glial nature (data 
not shown). The expression in Schwann cells was maintained up to 60hpf (Figure 
4.4G).
At 35hpf soxlO expression was seen in segmentally arranged cells adjacent to the 
notochord (Figure 4.3P). These could represent undifferentiated neural crest cells 
migrating on the medial pathway or differentiated neurons or glia associated with DRG 
and segmental nerves. Since they were all found at the exact same dorsal ventral 
position, unusual for migrating cells, and appeared as cell clumps of usually 3-4 
individuals, the latter was considered more likely. Double labelling with anti-Hu 
antibody or a glia marker such as fkd6  will be required to investigate the specification 
status of these cells. soxlO expression was absent from cells at this location shortly 
thereafter (approximately 36-40hpf; data not shown).
Enteric nervous system precursors expressed soxlO as early as 24hpf (R. Kelsh, unpubl. 
observation). By 60hpf, they were strongly labelled and surrounded the gut epithelium 
(Figure 4.4J).
We asked whether any ectomesenchymal neural crest derivatives (medial fin 
mesenchyme and craniofacial cartilage) expressed soxlO, even though els embryos do 
not show any overt defects in these structures. We failed to detect any soxlO expression 
in fin mesenchyme and craniofacial cartilage precursors. We used double in situ 
hybridisation to label craniofacial cartilage precursors with dlx2, but the regions of 
soxlO expression did not overlap with dlx2 at 29hpf (Figure 4.3K). However, at 48hpf 
and 60hpf, strong sox 10 staining was observed in the differentiating jaw cartilage 
(Figure 4.4A, D, G).
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Figure 4.4: soxlO expression in 48-60hpf wild-type and els embryos
soxlO expression in els embryos in differentiating craniofacial cartilage, pectoral fins
and CNS is indistinguishable from wild-types (WT).
(A-C) At 48hpf, els embryos show expression in the forming jaw cartilage (A, black 
arrowheads), the otic epithelium (A, o) and in the ventricular layer (A,B, black arrow). 
(C) Strong expression is also seen in oligodendrocytes in a transverse section of the 
spinal cord of a els embryo (black arrowheads). Staining persists until 60hpf in els 
embryos in the jaw cartilage (D, E, black arrowheads), in oligodendrocytes (F, black 
arrowheads) and in cartilage precursors in the pectoral fins (pf, D, E, H). (I) A 
transverse section through a 60hpf els pectoral fin demonstrates the typical “stack of 
coins” structure of cartilage precursor cells (black arrow). (F, G) Expression in the otic 
vesicle (o) at 60hpf is strong in wild-types (G). In contrast, soxlO expression in the otic 
vesicle (o) in els mutants is reduced by 60hpf (F). (G) Schwann cells on the posterior 
lateral line nerve (PLLn, black arrow) extending from the posterior lateral line ganglion 
(g) have maintained sox 10 in 60hpf WT embryos and expression is seen in branchial 
arches (1-5). (J-L) Melanophores (brown) have formed the dorsal (ds), ventral (vs) 
stripe and Schwann cells are located along the PLLn in WT (J), whereas both crest 
derivatives are absent in els siblings (K, L). Likewise, numerous enteric precursors 
surrounding the wild-type gut lumen (J, black arrowheads) are usually completely 
absent in els (K), but occasionally a single soxlO positive cells is observed in this region 
(L, black arrowhead). (K, M) In contrast, oligodendrocytes (black arrows) in 60hpf WT 
(M) is unaffected in els (K).
In longitudinal sections (A-B, D-F) and lateral views (G-H) anterior is to the left. In 
transverse sections (C, I-M) dorsal is up. ds, dorsal stripe; e, eye; g, posterior lateral line 
ganglion; Is, lateral stripe; m, muscle; no, notochord; o, otic vesicle; pf, pectoral fin; vs, 
ventral stripe. Scale bar: 165pm in A-B, D-F; 80pm in C; 95pm in G; 60pm in H-I;
65 pm in J-M.
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soxlO expression outside the neural crest
Aside from the neural crest, strong expression was observed in the otic placode and 
developing otic vesicle from the 11 somite stage onwards (Figure 4.2F,G, Figure 4.3A, 
C, I-K, Figure 4.4A, G). The cells of the otic epithelium were strongly labelled at all 
stages investigated (Figure 4.31, J, Figure 4.4A).
Faint staining could be detected in the ventricular layer in the hindbrain from 
24hpf (Figure 4.3H) and was seen additionally in the fore-and midbrain and the spinal 
cord at 36hpf (Figure 4.3J, M, N, Figure 4.4C). At 48hpf, soxl0-positive cells were 
found in what appeared to be the subventricular layer in the forebrain (Figure 4.4B) and 
also started to disperse throughout the brain (Figure 4.4F). Consistent with SoxlO 
expression in rodents (Kuhlbrodt et al., 1998a), this is likely to correspond to expression 
in developing oligodendrocytes. The staining in the floorplate was maintained at least 
up to 60hpf (Figure 4.4C, K, M).
At 24hpf weak soxlO expression was observed in the developing pineal organ in 
a double in situ hybridisation with fkd6  (Figure 4.6J, K). Interestingly, some cells 
appeared to express only Jkd6, but their identity is unknown.
Finally, sox 10 expression was detected in the pectoral fins at 48hpf and 60hpf 
(Figure 4.4D, H, I). The staining was restricted to cells in the central part of the fin in a 
“stack of coins” arrangement (Figure 4.41) typical for cartilage cells.
Does soxlO label all neural crest cells?
Analysis of the colourless phenotype showed that in contrast to non-ectomesenchymal 
derivatives, ectomesenchymal neural crest fates such as craniofacial cartilage and fin 
mesenchyme were unaffected (Kelsh and Eisen, 2000b; Dutton et al., 2001b). This 
prompted us to ask whether soxlO was expressed in all premigratory neural crest cells 
or just in a subset, which might be specified to give rise to non-ectomesenchymal fates.
In an attempt to answer this question, we compared the expression pattern of 
soxl 0 with crestin in a double RNA in situ hybridisation, crestin has been published as 
a pan-neural crest marker that labels all premigratory neural crest from approximately 
the 3 somite stage. It is then maintained in migrating neural crest cells until overt 
differentiation (Luo et al., 2001).
For this experiment, 6 and 12 somite stage embryos were chosen. By the 6 somite stage, 
premigratory cranial neural crest cells are known to be arranged in 6 tiers. The medial-
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lateral position predicts the type of derivative which a neural crest cell will likely form 
(Schilling and Kimmel, 1994). In addition, it was demonstrated that 88% of all labelled 
neural crest cells were fate-restricted and gave rise to only a single cell-type (Schilling 
and Kimmel, 1994). We predicted differential gene expression depending on the fate- 
restriction of each crest precursor. Two research groups have investigated fate maps of 
cranial neural crest cell precursors, with slightly differing results. Schilling and 
colleagues found that ectomesenchymal derivatives arose from more medial tiers (3-6) 
together with some non-ectomesenchymal derivatives, but cells from tier (6) were of an 
exclusively cartilage and connective tissue nature (Schilling and Kimmel, 1994). In 
contrast, Dorsky and colleagues reported to have observed cartilage precursors from all 
tiers, even in the most lateral tier (1), which never gave rise to this cell-type according 
to Schilling (Dorsky et al., 1998). Thus, if sox 10 was not expressed in cartilage 
precursors, such sox 10-negative cells are predicted to be seen mostly medially, but 
perhaps scattered across the entire neural crest region.
Embryos from a heterozygous clsm618 cross were used in these double in situ 
hybridisations. The rationale behind this decision was to test whether the transcription 
of crestin was dependent on Sox 10. If this was the case, one would expect to see 
differences in crestin expression in some embryos, presumably els mutants. 
Unfortunately, we were unable to reproduce the published expression pattern of crestin. 
In our hands, crestin appeared to label all trunk neural crest cells in 6 and 12 somite 
stage embryos as published. However, expression of crestin in cranial crest cells 
appeared to be absent. Only by the 16 somite stage were a few scattered cres/m-positive 
cells observed anterior to the otic vesicle and around the eye (Figure 4.5F, G). In 
comparison, a much greater number of sox/0-positive cells were observed in the cranial 
region at this stage (data not shown). Intriguingly, a small cluster of cells in the centre 
of the otic vesicle was labelled with crestin (Figure 4.5G).
Thus, in 12 somite stage embryos, sox 10 and crestin staining broadly overlapped in the 
trunk posterior to the otic vesicle, but premigratory and migratory cranial neural crest 
cells almost exclusively expressed soxlO (Figure 4.5A, B, E). We asked whether all 
neural crest cells in the trunk were labelled with both markers. We could not readily 
detect any crestin I soxlO' cells in the premigratory position of the anterior trunk. This 
assessment was more difficult caudally, since premigratory cells in this region only 
weakly expressed either marker. Embryos were sectioned to try to confirm this result. 
Unfortunately, these sections were uninformative due to persistent technical problems in
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Figure 4.5: Does sox 10 label all crest cells?
(A-E) Double RNA in situ hybridisation with sox 10 (brightfield, red, A, C, E; 
fluorescence, green, B, D, G) and crestin (purple) reveals incomplete overlap of 
expression patterns.
(A, B, E) In a 12 somite stage embryo the two markers show complete overlap in trunk 
neural crest cells (arrowhead) posterior to the otic placode (o), whereas anteriorly, 
cranial crest cells and the otic placode only express soxlO (A, B, E, red). (C, D) Crestin 
and soxlO transcription is initiated at approximately the same time. Even cells in further 
caudal regions (black arrowheads) in the enlarged region indicated by a black box in (A) 
express both genes. (F, G) crestin in situ hybridisation on 16 somite stage embryos 
shows some scattered crestin positive cells (black arrowheads in F and region enlarged 
in G) anterior to the otic placode (o) and around the eye (e), presumably cranial crest 
cells. A distinct patch of cells in the centre of the otic placode is labelled (G, black 
arrow).
In dorsal (A-D) and lateral views (F-G) anterior is to the left. In the lateral view (E) 
anterior is up. Scale bar: 260pm in A-B, E; 100pm in C-D; 75pm in F; 50pm in G.
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the sectioning process. Using the standard sectioning method, the fluorescent soxlO 
signal was lost.
Crestin and sox 10 expression in the neural crest is switched on at approximately the 
same time, at the 3 somite and 2 somite stage respectively (Dutton et al., 2001b; Luo et 
al., 2001). Consistent with the published data, even the developmentally youngest 
neural crest cells in the caudal-most region were labelled with both markers (Figure 
4.5C, D). No obvious difference in crestin expression could be detected in any embryos. 
Thus, transcription of crestin did not seem to require regulation by SoxlO.
The question whether sox 10 labelled all neural crest cells could not be answered 
with crestin for the reasons described above. Hence, we decided to compare the sox 10 
expression pattern with that offorkhead 6 (fkd6), which is widely expressed in 
premigratory neural crest from about 90% epiboly (Odenthal and Nuesslein-Volhard, 
1998). Double in situ hybridisation was carried out on 6 and 14 somite stage embryos 
from a heterozygous clsm618 cross. The 6 somite stage and use of els mutant embryos 
was chosen for the same reasons outlined above. 14 somite stage embryos were 
available and thus used instead of the 12 somite stage for trivial reasons.
Labelling with soxlO and fkd6  revealed an extensive, but incomplete overlap of signals. 
Occasionally, a few fkd6fI sox 10' cells at the anteriormost edge of neural crest 
expression were observed (Figure 4.6A, B). Whether such cells were found elsewhere 
was impossible to assess in our in situ hybridisation studies. When several layers of 
neural crest cells were present, the coloured NBT precipitate (fkd6 label) quenched the 
fluorescent signal (soxlO label). Thus, the staining of each individual cell could not be 
determined. Sections of these embryos were also uninformative since the fluorescent 
signal was lost during the sectioning process.
At the 14 somite stage, a larger number of neural crest cells were observed that either 
expressed sox 10 or jkd6. The majority of these cells were found within the cranial 
neural crest cells (Figure 4.6D-G).fkd6 expression is extinguished in migratory neural 
crest cells and by the 14 somite stage staining is also observed in somites and the 
tailbud (Figure 4.6C-D; Odenthal and Nuesslein-Volhard, 1998; Kelsh et al., 2000a). At 
this stage, most cranial neural crest cells have started their migration and thus it could 
be argued that soxl0+/fkd6’ cells were migratory and had switched offfkd6. However, 
there was also a number offkd6fIsoxlO' neural crest cells arranged in rows above the 
brain especially posterior to the developing eye (Figure 4.6F, G). The degree of fate 
restriction of these sox 10-negative cells is unknown, but they could represent
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Figure 4.6: Does fkd6  and sox 10 expression overlap completely in premigratory neural 
crest?
(A, B) Double in situ labelling of 6 somite stage embryos with fkd6  (brightfield, purple, 
A) and soxlO (fluorescent, green, B) shows incomplete overlap. A few cells (black 
arrows) on the anterior edge are exclusively labelled with fkd6. (C-I) 14 somite stage 
embryos double in situ labelled with jkd6  (brightfield, purple, C-D, F, H) and sox 10 
(fluorescent, green, E, G, I) are shown. (C) fkd6  is never expressed in the otic placode 
(o) and is switched off in most cranial crest cells (red) as they start migration, whereas 
premigratory trunk crest cells posterior to the otic placode still express both markers. 
(C-E) jkd6  also labels somites (s) and the tailbud (black arrowhead). The caudalmost 
neural crest cells (arrows) are soxlQfljkd6+ due to earlier onset offkd6 compared to 
soxlO. (D, E) Scattered cells in the head, mostly posterior to the eyes (e), show 
differential expression offkd6 and soxlO. The cranial region outlined (D, black box; 
enlarged in F, G) shows jkdfrlsoxlOf cells (arrowheads) and soxl0+ljkd6' cells (arrows). 
Similarly, soxlOfljkdff cells (arrowheads) are seen in the posterior trunk region (D, 
black box above somites; enlarged in H, I). (J, K) Incomplete overlap between soxlO 
and Jkd6 is also seen in the developing pineal organ (arrowhead) at 24hpf.
In dorsal views anterior is to the left (A-B, D-I) or anterior is up (J-K). In the lateral 
view (C) anterior is up. e, eye; nc, neural crest; o, otic placode; s, somite. Scale bar: 
50pm in A-B, F-G; 135pm in C-E; 55pm in H-I; 30pm in J-K.
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premigratory cartilage precursors that will contribute to craniofacial structures not 
affected in els mutants. The most newly formed neural crest cells were only labelled 
with fkd6  as shown by the caudalmost regions of these embryos. This was consistent 
with the onset offkd6  transcription at 90% epiboly preceeding sox 10 at the 2 somite 
stage in the neural crest (Odenthal and Nuesslein-Volhard, 1998; Dutton et al., 2001b; 
Figure 4.6D, E). Occasionally, a fk d t f  /soxlO' neural crest cell was observed in the trunk 
(Figure 4.6H, I). As in the head, it was difficult to distinguish between a true soxlO' cell 
and such cells that had not yet turned on soxlO. The majority of neural crest cells 
however appeared to be double-labelled.
Finally, fkd6  expression in premigratory crest cells was not disrupted in els mutants and 
thus fkd6  did not appear to be regulated by els. In els mutants, fewer fkd6  labelled 
Schwann cells were observed. However, this is likely to be due to a reduction in number 
of Schwann cells, rather than a reduction in fkd6  expression levels.
soxlO expression is disrupted in c/s mutant embryos
Pigment cells and enteric neurons and glia are almost absent in els mutant embryos.
Less severe defects are noted in other peripheral nervous system derivatives and the ear 
(Kelsh and Eisen, 2000b). Furthermore, els was shown to act cell-autonomously at least 
in the pigment cell lineage (Kelsh and Eisen, 2000b). Thus, if els encoded a soxlO 
homologue, we expected to see a disrupted sox 10 expression pattern in tissues of els 
mutants consistent with the els mutant phenotype.
m /i 1We performed RNA in situ hybridisation on embryos of a heterozygous els cross on 
stages suitable for a timecourse. Siblings were carefully examined for consistent 
differences in expression patterns in a quarter of embryos corresponding to homozygous 
els mutants.
soxlO expression patterns in els mutants in the neural crest
The pattern of sox 10 expressing premigratory neural crest cells in mutant embryos was 
indistinguishable from wild-type siblings up to approximately 18hpf (Figure 4.2G). In 
contrast to wild-types, 24hpf els mutants exhibited a distinctly clustered pattern of 
neural crest cells in the head (Figure 4.3B). The number of soxl0-positive cells around 
cranial ganglia and along cranial nerves was reduced (Figure 4.3B, D, F).
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Furthermore, in els mutants, neural crest cells appeared to accumulate in the 
premigratory area. We asked whether there were any differences in numbers of 
premigratory and migratory neural crest cells between els mutants and wild-types. Thus, 
sox/0-positive cells in the premigratory area, on the lateral and medial pathway were 
counted in the region of somites 1-5, 6-10,11-15 and 16-20 of wild-type and clsm618 
mutant embryos at the 24, 30 and 35hpf stages (Figure 4.7). Generally, the number of 
soxl 0-positive cells on the medial and lateral pathway was reduced in more posterior 
regions at all stages, whereas numbers of premigratory neural crest cells increased. This 
is readily explained by caudal neural crest cells being a developmentally younger cell 
population and thus entering the migration pathways after more anteriorly located 
neural crest cells.
The mean number of soxl 0-positive premigratory neural crest cells per somite segment 
at 24hpf (9.4 ±3.13) was broadly comparable to previous neural crest cell counts (11.3 
±3.5; Raible, Wood et al. 1992). Thus, soxlO might label all neural crest cells in the 
trunk at this stage.
As anticipated, the number of premigratory neural crest cells in wild-types decreased 
rapidly between the 24hpf and 30hpf stage as cells started migration and then remained 
fairly constant between the 30hpf and 35hpf stage (Figure 4.7). In contrast, the decrease 
in number of premigratory neural crest cells in mutant siblings was not as dramatic as in 
wild-types. This was observed as an accumulation of neural crest dorsal to the neural 
tube as a result of inhibited migration (Figure 4.3B, Q).
The number of soxl 0-positive cells on the medial pathway remained fairly constant at 
all stages investigated and no significant difference was observed between wild-type 
and els mutants at any stage and in all regions (Figure 4.7).
As described in section 4.1, pigment precursors rapidly down-regulated soxlO and thus 
did not appear in counts of the 30 and 35hpf stage. Occasional soxl 0-positive cells were 
seen in migration on the lateral pathway, but this was only true in els mutants and 
within somites 1-15 even in late stages (Appendix 4.1). Presumably, these represented 
neural crest precursors delayed in their differentiation, since equivalent pigment 
precursors in wild-types were differentiating by 30hpf and no longer expressed soxlO 
(Figure 4.7).
In summary, in els mutants neural crest cells appeared to be inhibited in their migration 
on the lateral pathway. In contrast, soxl 0-positive cells on the medial pathway did not 
seem to be significantly affected (Figure 4.3B). By 36-40hpf, labelled cells were absent
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Figure 4.7: Location of soxlO positive cells in wild-type and homozygous clsm618 mutants
Cells expressing soxlO were counted in 24hpf, 30hpf and 35hpf stage embryos from a heterozygous clsm618 cross, with cells counted 
independently in the premigratory area (pre), on the medial (MP) and on the lateral migration pathways (LP) in each of regions corresponding to 
crest adjacent to somites 1-5, 6-10, 11-15 and 16-20 in wild-type (WT; blue speckled) and els mutant (els; yellow) embryos. Graphs present the 
mean number (error bars indicate standard deviation) of soxl 0-positive cells for each region and stage (n=5 for each genotype; A-C) or the mean 
total number of soxl 0-positive cells within somites 1-20 (D-F). In els mutant embryos, soxl 0-positive neural crest cells tended to remain in the 
premigratory area at later stages, whereas they decreased rapidly in wild-types. Counts of cells on the medial pathway were broadly comparable 
between mutants and wild-type. Pigment cell precursors on the lateral pathway in wild-types rapidly turned off soxlO expression as they started to 
differentiate and thus these cells no longer appear in counts of the 30hpf and 35hpf stages. By contrast, in els mutants up to two soxl 0-positive 
cells were occasionally observed on the lateral pathway in more rostral somite segments at later stages.
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from this latter location and only detectable on the dorsal neural tube and weakly around 
cranial ganglia in els mutants (data not shown). By 60hpf, scattered cells, presumably 
satellite glia or undifferentiated neural crest cells (Britsch et al., 2001) associated with 
the posterior lateral line ganglion, showed weak expression (data not shown).
Enteric nervous system precursors expressing soxlO were essentially absent in mutants 
by 60hpf (Figure 4.4K). Very rarely, one or two soxl 0-positive cells were observed in 
more proximal parts of the intestine (Figure 4.4L).
soxlO expression patterns in els mutants outside the neural crest
Outside the neural crest, the developing otic placode and vesicle in els embryos strongly 
expressed soxlO as described for wild-type siblings (Figure 4.2F, G, Figure 4.3B, D), 
although from approximately 40hpf onwards, the staining in mutant embryos decreased 
(data not shown).
No differences from wild-type siblings could be detected in the level, location and 
timing of expression in hindbrain (Figure 4.4K), spinal cord, jaw cartilage (Figure 4.4A, 
E) and pectoral fins (Figure 4.4E, I).
Could Sox9a or Sox9b function redundantly with SoxlO in the neural 
crest?
Sox9 homologues are the most closely related members of the Sox gene family to SoxlO. 
Furthermore, just like mouse Sox9 at E8.5, the zebrafish sox9b paralogue is expressed in 
the neural crest (Ng et al., 1997), whereas sox9a is only found in the lateral neural plate 
during early somitogenesis stages (E. Cheng, pers. commun.). Both paralogues were 
seen to be expressed in forming cartilage during later development (Cheng et al., 2000). 
Since ectomesenchymal derivatives such as craniofacial cartilage are unaffected in els 
mutants, this could indicate some functional redundancy between Sox9 and SoxlO in 
the neural crest. We therefore asked, whether sox9a or sox9b expression co-localised 
with soxl 0-positive cells in the neural crest. To address this question, we performed 
double RNA in situ labelling with antisense probes against sox 10 and sox9a or sox9b on 
5 somite and 14 somite stage embryos derived from a heterozygous clsm618 cross. The 5 
somite stage was chosen because a high percentage of cranial neural crest cells are fate- 
restricted and give rise to single cell-types (Schilling and Kimmel, 1994; Dorsky et al.,
159
1998). 14 somite stage embryos on the other hand are suitable since they allow 
comparisons between premigratory and migratory neural crest cell populations.
Double in situ hybridisation with sox9a and sox 10 revealed largely non­
overlapping expression patterns at the 5 somite stage (Figure 4.8A-F). Although sox9a 
also labelled cells bordering the neural plate, they were found laterally to and at the 
posterior end of soxlO expressing cells, possibly the region from which the otic placode 
arises. In fact, expressing regions appeared complementary. By 14 somites, both genes 
were expressed in the otic placode, but in only partially overlapping regions. Sox9a 
strongly labelled the centre of the placode (Figure 4.8 G, H) and in distinct patches on 
the dorsal rim (Figure 4.81, J), whereas soxl0 was uniformly expressed in the entire otic 
epithelium. In contrast to soxlO, sox9a was also seen in somitic mesoderm. Both genes 
were expressed in a patch just anterior to the otic placode, but the nature of these cells is 
unknown. They might be precursors contributing to the pharyngeal arches later during 
development. It was hard to eliminate the possibility that cranial neural crest cells 
expressed both markers. If sox9a transcripts were present, the signal was obscured by 
very strong sox 10 labelling. To investigate any possible crest expression of sox9a, this 
experiment has to be repeated with the blue sox9a signal developed more strongly than 
the red soxlO. Alternatively, sox9a could be detected with the more sensitive fluorescent 
signal in a double or with the blue colour precipitate in a single in situ hybridisation on 
its own.
In contrast to sox9a, sox9b expression largely overlapped with sox 10 in the 
neural crest at all stages tested (Figure 4.9). However, in 5 somite stage embryos we 
observed neural crest regions that appeared to express predominantly either sox9b or 
soxlO. Most sox9b+/sox 10' cells were found laterally at the rostralmost and caudalmost 
end of the neural crest region, whereas sox9b'/soxl0+ cells seemed concentrated 
medially between areas of sox9b+/sox 10' expression (Figure 4.9B, D, F). Like soxlO, 
sox9b expression was maintained in premigratory crest until the 14 somite stage and 
was also noted in the otic vesicle (Figure 4.9G, H, I). Caudalmost neural crest cells 
stained with sox9b alone (Figure 4.9A, B, H, I). This expression pattern could easily be 
explained by the earlier onset of sox9b transcription and thus sox9b expression reached 
more posteriorly than soxlO. Differentially labelled cells were observed in the head 
reminiscent of sox 10 and fkd6  double in situ hybridisations (Figure 4.9J, K, 4.7F). Like 
fkd6 f/soxl O' cells, single sox9b+/soxl0~ cells accumulated on the dorsal head just above 
the brain, posterior to the eyes, and few were seen dorsally between the otic placodes
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Figure 4.8: Do sox9a and soxlO expression domains overlap?
Double RNA in situ hybridisation with sox9a (brightfield, purple) and soxl 0 
(fluorescent, green) on 5 somite stage embryos indicates complementary expression 
domains.
(A-D) soxlO (brightfield, red, A, C; fluorescent, green, B, D) is expressed in most neural 
crest cells (ncc), whereas sox9a (purple, A-D) appears to label a more lateral region 
from which the otic placode will arise. The region indicated by a black box in (C) 
enlarged in (E, F) again strongly indicates that patterns are largely complementary, 
although a possible overlap is seen in a narrow region (arrowhead). (G, H) In 14 somite 
stage embryos, sox9a (purple) is expressed in somites (s), in a patch in the centre of the 
otic placode (o, G, H and in dorsal view I, J) and a double labelled region just anterior to 
the otic placode (arrowhead in G-J). Any possible faint expression of sox9a in the neural 
crest was obscured by the strong soxlO signal.
In lateral (A-B, E-H) and dorsal (C-D, I-J) views anterior is to the left, e, eye; ncc, 
neural crest cells; o, otic placode; s, somite. Scale bar: 155pm in A-D; 80pm in E-F;
115pm in G-H; 55pm in I-J.
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Figure 4.9: Do sox9b and soxl0 expression domains overlap?
Double RNA in situ hybridisation with sox9b (brightfield, purple) and soxlO 
(brightfield, red; fluorescent, green) on 5 somite stage embryos shows a large overlap of 
expression in the neural crest. Areas of incomplete overlap are seen at the anterior 
border and lateral edges of the neural crest (white arrowheads, B, D, F) and in the 
posterior lateral neural plate (black arrow, A, B). The latter region is due to earlier onset 
of sox9b expression compared to soxlO. (C, D) The largely double labelled neural crest 
region is shown in an enlarged lateral view (white arrowheads). The region in between 
appears to contain crest cells with strong soxlO, but fairly weak sox9b expression (white 
arrow). The region outlined by a black box in (C) is shown in more detail in (E, F) to 
demonstrate clearly single sox9b+/soxlO' cells (white arrowheads). (G-I) A broad 
overlap of both markers in the neural crest and in the otic placode (o) is seen in 14 
somite stage embryos. Again, the caudalmost neural crest only expresses sox9b (black 
arrowhead in G and white arrow in I). Particularly strong sox9b expression is seen 
around the eye (e). The region outlined by a black box (H, enlarged in J, K) shows 
single crest cells which express either sox9b (arrows) or sox 10 (arrowheads), located 
mostly above the brain, just posterior to the eye (e).
In dorsal (A-B, H-K) and lateral (C-F) views anterior is to the left, in the lateral view 
(G) anterior is up. e, eye; o, otic placode. Scale bar: 155pm in A-B; 85pm in C-D;
55pm in E-F, J-K; 130pm in G-I.
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(Figure 4.9J, K). The staining of cells around the eye had a distinct dark purple hue, 
which suggests that both sox9b and sox 10 transcripts were present (Figure 4.9J, K). 
Whether each of these cells expressed one or the other or both markers could not be 
determined without sections. In contrast, areas of particularly strong soxl 0 staining 
were seen laterally, between the eyes and the otic placode (Figure 4.9H, I). Scattered 
sox9b'/soxl0+ cells were located in the same region on top of the neural tube (Figure 
4.9J, K).
The expression of neither sox9 paralogue showed any overt difference between els and 
wild-type embryos at the 14 somite stage.
Discussion
We have demonstrated that the expression pattern for the isolated zebrafish sox 10 was 
reminiscent of mammalian SoxlO and is thus consistent with conservation of SoxlO 
gene function. In wild-types, sox 10 expression was observed in premigratory and in 
some migratory neural crest cells. Once differentiated, soxlO was only maintained in the 
enteric nervous system and glial cells of the peripheral nervous system (PNS) and in 
addition, it was expressed later in jaw cartilage. Furthermore, presumed 
oligodendrocytes in the central nervous system (CNS), the otic vesicle and cartilage 
cells in the pectoral fins expressed soxlO.
soxlO in the premigratory neural crest
Premigratory neural crest cells expressed soxlO from approximately the 1-2 somite 
stage, soon after transcriptional initiation offkd6 , a neural crest marker (Odenthal and 
Nuesslein-Volhard, 1998). The neural crest appeared to form normally in soxKT618 
(clsm618) mutants and the soxl 0 expression pattern was indistinguishable from wild- 
types until approximately 24hpf.
Very similar observations have been made in mouse, where SoxlO is expressed in the 
premigratory crest of wild-types and homozygous Soxl(f>ornlDom mouse mutants from 
E8.5. Only from El 0.5, mutant expression patterns start to differ from wild-type 
siblings (Southard-Smith et al., 1998).
In addition, we were able to resolve the soxlO expression pattern in premigratory crest 
in more detail than has previously been reported from studies in mouse. We asked
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whether soxlO was expressed in all neural crest cells and found that occasionally, single 
cranial neural crest cells appeared to lack soxlO expression; this was confirmed by 
double in situ hybridisations with soxl 0 and fkd6  in 6 somite stage embryos. This result 
was intriguing, since premigratory cranial neural crest cells in zebrafish at this stage 
were shown to give rise to single cell fates only (Schilling and Kimmel, 1994). els 
mutants lack overt defects in ectomesenchymal crest derivatives, and thus, these 
derivatives might not require SoxlO function. Unfortunately, there is no early marker 
for those derivatives available to determine the specification status of these soxlO- 
negative cells.
Furthermore, we also demonstrated incomplete overlap of expression of soxlO and 
sox9b in double in situ hybridisations. Since Sox9 genes in mammals have roles in 
chondrogenesis, it would be interesting to perform a triple in situ hybridisation to 
determine whether these soxlO'tfkcK? were also sox9b+.
However, it appeared that sox 10 labelled all premigratory trunk neural crest cells at 
24hpf. Counts of soxl 0-positive cells in this region were comparable, but slightly lower 
than previous counts of premigratory neural crest cells (Raible et al., 1992). One 
explanation why the cell number of previous cell counts was slightly higher may be due 
to different observers and perhaps small differences in the stage at which counts were 
carried out. As demonstrated in counts of premigratory neural crest cells at later stages, 
the number of soxl 0-positive cells in this location decreases over time and thus, the 
stage at which cell counts are carried out is important, especially after 24hpf.
Thus, in agreement with mammalian data, soxlO is expressed and maintained in 
premigratory neural crest. However, soxlO was found to be transcribed in only a large 
subset of precursors of unknown specification, at least in the cranial neural crest. Thus, 
use of SoxlO expression as a marker for multipotent neural crest may be misleading 
(e.g. Pattyn et al., 1999).
soxlO in migratory neural crest cells and differentiating pigment 
cells
Neural crest cells on both migratory pathways in wild-types maintained soxl 0 
expression. Although neural crest cells have entered the lateral pathway by 24hpf 
(Raible et al., 1992), the number of soxl 0-positive cells on this pathway, which 
exclusively gives rise to pigment cell-types (Raible and Eisen, 1994), decreased rapidly
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after 30hpf. This was explained by a downregulation of soxlO as melanoblasts started to 
differentiate. At the same time, melanised cells, most of which appeared to lack soxlO 
expression, were migrating on the medial pathway.
This was in agreement with reports in mouse, in which extensive SoxlO expression was 
noted on the medial pathway and in presumptive melanoblasts in a region consistent 
with the dorsolateral pathway (Southard-Smith et al., 1998). However, it is unclear 
whether SoxlO was also rapidly turned off in differentiated melanocytes.
In els mutants, the initial migration on the medial pathway appeared normal at 
24hpf. Presumably, these cells contributed to DRG neurons, cranial and DRG glial 
cells, which are less affected in els embryos. Anterior DRG in els mutants are of 
approximately normal size, whereas they are missing in far posterior segments (Kelsh 
and Eisen, 2000b). However, from 24hpf, neural crest cells seemed to accumulate in 
their premigratory position. Consistent with these observations, we could demonstrate 
in comparative counts that els mutants had more soxl (9-positive cells in the 
premigratory area than wild-type siblings of the same stage. In wild-types, the number 
of premigratory neural crest cells rapidly decreased in older stages as expected, whereas 
in mutants the decrease was minimal up to 35hpf. In addition, hardly any soxl 0-positive 
cells or differentiated pigment cells were seen on the lateral pathway in mutants. Thus, 
our observations were consistent with previous proposals that the migration of neural 
crest cells in els mutants was inhibited, especially on the lateral pathway (Kelsh et al., 
1996; Kelsh and Eisen, 2000b). The clustering of neural crest cells observed in the head 
of 24hpf els mutant embryos might represent yet another example of this migrational 
defect. These cells are scattered in wild-type heads presumably due to active migration. 
Similar results to our observations were reported in mice. Initial neural crest migration 
also appeared to be normal in mice homozygous for a targeted SoxlO deletion until 
E10.5 (Britsch et al., 2001). However, in homo- and heterozygous Soxl0Pom mutants, 
migrating neural crest cells labelled with Ednrb were developmentally delayed in their 
pathway from E l0.5 and melanoblasts were absent in homozygotes (Southard-Smith et 
al., 1998). Detailed cell counts analysing the number of premigratory and migratory 
soxl 0-positive cells in wild-types and mutants of various stages have not been reported 
in mouse.
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soxlO in peripheral and cranial ganglia neurons
Strong soxlO expression was associated with forming cranial ganglia at 24hpf in wild- 
types. In contrast to cranial ganglia neurons, satellite glial cells surrounding cranial 
ganglia maintained high soxlO expression levels in wild-types.
From 24hpf, els mutants were distinguishable from wild-types by a reduction of soxl 0 
expression in satellite glia and Schwann cells along cranial neurons.
Comparable results were obtained in mouse and chicken. SoxlO staining was associated 
with cranial ganglia, but hybridisation signals for SoxlO and the neuronal marker SorLA 
in mouse were non-overlapping in the developing trigeminal ganglion (Kuhlbrodt et al., 
1998a). This was also demonstrated for neural crest derived ganglia in the head and 
trunk of chicken (Cheng et al., 2000). Although indistinguishable from wild-type up to 
E9.5, by El 0.5 SoxlODom,Dom miCe showed strongly reduced levels of SoxlO expression 
associated with cranial ganglia (Southard-Smith et al., 1998).
Expression of soxlO associated with DRG was difficult to distinguish from other 
soxl 0-positive cells on the medial pathway at the stages examined. Even at later stages, 
double labelling with soxlO and anti-Hu antibody will be necessary to determine 
whether soxlO is expressed in DRG neurons or glia.
In rodents and chicken, SoxlO expression was observed in DRG, but the exact neural 
cell-type was not determined (Kuhlbrodt et al., 1998a; Southard-Smith et al., 1998; 
Cheng et al., 2000).
soxlO in peripheral glial cells
Strong sox 10 expression was maintained in cranial ganglia glia and Schwann cells 
associated with the posterior lateral line nerve and other cranial and sensory nerves at 
least up to 60hpf in wild-types. Thus, the soxl 0 expression pattern in those locations 
was reminiscent of the glial marker jkd6  at the stages examined (Kelsh et al., 2000a) 
and did not overlap with the neuronal marker anti-Hu antibody. In els mutants, soxlO 
expression associated with all peripheral ganglia, presumably glial cells, was reduced 
from 24hpf.
Studies in rodents also reported extensive SoxlO expression in cells associated with 
nerve fibres, consistent with them representing Schwann cells. In particular, the 
trigeminal nerve, the sympathetic trunk and even on motor nerves, which originate from 
the CNS, not ganglia are described (Kuhlbrodt et al., 1998a). In chicken, sections
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through DRG double labelled with SoxlO and anti-Hu antibody also showed a non­
overlap of Soxl 0-positive cells with neuronal derivatives (Cheng et al., 2000). As an 
alternative explanation for these Soxl 0-positive cells, undifferentiated neural crest cells 
have been suggested in mice, since they did not express neuronal or glial markers 
(Britsch et al., 2001). In Soxl(Pom/Dom mutants, expression of SoxlO in cranial ganglia 
was drastically reduced by E l0.5 and absent from El 1.5 (SouthardSmith et al., 1998). 
Thus, soxlO expression in peripheral glial cells seemed to be conserved between 
vertebrates and fish. Since mice lack the posterior lateral line nerve, zebrafish show this 
additional region of sox 10 expression. The suggested presence of undifferentiated 
neural crest cells around cranial ganglia has not been investigated in zebrafish.
However, segmentally arranged soxl 0-positive cells at 35hpf in the trunk were thought 
to be glial cells associated with the DRG or Schwann cells associated with 
motomeurons. Since they only expressed soxlO up to 36-40hpf, in contrast to other glial 
derivatives, they too might be undifferentiated neural crest cells instead.
soxlO in the enteric nervous system
Enteric ganglia precursors were labelled by soxlO from 24hpf (R Kelsh, unpubl. 
observ.). Numerous 50x7 0-positive cells were seen in sections of wild-type guts 
surrounding the intestinal lumen at 60hpf, but these cells were missing in els mutant 
embryos. However occasionally, a few soxl0 labelled enteric precursors were also 
observed in mutants.
The results obtained in zebrafish paralleled those in mouse. SoxlO transcripts detectable 
at E l0.5 in wild-types, were absent in homozygous Soxl0lacZ/Soxl0lacZ knock-in mice 
(Southard-Smith et al., 1998; Britsch et al., 2001). Furthermore, the degree of intestinal 
innervation also showed a range from severe hypoganglionosis to aganglionosis (Puliti 
et al., 1996). These differences were explained by the presence of genetic modifier loci 
(Kapur et al., 1996).
sox10 in skeletal neural crest derivatives
A very interesting result represented the staining seen in the developing jaw cartilage. 
This was the first demonstration of soxl 0 expression in this tissue. Although 
craniofacial cartilage precursors are labelled by dlx2 at 29hpf, they did not express
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soxlO until 48hpf. By this time, soxlO expressing chondrocytes are arranged in a “stack- 
of-coins” structure. Consistent with our observations and onset of soxl 0 expression, 
facial cartilage condenses and starts to differentiate between 2 and 3 days of 
development (Kimmel et al., 1995). This might indicate a role for SoxlO in these 
cartilages. Although els mutants lack overt defects in the craniofacial skeleton, late 
mutants showed a slight retardation of arch development (Kelsh and Eisen, 2000b).
The median fin mesenchyme, another ectomesenchymal neural crest derivative, showed 
no expression of soxlO at any stage tested.
SoxlO in mouse or chicken has never been observed in craniofacial cartilage precursors. 
However, this might be another example of the cell-biological advantages of zebrafish 
due to its transparent embryos allowing higher sensitivity in in situ hybridisations. A 
second example of previously undetected SoxlO expression in mesenchymal 
condensations in mouse will be discussed below. Our result might be comparable to 
staining reported in the cephalic crest, which also gives rise to nasal bones in 6 week old 
human embryos (Bondurand et al., 1998a).
soxlO in the pectoral fin buds and pineal gland
sox 10 expression in the developing pectoral fins seemed to be the first report of soxlO in 
this tissue. No staining was reported in functionally equivalent expression domains in 
chicken (Cheng et al., 2000). Only very recently, weak P-galactosidase staining was 
discovered in mesenchymal condensations of the digits, radius and ulna in Soxl0lacZ 
knock-in mice (Britsch et al., 2001). Presumably, due to low levels of expression, these 
structures had been overlooked in less sensitive in situ hybridisations.
The nature of these soxl 0-positive cells in zebrafish has not been further investigated, 
but consistent with their location and “stack-of coins” arrangement, they too are likely 
to be differentiating non-neural crest derived cartilage. Labelled cells were not observed 
in the apical ectodermal fin folds, similar to a pattern seen in sox9a and sox9b labelled 
pectoral fins at 60hpf (data not shown; Chiang et al., 2001). Furthermore, the pectoral 
fin expression of sox 10 in els mutants was indistinguishable from wild-types, just as no 
overt differences in labelling intensities were noted between homo- and heterozygous 
Soxl0lacZ mice (Britsch et al., 2001).
At 24hpf, the developing pineal organ expressed soxlO. Apart from zebrafish, 
sox 10 expression in this tissue has only previously been observed in chicken (Cheng et
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al., 2000). This gland arises through delamination of cells from the neuroepithelium 
similarly to neural crest cells and thus Cheng and coworkers proposed a role for SoxlO 
in enabling this process by altering the expression of adhesion molecules. This area of 
soxlO expression intriguingly coincides with sox9a, sox9b (Chiang et al., 2001) and 
jkd6  expression. The roles and possible interactions of the above transcriptions factors 
in pineal development are still unknown.
soxlO in the central nervous system (CNS)
In zebrafish, expression in the developing CNS was noted from at least 24hpf up to 
approximately 48hpf in the ventricular zone. In chicken, this region gives rise to 
neuronal and glial precursors (Cheng et al., 2000). Consistent with this, we observed 
soxlO expression in putative oligodendrocytes from approximately 48hpf up to at least 
60hpf.
Thus far, it has not been demonstrated whether SoxlO in mice is maintained 
continuously in glial cells until adulthood, where it is found mostly in oligodendrocytes 
in the adult CNS (Kuhlbrodt et al., 1998a). In the PNS, SoxlO expression associated 
with peripheral ganglia and nerves was maintained up to P21 and along the sciatic nerve 
in adults (Kuhlbrodt et al., 1998a). Alternatively, transcription could be regulated 
independently in embryos and adults. An interesting future line of research to address 
this question would extend these expression studies to later stage zebrafish.
As an example to demonstrate the importance of SOX10 during postnatal human 
development, a SOX10 mutation in an 11 year old patient has been associated with 
deficiencies in myelin, produced by oligodendrocytes and Schwann cells in the CNS 
and PNS, respectively. The patient suffered from seizures, sensory dullness and reduced 
nerve conduction velocities in addition to the classical symptoms of WS4 (Inoue et al.,
1999).
soxlO in the developing ear
The onset of soxlO expression in the lateral head correlated approximately with the first 
appearance of the otic placode at around the 10 somite stage (14hpf; Whitfield et al., 
1996) and strong labelling of the otic epithelium was maintained at all stages examined, 
at least up to 60hpf. This is similar to expression data in chicken, where the first
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expression of SoxlO is seen in the otic placode at HH stage 9 (~6-7 somites; Cheng et 
al., 2000). Expression in the developing ear was maintained at least until HH stage 26 in 
chicken (Cheng et al., 2000) and E l6.5 and adults in mouse (Watanabe et al., 2000). 
els embryos show defects in ear morphology and thus suggest a role for SoxlO in otic 
development. The first visible defect in the otic vesicle of els mutant embryos has been 
noted at approximately 36hpf (Malicki et al., 1996) and by 48hpf, only 2 instead of 3 
cristae, labelled with mshC, were observed (Whitfield et al., 1996). Consistent with 
these observations, the labelling intensity of soxlO in the els otic epithelium started to 
decrease at around the same time, 40hpf. By 5 dpf, els mutant ears tended to be smaller 
than wild-types, with two small otoliths and a single sensory patch (Whitfield et al.,
1996). Thus, these sensory and morphogenetic defects strongly suggest a dysfunctional 
inner ear. This is consistent with human SOX10 mutations, even though the latter is 
usually attributed to a loss of melanocytes in the stria vascularis of the cochlea (Steel, 
1989; Pingault et al., 1998a) not present in fish.
Sox9a and sox9b were also expressed in the otic placode to various extents. It will 
certainly be an interesting line of future research to investigate the roles and possible 
interactions of these 3 transcription factors in this organ.
In summary, we provided evidence that the cloned sox 10 orthologue shows 
conservation of its expression patterns with mammalian Soxl 0s. We showed that soxl 0 
was strongly expressed in neural crest derivatives, consistent with our proposal of soxl 0 
as a candidate gene for the els mutation. Furthermore, we demonstrated that sox 10 
expression was disrupted in els mutant embryos. In the next chapter we will investigate 
whether sox 10 and els are tightly linked, as predicted if els encodes soxlO.
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Chapter 5 -  Mapping of soxlO on the radiation hybrid 
panel LN54
Introduction
In chapters 3 and 4 we have described the isolation and expression pattern of a sox 10- 
like homologue. The results were consistent with this soxlO-like gene being a true 
soxlO homologue and a strong candidate for the gene encoded by the els locus. To 
further test this hypothesis, we asked whether the els mutant locus maps to the same 
region on one of the linkage groups as soxlO.
The 1.7xl09 base pair zebrafish genome, approximately half the size of the mammalian 
genome, is contained within 25 linkage groups (LG) each corresponding to a 
chromosome. Each linkage group has been characterised by polymorphic markers such 
as RAPDs (Random Amplified Polymorphic DNAs), SSLPs (Simple Sequence-Length 
Polymorphisms) and RFLPs (Restriction Fragment Length Polymorphisms) that provide 
a framework into which genes and mutations of interest can be placed.
The els mutation is located on the distal end of LG 3
To test whether els and soxlO map to the same region, the mutation had to be placed on 
the linkage map. During a short collaborational visit to the Max Planck Institute fur 
Entwicklungsbiologie in Tubingen, Germany, Susana Lopes mapped els to the distal 
end of LG 3 (Dutton et al., 2001b).
To do so, Susana generated a mapping cross between clstwl, bred onto a Tuebingen 
wild-type background, and WIK wild-type zebrafish. These two different wild-type 
backgrounds are polymorphic for many microsatellite markers necessary to establish 
linkage of the els locus.
First she asked on which of the 25 linkage groups els was located. To test this, 
microsatellite markers on each linkage group polymorphic in those two backgrounds 
were assessed for linkage to the els mutant locus by PCR. If a marker was located on a 
different linkage group to els, recombination between those loci would be observed very 
frequently. On the other hand, the tighter the linkage and thus the closer marker and 
mutant locus are positioned to each other, the lower the probability of recombination in 
the sequence between them. Hence, the distance between markers is measured in
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centiMorgans (cM), where lcM represents 1% recombinants. Based on the relation of 
the physical (~1.7xl09 bp) and genetic size (~2720cM) of the zebrafish genome, lcM  is 
estimated to be equivalent to approximately 600kb (Postlethwait et al., 1994). 
Recombination between els and markers on LG 3 were less frequent than with markers 
for any other linkage group. Thus, els was tentatively placed on LG 3.
Next, she asked which region of LG 3 contained the els mutant locus. This was 
achieved by testing recombination rates between different markers on LG 3 and els. 
Again, the marker showing the least recombination was expected to be located nearest 
to the mutant locus. Thus, fine mapping of 274 meioses finally positioned els within a 
3.9 cM (2.3Mb) interval between markers z872 and zl3387 on the distal end of LG 3 
(Figure 5.1).
If els encoded sox 10, the gene would be expected to map to the same region on 
LG 3. There are several methods to map a cloned gene. The location of a gene can be 
determined by fluorescent in situ hybridisation (FISH), by linkage mapping or by 
radiation hybrid mapping. Syntenic regions can also provide a putative location, if 
homologues of the cloned gene have been identified and mapped in other species.
The FISH technique has been established in zebrafish, but is technically challenging 
(Amores and Postlethwait, 1999). There are syntenic regions found on the chromosome 
containing SoxlO/SOXl0 between mouse chromosome 15, human chromosome 22q and 
zebrafish LG 3 and LG 12. However, these regions don’t include the locus itself. Thus, 
they only provide an indication that soxlO might be located on the same LG as els. 
Classical linkage mapping requires the identification of a polymorphism in the cloned 
gene between different strains such as a restriction fragment length polymorphism 
(RFLP). However, this is not required for radiation hybrid mapping making it a 
straightforward method to use. Furthermore, there was the LN54 radiation hybrid panel 
(Hukriede et al., 1999) available to our lab, which had been used successfully to map 
genes. Thus, mapping soxlO on this panel appeared to be the most suitable approach.
The radiation hybrid panel LN54
Radiation hybrid panels represent a very convenient method of mapping a gene to a 
chromosomal region, since there is no requirement to identify polymorphisms. The 
radiation hybrid panel LN54 (Loeb, NIH, 5000 rad, 4000rad) was generated by Mark 




Figure 5.1: The els mutation is located on the distal end of Linkage group 3 (LG 3) 
Linkage mapping of 274 meioses (carried out by Susana Lopes) placed els in a 3.9cM 
interval between microsatellite markers zl3387 and z872 (Dutton et al., 2001). lcM 
(centiMorgan) represents 1% recombinants or approximately 600kb. The proximal 
centromeric end is indicated by the Q  .
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(Hukriede et al., 1999).
The panel represents a collection of genomic DNA isolated from 93 mouse cell lines 
each of which have incorporated various amounts of fragmented zebrafish genomic 
DNA. Each of the hybrid cell lines has been frame-work mapped with microsatellite 
markers specific for each zebrafish linkage group. The cell lines which contain the gene 
to be mapped (positive hybrids) are identified by PCR amplification of a gene specific 
product. The chromosomal region(s) common to all positive hybrids contains the gene 
in question with a certain probability (lod score). The lod score is defined as the log 10 
of the ratio of the probability that two markers are linked with a given recombination 
value and the probability that they are not linked. (Hukriede et al., 1999).
To generate the radiation hybrid panel, zebrafish fin AB9 donor cells were 
irradiated to introduce random chromosomal breaks. These irradiated cells were then 
fused to mouse B78 melanoma recipient cells. The resulting radiation hybrid cell lines 
retained various amounts of zebrafish chromosomal fragments. The percentage of the 
zebrafish to mouse chromosomal DNA ratio is called the retention rate. For selection, 
zebrafish chromosomes had been tagged with the aminoglycoside phosphotransferase 
(neo) gene, which rendered successfully fused hybrids resistant to gentamicin (G418). 
Out of several radiation doses tested, 5000rad and 4000rad, hence the name of the 
panel, produced hybrids with suitable retention rates of 18-21%. In total, 93 lines, 81 
from the 5000rad and 12 from the 4000rad irradiation dose, were expanded with an 
overall retention rate of 22%. Thus, a hybrid collection was created, large enough to be 
used for over 75000 assays in duplicate. The panel was analysed for completeness by 
characterising it with a total of 1053 markers, including SSLPs, ESTs, and sequence- 
tagged sites (STS) of cloned genes. The probability of mapping a marker or a gene on 
this panel was found to be 88%, which serves as an estimation for genome coverage. 
The distance between markers is measured in centiRays (cR). lcR represents 1% 
frequency of a breakage occurring between two markers after exposure to a specific 
radiation dose. With the radiation used to generate the LN54 panel, the average 
breakage frequency was estimated to be 148kb per cR. The resolution of the map 
corresponds to the average interval size between markers used to create the framework. 
With lcR=148kb the resolution is estimated to be approximately 500kb. After 
characterisation of the 93 hybrid lines, 4 possible gaps were identified, which might just 
represent regions where the marker density was too low to be mapped adequately.
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However, over time and with the addition of newly isolated genes placed on the panel, 
the coverage is expected to increase.
Results 
Mapping soxlO on the radiation hybrid panel LN54
Mapping of a gene on the radiation hybrid panel involves a PCR based screen. Gene 
specific primers are used to amplify a gene specific fragment from DNA isolated from 
each hybrid cell line. Those that contain the sox 10 genomic region will show 
amplification of this gene specific product. Thus, depending on the combination of 
hybrid cell lines positive in this PCR assay, a likely position of this gene can be 
deduced.
Thus, to map sox 10 on the radiation hybrid panel, two gene specific primers SI 1 
and S13 were designed (Materials and Methods). They are located within the 3'UTR of 
soxlO and amplify a 931bp fragment (Figure 5.2). This fragment is highly specific to 
sox 10 since there is very little sequence conservation outside the coding region.
The PCR conditions for this primer pair were optimised prior to the mapping assay. 
Conditions had to be obtained that reliably amplified a specific product from lOOng 
zebrafish genomic DNA and from a 1:10 mixture prepared from zebrafish and mouse 
genomic DNA, but not from lOOng of mouse genomic DNA alone. This was important 
to ensure no false positives or negatives were scored. The PCR conditions and the PCR 
program are described in Materials and Methods.
PCR reactions were set up with lOOng of genomic DNA from each of the 93 radiation 
hybrid cell lines and with 3 control DNAs; the donor zebrafish cell line AB9, the 
recipient B78 mouse cells and a 1:10 mixture of both (Figure 5.3). After amplification 
the reactions were then scored on a standard 1% agarose gel for specific products. To 
ensure the reliability of the mapping data obtained the PCR assay must be performed at 
least in duplicate, and in triplicate if more than 5% differences between the first two 
assays are experienced.
The first two screens that were undertaken only produced very faint products which 
were difficult to score reliably. This might be explained by differences in the genomic 
DNA samples. The genomic DNA that was used to optimise the PCR conditions had 
been prepared in our laboratory, whereas hybrid DNAs had been kindly provided by
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Figure 5.2: The location o f primers SI 1, S12 and S13 within the sox 10 3’ UTR 
The schematic shows the sox 10 cDNA including coding and untranslated regions.
Mapping assays were performed by amplification o f a sox 10 specific 931 bp product between primers SI 1 and S13. Primers were designed to the 
3’ untranslated region (3’UTR) to ensure specificity to sox 10 (non-coding regions show very low sequence conservation). Radiation hybrids 
scoring positive in the screen retained a fragment o f the linkage group containing soxlO. To increase the amount o f specific product, nested PCRs 







1 2 4 5 6 8 9 11
13 16 18 19 23 25 27 29
30 33 36 39 40 41 47 48
49 50 52 54 57 59 63 65
66 70 73 74 79 80 83 84
85 86 87 88 89 991 92 96
97 98 101 104 105 106 108 109
114 117 119 121 123 125 132 135
136 137 138 150 151 152 153 167
169 174 175 176 178 182 183 184
190 300 301 302 303 304 305 306
308 309 310 311 312 mix AB9 B78
Figure 5.3: The LN54 radiation hybrid panel
A total of 93 hybrid cell lines labelled 1-312, 81 from the 5000rad and 12 from the 
4000rad irradiation dose, had been chosen and DNA included in the panel (Hukriede et 
al., 1999). The sample labelled “mix” represents 1710th zebrafish and 9/10th mouse 
genomic DNA, whereas “AB9” contains genomic DNA from the zebrafish donor cell 
line and “B78” genomic DNA from the mouse recipient cell line. All three represent 
control DNA pools which are included in each mapping assay.
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Ekker. It was decided to increase the amount of product by either subjecting the PCR 
reactions to more cycles of amplification or by nested PCR. In a pilot study with a 
mixture of 1:10 zebrafish to mouse genomic DNA mix, increasing the number of cycles 
did not improve the screen result, whereas setting up a nested PCR reaction with nested 
primers S12 and S13 (Figure 5.2) proved to be very successful. Thus, after the first 
round of PCR with primers SI 1 and SI 3, the product was diluted 1:10 in milli-Q water 
and subjected to an equivalent reaction setup and PCR program as before, but including 
primers S12 and S13. The entire PCR reaction was loaded onto a standard agarose gel 
and scored for presence or absence of the specific product with the size of 863bp. 
Radiation hybrids 8,49, 59, 70, 73, 74, 80, 84, 87,109,135, 190, 304, 306, 308 and 311 
proved positive. Usually, two bright bands were observed. One of the expected size and 
one approximately 150bp smaller (Figure 5.4). As anticipated, no bands were observed 
in the control reaction containing mouse genomic DNA, but high levels of product were 
derived from zebrafish genomic DNA and also from the 1:10 mix of zebrafish and 
mouse genomic DNA. Individual radiation hybrids that proved positive in this first 
assay were recorded and the whole assay repeated a second time. This duplicate assay 
did not work as well as the first attempt and gave slightly weaker products, most likely 
because a fifth of the Taq DNA polymerase from Advanced Biotechnologies was 
replaced by Taq DNA polymerase from Promega. In this duplicate assay products were 
observed in 15 out of 16 (93.8%) hybrid cell lines previously positive in the first assay. 
Hybrid number 70, which produced the faintest band in the first assay, did not give a 
detectable product in the second assay. All previously negative hybrid cell lines were 
consistently negative in the duplicate screen. Since only one hybrid cell line gave an 
ambiguous result, the data was considered robust enough for submission.
Mapping results are returned as two lod scores indicating the probability of linkage to 
the two most likely markers on the 25 linkage groups. The lod score is defined as the 
logarithm of the likelihood ratio for linkage (Hukriede et al., 1999). The best lod score 
must be greater than a lod of five in order to be considered significantly linked. Also, if 
the difference between the best lod score and the lod score on the second best LG is less 
than three, this could be indicative of multiple linkage.
The mapping data for soxlO returned a best lod score of 17.6 for the marker z8492, 
which is located on LG 3, OcR from soxlO (Figure 5.5). The best marker in the second 
best linkage group, LG 1, is linked to sox 10 with a lod score of 5.4. In Figure 5.5, 
markers used in linkage mapping of the els locus and framework markers derived from
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Figure 5.4: Mapping soxlO on the radiation hybrid panel LN54.
The first round PCR between primers SI 1 and S13 only produced a few very faint 
products (data not shown). The control reaction of this PCR are shown in (E). In the 
PCR reaction labelled “SI 1-SI3 mix” containing zebrafish and mouse genomic DNA in 
a 1:10 ratio, no product was detectable after amplification with SI 1 and SI3. However, 
a strong product of the correct size (863bp, arrowhead) was observed after nested PCR 
with S12 and S13 (lane S12-S13 mix). As expected, soxlO specific bands were 
amplified from zebrafish genomic DNA (lanes AB9) in both rounds of PCR and no 
product was ever detectable using mouse genomic DNA as a template (lanes B78). No 
sample was loaded in the lane marked with a dash, /. Thus, nested PCR reactions in 
duplicate were used to map soxlO on the LN54 panel. Panels (A-E) show examples of 
the nested amplification between primers S12 and S13 from 93 radiation hybrids 
(numbers 1-312), controls (lanes mix, AB9 and B78) and lkb markers (lkb, Promega). 
A positive radiation hybrid was expected to show a nested PCR product of 863bp 
(arrowhead). Additionally, a second product, approximately 150bp shorter, was 
observed consistently. Radiation hybrids 8, 49, 59, 70, 73, 74, 80, 84, 87, 109,135, 190, 
304, 306, 308 and 311 proved positive. The very faint band amplified from hybrid 70 
was not reproducible in the duplicate screen. All other positives were confirmed in the 
second assay (data not shown). Submitting this data to the radiation hybrid mapping 
webpage placed soxlO OcR from z8492 with a high lod score of 17.6.
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Figure 5.5: Map of the distal end of LG 3 containing the soxlO locus 
On the left, three markers mapped on the radiation hybrid panel LN54 are shown and 
their distance to soxlO in cR. On the right, microsatellite markers from a linkage map of 
the equivalent region are shown. The marker Z872 has been placed on both maps and is 
2.4cM (~ 1.4Mb) or 6.8cR (~lMb) from the els mutant locus or soxlO, respectively. 
SoxlO was shown to be linked to LG 3 with a high lod score of 17.6, OcR away from 
Z8492 on the radiation hybrid panel LN54, whereas els was mapped to a 3.9cM region 
between markers Z13387 and Z872 by linkage mapping of 274 meioses (Dutton et al., 
2001).
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the radiation hybrid panel are combined in one map. The presence of some markers in 
both maps close to cls/soxlO shows that the els mutation is located in the same region as 
sox 10, consistent with the proposal that els encodes soxlO.
Discussion
We have demonstrated close linkage between the els mutant locus and soxlO. This 
result was unambiguous and strongly in support of the hypothesis that els encodes 
sox 10.
This method of mapping is based on a PCR screen, which, although very quick, is very 
sensitive to slight changes in conditions and DNA contamination of the template or 
solutions involved. For this reason, the screen was carried out in duplicate. Furthermore, 
variability of the intensity of PCR products between individual radiation hybrid cell 
lines can be explained by different amounts of radiated zebrafish genomic DNA 
retained by the recipient mouse cell line.
To ensure specificity and detection of fainter products, a nested PCR was carried out, 
which consistently amplified two bands. There are two possibilities for the origin of this 
second band. Although the primer pair SI 1-S13 had amplified a single PCR product, the 
nested primer S12 could have misprimed and amplified a slightly shorter product 
alongside of the one with the expected size in the nested PCR reaction. Alternatively, 
the reverse primer S13 in the first PCR reaction might have misprimed resulting in two 
first round PCR products. Both products were again amplified in the nested PCR 
reaction since they both contained the S13 primer sequence at their 3’ ends and S13 was 
also used as a nested primer. The latter explanation seemed more likely, since there 
were also two faint products observed in the AB9 control reaction of the first round of 
PCR amplification (Figure 5.4E). As expected they were both slightly larger than each 
of the two nested products and were only visible in the reaction with 100% zebrafish 
genomic DNA, but not in the mix containing 10% zebrafish and 90% mouse genomic 
DNA. Even though these two bands were obtained for each positive radiation hybrid, 
they were observed consistently and improved scorability immensely. To prevent the 
amplification of such a second product in the future, one should set up a fully nested 
second round PCR reaction. The latter uses two nested primers instead of one nested 
and one first round primer.
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Radiation hybrid 70 amplified a very faint soxlO specific product in the first nested 
assay, which was not reproducible in the duplicate screen. However, all positive hybrids 
consistently produced fainter bands in the second nested assay, most likely due to 
suboptimal conditions caused by a mixture of Taq DNA polymerases used. Thus, 
amplification from hybrid 70 might have failed or the amount of product obtained was 
below the detection sensitivity limit of a standard agarose electrophoresis. A 
discrepancy of 1 hybrid producing varying results is considered acceptable according to 
the radiation hybrid webpage (http://zfin.org/ZFIN/, LN54 mapping panel) in which is 
stated that a marker should be reconsidered, if 5 or more hybrid cell lines produce 
varying results.
The lod score of 17.6, with which soxlO was placed OcR from Z8492, was highly 
significant. It placed soxlO with great probability in close proximity to the els mutant 
locus on LG 3.
Very recently, Tom Carney showed that injection of a 30kb PAC clone containing 
sox 10 into 1-16 cell embryos was able to rescue the els mutant phenotype (T. Carney, 
unpubl. data). Thus, the distance between els and soxlO could in fact be decreased to 
30kb.
Although these results do not prove that els encodes sox 10, it is strongly consistent with 
the latter and encouraged us to look directly for lesions in sox 10 in different els mutant 
alleles.
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Chapter 6 -  Identification of mutant lesions in c/s 
alleles
Introduction
In the previous chapter, we showed tight linkage between sox 10 and the els mutant 
locus. This was consistent with our hypothesis that els encoded soxlO. However, it was 
necessary to further test this hypothesis by trying to identify a mutant lesion in at least 
one of our els alleles.
As described in the Introduction, the clstS mutant first arose spontaneously within the 
rose stock kept in Tuebingen. Four additional els alleles, elsty22^ , clste275, clstw2 and 
els*™11, were identified in the Tuebingen mutagenesis screen and two clsm241 and clsm618, 
in a similar screen in the Driever lab in the USA (Driever et al., 1996; Kelsh et al.,
1996; Malicki et al., 1996). Apart from els"1241, which might have been lost, all 6 other 
alleles are currently available in Bath.
Methods for identifying mutant lesions
There are at least three approaches to search for a mutant lesion. If a mutant phenotype 
is caused by a large deletion within the transcribed region, a difference in size of mutant 
and wild-type mRNA transcripts might be detectable in a Northern Blot.
Similarly, where point mutations or deletions are expected, a sequence difference may 
be detected in PCR amplified exon sequences of candidate genes by single-strand 
conformational polymorphism (SSCP) analysis.
Alternatively, point mutations or small deletions can be detected by direct sequencing of 
mutant and wild-type alleles and subsequent sequence comparison.
Which method is chosen depends on the type of mutation expected. All colourless 
alleles, apart from elstS, were isolated from large-scale mutagenesis screens and contain 
ENU-induced mutations. The ENU mutagen is known to mostly introduce point 
mutations rather than large deletions and thus a direct sequencing approach was chosen. 
This method is technically much easier compared to SSCP and methodology and 
equipment were readily available in our laboratory.
The 1455bp coding region was too long to be sequenced with one primer from either 
end. Hence, 4 primer pairs were designed spanning the entire coding region (Figure
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6.1). RT-PCR would amplify 4 overlapping fragments between each primer pair from 
wild-type and mutant alleles. Sequence comparison of corresponding wild-type and 
mutant allele fragments might then reveal the site of mutation.
This approach bears 3 caveats. Firstly, it is important to avoid contaminating wild-type 
embryos when collecting homozygous mutant embryos as a source for mRNA. Even 
one missorted wild-type embryo within mutants would result in amplification of a 
genotypically mixed sample and might return ambiguous sequence data. Wild-type 
embryos start to pigment at approximately 25hpf (Kelsh et al., 1996), but at that early 
stage it is very difficult to sort mutant embryos reliably. On the other hand, mutant 
embryos should be collected as early as possible, since the sox 10 expression level in els 
mutants decreases noticeably after 24hpf. Thus, total RNA from different els alleles was 
isolated from homozygous mutant embryos between 25hpf and 37hpf (prim6-prim25). 
Secondly, great care had to be taken to avoid cross contamination when setting up PCR 
reactions from wild-type and various mutant alleles. Thus, solutions including primers, 
buffers, magnesium chloride and milliQ-water used in RT-PCR from mutant alleles 
were prepared freshly and kept separately. Furthermore, all PCR reactions were set up 
using filter tips to avoid contamination originating from pipettes.
Finally, PCR errors introduced by the Taq polymerase had to be distinguished from 
actual sites of mutations. One of the two possible approaches is to clone PCR fragments 
and sequence several clones. In contrast to a true point mutation, it is unlikely that a 
PCR error would be found in all sequenced clones in the same location. For the same 
reason, the alternative approach is to directly sequence the entire pool of PCR 
fragments. Only the aberrant base of the point mutation would be found in all templates 
and thus, be detected as a strong band on a sequencing gel.
Results
The method chosen for the search of mutant lesions involved RT-PCR of 4 overlapping 
fragments from wild-type and various mutant alleles and sequence comparison of 
equivalent wild-type and mutant regions.
Thus, total RNA was prepared from 25-37hpf els mutant embryos using TRI 
reagent. Numbers of mutant embryos varied between alleles depending on the size and 
quality of the batch of eggs. RNA pellets were resuspended in a suitable volume of
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Primers to search for mutant lesions
S21 S19 HMG S24 S26
► ► ► ►
5’ It | | (( AAAA 3’
5’UTR + < < *  3’UTR
S22 S20 S25 S27
lOObp
Figure 6.1: Location of primers used to sequence wild-type soxlO and els mutant alleles in search for mutant lesions.
The coding (open box) and untranslated regions (5’ UTR, 5’ untranslated region; 3’ UTR, 3’ untranslated region) o f sox 10 are shown together 
with the HMG box (black). Four overlapping primer pairs were designed, which span the entire length o f the coding region, S21-S22, S19-S20, 
S24-S25 and S26-S27. RT-PCR with total RNA from wild-type and homozygous els mutant embryos was performed with each primer pair. 
Sequences o f equivalent wild-type and mutant fragments were compared to identify mutant lesions. The scale bar represents the length o f a 
1 OObp fragment.
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DEPC-treated water (Appendix 6.1). Agarose gel electrophoresis of samples of total 
RNAs confirmed the good quality of the RNA preparations (Figure 6.2). In each 
sample, the 3 ribosomal RNA bands, 23S, 16S and 5S, were observed. A slight 
background smear indicated the presence of mRNA transcripts. For each allele, 
approximately 3pg total RNA were reverse transcribed using an oligo(dT) primer. The 
RT-PCR conditions and amplification program for each of the 4 primer pairs were 
determined in advance by using the PCR optimisation scheme (Materials and Methods). 
This scheme tested different combinations of magnesium, dNTP and primer 
concentrations on cDNA derived from 19hpf wild-type total RNA. The conditions, 
which produced the strongest band with the least non-specific by-products were chosen 
for mutant RT-PCRs (Figure 6.3). For each primer pair, RT-PCR reactions were set up 
with the optimised conditions and cDNA from each of the mutant alleles, e l s c l s tw2/1, 
clst3/ 1, clstwl\  els®22* and clsm618/ 1, and a “no cDNA” negative control (Materials and 
Methods). Expected products ranged from 432bp to 547bp depending on the primer pair 
(Figure 6.4). No such bands were observed in the “no cDNA” controls. Equivalent 
fragments derived from different mutant alleles were always the same size and thus, 
were unlikely to contain larger insertions or deletions. All 4 primer pairs amplified 
products from clstw2, clstS, clstw!1 and clsm618. Very faint products were observed from 
cA ^^w ith  primer pair S19/S20 and S21/S22, but no products were detectable with 
primer pair S24/S25 and S26/S27. The opposite was true for clstwl; no bands were 
obtained with primers S19/S20 and S21/S22 and faint bands with S24/S25 and S26/S27 
(Figure 6.4).
Mutant PCR products and the equivalent wild-type fragments from the PCR 
optimisation were purified using the QIAquick PCR Purification Kit (Qiagen). After the 
DNA was bound to the column, an additional wash with 35% guanidine hydrochloride 
was included. This wash was not part of the standard protocol, but was suggested in the 
instruction manual to completely remove primer dimers longer than 20bp. This step was 
important, since these purified PCR products were subsequently included in a 
sequencing reaction, in which either forward or reverse PCR primers were used as a 
sequencing primer. Presence of primer dimers might cause failure of the sequencing 
reaction by binding the sequencing primer. The concentration of purified samples was 
estimated by agarose gel electrophoresis and comparison to a quantitative DNA marker 
(data not shown). Suitable amounts of each product were sent off for automated 
sequencing with the appropriate forward and reverse PCR primer.
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M tw l tw 2 /l tw2/2 t3/l t3/2 tw ll  ty22f m 618/1 m 618/2
1.5 kb
0.5 kl>
Figure 6.2: Agarose gel electrophoresis of total RNA preparations from els mutant 
alleles
The quality of total RNA from 25-37hpf homozygous els mutant embryos was judged to 
be good by the presence of 3 distinct ribosomal RNA bands, 23S, 16S and 5S 
(asterisks), in combination with a slight background smear corresponding to mRNA 
transcripts. RNA from the following mutant alleles was analysed: clstwl (twl), 2 
separate batches of clstw2 (tw2/l and tw2/2), 2 separate batches of els'3 (t3/l and t3/2), 
clstw11 (twl 1), cls^22^ {ty22f), 2 separate batches of clsm618 (m6182/1 and m618/2). A 
lOObp marker (lOObp M, Promega) was used to estimate the size of the bands.
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Figure 6.3: PCR optimisations for primer pairs S19-S20, S21-S22, S24-S25 
and S26-S27
(A-D) Agarose gel electrophoresis of PCR reactions with wild-type RNA and primer 
pairs S19-S20 (A), S21-S22 (B), S24-S25 (C) and S26-S27 (D) are shown to test 
optimum PCR conditions. Expected PCR products are shown (arrowheads in A-D) for 
each primer pair together with lOObp markers (lOObp M, Promega; lOObp M l, 
Promega; lOObp M2, Generuler). Lanes 1-12 (A-D) correspond to 12 different 
combinations of magnesium, dNTP and primer concentrations (reactions “111 ”-“722” 
in PCR optimisation scheme, Materials and Methods). For each primer pair, the 
conditions which produced the strongest product with the least non-specific by-products 
were used to set up RT-PCR reactions with RNA from homozygous els embryos. For 
primer pairs S19-S20 (A) and S21-S22 (B) reaction condition 4 (white asterisk) was 
chosen (reaction “ 122” in the PCR optimisation chart), whereas for primer pairs S24- 
S25 (C) and S26-S27 (D) reaction condition 3 (white asterisk, reaction “121”).
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Figure 6.4: RT-PCR from cls mutant alleles
(A-D) Samples of RT-PCR reactions with els mutant alleles (lane 1, clstw lane 2, 
c/5/w2; 1^0  3  ^cjst3  ^iane 11} clstw ll\ lane 22f, clsty22f; lane 618, clsmH&) and 4 
primer pairs are shown together with lOObp markers (lOObp M, Generuler, A; Promega, 
B and C) and lkb markers (lkb M, NEB). (A) Amplification between primers S19 and 
S20 obtained a band of the expected size of 435bp (arrowhead) from mutant alleles 
clstM>2, cls*3, els*™H and clsm61$. Only a faint product was observed from clsty22f,  
and no band was detectable from clstw 1 or the “noDNA” negative control (not shown).
(B) Primer pair S21 and S22 amplified a 432bp product (arrowhead) from mutant alleles 
cls*™2, clst2, cls*™ 11 cism618? but again, only a barely visible band from clsty22f  
and no band was detectable in the negative control (lane “-ve”) or from clstw 1 (Q  
shows 547bp PCR products (arrowhead) derived from the primer pair S24 and S25 in an 
RT-PCR reaction from clstw2 ^ d st3  ^t fstw ll  and clsm Here, clstw 1 produced a very 
faint band, while no band was generated from clsty22f.  No band was seen in the 
negative control (lane “-ve”) as expected. (D) RT-PCR reactions with primer pair S26 
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Sequences of equivalent fragments of wild-type and each mutant allele were 
aligned using Pileup (gcg package). The sequence from the faint products obtained 
with S24/S25 and S26/S27, and the cls®22* sequence from primer pair S19/S20 and 
S21/S22 matched the wild-type sequences completely. The same was found to be true 
for all 4 overlapping clstS fragments. Thus, we did not identify any mutant lesion in 
these regions of the clstM>\  cls13 and cls®22* alleles.
In contrast, putative point mutations were identified for clsm618i clstw2 and clstw11. Thus, 
the clsm618 sequence showed one non-silent single base pair mismatch from WT, which 
was identified in the HMG box fragment (primer pair S19-S20). Even after sequencing 
both strands multiple times, a thymine (T) at position 800 was consistently replaced by 
an adenine (A) resulting in a leucine to glutamine (L142Q) change (Figure 6.5). To 
confirm this result, the second batch of clsm618 total RNA (m618/2, Figure 6.2) was 
reverse transcribed and the RT-PCR product between primers S19 and S20 sequenced. 
Again, the same mutant lesion was identified.
Similarly, a point mutation was detected in the overlap between fragments S24-S25 and 
S26-S27 in clstw2 and clstw11. In both alleles, an A-to-T transversion at position 1501 
resulted in an in-frame stop codon (TAA) instead of a lysine (K376X, Figure 6.5). This 
prematurely truncates the protein just upstream of the putative transactivation domain. 
Again, the lesion was confirmed by multiple sequencing runs of the S24-S25 and S26- 
S27 PCR products of both alleles and also by sequencing the equivalent RT-PCR 
product from the second clsw2 batch (tw2/2, Figure 6.2).
Discussion
We have described the successful identification of mutant lesions in 3 cls alleles. As 
expected, all 3 mutations induced by the chemical mutagen ENU were point mutations.
clsm618 was found to be caused by a point mutation within the HMG domain. 
This replaced a leucine with a glutamine at residue 142, located in the second of 3 a- 
helices that give the HMG domain its L-shaped structure. The exact function of this 
residue has not been elucidated. However, it is fully conserved across all members of 
the Sox gene family and even in the outgroups LEF1 and TCF1 from mouse and C. 
elegans (Bowles et al., 2000), which might indicate an important structural or functional 
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Figure 6.5: The mutant lesions in clsm618, cls*™21 cls*”11 and cls*3
(A) The schematic compares wild-type (wt, residues 1-485) to mutant (m618, tw2, tw ll, 
t3) SoxlO proteins. In m618, a T425A transversion within the HMG domain (red) 
replaced a leucine (L142) with a glutamine (Q). In tw2 and tw ll, an Al 126T 
transversion introduced a Stop codon truncating the protein just N-terminal to the 
transactivation domain (blue). t3 was found to be disrupted by a 1.4kb transposon (T. 
Carney; Dutton, Pauliny et al. 2001). After introducing a C-terminal extension of 8 
novel amino acids (yellow), the protein is truncated just N-terminal to the HMG 
domain. (B) Chromatogram traces show the nucleotide changes (arrows) causing the 
m618 and tw2/twll mutant alleles.
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in the maintenance of orientation of the long and short arms of the L-shaped HMG 
domain structure (Werner et al., 1995). The mutation is thus likely to disrupt the three- 
dimensional structure of the DNA binding domain reducing the ability of SoxlO to bind 
to its DNA target sites.
In collaboration with Bill Pavan, National Institute of Health, Bethesda, MD, the 
transcriptional abilities of wild-type and mutant zebrafish SoxlO proteins were tested in 
luciferase reporter assays (M. Brady, unpubl. data). In transiently transfected HeLa 
cells, the ability of SoxlO to induce the nacre promoter was measured by the activation 
of a luciferase reporter gene regulated by the nacre promoter as previously described in 
Potterf et al. (2000). The transcriptional activation ability of SoxlO is measured as the 
fold increase relative to a promoterless basic reporter plasmid. Wild-type SoxlO 
produced a 46.14 fold induction of luciferase activity, whereas L142Q only a 0.83 fold 
induction. The loss of function demonstrated in this in vitro system confirms this 
residue’s importance for SoxlO as a transcription factor observed in the mutant 
phenotype. If the mutation renders SoxlO unable to bind to its consensus sites in the 
promoter regions of downstream targets, this might also abolish its synergistic abilities. 
It has been demonstrated that both the synergy and the HMG domain are necessary for 
SoxlO to act cooperatively with partner transcription factors like Pax3 or Tst- 
l/Oct6/SCIP (Kuhlbrodt et al., 1998a; Bondurand et al., 2000).
Alleles clstw2 and clstw11 contained the same mutant lesion in the exact same 
location. At first, this seemed a surprising result, but it could be explained by the fact 
that they were derived from the same mutagenised family founder male, W. Thus, very 
likely they represented two independent isolations of the same mutation. The point 
mutation introduced a stop codon, 18 residues upstream of the putative transactivation 
domain, which resulted in a protein truncated by 109 residues. Due to the loss of the 
transactivation domain, the protein’s function is expected to be severely affected. The in 
vitro analysis of the K376X mutation (W. Pavan, unpubl. data) showed only a 0.87 fold 
induction of the luciferase reporter construct in comparison to 46.14 fold induction by 
the wild-type protein. This drastic decrease in transcriptional activity was comparable to 
the L142Q mutation (0.83 fold induction).
Thus far, we were unable to identify a mutant lesion in the cls®22*coding region. 
Faint PCR products could only be obtained from the first two overlapping fragments. 
This observation might be explained in several ways. Firstly, only a small number of 
embryos were available from which total RNA was isolated (Table 6.1). Although it
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was attempted to compensate for this by resuspending the RNA pellet in a smaller 
volume and using a larger volume of cDNA to set up PCR reactions, it might have 
caused fainter products. Secondly, one of the primer sites might be changed by the 
mutant lesion causing the amplification between primer pair S24-S25 or S26-S27 to fail. 
Even so, this could not explain why PCR reactions with both primer pairs failed to 
produce products. Alternatively and most likely, it is possible that the products observed 
were derived from a small contamination of wild-type RNA. This might have been 
caused by a missorted wild-type embryo within the els siblings or whilst setting up the 
PCR reaction. Consistent with this possibility, the sequence of the faint products 
matched wild-type sox 10 completely. Furthermore, sox 10 in situ hybridisation on elsty22^  
revealed overall reduced expression levels in a quarter of the embryos, presumably 
corresponding to homozygous siblings (Figure 6.6). Taken together, these observations 
indicate that els**22*is caused by a further mutant lesion different to L142Q and K376X. 
It might be located outside the coding region in one of the regulatory elements, in which 
case one approach to find the mutant lesion is to compare the promoter regions of wild- 
type and els®22*mutants by sequencing. Alternatively, the transcript might be 
destabilised due to the lesion affecting intron/exon boundaries and thus correct splicing 
of the transcript. To identify such a lesion, one could sequence across intron/exon 
boundaries in genomic DNA of cls^22^ mutants.
The search for a mutant lesion by sequencing the 2 faint products obtained from 
clstwl was unsuccessful. There are a two explanations why only the two C-terminal 
fragments, which matched wild-type sox 10 completely, were amplified. Either, mutant 
transcripts were produced, but the PCR reactions with the N-terminal primer pairs SI 9- 
S20 and S21-S22 failed altogether and hence, no products were obtained or PCR 
products might have been present, but too faint to be detectable by agarose gel 
electrophoresis. Alternatively, the mutant lesion could be located in a regulatory 
element and hence no transcripts are synthesised or only at a drastically reduced level. 
Thus, the PCR products obtained might have resulted from wild-type contaminations. 
Consistent with this hypothesis, sox 10 in situ hybridisation on clstwl embryos showed 
that in a quarter of embryos at any stage, expression was barely visible apart from the 
expression in the otic vesicle (Figure 6.6). This is different to most other alleles, in 
which els mutants are indistinguishable from wild-type siblings up to 24hpf.
Only recently, we discovered that clstwl and clstS were identical. For reasons unknown, 
clstS had been renamed clstwl in the Tuebingen stock centre. Furthermore, T. Carney
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Dc ls ^ V l  r/t (%) clsiy22fl l  r/t (%) c tT 1/1 r/t (%) CUT1!! r/t (%)
2 somites 9/36 (25%) nd 10/27 (37%) 8/32 (25%)
18 somites 10/38 (26%) 7/25 (28%) 8/30 (27%) 7/26 (27%)
24 hpf 3/12 (25%) 3/21 (14%) 3/20 (15%) 6/25 (24%)
Figure 6.6: The els®22* and clstwl (els'3) mutant alleles
(A-C) In situ hybridisation with sox 10 on 18 somite stage embryos derived from a 
heterozygous els**22*cross shows a reduction (B, black arrows) of sox 10 transcripts in 
approximately a quarter of embryos, presumably homozygous mutants, whereas 
equivalent clstwl (clst3) embryos reveal an even more severe reduction (C, black arrows) 
of soxlO staining. In comparison, els mutants of other alleles at this stage are still 
indistinguishable from wild-types (A). The expression in the otic vesicle (o) in elsty22f
(B) is comparable to wild-types (A) and significantly reduced in els*™1 (C). (D) The 
number of embryos with reduced sox 10 expression (r) from 2 independent hybridisation 
reactions (clsP22*/!, elsty22^ !2 and clstwI/\, clstwI/2) was compared to the total number (t) 
of embryos included in each staining reaction and the percentage (%) calculated for 
different stages (2 somite, 18 somite and 24hpf stage). If the siblings with reduced 
sox 10 staining corresponded to homozygous els mutants, a percentage value of 
approximately 25% of the total number of embryos is expected in all cases, e, eye; hpf, 




recently showed by sequencing genomic DNA from clst3 embryos, that clst3 was caused 
by a 1.4kb insertion of a transposable element at nucleotide 255 of the transcript, a 
position 20 amino acids upstream of the HMG domain (Genbank accession number 
AF404490; Dutton et al., 2001b). The clst3 lesion results in premature truncation of the 
N-terminal domain with an extension of 8 novel amino acids. The protein thus only 
consists of what has been defined as the synergy domain (residues 1-89; Kuhlbrodt et 
al., 1998a). Since products of expected sizes were amplified between all 4 primer pairs
/ 3from els cDNA, at least the band between primer S21 and S22 must have been 
contamination from either wild-type or other mutant cDNAs. With the knowledge of 
clstwl and clstS being identical, it is more likely that all bands amplified resulted from 
wild-type DNA contamination, which helps to explain our confusing and inconsistent 
results obtained from these two mutant PCR reactions. It will be interesting to 
characterise this allele in greater detail in vivo (rescue experiments) and in vitro 
(luciferase reporter assays). However, it is likely to be a null, since the DNA binding 
domain, which also contains two nuclear localisation signals (Suedbeck and Scherer, 
1997), and the transactivation domain are missing.
Preliminary phenotypic comparisons by project students did not reveal greatly 
significant differences between these alleles. The effect of els on the pigment phenotype 
was assessed by counting melanoblasts in 22-24hpf wild-type and els mutants labelled 
by dopachrome tautomerase (dct) in situ hybridisations (Sanders, 2000). This marker is 
expressed in melanoblasts approximately 5 hours prior to melanisation (Kelsh et al., 
2000c). In a similar project, the effect of els on the peripheral nervous system was 
investigated. The reduction of DRG and enteric neurons in 3dpf and 5dpf els mutants 
was assessed by counting neurons labelled with the pan-neuronal anti-Hu antibody 
(Ford, 2000). Some allelic differences that students observed in various cell-types and 
stages might have been artefacts due to small sample numbers. This suggestion is based 
primarily on the discrepancies in allelic strengths reported for the elswl and clst3 alleles, 
which are now known to contain identical mutant lesions. However, overall the severity 
of phenotypes in alleles investigated was largely comparable and approximately 
equivalent.
In conclusion, we demonstrated mutant lesions in 3 of the colourless alleles and 
a fourth was identified by T. Carney. Together with the expression studies and the 
mapping result, this presents a very strong indication that els is soxlO. Preliminary data 
from two undergraduate project students showed that all alleles were phenotypically
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very similar. The clstS allele seems highly likely to be a null due to the location of the t3 
lesion. However, the severity of effects caused by the clsm6]8 and clstw2 lesions is not 
quite so clear cut. In the next chapter we attempt to test whether these mutant proteins 
have any residual function in vivo.
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Chapter 7 -  Rescue of the c/s phenotype by heatshock 
construct injections
Introduction
Can sox 10 rescue the colourless phenotype? This is the last of a series of tests to 
investigate whether els encodes soxlO. In previous chapters, we have demonstrated that 
sox 10 and the els mutant locus are very tightly linked, that sox 10 is expressed in a 
pattern consistent with the mutant phenotype and identified genetic lesions expected to 
disrupt the SoxlO protein. If els encodes sox 10, we would also expect to rescue at least 
partially the els phenotype by expressing wild-type soxlO in els mutant embryos.
There are generally two methods to ectopically express a gene, either by directly 
injecting mRNA or a construct containing the cDNA of interest under the regulation of 
a suitable promoter. If mRNA is injected, the timing of expression of the protein cannot 
be regulated. It has been previously suggested that RNA injections lead to sufficient 
RNA and thus protein levels up to midsegmentation stages, while DNA injections 
become necessary to affect processes that occur after the 20hpf stage (Hammerschmidt 
et al., 1999). Judged by the first visible defect in els embryos at 24hpf, SoxlO function 
is likely to be required at a time when ectopic SoxlO protein is unlikely still to be 
present. Consistent with this, injection of sox 10 mRNA into 1 cell stage embryos of a 
heterozygous clstw11 cross failed to rescue els mutants (S. Elworthy, unpubl. data).
In contrast, driving ectopic expression of the gene of interest by a known 
promoter allows controlled expression of the protein at a particular time and duration 
during development. A heatshock promoter was chosen, since initiation of expression is 
easily achieved by incubating embryos containing the heatshock construct at the 
permissive temperature. The heatshock construct is made by cloning the sox 10 coding 
region into a suitable expression vector, downstream of a heatshock promoter. This 
construct is then injected into the yolk of early cleavage stage embryos (1-4-cell stage) 
where it becomes distributed by yolk streaming. Upon raising the incubation 
temperature of injected fish embryos from 28.5°C to 37°C, transcription of sox 10 from 
the heatshock promoter is initiated in those cells that have received the construct.
To achieve rescue, it is important that SoxlO is expressed at the correct concentration 
and time required. To maximise the degree of rescue, we thus anticipated having to
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optimise the amount of injected construct per embryo, and the time and number of 
heatshock treatments. We chose to score rescue based on the rescue of melanophores. 
This neural crest derivative is severely affected in els embryos of all strong alleles, in 
which pigmented melanophores with stellate wild-type morphology are never observed. 
In wild-type embryos, melanophores are easily detected under the dissecting 
microscope from approximately 30hpf. Thus, rescue was defined as presence of at least 
one fully differentiated melanophore with wild-type morphology.
We wanted to establish the severity of a mutant allele in relation to the location 
of the mutant lesion and asked the question whether the resulting mutant protein 
retained any function in vivo. Results from corresponding in vitro studies, discussed in 
the previous chapter, indicated that clsm618 and elstw2/tyvI1 had no transcriptional activity. 
We used rescue experiments to characterise these mutant alleles and specifically we 
tested the prediction that they would fail to rescue the els mutant phenotype.
Finally, we wanted to investigate the possibility of functional redundancy 
between sox9 and soxlO. Although there is no previous evidence for redundancy of Sox 
proteins, it is not unreasonable to assume that highly conserved proteins might function 
redundantly when co-localised in the same tissues.
sox9 and sox 10 are the most closely related members of the Sox gene family. Zebrafish 
sox9b and maybe also sox9a, were shown to be expressed in the neural crest (E. Chiang, 
pers. commun.; this study) consistent with reports of mouse Sox9, which labels cephalic 
crest (Ng et al., 1997). To test whether either sox9a or sox9b could rescue aspects of the 
els phenotype, we replaced the soxlO coding region in the expression vector with that of 
sox9a or sox9b. The same method and scoring criteria were to be applied as had 
previously been established for soxlO.
Results 
Preparation of sox9 and soxlO heatshock constructs
To generate heatshock constructs, we chose a strategy of PCR amplification of the Sox 
protein coding regions and cloning them into a heatshock expression plasmid. Clones 
were sequenced to select against PCR errors which might have been introduced.
This approach required the design of PCR primers outside the coding region and a 
suitable vector containing a heatshock promoter. The plasmid pCSHSP was chosen as
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the expression vector, since it had been successfully used in rescue experiments with the 
zebrafish mzT/'homologue, nacre (nac\ Lister et al., 1999). It is based on the pCS2+ 
plasmid, in which the CMV (cytomegalovirus) promoter had been replaced by a 
heatshock promoter (HSP; Halloran et al., 2000). This modified vector was kindly 
provided by D. Raible (Figure 7.1). Cla I and Xba I restriction sites within the multiple 
cloning site of the vector were selected for subcloning the sox 10, sox9a and sox9b 
coding regions, since neither enzyme was predicted to cut within these fragments.
Thus, primers S21 and S27, 9A-1 and 9A-2 and 9B-1 and 9B-2, located just outside the 
sox 10, sox9a and sox9b coding regions, respectively, were redesigned to include Cla I 
and Xba I sites at their 5’ ends (Figure 7.2).
RT-PCR amplifications were performed on total RNA derived from 38hpf wild- 
types and clsm618 and clstw2 mutants and primers Cla I-S21 and S27-Xba I (Materials and 
Methods; Figure 7.3). The sox9a and sox9b coding regions were amplified from 
plasmid minipreparations containing the appropriate full-length cDNAs using primers 
9A-1 and 9A-2 or 9B-1 and 9B-2, respectively (Materials and Methods; Figure 7.3). For 
all PCR reactions, either Herculase or TaqPlus Precision PCR system (Stratagene), both 
high fidelity DNA polymerases, were used to reduce the frequency of PCR errors. PCR 
reactions usually produced a single product of the expected size, which was directly 
subjected to a restriction digestion with Cla I and Xba I (Promega) in multicore buffer 
(Promega). However, with the clsm618 cDNA, primers Cla I-S21 and S27-Xba I 
amplified a non-specific product of approximately 400bp alongside the specific 1614bp 
band. Thus, the specific product was excised and gel purified using the QIAquick Gel 
Extraction Kit (Qiagen) before restriction digestion with Cla I and Xba I (data not 
shown). Digested coding regions were purified using the QIAquick PCR Purification 
Kit (Qiagen) and the concentration of eluted samples was estimated by agarose gel 
electrophoresis and comparison to a quantitative DNA marker (NEB; data not shown). 
In parallel, the pCSHSP plasmid had also been restriction digested with Cla I and Xba I 
and purified by standard phenol/chloroform extraction and ethanol precipitation. 
Heatshock constructs were created by ligating each coding region into linearised 
pCSHSP plasmids and transforming the constructs into Gold Super-competent 
Epicurian Coli cells (Stratagene). A suitable number of white colonies were picked and 
analysed by restriction digestion for inserts of the expected size (Figure 7.4). Only 4/18 
(22%) white colonies from the cloning of wild-type sox 10 contained inserts of the 
correct size. All 4 clones contained a non-conservative PCR error altering the protein
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Figure 7.1: Plasmid map of pCSHSP
This map was adapted from http://faculty.washington.edu/rtmoon/
This expression vector is based on the pCS2+ plasmid, in which the cytomegalovirus 
(CMV) promoter had been replaced by a heatshock promoter, HSP70/4 (Halloran et al., 
2000). To create the heatshock constructs, the sox 10 coding region was cloned into the 
Cla I (87) and Xba 1(115) sites within the multiple cloning site, downstream of the 
HSP. The ampicillin resistance gene (amp) is used as the selectable marker. For RNA 
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Figure 7.2: Primers used to create the soxlO, sox9a and sox9b heatshock constructs
(A-C) The coding (open box) and untranslated regions (5’ UTR, 5’ untranslated region; 3’ UTR, 3’ untranslated region) of sox 10 (A), sox9a (B) 
and sox9b (C) are shown together with their HMG box (HMG, black box). (A) Primer pair Cla I-S21 and S27-Xba I are located just outside the 
stop and start codons and thus amplify the entire sox 10 coding region or els mutant allele coding regions if mutant cDNAs were used as 
templates. After cloning these fragments into pCSHSP vector, the constructs were analysed for possible PCR errors by sequencing with a 
combination of primers as indicated. (B, C) The sox9a (B) and sox9b (C) coding regions were amplified from plasmid DNA minipreparations 
containing the appropriate full length cDNA between primers 9A-1 and 9A-2 or 9B-1 and 9B-2, respectively. These primers had been designed to 
include Cla I (9A-1 and 9B-1) and Xba I (9A-2 and 9B-2) restriction enzyme recognition sites at their 5’ ends facilitating subsequent cloning into 
the heatshock plasmid pCSHSP. The sequence of the cloned sox9a and sox9b heatshock constructs were checked for PCR errors using the 
sequencing primers as indicated. The scale represents the length of a lOObp fragment.
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Figure 7.3: PCR of wild-type and mutant sox 10, and wild-type sox9a and sox9b 
(A, B) To amplify the sox 10 coding region, RT-PCR was performed on total RNA from 
38hpf wild-types (A) or 25-37hpf clsm618 (B, lane 1 and 2) and els*™2 mutants (B, lane 3 
and 4) between primers C/aI-S21 and §21-Xbal. (A) Reactions were set up with lpM  
(lane 1), 0.5pM (lane 2) and 0.2pM primers (lane 3). (A, B) All reactions produced 
bands of the expected size (1614bp, arrowhead). (A) Additionally two smaller non­
specific bands were obtained with approximate sizes of 250bp and 400bp in lanes 1 and 
2, and thus, the product of lane 3 was digested with Clal and Xbal and cloned into 
pCSHSP. (B) An additional non-specific by-product was observed in the reaction in 
lane 1 (cDNA prepared with random hexamers, white arrowhead). cDNA in lane 3 was 
also prepared with random hexamer primers. Reactions in lanes 2 and 4 (both cDNA 
prepared with oligo dT primer) were digested with Clal and Xbal and cloned into 
pCSHSP. (C, D) PCR between primers 9A-1 and 9A-2, or 9B-1 and 9B-2 amplified the 
1476bp sox9a or the 1390bp sox9b coding region (arrowhead), respectively, from 
plasmid minipreparation containing the entire sox9a or sox9b cDNA. Samples of 
reactions with 0.2pM primers (C, D lane 1), 0.5pM primers (C, D lane 2) and ljuM 
primers (C, D lane 3) are shown. (C) Reaction in lane 3 was digested with Clal and 
Xbal and cloned into pCSHSP. (D) Products of lanes 1-3 were gel purified, digested 
with Clal and Xbal and cloned into pCSHSP. In all panels, product sizes can be 
estimated using the quantitative lkb DNA ladder (lkb M, NEB).
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Figure 7.4: Restriction digestion of putative heatshock constructs 
(A, B) Samples of plasmid DNA minipreparations of putative hs>cAffT (A, lanes 1-8), 
hs>clsm618 (B, lane m618) and hs>clstw2 (B, lane tw2) constructs were digested with 
Pvull to test the size of the insert and are shown together with a quantitative lkb DNA 
marker (lkb M, NEB), sox 10 coding regions contain a Pvu II restriction recognition site 
and thus, positive clones were expected to release a 967bp band and a 1871 bp band 
(black arrowheads) in addition to a 3243bp band corresponding to the linearised vector
rjrrnn £  i  o
(asterisk). Positive hs>c/.s clones (A, lanes 1-3) and one hs>clsm clone (B, lane 
m618) could be identified, but the hs>clstw2 clone (lane tw2) was not correct, since the 
size of the insert (open arrowhead) was too small. The lane marked with a dash, /, is 
irrelevant to this experiment. (C) Samples of 3 putative hs>sox9a clones (lane 1-3) were 
digested with EcoRV and Xba I and positive clones were expected to show a 600bp and 
a 927bp band (arrowhead) compared to a lOObp marker (lOObp M, Promega) together 
with a 3243bp band corresponding to the linearised vector (asterisk). (D) 6 samples of 
putative hs>sox9b (lane 1-6) were digested with Pvu II to test the size of the insert and 
shown here together with a quantitative lkb marker (lkb M, NEB). Positive sox9b 
clones were expected to produce a restriction pattern consisting of a 1066bp, 809bp, 
570bp and 213bp band (arrowheads) and a 3243bp band corresponding to the linearised 
















sequence when sequenced. None of 6 plasmid minipreparations derived from the tw2 
cloning released inserts of the correct size corresponding to the full length coding 
regions. However, sequencing a positive clone derived from the m618 cloning revealed 
no aberrations to the wild-type protein sequence apart from the m618 mutant lesion 
within the HMG domain. This construct will be referred to as hs>clsm618 from this point 
onwards. Likewise, clones sox9A-l and sox9B-l proved to contain error free sox9a and 
sox9b coding regions respectively and will be referred to as hs>sox9a and hs>sox9b 
hereafter.
Since an error-free hs>clsm618 construct was available and creating a wild-type 
(hs>c/5ffT) and tw2 (hs>cA/w2) heatshock construct using RT-PCR had presented 
difficulties, a new strategy of site-directed mutagenesis of the hs>clsm618 construct was 
chosen. We followed the guidelines from the QuikChange Site-Directed Mutagenesis
1X7rp
Kit (Stratagene; Figure 7.5; see also Materials and Methods) to generate hs>cA . 
Subsequently, the tw2 mutant lesion was to be introduced into this wild-type construct 
by the same method to create the hs>clstw2 construct.
In the site-directed mutagenesis method, one or more nucleotide changes are introduced 
during in vitro replication of parental plasmid strands. The replication is primed from 
long reverse complementary mutagenesis primers, which contain the nucleotide 
mismatch to be introduced. To specifically remove the original parental strands after 
twelve rounds of strand replications, their bacterial origin and thus methylation status is 
utilized. In contrast to strands newly synthesised in vitro, parental strands derived from 
bacteria are methylated and are thus digested with the methylation sensitive restriction 
enzyme Dpn I. The remaining unmethylated, mutagenised linear DNA fragments align 
and form nicked open circular plasmids. After transformation into competent cells, 
these nicked plasmids are repaired and propagated normally.
Two pairs of mutagenesis primers were designed (Figure 7.6). The forward and reverse 
mutagenesis primers clsm618-+ WT1 and clsm618-+ WT2 encoded 35bp of wild-type 
sequence surrounding the m618 nucleotide change. Thus, the nucleotide sequence of the
urr /CIO _
resulting hs>c/s would be identical to hs>clsm apart from the T—>A mutant lesion. 
Mutagenesis primers WT\^>clsiw2 and WT2-±clstw2 were designed to introduce the tw2
jx/rp . W/T1
mutant lesion transforming hs>cls into hs>cls . The two constructs hs>cls and 
hs>clstw2 would be identical apart from the single change of nucleotide causing the 
K376X mutation.
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Figure 7.5: Schematic of site-directed mutagenesis
The schematic was adapted and redrawn from the QuikChange Site-Directed 
Mutagenesis Kit Instruction Manual (Stratagene). The methylated parental strands 
(black) contain the site to be changed, indicated by an “X”. Mutagenesis primers (red) 
contain the site to be introduced (asterisk) in the centre of the primer sequences. When 
parental strands are replicated, the mutation (asterisk) is incorporated. The parental 
strands (methylated, black) are selectively digested with a methylation sensitive 
restriction enzyme, whereas the new daughter strands (red) align and form open nicked 
circular plasmids, which are transformed into competent cells.
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Figure 7.6: Mutagenesis primers to create the h s> c /s^ a n d  hs>clstw^ constructs
The soxlO coding region is shown including the HMG domain (black box). The reverse complementary mutagenesis primers clsm^ ^ - > WT1 and 
clsm618^>WT2 were designed to transform clsm61$ into a wild-type coding region. Subsequently, the clstw^ mutation was introduced into the 
wild-type sequence using primers WT1—> c ls ^ ^  and WT2—» elstw^. The scale bar represents the length o f a lOObp fragment.
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Depending on which nucleotide change was to be introduced, reactions were set up with
/CIO TTTT1
a range of amounts of either hs>clsm or hs>cls template and a “no primer” control. 
After 12 cycles of replication, an aliquot of each reaction was analysed by agarose gel 
electrophoresis (Figure 7.7A, B). As expected, the amount of the 6103bp product 
generally increased with the amount of template. A very faint band was observed in the 
“no primer” control corresponding to the amount of template included in the reaction. 
However, a significant increase in product was observed in the equivalent reaction 
including the primers demonstrating successful replication. The reaction that produced 
the strongest product and the “no primer” control were separately digested with the 
methylation sensitive enzyme Dpn I to digest the parental methylated strands. A small 
aliquot was transformed into Gold Super-competent Epicurian Coli cells (Stratagene). 
As expected, no colonies were obtained from the control reaction due to complete 
digestion of parental methylated strands. In contrast, approximately 400 transformed 
colonies were counted from experimental reactions. 16 colonies from each of the two 
mutagenesis experiments were streaked out on fresh LB agar plates containing 
ampicillin to avoid genotypically mixed clones in a colony. A suitable number of these 
were picked and plasmid DNA isolated from them by plasmid minipreparations using 
the Wizard Plus SV Miniprep DNA Purification System (Promega). The potential
TITT* . . . /  tO
hs>cls clones could be distinguished from parental hs>cls clones by a diagnostic
restriction enzyme digest. In the wild-type sequence, an additional 7s/?RI restriction site 
is created digesting an approximately 2000bp band, present in elsm618, into a 1200bp and 
a 800bp band. Of 8 clones analysed all appeared to have lost the m618 mutant lesion 
(Figure 7.7C). An equivalent diagnostic restriction digest was unavailable to test for 
successful synthesis of hs>clstw2 constructs. Thus, 6 clones were digested with Pvull to 
test for inserts of the correct size. All 6 produced a pattern of 3 bands as expected for a 
sox 10 insert; a 3243bp vector band and 967bp and 1871 bp bands, since the soxlO 
coding region contains a Pvull site (Figure 7.7D). One clone of each experiment, later 
renamed hs> cls^  and hs>clstw2 respectively, was sequenced to confirm successful 
mutagenesis.
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Figure 7.7: Site-directed mutagenesis to create hs>c/5ffTand hs>clstw2 
(A, B) Samples of the site-directed mutagenesis reaction converting hs>clsm618 into 
hs>cAffT (A) and hs>cAWT into hs>clstM>2 (B) are shown together with quantitative lkb 
markers (lkb M, NEB). Experimental reactions were set up with 5ng (lane 5), lOng 
(lane 10), 20ng (lane 20), and 50ng (lane 50) template. A negative “no primer” control 
(-ve) was included with 20ng template. As expected, the amount of the 6103bp product 
(arrowhead) generally increased with the amount of template. A very faint band was 
observed in the “no primer” control corresponding to the amount of template included 
in the reaction. (C, D) An aliquot of the reaction from lane 50 (A) and from lane 20 (B) 
was transformed into Gold Super-competent Epicurian Coli cells (Stratagene). (C) 8 
clones (lanes 1-8) were restriction digested with T-spRI to distinguish between parental
/ i n  TMm
hs>clsm (lane m618) and successfully created hs>c/s clones. In the latter wild-type
clones, a 7j/?RI site was expected to be gained resulting in an approximately 1.2kb and 
a 800bp band (arrowheads) instead of a 2.0kb band seen in m618 (asterisk). All 8 clones 
tested had successfully lost the m618 mutant lesion. A quantitative lOObp marker 
(lOObp M, NEB) was loaded for size comparison. (D) 6 clones (lanes 1-6, D) were 
restriction digested with Pvull to test for inserts of the correct size corresponding to 
wild-type or mutant soxlO coding regions, since no diagnostic restriction digestion for 
successfully introduced tw2 mutant lesions was available. All 6 clones produced the 
expected bands, 1871 bp and 967bp (arrowheads) and a 3243bp band (asterisk) 
corresponding to the linearised vector. A quantitative lkb marker (lkb M, NEB) was 
loaded for size comparison. (C, D) One positive clone each (C, lane 1 and D, lane 4) 
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Injection of the hs>clsWT construct shows partial rescue of the c/s 
phenotype
The following experiments were performed to test whether ectopic sox 10 driven by a 
heatshock promoter could rescue the els mutant phenotype.
ir r r
Firstly, we injected a suitable concentration of the hs>cls construct into the
yolk of early cleavage stage embryos from a els heterozygous cross (Materials and 
Methods). At this early stage, the construct is distributed to all blastomeres by yolk 
streaming, since there are no physical boundaries between blastomeres and yolk up to 
the 8 cell stage (Kimmel et al., 1995). The embryos were then raised at 28.5°C. In initial 
experiments, based on descriptions of rescue with a nacre heatshock construct (Lister et 
al., 1999), two one hour heatshocks were carried out at 37°C, the first between 10-13hpf 
and the second heatshock between 22-24hpf. The rationale for choosing these time 
points was that sox 10 expression is first observed at the 2 somite stage corresponding to 
10 Vi hpf. Secondly, the first phenotype in els embryos is apparent at approximately 
24hpf, when pigment cell precursors on the lateral pathway fail to migrate (Kelsh et al., 
1996). Thus, SoxlO function commences before or at approximately this time. Embryos 
from a e l f 1618 cross were chosen, because preliminary phenotypic studies (previous 
chapter) indicated that it might be one of the strongest alleles and for reasons of 
consistency since all in situ hybridisations had been carried out on clsm618 embryos.
Of a total of 92 injected els mutant embryos that survived, 44 (48%) were 
rescued. On average, they developed 15 melanophores per embryo with stellate wild- 
type morphology and dark pigmentation (Figure 7.8, Appendix 7.1 A).
Investigation o f  deformities
Although hs>c/^^ clearly rescued the melanophore phenotype in els mutants, 63.8% of 
injected embryos also showed various degrees of malformations. Defects ranged from 
slightly smaller eyes and mildly deformed axes to grossly amorphic tissue with pigment 
cells surrounding the yolk sac.
We were concerned about malformations since they might have an influence on the 
rescue experiments. For example, to identify a rescued embryo, its eyes have to be 
present and fully pigmented in order to distinguish it from a malformed wild-type 
sibling. A developmentally delayed wild-type sibling might easily be mistaken for a
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WTFigure 7.8: Rescue of the pigment phenotype in homozygous els mutants by ectopic expression of hs>c/j
(A-C) In 48 hpf wild-type embryos, numerous neural crest precursors have differentiated into stellate, pigmented melanophores (A). Such cells 
are never observed in uninjected homozygous clsm618 mutants (data not shown) or when injected with hs>clsm618 (B). Occasionally, faintly
UPT #
pigmented, rounded cells are seen in the premigratory neural crest area (B, arrowheads). After ectopic expression of hs>cls , a variable number 
of melanophores are rescued to a wild-type morphology and are able to migrate to ventral locations (C). In this embryo, one melanophore was 
noted in the premigratory neural crest area (C, asterisk), one on the yolk sac (F) and two in the anal region (C, arrows). Rescued melanophores 
adopt a morphology characteristic for their final location as can be seen by comparing the melanophores in the anal region (arrows in C, enlarged 
in E) with the equivalent region in wild-type siblings (D). Scale bar: 125pm (A-C), 70pm (D-F).
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rescued els embryos, but this can be overcome by comparing the extent of pigmentation 
in its eye to other wild-type siblings. An undoubtedly rescued els embryo would show 
the same extent of pigmentation in the eye as its wild-type siblings, but less along its 
body.
Furthermore, heavily malformed embryos might not show any rescue or rescue to a 
lesser degree regardless of SoxlO’s functional abilities.
A low level of these deformities were likely to be caused by a proportion of bad eggs 
and/or by injection trauma. To control for bad batches of eggs, we also raised 10-30 
uninjected siblings from each batch and scored the proportion of surviving embryos 
(Appendix 7.1) and the percentage of malformed within the surviving embryos 
(Appendix 7.3). The difference between the proportion of deformed embryos in 
uninjected and injected siblings was a measure for malformation due to the injection 
process, overexpression of SoxlO protein or toxicity of the heatshock plasmid itself. 
Trauma caused by the injection process likely varied slightly on a daily basis due to 
personal skilfulness and differences in injection needles. However, by comparing the 
mean results of several batches, we hoped to control for this variability.
To investigate the origin of these deformities and optimise the injection protocol 
accordingly, we carried out a series of experiments testing the effect of parameters 
likely to influence the occurrence of malformation such as the amount of construct 
injected and the time of heatshock.
First, we carried out a x -test (using the Yates’ correction formula) on els/WT pairs of 
individual datasets to test whether these malformations were linked to a certain 
genotype. It was asked whether the ratio of malformed:total wild-type (WT) embryos 
was different to the equivalent ratio in els embryos. Appendix 7.3 lists all malformation 
data collected. Under all conditions, no significant difference was found in 
malformation frequency between els mutant and wild-type embryos (Appendix 7.4A). 
We then employed a single factor ANOVAR analysis with 2 levels to investigate the 
effect of various parameters, such as heatshock (hs) treatments, on the frequency of 
malformed embryos.
First, we asked, whether the heatshock treatment itself increased the amount of 
malformations. To do so, we compared the number of malformed embryos depending 
on early (15-16hpf) or late hs (18-19.5hpf) versus no hs at both 50pg (high) and 25pg 
(low) DNA injected per embryo. The “no hs” control was included to assess the 
leakiness of the heatshock promoter. All experiments were scored for percentage of
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malformed embryos (Appendix 7.3). At high concentration, a very significant difference 
at the 0.1% level was found regardless of whether it was an early or late heatshock, 
whereas at low concentration, no significant difference was observed even at the 5% 
level (Appendix 7.4B). Thus, an early or late heatshock does increase malformations, 
but only when high concentrations of DNA are injected.
Next, we asked whether the toxic effect observed was due to the sox 10 cDNA or 
the plasmid vector itself. We injected embryos with 50pg (high) and 25pg (low) pCS 
plasmid only (without the soxlO cDNA) and heatshocked early and late. We found no 
significant difference at the 0.1%, 1% or 5% level between pCS or hs>c/^ffT injections 
when constructs were injected at the low concentration, irrespective of the time of 
heatshock and at the high concentration when heatshocked late. When high 
concentrations were injected and embryos heatshocked early, there seemed to be a
wrsignificant difference between pCS and hs>cls at the 5% level. This could point to a 
slight toxicity of soxlO when overexpressed during early development. For all the other 
conditions, the malformations appeared to be attributable to toxic effects of the 
heatshock plasmid alone (Appendix 7.4C).
When we compared the effect of high and low amounts of hs>cls1^  construct on 
malformation, no significant difference was found when heatshocked early, but a very 
significant difference (at the 0.1% level) when heatshocked late. The equivalent 
comparisons with pCS injections resulted in a significant difference at the 1% level 
between high and low concentration regardless of the time of heatshock (Appendix 
7.4D).
Next, we investigated whether the time of heatshock had an effect on the 
percentage of deformed embryos. Consistent with the heatshock versus no heatshock 
results, a significant difference between early and late hs was observed when high 
concentrations of either hs>cAWTor pCS was injected, but no significant difference at 
low concentration. Furthermore, the effect was more pronounced in the presence of 
sox 10 cDNA (Appendix 7.4E).
Finally, we asked whether malformations had any effect on the rescue 
experiment. For example, are rescued embryos more or less likely to be malformed than 
others with normal morphology. We tested this with a % -test and investigated whether 
the ratio normal:malformed within the rescued els embryo population was significantly 
different from 1:1. Individual tests were carried out within the different types of 
treatments and also for all of the 22 datasets together (Appendix 7.4F). In any case,
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within the population of rescued embryos, the number of malformed embryos was not 
significantly higher than rescued embryos with normal morphology. Thus, the presence 
of malformation did not appear to affect the proportion of els embryos rescued.
The results of these previous experiments generally indicated that malformations 
tended to be lower if less DNA was injected and the hs was carried out earlier, at 15- 
16hpf. Thus, to optimise the assay further, we tested an even lower (12pg) and higher 
(120pg) concentration of hs>clsWTm  combination with an early hs. For each of the 4 
construct concentrations, embryos were scored for the percentage of rescued els 
mutants, the degree of rescue (mean number of melanophores per rescued embryo) and 
the percentage of malformation. For comparison, all results were combined and plotted 
in a graph (Figure 7.9, Appendix 7.1 A). As expected, the percentage of rescued els 
embryos and malformations generally increased with the amount of DNA injected. 
However, the number of rescues seemed to plateau or slightly decrease between 50pg 
and 120pg of hs>clsWT, whereas the deformities steadily increased. The mean number of 
melanophores remained fairly constant throughout, apart from a significant peak of 3 
times increase at 50pg.
Taken together, in our hands 50pg construct in combination with an early hs at 15-16hpf 
produced the highest degree of rescue (on average 18.7 melanophores) in the highest 
proportion (61%) of els mutant embryos with relatively low levels of malformation 
(35.7%).
Can mutant soxlO alleles rescue the melanophore aspect of the c/s 
phenotype?
In the previous section we could show that hs>clsWT was able to partially rescue the 
melanophore phenotype in els mutant embryos. We decided to use the same assay to 
characterise some of the els mutant alleles in an in vivo system. We wanted to ask 
whether the mutant proteins had retained any residual function by testing the ability of 
them to rescue pigment cells. Furthermore, we were interested to see whether alleles 
exhibited any dominant negative effects as had been hypothesised for some of the 
human SoxlO alleles (1400dell2, Inoue et al., 1999; E189X and 1076delGA, Pingault et 
al., 1998a) and so far only been shown conclusively in vitro for the mouse allele C190X 
(SoxlOdel, Potterf et al., 2000). In accordance with the mammalian SoxlO pigmentation 
phenotype, we predicted that such a dominant
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Figure 7.9: Summary of rescue and malformation data
(A, B) The graphs show the percentage of homozygous els mutant embryos rescued 
after injection of various amounts of either hs>clsm  (sox 10), hs>c/.sm6;s (m618), 
hs>c/5nv2 (tw2), hs>sox9a (sox9a) or hs>sox9b (sox9b) (A) and the mean number of 
melanophores per rescued els embryo (B). hs>clsm618 and hs>c/5^2 were only assessed 
at 50pg and 120pg, whereas hs>sox9a and hs>sox9b only at 50pg. Only hs^ls™7 was 
able to rescue the pigment phenotype in els embryos. The highest percentage rescue and 
rescued melanophores per els embryo were observed with 50pg. (C) The graph depicts 
the percentage of all malformed embryos (wild-type and els mutants) observed for each 
amount of construct injected. The same abbreviations were used as described in (A) 
with the addition of the heatshock vector without the soxlO coding region (pCS). 
Regardless of the construct, malformations increased with the amount of construct 
injected. hs>sox9a and hs>sox9b were only assessed at 50pg, pCS only at 25pg and 
50pg and hs>clsm618 and hs>c/srw2 were tested at 50pg and 120pg.
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negative effect in zebrafish would be reflected in a reduction in number, aberrant 
distribution or perhaps changed morphology of melanophores due to cell death. No 
phenotype was noticed in uninjected heterozygous siblings of a heterozygous clsm618 or 
clstw2 cross. However, the dominant effect might only become apparent when mutant 
sox 10 is overexpressed in wild-types or in heterozygous mutants, in which the amount 
of SoxlO is halved already.
Consistent with the injection protocol for hs>clsWT, in most cases an early 
heatshock at 15-16hpf was performed. As a control for the initial experiment with
J A /T  A  1 Qhs>cls , most hs>c/57” injected embryos were also subjected to two heatshocks at the 
time points used before. There was the possibility that a mutant protein with only little 
residual function would be required at higher concentrations for rescue than the wild- 
type protein. Thus, 50pg and 120pg of hs>clsm618 and hs>clstw2 was injected as 
described before. Even though we expected to see a high percentage of malformations 
as a result, the chances of rescue might be increased as well.
Of a total of 125 clsm618 mutant embryos injected with either 50pg or 120pg 
hs>clsm618 that survived to be scored for rescue, none showed any melanophores with 
wild-type morphology (Figure 7.9, Appendix 7.IB). Uninjected siblings usually showed 
only very low levels of deformities. Although the proportion of malformations in the 
uninjected siblings were comparable to the equivalent 50pg hs>cls injections, 
indicating a batch of eggs with similar quality, the percentage of malformed embryos
✓ - in  lATT1
injected with hs>clsm was approximately half of that of the hs>c/s injections 
(Figure 7.9, Appendix 7.3). When 120pg hs>cA^Tor hs>clsm618 was injected, the 
proportion of malformed embryos was comparable.
Similarly, none of 249 clstw2 embryos could be scored as rescued (Figure 7.9, 
Appendix 7.1C). In these injections, 3 embryos injected with 120pg hs>clstw2 and 3 
injected with 50pg exhibited 1-12 melanophores in the dorsal and ventral stripe of trunk 
and tail. Unfortunately, all 6 were very severely malformed and lacked eyes or even 
head structures, which made it impossible to identify them as els mutant embryos. We 
could not exclude the possibility of them being severely delayed wild-type siblings and 
thus, they could not be counted as rescues. Although comparable proportions of 
deformed embryos were recorded in uninjected siblings, twice as many embryos 
injected with 50pg of hs>clstw2 were malformed than with hs>clsWT, whereas with 
120pg the percentages were not significantly different (Figure 7.9, Appendix 7.3).
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We noticed melanophores with abnormal morphology in 20-90% of 
phenotypically wild-type embryos obtained from a heterozygous cross that had been 
injected with hs>clstw2 (Figure 7.10A, B). In the majority of cases, the percentage was 
between 55-85% (Figure 7.10C). As described in the beginning of this section an 
abnormal melanophore morphology might be expected for a dominant negatively acting 
SoxlO protein. Furthermore, the proportion of embryos exhibiting this phenotype was 
also broadly consistent with wild-type and heterozygous mutant siblings, in which a 
possible dominant negative mutant protein had been overexpressed. Thus, a possible 
dominant negative function of clstw2 was further investigated. A simple genetic test 
eliminated this hypothesis very quickly. If the clstw2 allele encoded a dominant negative 
protein, a similar pigmentation phenotype would be expected to be seen in all 
heterozygotes of an uninjected clstw2 cross. No abnormal melanophores were observed 
in heterozygous els mutants, thus ruling out any dominant negative effect of this allele 
at least on the pigment cell lineage.
Can sox9a or sox9b rescue the melanophore aspect of the c/s 
phenotype?
For reasons explained in the introduction to this chapter, we were interested to 
investigate a possible functional redundancy between soxlO and its closest relative, 
sox9. The same rescue protocol and scoring criteria were applied as had been
Vf/Testablished for the rescue experiments with hs>cls .
Of 325 surviving embryos after injection with 50pg hs>sox9a and heatshocked at 15- 
16hpf (early), 76 els embryos were identified. None exhibited any rescued 
melanophores (Figure 7.9, Appendix 7.2A). Although the level of malformation in 
uninjected siblings was comparable, injection with 50pg of hs>sox9a instead of 
hs>c/5^ appeared to result in an increased proportion of deformed embryos (Figure
7.9, Appendix 7.3).
A similar result was obtained with hs>sox9b. Of 263 surviving embryos injected with 
50pg hs>sox9b and heatshocked early, none of the 58 els embryos were rescued (Figure
7.9, Appendix 7.2B). Again, embryos injected with hs>sox9b showed a higher 
proportion of malformed embryos than a comparable batch injected with hs>clsWT 




















Figure 7.10: Investigation of a possible dominant negative effect in elsm'2 
(A, B) The two panels show examples of the aberrant melanophore phenotype (black 
arrowheads) in 48hpf embryos of a heterozygous els'71618 cross injected with the 
hs>c/ls,nv2 construct, which could indicate a possible dominant negative (DN) function of 
the els'”2 allele. These melanophores appeared rounded, often bipolar or elongated and 
were dispersed between melanophores with wild-type morphology (black arrows), o, 
otic vesicle; y, yolk sac. (C) The table summarises counts of embryos in which such a 
phenotype was observed. The first column indicates the injected batch analysed, column 
2 contains the number of embryos exhibiting the abnormal melanophores (Abn. M) in 
relation to the total number of embryos injected in this batch (total embryos). In column 
3, the percentage of embryos that show these abnormal melanophores is given (% Abn. 
M). Genetically, 3A (75%) of embryos corresponding to wild-type and heterozygous 
els™618 siblings, might exhibit the aberrant phenotype, but at least all heterozygotes 
(50%), in which the amount of SoxlO is halved already.
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Discussion
We have described the successful rescue of the pigment phenotype in clsm618 mutants by 
ectopic expression of soxlO. This was achieved by driving the expression of sox 10 with 
a heatshock inducible promoter. In addition, we demonstrated that neither Sox9a nor 
Sox9b can replace SoxlO function in this assay.
Generation of the hs>clsWT construct by RT-PCR and cloning into the heatshock 
vector was unsuccessful. Even though a high-fidelity Taq polymerase was used in this 
PCR reaction, it seemed difficult to identify such a hs>clsWT construct without any non­
conservative nucleotide changes, which altered the amino acid sequence. The reason for 
this increased error rate might have been the high number of PCR cycles required to 
amplify the coding region from cDNA. However, an error-free hs>clsm618 was identified 
and thus, using site-directed mutagenesis to create the missing heatshock constructs had 
several advantages. In this method, all mutagenised strands are created by a single 
replication of only parental strands (Figure 7.5) and thus, any mistake introduced is not 
amplified in subsequent rounds of replication. Hence, this approach proved to be an 
easy and very reliable method, which was employed repeatedly to create 2 heatshock 
constructs. The sample of constructs analysed all proved to have incorporated the 
desired nucleotide change and were tested in in vivo rescue assays.
Injection of 50pg hs>c/5WT construct followed by a heatshock treatment resulted 
in rescue of a mean number of 15 melanophores in 48% of surviving els mutant 
embryos. In the control experiment, in which embryos were also injected with 50pg of 
hs>c/5WTbut not heatshocked, resulted in only a slightly lower percentage of rescued 
embryos, 35% instead of 48%. This indicated a fairly high degree of leakiness of the 
heatshock promoter, sox 10 transcripts were thus produced even without the requirement 
of a heatshock. This finding did not invalidate the rescue results. Firstly, although the 
number of rescued embryos was similar with or without heatshock, the proportion of 
rescue was significantly higher in heatshocked embryos (mean number of rescued 
melanophores per embryo 15.0 instead of 4.3). Secondly, embryos injected with the 
control construct hs>pCS, failed to rescue melanophores, whether or not heatshocked. 
Thirdly, a similarly high degree of leakiness for the same heatshock plasmid was 
reported for nacre rescue experiments (Lister et al., 1999).
The leakiness of the heatshock promoter might also be partially responsible for the high 
percentage of malformation observed in injected embryos. However, our control
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injections revealed that a large proportion of the deformations observed were not likely 
to be caused by SoxlO, but by either the plasmid itself or the heatshock promoter. The
Tl/rp
proportion of malformed embryos obtained with hs>c/s was usually not significantly
different to those obtained with an equivalent amount of control plasmid hs>pCS, which 
only lacked the sox 10 sequence. Additionally, the optimisation procedure revealed that 
not only the proportion of embryos with malformations, but also the percentage and 
degree of melanophore rescue, generally increased with increasing amounts of sox 10 
DNA injected. The former result was consistent with the construct showing slightly 
toxic effects. Furthermore, one instead of two heatshock treatments lowered the 
proportion of deformed embryos, although a heatshock treatment in general did not 
increase malformations as long as low amounts of construct were injected. This could 
be interpreted as a slight toxicity of the SoxlO protein itself. Lastly, if the heatshock was 
carried out early (15-16hpf) instead of late (18-19.5hpf), slightly less malformed 
embryos were observed. The reason for this might be greater sensitivity to high levels of 
SoxlO at earlier stages during development. Misregulation of gene transcription at this 
earlier stage is likely to result in more deleterious defects.
In summary, the best results overall in our assay were achieved with 50pg hs>clsWT and 
a heatshock at 15-16hpf. The amount of construct injected per embryo is similar to that 
reported for rescue of homozygous nac embryos with hs>nac (Lister et al., 1999). 
However, more nacre embryos were rescued if the heatshock treatment was carried out 
later, between 18-20hpf.
For future experiments, it might be worthwhile to assess whether the toxic effects 
observed above resided in the plasmid or the heatshock promoter itself. This could be 
tested by comparing deformities after injection of the expression plasmid with and 
without the heatshock promoter. In the case of promoter toxicity, rescue experiments 
might be much improved if SoxlO expression was regulated by another promoter, e.g. 
its own promoter, especially if experiments require injection of large amounts of 
construct as in the case for testing mutant alleles. The sox 10 promoter would also direct 
SoxlO expression to more specific locations and time.
Rescued melanophores were observed mosaicly as was expected for DNA injections 
into early embryos (Oliver et al., 1996; Hammerschmidt et al., 1999). During 
development, hs> c/5^is distributed unevenly between dividing daughter cells and 
thus, not every cell will have received the construct.
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SoxlO not only enabled pigment precursors to differentiate and adopt the typical 
morphology for wild-type melanophores, but also rescued their migration to ventral 
positions. Thus, rescued melanophores were often observed in the ventral stripe or on 
the yolk sac. The role of SoxlO could therefore be primarily in enabling the migration 
of crest cells, which then encounter the appropriate signals for differentiation. Judging 
by the sox 10 expression pattern in els embryos at approximately 24-3 Ohpf, a greater 
number of soxl 0-positive neural crest cells failed to migrate and appeared to remain in 
the crest staging area compared to wild-type. They still did not differentiate in that 
location as would be expected from a primarily migrational defect. Furthermore, the 
premigratory area is also the final location for some melanophores residing in the dorsal 
stripe and hence all necessary factors for differentiation have to be present. However, 
melanophores still did not differentiate properly in els mutants in this area. In summary, 
the most likely explanation for the observations above is that neural crest cells that 
receive sox 10 are able to become specified as pigment cell precursors and so are 
enabled to migrate to their final locations.
The rescue of els mutants by heatshock after injection of a hs>c/5^Tconstruct 
raised the question of whether mRNA injection might also be an appropriate strategy for 
achieving rescue. However, melanophores failed to be rescued by soxl 0 mRNA 
injection (S. Elworthy, unpubl. data). This result was not surprising since SoxlO may 
not be required until approximately 24hpf of development, whilst it is unlikely that 
injected RNA is still present in sufficient amounts this late (Hammerschmidt et al., 
1999). However, the injected soxlO mRNA was functional, since transcripts of a 
downstream target, nacre, were detectable by in situ hybridisation in 6hpf stage 
embryos, some 12 hours prior to endogenous gene expression (Lister et al., 1999).
It will be very interesting to test for other rescued neural crest derivatives in 
future experiments. This has been attempted for the enteric lineage (S. Elworthy and R. 
Kelsh, unpubl. data), but to date has been unsuccessful, perhaps because the number of 
enteric precursors maybe very small compared to pigment precursors. Due to the mosaic 
characteristics of the injection technique, this small group might be very difficult to 
target and thus, rescue would be much harder to observe.
In clsm61\  the L142Q lesion is expected to significantly decrease the binding 
ability of SoxlO to its recognition sequences in the promoter of downstream targets.
m/il J?Reduced DNA binding ability might also prevent SoxlO from interacting with its 
partner transcription factors, since both the HMG and the synergy domain are required
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for synergistic activity (Kuhlbrodt et al., 1998a). Furthermore, failure to interact 
synergistically with other transcription factors was observed for similar human 
mutations containing disrupted HMG domains (Kuhlbrodt et al., 1998b). Diminished 
DNA binding might also affect the efficiency of the transactivation domain as was 
demonstrated for the human 482ins6 mutant (Bondurand et al., 2000). Although the 
clstw2 allele has likely retained its binding ability, it has lost the transactivation domain 
due to a premature truncation of the protein caused by the K376X lesion. Consistent 
with this, these two els alleles failed to show any significant transcriptional activation 
abilities in the in vitro study described in the previous chapter, indicative of them being 
null alleles. However, there is a possibility that they might show some residual function
1Rthrough their putative synergy domains. This is less likely to be true for els , since a 
functional DNA binding domain is required for synergistic activity, at least for rat 
SoxlO (Kuhlbrodt et al., 1998a). Thus, taken together, it seemed unlikely that either of 
the two alleles, but in particular els™618, would rescue any aspect of the els phenotype. 
As predicted, both mutant SoxlO proteins encoded by clsm618 and clstw2 failed to rescue 
the pigment aspect of the els phenotype. It would be interesting to investigate whether 
other neural crest derivatives affected in els embryos, for example the peripheral 
nervous system (PNS), could be rescued.
All human and mouse alleles exhibit a dominant phenotype. Some of those 
dominant effects are thought to be due to dominant negativity and manifest themselves 
in patients with white forelocks and occasionally depigmented skin patches, blue eyes 
or heterochromic irides (Pingault et al., 1998a; Bondurand et al., 1999; Southard-Smith 
et al., 1999) and white belly spots and feet in mice (Lane and Liu, 1984; Herbarth et al., 
1998; Southard-Smith et al., 1998). In batches of embryos injected with els*™2, 
melanophores with abnormal morphology were observed, which in principle could have 
been due to a dominant negative effect. However, these abnormal melanophores were 
not seen in heterozygous offspring of an uninjected clstw2 cross. Furthermore, petri- 
dishes and embryo medium had irrationally been re-used once for these batches of 
injected embryos. Thus, possible changes of the medium concentration due to 
evaporation, perhaps exacerbated by injection trauma, are more likely to have caused 
this aberrant pigment morphology.
We have created two further heatshock constructs, hs>clsY83X and hs>clsE189X, by
w r  jriRoy
site-directed mutagenesis from hs>cls . The rationale behind creating the hs>cls 
allele was that the mouse SoxlOdel and SoxlODom mutations are almost in exactly the
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some nucleotide position, but the mutant human protein lacks the additional novel 
amino acids created by the frameshift mutation in the mouse alleles. Furthermore, 
SoxlOdel was shown to encode a dominant negative protein in in vitro transcription 
assays (Potterf et al., 2000), whereas the SoxlO00"1  phenotype can be fully explained 
by haploinsufficiency as was shown by comparison to a SoxlOIacZ/+ mouse (Britsch et 
al., 2001). To test whether any of these dominant phenotypes could be reproduced in 
zebrafish, in which lesions in soxlO normally only cause a recessive phenotype, would 
represent an interesting future extension of this work.
The location of the lesion in the human Y83X allele is similar to our clst3 allele and 
truncates the protein upstream of the HMG domain. However, at the time this construct 
was made, the clstS lesion had not been identified. The Y83X allele, together with 
El 89X and K376X represented a convenient set of truncated proteins to investigate the 
functional abilities of SoxlO lacking each domain. Y83X and E189X truncate SoxlO 
approximately after the synergy domain and after the HMG domain respectively, 
whereas K376X only lacks the transactivation domain (Figure 7.11).
These constructs are prepared and ready to be assessed in overexpression studies and in 
a luciferase reporter construct assay as previously described for other heatshock 
constructs. Unfortunately, none of these experiments have been started to date.
Ectopic expression of either sox9a or sox9b was unable to rescue melanophores 
in els mutants. It would be interesting to investigate rescue of other neural crest 
derivatives. The partial expressivity of the defect in sensory neurons of DRG compared 
to an essentially full expressivity of the pigment phenotype might indicate a functional 
redundancy with a similar protein in DRG. Very recently, K. Dutton has shown that 
injection of either sox9a or sox9b morpholino, which knocks-down sox9a and sox9b
t ?transcription, respectively, exacerbates the DRG defect in els embryos (K. Dutton, 
unpubl. data). Thus, Sox9a and Sox9b might act redundantly with SoxlO within the 
DRG lineage.
Overexpression of Sox9a, Sox9b and mutant SoxlO proteins resulted in a higher 
proportion of deformed embryos. However, this result is likely to be artefactual, since 
the concentration of the various heatshock constructs was only estimated by gel 
electrophoresis and comparison to a quantitative DNA marker. Thus, some variation in 




















Figure 7.11: Location of mutagenesis primer pairs used to introduce mutant lesions identified in human alleles Y83X and E189X.
(A) The coding and untranslated regions (5’ UTR, 5’ untranslated region; 3’ UTR, 3’ untranslated region) of soxl 0 are shown together with the 
HMG domain (black), the synergy domain (dotted) and the transactivation domain (checked). Long reverse complementary primers 
WT1->Y83X and WT2—»Y83X were designed to introduce a premature stop codon truncating the protein at the C-terminal end of the synergy 
domain. Another primer pair WT1—>E189X and WT2-»E189X introduces a stop codon just downstream of the HMG domain and hence, the 
protein truncates after the synergy and HMG domain. The zebrafish mutant lesion found in e l s ^  (K376X) is indicated. The scale bar represents 
the length of a lOObp fragment. (B) The diagram shows the 3 mutant heatshock constructs and their remaining functional domains, hs>cls&376X 
(hs>c/5^^) only lacks the transactivation domain (checked), h s > c l s ^ ^ ^  contains the entire N-terminal domain including the synergy (dotted) 
and the HMG domain (black), whereas hs>clsY$3X 0nly contains the synergy domain (dotted). It is noted that these domains of zebrafish SoxlO 
are only putative and based on those defined in mouse SoxlO.
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In summary, we could demonstrate rescue of the melanophore lineage in els 
mutants by ectopic expression of soxlO, but not with mutant els alleles, clsm618 and 
clstw2, sox9a or sox9b. These results, together with the disrupted expression of sox 10 in 
els mutants, the identification of 3 distinct soxlO mutant lesions in els alleles and tight 
linkage between the els locus and soxlO show beyond any reasonable doubt that els 
encodes soxlO. Hereafter, mutant alleles, for example els'”618 and elstw2, will be renamed 
as soxl (T618 and soxlOtw2, respectively.
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Final discussion and conclusions
The aim of this project was to identify the gene encoded at the colourless locus; 
specifically, to test the candidate gene sox 10, an HMG domain transcription factor.
To address this objective we had to clone sox 10 and then test whether els encoded 
soxlO.
To clone els we chose the candidate gene approach. Although there are several 
loci in mice and humans causing neurocristopathies with a similar combination of 
defects as observed in els, detailed analysis of their phenotypes revealed SoxlO as the 
most promising candidate gene. We chose RT-PCR and RACE PCR as the method to 
clone soxlO using the then available mammalian SoxlO sequences to design primers.
The reliability of the primer design might have been improved, if the only recently 
published chicken SoxlO could have been included. In the not too distant future, the 
entire zebrafish genome will have been sequenced and thus, cloning of zebrafish genes 
will be trivial.
Once a soxl 0-like cDNA was isolated, we were very cautious in assigning its 
true identity. Sox genes of the same subgroup show high similarities to each other and 
some Sox genes in the database were originally misidentified. Sequence alignments with 
other SoxlO, Sox9 and Sox8 proteins, all members of subgroup E, and phylogenetic 
analysis both indicated that our clone represented a true SoxlO homologue.
Furthermore, in situ hybridisation with a large fragment of this soxl 0-like gene also 
showed expression patterns highly reminiscent of other SoxlO homologues in mouse, 
human and chicken. Lastly, our clone was placed next to the polymerase POLRF gene 
on LG3. SOXIO on human chromosome 22ql3.1 was very tightly linked to human 
POLRF consistent with our isolated cDNA being a soxl 0 orthologue and with these 
genes defining a synteny between fish and human. Together, these data were in strong 
agreement with the proposition that the cloned cDNA represented a soxl 0 homologue.
Next we presented very strong support in favour of the hypothesis that 
homozygous lesions in soxlO caused the els phenotype. First, we showed that soxlO 
expression was disrupted in els mutant embryos. Interestingly, sox 10 expression in all 
mutant alleles apart from soxlOP22^  and soxl 01 Of3 was indistinguishable from wild-types 
up to approximately 24hpf. From 24hpf, sox 10 expression levels associated with cranial 
ganglia and in Schwann cells on the posterior lateral line nerve were reduced and soxlO-
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positive neural crest cells in the head and trunk showed a migrational defect. Thus, 
mutant soxl 0 was first transcribed at normal levels, but the resulting mutant protein 
might have been unable to maintain its expression. Secondly, we demonstrated tight 
linkage between sox 10 and the els mutant locus. Thirdly, we identified non-conservative 
point mutations in 3 of the els alleles, which correlate with the mutant phenotype.
Molecular characterisation revealed that all three lesions were found in the 
coding region of soxlO. L142Q in soxl (F618 affects a fully conserved residue in the 
HMG domain and is likely to diminish the ability of the mutant protein to bind to its 
DNA target sequences. K376X in soxlOtw2 and soxlOtw11 truncates the protein 
prematurely upstream of the transactivation domain. A fourth lesion was identified in 
soxtS by T. Carney, which caused truncation of the protein N-terminal to the HMG 
domain due to an insertion of a transposable element. No lesion has yet been found in 
soxlOty22^  but it seems likely to be different to other previously identified alleles, soxty22^  
transcripts were produced at lower levels at a stage when other alleles showed normal 
soxlO expression. This indicates that the mutation might be in one of the regulatory 
elements or might destabilise the transcript.
The functional abilities of these 3 alleles were analysed in in vitro and in vivo 
studies. Consistent with our molecular characterisation of these mutant alleles, L142Q 
(soxl(F618) and K376X (soxlOtw2 and soxlOtw11) did not show any significant 
transcriptional activation ability in in vitro studies (W. Pavan, unpubl. data). 
Furthermore, unlike wild-type SoxlO, mutant SoxlO proteins were unable to rescue the 
pigment phenotype in vivo, soxl 013 was not included in such in vivo or in vitro 
experiments, since the lesion had not been identified at that time. Due to the very 
premature truncation of the protein, soxlO13 is likely to be a functional null allele. Like 
soxlO13, the human Y83X allele lacks the conserved DNA binding domain, both nuclear 
localisation signals and the transactivation domain, which leads to complete functional 
inactivation of the protein (Kuhlbrodt et al., 1998b).
Preliminary studies carried out by project students compared the severity of the 
els mutant phenotype in various alleles and did not reveal any striking differences 
between any of the alleles. The phenotype of these alleles was also very similar to the 
maximal morphant phenocopy obtained with the highest doses of sox 10 morpholino 
(Dutton et al., 2001a). In strong soxlO mutant phenotypes produced by the soxl OF618 or 
soxlOtw2/tw11 allele for example, melanophores with wild-type morphology are never 
present. However, even with the highest doses of soxl 0 morpholino, an average of 11
240
normal melanophores were observed. Thus, taken together, these data suggest that 
soxlCT618, soxlOtw2 and soxlOtw11 are likely to be nulls (Dutton et al., 2001a).
Consistent with being a null, mutant alleles failed to rescue pigment cells when 
ectopically expressed in soxlO mutants despite the fact that under such circumstances, 
mutant proteins might be expected to be expressed at levels above endogenous 
expression levels. However, it remains to be tested whether mutant SoxlO protein can 
rescue other crest derivatives affected in els mutants such as enteric ganglia or DRG. In 
accordance with the results from the in vitro studies testing transcriptional activation 
ability of mutant SoxlO proteins, failure to rescue pigment cells was most likely due to 
the inability to transactivate downstream targets such as nacre. In a similar experiment, 
the SoxlO00” mouse mutation and human SoxlO059 failed to induce endogenous protein 
zero (.Po) expression in an in vitro cell line, a protein involved in regulating Schwann 
cell specific expression (Lemke et al., 1988; Peirano et al., 2000a).
The mammalian SoxlO mutants showed a dominant phenotype, whilst only fully 
recessive phenotypes have been detected in sox 10 mutant alleles in zebrafish.
Phenotypes in WS4 patients have been suggested to be generated via haploinsufficiency 
(Pingault et al., 1998a), but this has only been tested for the SoxlODom mouse mutant. 
Heterozygous mutants in which the SoxlO coding region was replaced with lacZ 
exhibited an identical phenotype to heterozygous Soxl0Dom,+ mice (Britsch et al., 2001). 
It is likely that the effects in these mice is due to the halving of the amount of SoxlO 
protein, thus suggesting the proposal that the Soxl0Pom/+ heterozygous phenotype is 
explained by the same mechanism. Heterozygous els mutants however do not appear to 
have any defects. It will certainly be very interesting to investigate the cause of this 
discrepancy.
Dominant negativity has been suggested for several human alleles, but only 
conclusively shown in vitro for the artificially created SoxlOdel mouse allele (Potterf et 
al., 2000). None of the els alleles appeared to be dominant negative when mutant 
protein was expressed ectopically. Likewise, uninjected heterozygous els embryos also 
did not exhibit a lower number of pigment cells or show any kind of aberrant pigment 
cell morphology or distribution, which might be the result of dominant negatively acting 
SoxlO protein. However, the effect might be subtle and thus to assess dominant 
negativity conclusively, a concentration dependent effect of mutant SoxlO on the 
functional ability of co-transfected wild-type SoxlO would have to be demonstrated. For 
example, one could show wild-type SoxlO activating the nacre promoter in a luciferase
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reporter construct. If any of the els alleles were dominant negative, this activation by 
wild-type protein would be progressively inhibited by increasing amounts of co­
transfected mutant protein. Alternatively, cultured undifferentiated neural crest cells 
might fail to survive or differentiate when transfected with mutant soxl 0.
The difference in dominance in mouse and fish might also be due to other factors such 
as genetic background. Thus, it will be interesting to investigate whether the artificially 
created mouse SoxlOdel allele exhibits any dominant negative function when 
overexpressed in zebrafish. SoxlOdel and the haploinsufficient SoxlODom allele (Britsch 
et al., 2001), are caused by frameshift mutations which introduce 8 and 99 novel amino 
acids respectively, before premature truncation of the protein (Herbarth et al., 1998; 
Southard-Smith et al., 1998; Potterf et al., 2000). However, these extraneous residues 
are difficult to replicate and thus we have recreated the human E189X allele instead, 
which is truncated at almost exactly the same location as the two mouse alleles 
SoxlOdel (C190X) and SoxlODom (E193insG; Pingault et al., 1998a; Southard-Smith et 
al., 1998; Potterf et al., 2000). No experiments with this artificial zebrafish soxlO 
mutant allele have been carried out to date. However, this allele will hopefully be tested 
in our rescue assays for residual function and possible dominant negative effects by 
ectopic expression in wild-type embryos.
Finally, having identified soxlO, we can now exploit the cell biological 
advantages of zebrafish to investigate the role of this transcription factor during neural 
crest development in detail. In neural crest cell transplant studies, it was shown that 
soxlO acted cell autonomously in pigment cells (Kelsh and Eisen, 2000b), consistent 
with it being a transcription factor. Iontophoretic labelling of single neural crest cells 
revealed that ectomesenchymal fates differentiated normally, but non-ectomesenchymal 
crest derivatives died in els embryos before differentiation. Furthermore, these cells 
were dying by an apoptotic mechanism within a discrete time window (Dutton et al., 
2001b). Most neural crest cells in els embryos showed restricted migration consistent 
with the counts of soxl  ^ -positive cells in soxlO in situ hybridisations described here.
Potentially, SoxlO could be involved in survival, migration, proliferation, 
differentiation or specification of neural crest cells. However, results from our sox 10 in 
situ hybridisation studies suggest that the timing and distribution of soxl 0 expression is 
consistent with a primary role for SoxlO in specification of neural crest derivatives.
A primary role for SoxlO in survival of neural crest cells seems unlikely since 
this would predict a very short time between the earliest defect and the onset of neural
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crest cell death. At approximately 20hpf els mutants are first distinguishable from wild- 
types by a lack of nacre expression, whereas apoptosis of neural crest cells in els 
embryos is only observed approximately 15 hours later (Dutton et al., 2001b). In 
contrast, previous reports suggest that the delay between induction of apoptosis and 
detectable changes in cellular morphology is approximately 3-4 hours (Ikegami et al., 
1999). SoxlO was shown to support survival of murine undifferentiated postmigratory 
neural cells in vitro. It was suggested that this function of SoxlO was mediated by 
regulating neuregulin (NRG1) signalling (Paratore et al., 2001). However, they failed to 
show that cell death due to lack of NRG 1 signalling was the primary defect. Thus, this 
in vitro study is consistent with our observations and conclusions in vivo that survival is 
not SoxlO’s primary function.
A primary role of SoxlO in migration of neural crest cells is equally unlikely. 
Cranial neural crest cells are scattered across wild-type heads, whereas they tend to 
form clusters in els mutants indicative of inhibited migration. Trunk neural crest cells 
fail to enter the lateral migration pathway and accumulate in the premigratory position.
It could be argued that a migrational defect in crest derivatives lacking SoxlO might 
prevent them from encountering the appropriate environments for their trophic support 
and hence they die before differentiation. However, this does not hold true for the 3 
pigment cell derivatives. The premigratory area is also a final location for those pigment 
cells which will form the dorsal stripe and thus, all the necessary factors have to be 
present. Despite this, fully differentiated pigment cells are not observed in the dorsal 
stripe of els embryos.
Instead, we have proposed that SoxlO’s primary function is in specification of non- 
ectomesenchymal fates. In els mutants the failure to become specified properly then 
leads to all other secondary defects observed such as inhibited migration, slightly 
reduced proliferation (K. Dutton and R. Kelsh, unpubl. data) and apoptosis prior to 
differentiation (Dutton et al., 2001b). This proposal fits well with observations of 
melanophore lineage markers in els embryos (Dutton et al., 2001b; Figure 8.1). Nacre, 
like mammalian MzY/’homologues, was shown to play an important role in specifying 
the melanophore fate and its expression was absent in els embryos (Tachibana et al., 
1996; Opdecamp et al., 1997; Lister et al., 1999). In fact, ectopic expression of nacre in 
els embryos was sufficient to rescue melanophores (S. Elworthy, unpubl. data) 
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Figure 8.1: Schematic of possible upstream and downstream targets of SoxlO
Information on included interactions were taken from :1 Lister et al., 1999,2 Bondurand et al., 2000,3 Potterf et al., 2000,4 Parichy et al., 1999,5 
Kelsh et al., 2000c, 6 Kelsh et al., 1996,7 Britsch et al., 2001,8 Peirano et al., 2000a,9 Peirano et al., 2000b,10 Sommer et al., 1996,11 Lang et al., 
2000,12 Pattyn et al., 1999, 13 Stolt et al., 2002,14 K. Dutton, unpubl. observ.,15 Bell et al., 1997.
Solid arrows indicate a direct regulation, dashed arrows an unknown interaction, d, differentiation; m, migration; p, proliferation; s, survival; glia 
spec, expr., glia specific expression; redund., functionally redundant; BMP, Bone morphogenetic protein; dct, dopachrome tautomerase; FGF, 
fibroblast growth factor; GDNF, glial derived neurotrophic factor; MBP, myelin basic protein; Mitf, microphthalmia; ngnl/2, neurogenin 1/2; 
PLP, proteolipid protein; Po, myelin protein zero; trp2, tyrosinase related protein-2; tyr, tyrosinase.
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(Bondurand et al., 2000; Potterf et al., 2000). Sparse, a c-kit homologue, was shown to 
have a role in migration of melanoblasts and survival of both melanoblasts and 
melanophores and its expression was lost in els and nacre embryos (Parichy et al.,
1999; Kelsh et al., 2000c; Dutton et al., 2001b). The enzyme Dopachrome tautomerase 
(.Dct; Kelsh et al., 2000c), an early melanoblast marker, is involved in synthesis of the 
melanin precursor and its expression is absent in nacre mutants (Lister et al., 1999). 
Furthermore, in mice, SoxlO was shown to activate the Dct promoter in vitro and was 
suggested to transiently regulate early Dct transcription directly (Potterf et al., 2001). 
Thus, the proposed model for SoxlO in melanophore specification included direct 
activation of nacre, likely in synergy with Pax3, which in turn directly or indirectly 
induced the expression of genes involved in migration, survival and differentiation of 
melanoblasts, such as sparse and dct (Dutton et al., 2001b).
Further tests of this model of SoxlO function will require the demonstration of similar 
scenarios to explain other neural crest defects, for example those in the enteric and 
sensory ganglia lineages. A schematic of suggested downstream targets of SoxlO in 
various neural crest derivatives is shown in Figure 8.1.
els mutant embryos exhibit defects in only a subset of neural crest derivatives, 
the non-ectomesenchymal lineages, whereas ectomesenchymal derivatives appear 
unaffected (Kelsh and Eisen, 2000b; Dutton et al., 2001b). Our model suggests a role 
for SoxlO in specifying only the non-ectomesenchymal lineages. Thus, we asked 
whether soxlO was expressed in all neural crest cells at a stage in which most cells are 
fate-restricted, or perhaps only in a subset of cells, which might represent non- 
ectomesenchymal precursors.
We first compared sox 10 expression to crestin, published as a pan-neural crest 
marker. However, at early stages we found that crestin was not expressed in cranial 
crest, which was subsequently confirmed by the original authors (P. Henion, pers. 
commun.). At the 16hpf stage, we observed a few scattered neural crest cells in the head 
starting to express crestin, but their fate restriction or specification is unknown. 
Nevertheless, crestin represents a useful marker for all trunk neural crest cells for future 
experiments.
Although SoxlO has been used as a pan-neural crest marker in mouse (e.g.
Pattyn et al., 1999), we showed in our double in situ labelling studies with fkd6  and 
soxl0 that this was not true, at least in zebrafish. We observed some premigratory 
neural crest cells at the 6 somite and at the 14 somite stage, which were only labelled
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with fkd6, but not soxlO, demonstrating an incomplete overlap between these two crest 
markers.
One possible explanation for these soxlO'Ijkdtf cells would be that they represent 
ectomesenchymal precursors. This hypothesis would be consistent with these fates 
being unaffected in els mutant embryos (Kelsh and Eisen, 2000b). Craniofacial 
cartilage, an ectomesenchymal neural crest lineage, is only derived from the cranial 
neural crest, a region in which we had observed these soxl 0-negative cells. They appear 
to become distinct from non-ectomesenchymal lineages early during neural crest 
development (Schilling and Kimmel, 1994; Dutton et al., 2001b). Unfortunately, there 
is no marker for early ectomesenchymal precursors available to date. The hypothesis 
could then be confirmed by showing a non-overlapping signal with soxlO.
In absence of a marker, one could hypothesise about the likely identity of these soxl O' 
!fkd6f cells depending on their location. At least 88% of cranial neural crest cells were 
shown to be fate-restricted and give rise to single cell-type fates (Schilling and Kimmel, 
1994). Two research groups have investigated fate maps of cranial crest cell precursors, 
with slightly differing results. Schilling and colleagues found that the most lateral tier 
(1) of neural crest cells in a 6 somite stage embryo gave rise exclusively to neural cells, 
whereas Schwann cells, neural and pigment cells were derived from tier (2). More 
medial tiers (3-5) gave rise predominantly to pigment cells, glia and cartilage cells and 
clones from tier (6) were of an exclusively cartilage and connective tissue nature 
(Schilling and Kimmel, 1994). Although lateral cells never produced cartilage according 
to Schilling, Dorsky reported cartilage derived from both lateral and medial cells. 
Dorsky found that neurons were mostly derived from lateral cells, pigment from medial 
cells and glia from all positions (Dorsky et al., 1998). One possible explanation for this 
discrepancy is that Schilling only labelled the most superficial 20% of neural crest cells 
and thus, cartilage precursors observed by Dorsky could have been lateral cells in a 
deeper layer.
In our study in 6 somite stage embryos, soxl0'lfkd6f cranial neural crest cells could only 
be identified on the very surface due to visibility problems in deeper layers.
Furthermore, the two cells documented in Figure 4.6A and B were located medially in 
tier (5) or (6) and thus could represent cartilage precursors according to (Schilling and 
Kimmel, 1994; Dorsky et al., 1998). This would support the hypothesis that soxlO 
might not be expressed in ectomesenchymal derivatives and thus, they are unaffected in 
soxlO mutant embryos.
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Alternatively, the lack of defects in the cartilage lineage in els mutants might be 
explained by functional redundancy of SoxlO with another protein in this cell-type. 
Functional redundancy might not only affect ectomesenchymal derivatives to prevent 
overt defects in els mutants. It might also help to explain differences in severity of the 
DRG defect along the rostrocaudal axis or even the recessive phenotype observed in 
zebrafish sox 10 mutants in contrast to mammalian SoxlO mutants. Such redundant 
action could be achieved between sox 10 and a second paralogue or sox 10 and a closely 
related Sox gene.
It is possible that a second paralogue of soxlO exists in zebrafish that arose during the
additional genome duplication event in ray-finned fish (Amores et al., 1998;
Postlethwait et al., 1998). So far, for zebrafish sox9 and soxl 1, such duplicated
paralogues have been identified, but functional redundancy between those paralogues
has not been investigated (Rimini et al., 1999; Chiang et al., 2001). However, functional
redundancy between duplicated genes has been suggested for the two zebrafish m itf
paralogues. It was shown that mitjb misexpression could rescue the formation of
melanophores in nacre (mitfa) mutant embryos although at lower efficiency. Thus,
Mitfb protein could functionally substitute for Mitfa (Lister et al., 2001).
There are several suitable approaches to investigate the existence of a second soxlO
paralogue. The degree of conservation between the pairs of Sox9 and Soxl 1 paralogues
is high with 60% and 70% overall amino acid identity respectively (Rimini et al., 1999;
Chiang et al., 2001). Thus, if they exist, the sequences of the two soxl 0 paralogues
would be expected to be very conserved at least within important functional domains.
PCR-based methods could be designed that attempt to bias against the previously
cloned soxl 0 and thus, favour amplification of a second paralogue. Firstly, one could
perform a PCR amplification on soxl0tS cDNA with degenerate primers designed
against sequences conserved in soxlO, but not sox9 regions, sox 10 expression in the 
/ ?soxlO allele is drastically reduced (chapter 6) and thus contains less sox 10a transcript 
that could serve as a template. Secondly, a PCR amplification could be performed on 
soxlOt3 cDNA with degenerate soxl 0-specific primers designed to flank the t3 insertion 
site. PCR products derived from the previously cloned soxlOa would be distinguished 
from soxl 0b derived products by an 1.4kb increase in size, corresponding to the 
insertion of the transposable element. Alternatively, a soxl 0b fragment could be 
amplified using degenerate soxl0-specific primers and genomic DNA from the c l033
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line. The latter is a deletion mutant, which lacks markers surrounding soxlOa and thus is 
likely also to lack soxlOa itself.
Another consideration when trying to identify a putative sox 10b is the time of its 
expression. To successfully isolate soxlOb, one has to guess when it might be expressed 
during development. To use one of the first two approaches, cDNA from sox ltf3 
embryos would have to be isolated from various timepoints. However, cDNA from els 
mutant adults cannot be obtained, since els alleles are embryonic lethal. The third 
approach, PCR from genomic DNA, avoids this problem and might thus be the most 
promising method.
Once cloned, one would have to test whether this putative soxlOb was expressed at the 
correct stage to be able to act redundantly with SoxlOa. Next, a functional redundancy 
between SoxlOa and SoxlOb could be investigated by ectopic soxlOb expression in els 
embryos. If they acted redundantly, one might expect to see partial rescue of the els 
phenotype. The demonstration of the enhancement of the els phenotype by injection of a 
soxlOb morpholino into els embryos would also suggest functional redundancy between 
the SoxlO paralogues.
Even in the absence of a soxlOb, a closely related Sox gene might act 
functionally redundantly with soxlO. Such an action in the ectomesenchymal lineage 
might explain the lack of defects in these cell-types in els mutants. In addition or 
alternatively, this close relative might substitute for lack of sox 10 in DRG development. 
In els embryos, DRGs in anterior segments are much less severely affected than in 
posterior segments (Kelsh and Eisen, 2000b) which might suggest a possible 
redundancy.
Sox genes of subgroup E (sox8, sox9 and sox 10 and likely any possible duplicated 
paralogues) are all closely related on the basis of their sequence and gene structure 
(Bowles et al., 2000). The regions of their expression are overlapping in the neural crest 
(sox8, sox9 and sox 10), in the otic vesicle (sox9, sox 10), in the eye (sox8, sox9), in 
DRGs (sox8, sox 10), limbs or pectoral fin buds (sox8, sox9, sox 10), somites (sox8, 
sox9), CNS (sox8, sox9, soxlO), gut (sox8, sox9, sox 10), testis (sox8, sox9) and the heart 
(sox8, sox9, soxlO) (Wright et al., 1995; Ng et al., 1997; Bondurand et al., 1998b; 
Herbarth et al., 1998; Kuhlbrodt et al., 1998a; Southard-Smith et al., 1998; Bell et al., 
2000; Cheng et al., 2000; Schepers et al., 2000; Chiang et al., 2001; Dutton et al., 
2001b). Together, these facts could suggest some functional redundancy between these 
proteins, although this has not been demonstrated between Sox genes in any organism.
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In chicken, closely related Soxl, Sox2 and Sox3 proteins, which are involved in lens 
development, were all shown to bind to and activate the DC5 minimal enhancer of the 
chicken 51 -crystallin gene (Kamachi et al., 1995). This makes functional redundancy 
between them likely, although no such studies have yet been carried out to test this.
If SoxlO functioned partially redundantly with either Sox9a or Sox9b we would predict 
overlapping expression domains.
To begin to test this, we performed double in situ hybridisations with sox 10 and 
sox9b which revealed a pattern of incomplete overlap of expression. sox9b+/sox 10' cells 
tended to be found in lateral cranial neural crest regions in 6 somite stage embryos, a 
region thought to give rise to mostly neural derivatives (Schilling and Kimmel, 1994). 
At the 14 somite stage, the majority of migratory cranial and premigratory trunk neural 
crest cells were double labelled, although some cells above the brain and anterior to the 
otic placode clearly expressed only soxlO or sox9b, similarly to double labelling with 
fkd6  and soxlO. It is unclear, how this differential labelling could correspond to a 
distinct specification status of each cell.
In chapter 7 we have described the failure to rescue the melanophore phenotype in els 
mutants by ectopic sox9b expression, which represents evidence against functional 
redundancy at least in pigment precursors. However, from our in situ hybridisation 
results, a redundancy in neuronal derivatives for example in DRGs or in non- 
ectomesenchymal derivatives in general, seems possible.
Alternatively, SoxlO could exhibit a repressive function on Sox9b in specifying 
ectomesenchymal fates. Thus, double-labelled cells would contribute to non- 
ectomesenchymal fates, and the few sox9b+/soxl0' cells represented cartilage 
precursors. In els mutants, these latter fates indeed form normally, whereas non- 
ectomesenchymal derivatives fail to be specified properly. If this hypothesis held true, 
one would expect to be able to demonstrate rescue of non-ectomesenchymal crest 
precursors with ectopic sox 10 alone and when co-injected with sox9b. If sox9b alone 
was overexpressed in els mutants, an increase of ectomesenchymal derivatives might be 
expected to be seen. However, this has not yet been investigated to date.
In double in situ hybridisations with soxlO and sox9a, expression domains did 
not seem to broadly overlap, but rather appeared complementary. It was difficult to 
determine whether signals were complementary or overlapping in adjacent regions, 
because the expression signals for both probes were very strong. To confirm non­
overlap or complementarity of expression domains, future experiments should include
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sectioning of these embryos. We did not investigate the developmental potential of 
these sojcPa-positive cells, but they were found in a position approximately where the 
otic placode will be formed 3 hours later. In 14 somite stage embryos, it was impossible 
to determine whether sox9a was expressed weakly in any neural crest cells. However, if 
sox9a was expressed at reasonable levels, it should have been possible to observe some 
purple staining as was seen in the equivalent sox9b/soxl0 double in situ hybridisations 
(compare Figure 4.8G to Figure 4.9G). Likewise, the precise expression domains for 
sox9a in the otic placode were difficult to establish without sectioning the specimen. 
Overall, it appeared that sox9a and sox 10 expression domains, in contrast to sox9b and 
sox 10, did not overlap broadly although further tests are required to confirm this 
tentative result.
Only recently, K. Dutton was able to demonstrate a redundant action of SoxlO 
and Sox9a and Sox9b in DRG. sox9a and sox9b morpholino injections into els mutants 
each exacerbated the DRG phenotype of els mutants indicating functional redundancy 
between Sox9a, Sox9b and SoxlO in this cell lineage (K. Dutton, unpubl. data). On the 
other hand, neither sox9a nor sox9b was able to rescue melanophores. Thus, this 
functional redundancy appears to be specific to the DRG cell lineage and does not 
extend to the pigment derivatives. Elucidating the exact role and interplay of SoxlO 
with each of the Sox9 paralogues in different cell lineages will be an interesting and 
rewarding line of future research.
Overall, the identification of colourless as a zebrafish sox 10 homologue 
reinforces the value of this fish model for human Waardenburg Shah Syndrome, since 
neural crest development in zebrafish and other vertebrates shares many characteristics 
(Raible et al., 1992). The work described herein opened up the possibility of utilizing 
the cell biological advantages of this model organism to elucidate the role of SoxlO 
during neural crest development in vivo at a level of resolution difficult to achieve in 
other model species and to look at evolutionary conservation of SoxlO function.
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24hpf-WT LP MP pre LP MP pre LP MP pre
som 1-5 3 22 27 3 13 15 5 13 36
som 6-10 1 34 48 / 17 22 2 21 50
som 11-15 / 21 53 / 22 44 / 25 75
som 16-20 / 8 66 / 15 41 / 22 60
24hpf-WT LP MP pre LP MP pre
som 1-5 6 13 38 6 17 45
som 6-10 2 24 40 4 19 59
som 11-15 / 14 46 1 20 72
som 16-20 / 16 43 / 16 60
24hpf-cls LP MP pre LP MP pre LP MP pre
som 1-5 2 16 29 2 17 32 / 22 52
som 6-10 / 22 37 / 21 43 / 23 71
som 11-15 / 15 45 / 16 61 / 11 64
som 16-20 / 13 65 / 14 45 / 8 56
24hpf-cls LP MP pre LP MP pre
som 1-5 2 17 48 1 17 51
som 6-10 / 22 81 / 28 81
som 11-15 / 19 84 / 19 79
som 16-20 / 6 74 / 14 69
Appendix 4.1: Counts of soxl 0-positive premigratory and migratory cells. 
soxl 0-positive cells (sox 10+) and differentiated melanophores (M+) were counted in the 
premigratory area (pre), on the lateral pathway (LP) and the medial pathway (MP) 
within muscle segments (som) 1-5, 6-10, 11-15 and 16-20 of wild-type (WT) and els 
mutant embryos (els). Counts were performed on 5 WT and els embryos of each of 
24hpf, 30hpf and 35hpf stages.
266
30hpf-WT
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+. soxl0+ pre
som 1-5 3 / 2 25 4 4 / 2 25 4
som 6-10 2 / 6 26 7 1 / 9 18 6
som 11-15 3 / 7 24 12 2 / 10 26 7
som 16-20 / / 4 23 8 3 / 10 14 10
30hpf-WT
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+ soxl0+ pre
som 1-5 3 / 6 29 2 2 / 3 25 3
som 6-10 6 / 10 35 7 3 / 7 20 5
som 11-15 2 / 15 32 12 3 / 9 26 11
som 16-20 1 / 5 27 11 1 / 5 14 7
30hpf-WT
LP MP
M+ soxl0+ M+ soxl0+ pre
som 1-5 1 / 2 27 5
som 6-10 1 / 12 18 8
som 11-15 2 / 12 27 5
som 16-20 1 / 10 22 6
30hpf-cls
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+ soxl0+ pre
som 1-5 / 1 / 25 10 / 1 / 30 18
som 6-10 / 1 / 26 24 / / / 33 27
som 11-15 / / / 22 32 / / / 30 50
som 16-20 / / / 20 33 / / / 16 62
30hpf-cls
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+ soxl0+ pre
som 1-5 / / / 31 14 / / / 31 22
som 6-10 / / / 30 18 / / / 35 23
som 11-15 / / / 24 63 / / / 29 56
som 16-20 / / / 15 65 / / / 24 64
30hpf-cls
LP MP
M+ soxl0+ M+ soxl0+ pre
som 1-5 / / / 28 9
som 6-10 / / / 29 18
som 11-15 / / / 21 39
som 16-20 / / / 11 42
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35hpf-WT
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+ soxl Oh- pre
som 1-5 3 / 3 16 7 5 / 2 17 5
som 6-10 1 / 3 11 7 3 / 7 17 8
som 11-15 / / 7 7 13 6 / 5 20 10
som 16-20 1 / 5 13 9 / / 8 20 13
35hpf-WT
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+ SOX10+ pre
som 1-5 1 / 2 19 8 6 / 1 26 8
som 6-10 2 / 6 18 9 3 / 7 20 11
som 11-15 2 / 6 15 12 3 / 2 23 8
som 16-20 2 / 8 23 11 3 / 7 20 8
35hpf-WT
LP MP
M+ soxl0+ M+ soxl0+ pre
som 1-5 3 / 3 17 8
som 6-10 4 / 4 23 8
som 11-15 4 / 8 20 10
som 16-20 1 / 8 26 11
35hpf-cls
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+ soxl0+ pre
som 1-5 / / / 21 29 / / / 26 23
som 6-10 / / / 26 32 / / / 21 26
som 11-15 / 1 / 20 46 / / / 22 39
som 16-20 / / / 19 36 / / / 20 30
35hpf-cls
LP MP LP MP
M+ soxl0+ M+ soxl0+ pre M+ soxl0+ M+ soxl0+ pre
som 1-5 / 1 / 14 29 / / / 20 21
som 6-10 / / / 16 39 / 1 / 23 36
som 11-15 / / / 12 46 / / / 14 37
som 16-20 / / / 12 38 / / / 13 28
35hpf-cls
LP MP
M+ soxl0+ M+ soxl0+ pre
som 1-5 / 2 / 16 20
som 6-10 / 1 / 21 29
som 11-15 / / / 14 35
som 16-20 / / / 18 32
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twl 38 20 1.9
tw2/\ 123 40 3.1
tw2/2 117 40 2.9
t3/l 113 40 2.8
t3/2 63 40 1.6
tw ll 49 30 1.6
ty22f 15 20 0.8
m618/\ 83 40 2.1
m618/2 46 30 1.5
Appendix 6.1: Preparation of total RNA from els mutant alleles 
The table summarises the number of homozygous els mutant embryos that were 
collected from each allele and the volume DEPC-treated water used to resuspend the 
RNA pellet. For alleles tw2, t3 and m618 enough mutant embryos were available to split 
them into two batches. The last column (No. embryos/pl) attempts to give a rough 
estimation of relative differences in resulting RNA concentrations of each sample by 
listing the number of embryos RNA was isolated from per pi final volume of resulting 
RNA sample. No., number; Vol., volume.
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Appendix 7.1: Comparison of rescue of homozygous els mutant embryos by ectopic 
expression of wild-type and mutant SoxlO proteins under varied heatshock and 
microinjection regimes
(A) Various batches of embryos (WT-A to WT-G and WT-1 to WT-37) from a 
heterozygous clsm618 cross were injected with either 12pg, 25pg, 50pg or 120pg of 
hs>elsWT. (B, C) Similarly, 50pg or 120pg of hs>clsm618 (B) or hs>clstw2 (C) were 
injected into various batches of embryos (M-l to M-l 1 for hs>clsm618 and T-l to T-18 
for hs>c/yw2) from a heterozygous clsm618 cross. Batches grouped by a bracket were 
injected on the same day. (A-C) All batches were heatshocked as indicated in column 
labelled “heatshock”. The column “uninjected/ % survived” in all tables list the total 
number of uninjected embryos and the percentage of uninjected embryos that had 
survived after 48hours. In the columns “injected/ % survived”, the total number of 
injected siblings and the percentage of injected embryos that had survived after 48hours 
are listed. The number of els embryos within these alive and injected embryos is shown 
together with the percentage of rescued els embryos within the surviving els siblings in 
the columns “els/ % rescued”. The last columns list the mean number of melanophores 
(M) with wild-type morphology observed per rescued els embryo, nd, not determined; 




hs>cls injections (50pg) with two heatshocks:











WT-A 11.7hpf/18hpf nd 260/31.5% 20/50% 6.6
WT-B J 10hpf/16hpf nd 80/50% 4/0% -
WT-C 18hpf/24hpf nd 35/17% 0/0% -
WT-D V 18hpf/24hpf nd 28/25% 1/0% -
WT-E J 18hpf/24hpf nd 33/30.3% 2/100% nd
WT-F 1 13hptf24hpf 30/97% 157/90% 20/35% 12.3
WT-G 11.3hpf/22hpf 29/86% 213/85% 28/61% 7.4
WT-3 llhpf/23hpf 14/64% 91/56% 12/42% 12.2
WT-4 ► 10.5hpf722.5hpf nd 19/79% 3/100% 17.6
WT-5 J 10hpf/22hpf 15/93% 218/69% 27/37% 14.7
r i^ r
hs>c/s injections (50pg) without heatshock:




c/s / % rescued mean number 
of M
WT-6 / 10/100% 64/57.8% 10/0% -
WT-7 / 22/45% 126/25.4% 7/28.6% 2.0
WT-8 / 11/0% 120/11.7% 1/0% -
WT-9 / 20/70% 119/24.4% 4/75% 3.3
WT-10 / 38/76.3% 178/43.8% 14/57% 4.0
WT-llJ / 17/47% 155/28.4% 12/33.3% 7.0
TJ/T
hs>c/s injections (25pg) without heatshock:




c/s / % rescued mean number 
of M
WT-25^ 1 / 12/83.3% 123/70.7% 28/10.7% 3.0
WT-26 / 11/63.6% 81/40.7% 8/12.5% 1.0
WT-27 > / 16/100% 188/86.7% 43/14% 5.2
WT-28 / 106/90.6% 224/77.2% 36/5.5% 1.5
WT-29-J / nd 33/84.8% 7/14.3% 2.0
\xrp
hs>cls injections (25pg) and only one heatshock:




c/s / % rescued mean number 
of M
WT-12I 15.5hpf 4/50% 13/23.1% 0/0% -
WT-13 J 16hpf 9/100% 104/75% 21/23.8% 6.2
WT-14 18.5hpf 18/100% 238/91.2% 51/31.4% 6.3
WT-15 >■ 15.5hpf 20/100% 111/87.4% 19/21.1% 1.3
WT-16 J 15.5hpf 13/100% 44/88.6% 8/12.5% 2.0
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w r
hs>c/s injections (50pg) and only one heatshock:




els / % rescued mean number 
of M
WT-17 15.5hpf 15/100% 175/70.9% 9/77.8% 31.9
WT-18 15.5hpf 16/100% 246/77.7% 24/54.2% 11.6
WT-19^ 18hpf nd 22/0% 0/0% -
WT-20 18.5hpf 20/80% 134/41% 13/61.5% 2.4
WT-21 18.5hpf 16/50% 94/37.2% 6/50% 3.6
WT-22 ...  ' 18npf 32/31.3% 234/26.5% 16/25% 9.0
WT-23 18hpf 17/29.4% 66/22.7% 1/0% -
WT-24 J 18.5hpf 9/100% 72/40.3% 7/85.7% 9.0
WThs>c/s injections (12pg) with one early heatshock:




c& / % rescued mean number 
of M
WT-30 ] 15-16hpf 15/66.7% 199/14.1% 5/0% -
WT-31 15-16hpf 13/0% 69/39.1% 9/11.1% 1.0
WT-32 > 15-16hpf 10/50% 162/22.8% 14/14.3% 1.0
WT-33 15-16hpf / 76/5.3% 1/0% -
WT-34^ 15-16hpf 10/20% 93/4.3% 0/0% -
WT-381 15-16hpf nd 133/71.4% 20/5% 2.0
WT-39-J 15-16hpf 15/93.3% 276/44.6% 33/12.1% 11.8
WThs>c/s injections (120pg) with one early heatshock:




/ % rescued mean number 
of M
WT-35 ' 15-16hpf 15/53.3% 191/39.3% 13/76.9% 14.1
WT-36 f 15-16hpf 15/80% 243/44.4% 33/60.6% 8.6
WT-37 J 15-16hpf 15/93.3% 310/66.1% 47/29.8% 3.1
B











M-l 9hpf/20hpf 3/0% 80/1% 0/0% -
M-2* 13hpf/24hpf 42/95% 240/94% 41/0% -
M-3~l H.Shp^.Shpf 17/53% 148/33% 9/0% -
M-4J 12hpf/24hpf 20/80% 193/77% 32/0% -
M-5] 12hpf/24hpf 19/15.8% 208/9.1% 6/0% -
M-6 >- 1 lhpf/23hpf 24/20.8% 151/4.6% 2/0% -
M-7J 10.5hpf/24hpf 29/93% 246/43.5% 32/0% -
* The only batch that was injected into ~8 cell stage embryos. All the other hs>clsmoJ* injections were 
carried out in 1-4 cell stage
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hs>clsm618 injections (120pg) and one early heatshock:




els / % rescued mean number 
of M
M-8 -j 15-16hpf 15/80% 121/1.6% 0/0% nd
M-9 L 15-16hpf 15/60% 99/4% 0/0% nd
M-10 J 15-16hpf 10/60% 142/7% 3/0% -
hs>clsm618 injections (50pg) and one early heatshock:




els / % rescued mean number 
of M
M-l 1 15-16hpf 15/100% 218/3.2% 0/0% nd
hs> cl^ 2 injections (120pg) with one early heatshock:




c/s / % rescued mean number 
of M
T-l 3 15-16hpf 15/100% 226/40.3% 18/11.1% 3.0
T-2 > 15-16hpf 11/63.6% 114/26.3% 7/14.3% 12.0
T-3 15-16hpf 10/20% 209/28.2% 2/0% -
hs>c/s^2 injections (50pg) with one early heatshock:




c/s / % rescued mean number 
of M
T-4 -n 15-16hpf 15/86.7% 165/13.9% 7/0% -
T-5 15-16hpf 15/86.7% 174/61.5% 25/0% -
T-6 r ’ 15-16hpf 15/86.7% 277/65.3% 51/0% -
H 1 -J 15-16hpf 15/93.3% 191/49.7% 23/0% -
T-8 ^ 15-16hpf 16/68.8% 170/37.6% 19/5.3% 1.0
T-9 y 15-16hpf 15/53.3% 151/25.8% 7/14.3% 2.0
T-IOJ 15-16hpf 12/75% 112/26.8% 8/12.5% 9.0
T-15 1 15-16hpf 11/73.3% 80/41.9% 19/0% -
T-16 15-16hpf 11/73.3% 53/27.7% 10/0% -
T-17 15-16hpf 13/86.7% 172/60.1% 36/0% -
T-l8 ^ 15-16hpf 13/86.7% 69/38.8% 15/0% -
hs>c/sfl*’2 injections (35pg) with one early heatshock:




c/s / % rescued mean number 
of M
T-l 1 "I 15-16hpf 7/87.5% 22/32.4% 1/0% -
T-12 L 15-16hpf 11/73.3% 56/25.6% 0/0% -













9A-1 4/15 (26.7%) 36/357(10.1%) 1/0 (0%) -
9A-2 23/31 (74.2%) 111/240(46.3%) 31/0 (0%) -
9A-3 16/16(100%) 178/239 (74.5%) 44/0 (0%) -













9B-1 6/12 (50%) 30/278 (10.8%) 6/0 (0%) -
9B-2 8/8 (100%) 69/256 (27%) 14/0 (0%) -
9B-3 8/15 (53.3%) 164/341 (48.1%) 38/0 (0%) -
Total 22/35 (62.9%) 263/875 (30.1%) 58/0 (0%) -
Appendix 7.2: hs>sox9a and hs>sox9b injections fail to rescue melanophores in
✓ t o
homozygous els mutant embryos.
W)/ip
(A, B) Three independent batches of embryos from a heterozygous els cross each 
were injected with 50pg of either hs>sox9a (A, 9A-1 to 9A-3) or hs>sox9b (B, 9B-1 to 
9B-3) and heatshocked at 15-16hpf for an hour at 37°C. The two tables list the total 
number of uninjected (control) and injected siblings and give the number and 
percentage (in brackets) of embryos that had survived after 48hours. In the fourth 
columns, the number of els embryos that survived is put in relation to the number that 
were rescued. The percentage of rescued embryos is noted in brackets. The last columns 
list the mean number of melanophores (M) with wild-type morphology observed per 
embryo, whereby indicates no rescued melanophores. The last row (Total) allows a 
comparison between survival rates of injected and uninjected control embryos. The 
difference corresponds to embryos dying most likely due to injection trauma. 
Furthermore, the total number of screened els embryos (els survived), rescued els 
embryos (els rescued) and the total mean of melanophore number is depicted.
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T otal: m alf/total 
(% m alf)
9 A -fj WT 0/3 (0%) 0/33 (0%) 29/35 (82.9% ) 195/249 (78.3% )
els 0/1 (0%) 0/10 (0%) 0/1 (0%) 60/76 (78.9% )
9A -2 L 50pg WT 0/17(0% ) 56/80 (70%)
early hs els 0/6 (0%) 24/31 (77.4% )
9A-3 WT 0/13 (0%) 110/134 (82.1% )
J els 0/3 (0%) 36/44 (81.8% )
hs>sox9b phenotype U ninjected: 
m alf/total 










9 B -n WT 0/6 (0%) 0/20 (0%) 23/24 (95.8% ) 153/205 (74.6% )
els 0/0 (0%) 0/2 (0%) 6/6(100% ) 42/58 (72.4% )
9B-2 1 5 0 p g WT 0/7 (0%) 43/55 (78.2% )
early hs els 0/1 (0%) 13/14 (92.9% )
9B-3 WT 0/7 (0%) 87/126 (69%)
J els 0/1 (0%) 23/38 (60.5% )
Appendix 7.3: Summary of malformation data
In the first column the Table lists the names of batches of embryos and constructs 
injected (WT 3-37, hs>clsWT\ pCS 1-11, control plasmid pCS2+; M 3-11, hs>clsm^ ^ \  
T 1-18, h s 9 A  1-3, hs>sox9a\ 9B 1-3, hs>sox9b) and indicates which were 
injected on the same day (brackets), the approximate amount of construct stock solution 
injected per embryo and the number and time of heatshock treatment(s) (early, 15- 
16hpf; late, 18-19.5hpf; hs, heatshock). The column labelled “phenotype” indicates 
whether subsequent columns refer to WT or els embryos. Column 3 and 5 list the 
number of malformed embryos within the total number of embryos (malf/total) and the 
percentage of malformed embryos (% malf) in phenotypically wild-type or homozygous 
els mutant siblings in uninjected (column 3) and injected batches (column 5). Column 4 
and 6 contain the number of total malformed/total embryos (% malf) for all injected 
(column 6) and uninjected batches (column 4) for each injection day (brackets in 
column 1). nd, not determined.
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Total: m alf/total 
(%  m alf)
WT-3 WT 0/6 (0%) 1/12 (8%) 23/38 (60.5% ) 82/132  (62.1% )
els 0/2 (0%) 0/16 (0%) 9/12 (75%) 29/42  (69%)
W T-4 50pg W T nd 5/7 (71.4% )
r 2 h s els nd 3/3 (100% )
WT-5 W T 0/4 (0%) 54/87 (62%)
els 1/10(10% ) 17/27 (63%)
W T-6 W T 0/10 (0%) 1/54 (1.9%) 7/27 (25.9% ) 104/186 (55.9% )
els 0/0 (0%) 1/15 (6.7%) 4/10 (40%) 25/48 (52.1% )
W T-7 WT 1/6 (16.6%) 17/25 (68%)
els 1/2 (50%) 6/7 (85.7% )
W T-8 WT 0/0 (0%) 9/13 (69.2% )
>50pg els 0/0 (0%) 0/1 (0%)
W T-9 no hs WT 0/11 (0%) 16/25 (64%)
els 0/3 (0%) 3/4 (75%)
W T-10 WT 0/22 (0%) 47/64 (73.4% )
els 0/7 (0%) 8/14(57.1% )
WT-11 WT 0/5 (0%) 8/32 (25%)
y els 0/3 (0%) 4/12(33% )
W T-12 WT 0/0 (0%) 1/52 (1.9%) 3/3 (100% ) 30 /169(17 .8% )
>-25pg els 1/2 (50%) 1/23 (4.3%) 0/0 (0%) 12/48 (25%)
W T-13 early hs WT 0/7 (0%) 17/57 (29.8% )
els 0/2 (0%) 6/21 (28.6% )
W T-14 >-25pg WT 0/12(0% ) 0/12 (0%) 37/165 (22.4% ) 37/165 (22.4% )
J  late hs els 0/6 (0%) 0/6 (0%) 8/51 (15.7% ) 8/51 (15.7% )
WT-15 WT 0/15(0% ) see W T-12 9/78(11 .5% ) see W T-12
^25pg els 0/5 (0%) 5/19 (26.3% )
W T-16 early hs WT 1/10(10% ) 1/31 (3.2% )
els 0/3 (0%) 1/8 (12.5% )
W T-17 WT 0/10(0% ) 0/20 (0%) 11/30 (36.7% ) 37/100  (37%)
L s o p g els 0/5 (0%) 0/11 (0%) 5/19 (55.5% ) 14/43 (32.6% )
W T-18 early hs WT 0/10(0% ) 26/70 (37.1% )
els 0/6 (0%) 9/24 (37.5% )
W T-19 WT nd 0/33 (0%) 0/0 (0%) 141/152 (92.8% )
els nd 0/15 (0%) 0/0 (0%) 36/43 (83.7% )
W T-20 WT 0/11 (0%) 39/41 (95.1% )
els 0/5 (0%) 13/13 (100% )
WT-21 WT 0/5 (0%) 29/29 (100% )
>50pg els 0/3 (0%) 6/6(100% )
WT-22 late hs WT 0/8 (0%) 39/46 (84.8% )
els 0/2 (0%) 9/16 (56.3% )
WT-23 WT 0/3 (0%) 14/14 (100% )
els 0/2 (0%) 1/1 (100% )
W T-24 WT 0/6 (0%) 20/22 (90.9% )
*\ els 0/3 (0%) 7/7 (100%)
WT-25 WT 0/9 (0%) 1/124 (0.8%) 10/59 (16.9% ) 51 /360(14 .2% )
els 0/1 (0%) 0/20 (0%) 5/28 (17.8% ) 21/122(17 .2% )
W T-26 WT 0/6 (0%) 9/25 (36%)
els 0/1 (0%) 2/8 (25%)
W T-27 >25p g WT 0/13 (0%) 23/120 (19.2% )
no hs els 0/3 (0%) 12/43 (27.9% )
WT-28 WT 1/96 (1%) 8/137 (5.8%)
els 0/15 (0%) 1/36 (2.8%)
W T-29 WT nd 1/19(5.3% )
J els nd 1/7 (14.3% )
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W T-30 \ WT 3/8 (37.5%) 4/26 (15.4% ) 11/23 (47.8% ) 94/236  (39.8% )
els 1/2 (50%) 1/5 (20.0% ) 4/5 (80%) 33/82 (40.2% )
W T-31 WT 0/0 (0%) 9/18(50% )
els 0/0 (0%) 6/9 (66.6% )
W T-32 WT 0/4 (0%) 13/23 (56.5% )
els 0/1 (0%) 7/14 (50%)
WT-33 \  12pg WT nd 2/3 (75%)
early hs els nd 0/1 (0%)
W T-34 WT 1/2 (50%) 4/4 (100% )
els 0/0 (0%) 0/0 (0%)
W T-38 WT nd 14/75 (18.7% )
els nd 5/20 (25%)
W T-39 WT 0/12(0% ) 41/90 (45.6% )
J els 0/2 (0%) 11/33 (33.3% )
W T-35 WT 0/5 (0%) 0/22 (0%) 42/62 (67.7% ) 216/294  (73.5% )
els 0/3 (0%) 0/12 (0%) 12/13 (92.3% ) 70/93 (75.3% )
W T-36 L 1 20p g WT 0/8 (0%) 56/74 (75.7% )
early hs els 0/4 (0%) 26/33 (78.8% )
W T-37 WT 0/9 (0%) 118/158(74.7% )
els 0/5 (0%) 32/47 (68.1% )








(%  m alf)
Total: m alf/total 
(% m alf)
pCS-1 WT 0/12 (0%) 0/12 (0%) 25/41 (61%) 87/146 (59.6% )
els 0/2 (0%) 0/2 (0%) 11/20 (55%) 23/46 (50% )
pCS-3 ^ .5 0 p g WT nd 11/18(61.1% )
early hs els nd 1/3 (33.3% )
pCS-4 WT nd 51/87 (58.6% )
J els nd 11/23 (47.8% )
pCS-2 WT 0/4 (0%) 0/13 (0%) 35/41 (85.4% ) 102/137 (74.5% )
L s O p g els 0/5 (0%) 0/7 (0%) 14/15 (93.3% ) 27/37 (73% )
pCS-5 late hs WT 0/9 (0%) 67/96 (69.8% )
els 0/2 (0%) 13/22 (59.1% )
pCS-6 WT 0/2 (0%) 0/28 (0%) 1/2 (50%) 57/146 (39% )
els 0/0 (0%) 0/8 (0%) 0/0 (0%) 18/51 (35.3% )
pCS-7 WT 0/6 (0%) 12/25 (48%)
f2 5 p g els 0/2 (0%) 6/11 (54.5% )
pCS-8 late hs WT 0/10(0% ) 35/75 (46.7% )
els 0/3 (0%) 10/28 (35.7% )
pCS-9 WT 0/10(0% ) 9/44 (20.5% )
J
"V els 0/3 (0%) 2/12(16.7% )
pCS-10 WT 0/7 (0%) 0/7 (0%) 15/43 (34.9% ) 3 8 /118(32 .2% )
^■25pg els 0/7 (0%) 0/7 (0%) 2/9 (22.2% ) 6/27 (22.2% )
pC S-11 early hs WT nd 23/75 (30.7% )
J els nd 4/18 (22.2% )
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M -3 ^ WT 0/4 (0%) 2/39 (5.1%) 7/35 (20%) 72/231 (31.2% )
els 0/4 (0%) 0/20 (0%) 1/9(11% ) 23/81 (28.4% )
M -4 WT 0/12(0% ) 21/103 (20%)
els 0/4 (0%) 6/32 (18.8% )
M -5 50pg WT 0/3 (0%) 6/13 (46%)
> 2hs els 0/0 (0%) 2/6 (33%)
M -6 WT 0/3 (0%) 3/5 (60%)
els 0/2 (0%) 1/2 (50%)
M -7 WT 2/17(11.8% ) 35/75 (46.6% )
els 0/10 (0%) 13/32 (40.6% )
M -8 WT 0/7 (0%) 0/20 (0%) 2/2(100% ) 13/13 (100% )
els 0/5 (0%) 0/7 (0%) 0/0 (/) 3/3 (100%)
M -9 >120pg WT 0/7 (0%) 4/4(100% )
early hs els 0/2 (0%) 0/0 (/)
M -10 WT 0/6 (0%) 7/7 (100%)
> els 0/0 (0%) 3/3 (100%)
M - ll  i_50pg WT 0/11 (0%) 0/11(0% ) 7/7 (100%) 7/7 (100%)
early hs els 1/4 (25%) 1/4 (25%) nd nd








(%  m alf)
Total: m alf/total 
(% m alf)
T -l ^ WT 0/9 (0%) 0/17 (0%) 66/73 (90.4% ) 138/153 (90.2% )
els 0/6 (0%) 0/7 (0%) 17/18 (94.4% ) 24/27 (88.9% )
T-2 120pg WT 0/6 (0%) 21/23 (91.3% )
early hs els 0/1 (0%) 6/7 (85.7% )
T-3 WT 0/2 (0%) 51/57(89.5% )
J els 0/0 (0%) 1/2 (50%)
T-4 WT 0/7 (0%) 0/35 (0%) 7/16 (43.8% ) 170/300 (56.7% )
els 0/6 (0%) 0/18 (0%) 3/7 (42.9% ) 47/106 (44.3% )
T-5 WT 0/10 (0%) 45/82 (54.9% )
►50pg els 0/3 (0%) 14/25 (56%)
T-6 early hs WT 0/9 (0%) 72/130 (55.4% )
els 0/4 (0%) 21/51 (41.2% )
T-7 WT 0/9 (0%) 46/72 (63.9% )
els 0/5 (0%) 9/23 (39.1% )
T-8 WT 1/6 (16.7% ) 2/20(10% ) 43/45 (95.6% ) 97/99 (98%)
els 1/4 (25%) 1/7 (14.3% ) 16/19 (84.2% ) 31/34 (91.2% )
T-9 >-50pg WT 0/8 (0%) 32/32 (100% )
early hs els nd 7/7(100% )
T-10 WT 1/6(16.7% ) 22/22 (100% )
> els 0/3 (0%) 8/8 (100% )
T -l 1 WT 0/7 (0%) 0/21 (0%) 11/11 (100% ) 17/18 (94.4% )
els 0/0 (0%) 0/5 (0%) 1/1 (100%) 2/2(100% )
T-12 ►35pg WT 0/8 (0%) 3/4 (75%)
early hs els 0/3 (0%) 0/0 (/%)
T-13 WT 0/6 (0%) 3/3 (100% )
J els 0/2 (0%) 1/1 (100% )
T -l 5 WT 0/7 (0%) 1/58 (1.7%) 43/61 (70.5% ) 194/294 (66%)
els 0/4 (0%) 0/17(0% ) 12/19(63.2% ) 50/80 (62.5% )
T-16 WT 0/19(0% ) 29/43 (67.4% )
V  Opg els 0/2 (0%) 8/10 (80%)
T -l 7 early hs WT 1/9(11.1% ) 91/136 (66.9% )
els 0/4 (0%) 23/36 (63.9% )
T-18 WT 0/6 (0%) 31/54 (57.4% )
els 0/7 (0%) 7/15 (46.7% )
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Appendix 7.4: Statistical test results assessing various influences on malformation 
(A) With this x test it was asked whether els mutant embryos were affected more 
severely by malformations and thus, whether the genotype had any influence on the 
occurrence of malformations. Batches of embryos injected with hs>clsWT (WT3-29), 
control plasmid (pCSl-11) or hs>clsm618 (M3-7) were assessed in groups corresponding 
to groups with different treatments (heatshock times, construct concentrations etc, 
Appendix 7.1). The column “WT ratio” lists the ratio of malformed:normal embryos 
with a wild-type phenotype (WT). “els observed” contains the number of malformed 
homozygous els mutants, whereas “els expected” is the number of malformed els 
embryos that would be expected to be deformed, if the same ratio applied to els as did 
for WT. The % -test assesses whether there is a significant difference between the
9 9number of “els observed” and “els expected”. If the calculated x value in column “% ”
• * 9is larger than the tabulated one at a particular confidence level ( x  df, 5-0.1%) there is a 
significant difference (5% level) or even highly significant difference (0.1% level) 
between the expected and observed numbers of malformed els embryos. (B-E) 
Influences on malformation frequency was tested with a single factor ANOVAR 
analysis, which tests whether the variation between different treatments is any different 
to the variation observed within injection batches of the same treatment. Columns 
labelled hs (heatshock) indicate whether an early (15-16hpf), late (18-19.5hpf) or no 
heatshock (no hs) had been carried out. The column “DNA amount” shows whether a 
high (50pg) or low (25pg) amount of a construct (hs>cls or pCS) had been injected. If 
the calculated F value (F) is higher than the tabulated F value (Fdn, df2, %) at a particular 
confidence level (0.1%, 1% or 5%), there is a significant difference (5% level) or even a 
highly significant difference (0.1% level) between variation within and between groups 
of treatments, df, degree of freedom. (F) A x2-test was used to test whether the ratio of 
the number of rescued embryos with normal morphology and malformed rescued 
embryos was different to a ratio of 1:1. It was asked whether malformed embryos were 
less likely rescued and thus, whether the presence of malformations had any influence 
on the rescue. The column “treatment” describes the DNA concentration, number and 
time of heatshock as outlined in (B-E). The column “malf.inormal” lists the ratio of 
malformed (malf.) to normal rescued els embryos taken from Appendix 7.1. If the 
calculated x2-value is smaller than the tabulated one ( x  df, 5%) for the 5% confidence 
level, there is no significant difference from the ratio 1:1.
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A) Do m alform ations vary with the genotype (W T vs. els'1')?
X2-test on els/WT pairs o f individual datasets using the Yates’ correction formula. 
Degree o f freedom =1 in all datasets: x2 1, 5«/o = 3.841, x2 1, i%= 6.635, x2 i, o.i%= 7.879
WT ratio c/5 observed c/5 expected I 2 Result
WT-3 23/38 9 7.3 1 0.2788 no sign diff on any level
WT-4 5/7 3 2,1  r
WT-5 54/87 17 16.8 J
WT-6 7/27 4 2.6 0.8725 no sign diff on any level
WT-7 17/25 6 4.8
WT-8 9/13 0 0.7
WT-9 16/25 3 2.6
WT-10 47/64 8 10.3
WT-11 8/32 4 3.0
WT-13 17/57 6 6.3 2.544 no sign diff on any level
WT-15 9/78 5 2.2 f
WT-16 1/31 1 0.3 J
WT-14 37/165 8 11.4 0.7377 no sign diff on any level
WT-17 11/30 5 7.0 0.3394 no sign diff on any level
WT-18 26/70 9 8.9 f
WT-20 39/41 13 12.4 1.5301 no sign diff on any level
WT-21 29/29 6 6.0
WT-22 39/46 9 13.6 /
WT-23 14/14 1 1.0
WT-24 20/22 7 6.4
WT-25 10/59 5 4.7 1.6203 no sign diff on any level
WT-26 9/25 2 2.9
WT-27 23/120 12 8.2
WT-28 8/137 1 2.1
WT-29 1/19 1 0.7
pCS-1 25/41 11 12.2 0.3865 no sign diff on any level
pCS-3 11/18 1 1.8 I
pCS-4 51/87 11 13.5 J
pCS-2 35/41 14 12.8 0.2727 no sign diff on any level
pCS-5 67/96 13 15.4
pCS-7 12/25 6 5.3 0.5236 no sign diff on any level
pCS-8 35/75 10 13.1
pCS-9 9/44 2 2.5 J
pCS-10 15/43 2 3,1 1 0.2979 no sign diff on any level
pCS-11 23/75 4 5.5 J
M-3 7/35 1 1.8 0.2887 no sign diff on any level
M-4 21/103 6 6.5
M-5 6/13 2 2.8
M-6 3/5 1 1.2
M-7 35/75 13 14.9 J
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B) Does a heatshock increase malformations?
Single factor anovar analysis with 2 levels
hs DNA amount construct F Fdfl,df2, % Result
no hs high hs>c/^lf/ 92.88 0.1%- 17.82 sign. diff. even on 0.1% level
early high hs >clsni






hs >clswl 3.24 5% -4.75 no sign. diff. even on 5% level
no hs low hs > Cls 0.057 5% - 4.96 no sign. diff. even on 5% level
late low hs>clsWT
C) Is there a difference in malformation between hs>clsW T and pCS?
Single factor anovar analysis with 2 levels
construct DNA amount hs F Fdfi, d n, % Result
h s^ /s* ' high early 9.81 5% -5.32 sign. diff. only on 5% level
pCS high early
hs>c/j^r high late 3.52 5% - 4.75 no sign. diff. even on 5% level
pCS high late
h s^ /s1*' low early 0.027 5% -5.12 no sign. diff. even on 5% level
pCS low early
hs>c/s 1 low late 3.10 5% - 5.59 no sign. diff. even on 5% level
pCS low late
D) Is there a difference in malformation between high and low  
DNA concentration?
Single factor anovar analysis with 2 levels
DNA amount construct hs F Fdfi.dn, % Result
high h s > c / /J early 0.059 5% -5.12 no sign. diff. even on 5% level
low hs >clsm early
high hs >clswl late 51.84 0.1% -21.04 sign. diff. even on 0.1% level
low hs >clsm late
high pCS early 17.70 1% - 11.26 sign. diff. on 1% level
low pCS early
high pCS late 16.04 1% - 10.56 sign. diff. on 1% level
low pCS late
2 8 1
E) Do malformations change depending on when the heatshock was 
carried out?
Single factor anovar analysis with 2 levels
hs time DNA amount construct F Fdfl,df2, % Result
early high h s > c / / ; 64.36 0.1%- 18.64 sign. diff. even on 0.1% level
late high h s > c //J
early high pCS 8.67 5% - 5.32 sign. diff. only on 5% level
late high pCS
early low hs >clsni 0.217 5% - 5.59 no sign. diff. even on 5% level
late low hs >clsiyl
early low pCS 2.0 5% -5.12 no sign. diff. even on 5% level
late low pCS
F) Are malformed embryos more likely to be rescued? Hence, 
does malformation have any effect on the rescue experiment?
X 2 - t e s t  t o  c o m p a r e  w h e t h e r  t h e r e  is a significant d i f f e r e n c e  b e t w e e n  t h e  ratio 
n o r m a l : m a l f o r m e d  a n d  1 : 1  w i t h i n  t h e  p o p u l a t i o n  o f  r e s c u e d  e m b r y o s .  
H 0: norm al/m alf =1 : 1  
X2-tests carried out on all 22 datasets and also within groups o f  different treatments.
treatment normal/malf iX df, 5% Result








WT-13 low, early 4:1 1.5625 5.991 no sign diff
WT-15 3:2
WT-16 1:0
WT-14 low, late 11:5 na na na
WT-17 high, early 4:3 0.1389 3.841 no sign diff
WT-18 7:6 /
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SUMMARY
W aardenburg-Shah syndrome com bines the reduced 
enteric nervous system  characteristic o f  H irschsprung’s 
disease with reduced pigment cell number, although the cell 
biological basis o f the disease is unclear. We have analysed  
a zebrafish W aardenburg-Shah syndrom e model. We show  
that the colourless gene encodes a soxlO  hom ologue, 
identify soxlO  lesions in mutant alleles and rescue the 
m utant phenotype by ectopic soxlO  expression. Using 
iontophoretic labelling of neural crest cells, we dem onstrate  
that colourless m utant neural crest cells form  
ectom esenchym al fates. By contrast, neural crest cells 
which in wild types form non-ectom esenchym al fates 
generally fail to m igrate and do not overtly differentiate.
These cells die by apoptosis between 35 and 45 hours post 
fertilisation. We provide evidence that m elanophore defects 
in colourless m utants can be largely explained by 
disruption o f nacre/milf expression. We propose that all 
defects o f  affected crest derivatives are consistent with a 
primary role for colourless/sox 10 in specification o f  non- 
ectom esenchym al crest derivatives. This suggests a novel 
mechanism  for the aetiology o f W aardenburg-Shah  
syndrom e in which affected neural crest derivatives fail to 
be generated from the neural crest.
K e y  w ords: Danio rerio, W aard en b urg-Sh ah  sy n d ro m e ,  
H irsch sp ru n g ’s d is e a s e , P ig m en t c e l ls ,  M e la n o p h o re , A p o p to s is
INTRODUCTION
T h e  n e u r a l c r e s t  is  a  v e r te b r a te  t i s s u e  o f  d e v e lo p m e n t a l  a n d  
m e d ic a l  im p o r ta n c e . D e v e lo p m e n ta l ly ,  n eu ra l c r e s t  is  
in tr ig u in g  b e c a u s e  th e  c e l l s  are  in i t i a l ly  m u lt ip o t e n t  a n d  
s u b s e q u e n t ly  fo r m  a  g r e a t  d iv e r s i ty  o f  d e r iv a t iv e  c e l l  t y p e s ,  
in c lu d in g  e c to m e s e n c h y m a l  fa te s , s u c h  a s  c r a n io fa c ia l s k e le to n  
a n d  f in  m e s e n c h y m e ,  a n d  n o n - e c t o m e s e n c h y m a l  fa te s , s u c h  a s  
n e u r o n e s ,  g l i a  a n d  p ig m e n t  c e l l s  ( L e  D o u a r in , 1 9 8 2 ;  S m ith  
e t  a l . ,  1 9 9 4 ) .  M e d ic a l ly ,  n eu r a l c r e s t  i s  im p o r ta n t b e c a u s e  
s o m e  d is e a s e s ,  k n o w n  as  n e u r o c r is to p a th ie s  a n d  in c lu d in g  
d iv e r s e  c o n d it io n s  s u c h  a s  a lb in is m , n e u r o f ib r o m a to s is  a n d  
H ir s c h s p r u n g ’s  d is e a s e  ( a g a n g l io n ic  m e g a c o lo n ) ,  a f f e c t  c e l l  
t y p e s  d e r iv e d  fr o m  th is  t i s s u e  ( B o la n d e ,  1 9 7 4 ) .
U n d e r s ta n d in g  th e  g e n e t ic  a n d  e m b r y o lo g ic a l  b a s i s  o f  
n e u r o c r is to p a th ie s  h a s  d e p e n d e d  o n  a n im a l m o d e ls .  T h u s ,  
m o d e ls  fo r  H ir s c h s p r u n g ’s  d is e a s e ,  in  w h ic h  in d iv id u a ls  h a v e  
f e w  o r  n o  e n te r ic  g a n g lia  in  th e  c o lo n ,  o r  th e  r e la te d  
W a a r d e n b u r g -S h a h  s y n d r o m e , in  w h ic h  in d iv id u a ls  c o m b in e  
H ir s c h s p r u n g ’s  d is e a s e  w it h  p ig m e n ta r y  a n o m a lie s  o f  th e  s k in ,  
h a ir  a n d  ir is e s ,  h a v e  b e e n  d e s c r ib e d  in  s e v e r a l s p e c ie s ,  
in c lu d in g  m o u s e  a n d  z e b r a fis h  ( H o s o d a  e t  a l., 1 9 9 4 ;  K e ls h  a n d  
E is e n ,  2 0 0 0 ) .  A n a ly s i s  o f  s u c h  m o d e ls  in  m ic e  h a s  id e n t if ie d  
th r e e  lo c i  th a t  are c r u c ia l fo r  W a a r d e n b u r g -S h a h  s y n d r o m e
(A tt ie  e t  a l . ,  1 9 9 5 ;  E d e r y  e t  a l . ,  1 9 9 6 ;  H o f s t r a  e t  a l . ,  1 9 9 6 ;  
P in g a u lt  e t  a l. ,  1 9 9 8 ;  P u f fe n b e r g e r  e t  a l . ,  1 9 9 4 ;  S o u th a r d -S m ith  
e t  a l., 1 9 9 9 ) .  T h u s ,  m u ta t io n s  in  l o c i  e n c o d in g  t h e  G -p r o te in -  
c o u p le d  tr a n s m e m b r a n e  r e c e p to r  p r o te in  e n d o th e l in  r e c e p to r  B  
(E d n r b )  o r  it s  n a tu ra l l ig a n d  e n d o th e l in  3  ( E d n 3 )  r e s u lt  in  
a g a n g l io n o s is  o f  te r m in a l g u t  in  h o m o z y g o u s  m u ta n ts  
(B a y n a s h  e t  a l . ,  1 9 9 4 ;  H o s o d a  e t  a l . ,  1 9 9 4 ) ,  a s  d o  h e t e r o z y g o u s  
m u ta t io n s  in  th e  S V y -re la ted  tr a n s c r ip t io n  fa c to r  g e n e  SoxlO 
(H e rb a rth  e t  a l . ,  1 9 9 8 ;  S o u th a r d -S m ith  e t  a l . ,  1 9 9 8 ) .  
H o m o z y g o u s  SoxlO m u ta n t  a n im a ls  s h o w  a  m o r e  s e v e r e  
p h e n o ty p e  w ith  a g a n g l io n o s i s  o f  th e  w h o l e  g u t  (H e r b a r th  e t  a l. ,  
1 9 9 8 ;  S o u th a r d -S m ith  e t  a l . ,  1 9 9 8 ) .  A d d it io n a l ly ,  m u ta t io n s  in  
a ll th e s e  g e n e s  a f f e c t  b o d y  p ig m e n ta t io n  (L a n e  a n d  L iu , 1 9 8 4 ;  
M a y e r , 1 9 6 5 ;  M a y e r  a n d  M a ltb y , 1 9 6 4 ) ,  b u t  o n ly  SoxlO 
m u ta t io n s  r e s u lt  in  w id e s p r e a d  p e r ip h e r a l n e r v o u s  s y s t e m  
d e f e c t s  (H e rb a r th  e t  a l . ,  1 9 9 8 ;  K a p u r , 1 9 9 9 ;  S o u th a r d -S m ith  e t  
a l.,  1 9 9 8 ) .
T h e  S o x  g e n e  f a m ily  e n c o d e s  a  la r g e  f a m ily  o f  t r a n s c r ip t io n  
fa c to r s , w ith  v e r te b r a te s  l ik e ly  to  h a v e  m o r e  th a n  2 0  S o x  g e n e s  
e a c h  (W e g n e r , 1 9 9 9 ) .  T h e ir  p r e c is e  r o l e s  a re  n o t  w e l l  
u n d e r s to o d , a lth o u g h  m a n y  a re  p r e s u m e d  to  fu n c t io n  in  c e l l  
fa te  s p e c if ic a t io n  ( P e v n y  a n d  L o v e l l - B a d g e ,  1 9 9 7 ) .  F o r  
e x a m p le ,  th e  fo u n d in g  f a m ily  m e m b e r , Sry, i s  l ik e ly  to  b e  
r e s p o n s ib le  fo r  S e r to l i  c e l l  s p e c i f i c a t io n ,  a n d  th u s  m a le  s e x
4114 K. A. Dutton and others
d e te r m in a t io n , in  m a m m a ls .  W h ile  SoxlO i s  c le a r ly  an  
im p o r ta n t  t r a n s c r ip t io n a l r e g u la to r  in  n e u r a l c r e s t  c e l l  ( N C C )  
d e v e lo p m e n t ,  th e  c e l lu la r  b a s i s  o f  th e  SoxlO m u ta n t  p h e n o ty p e  
r e m a in s  u n c le a r . It h a s  b e e n  s u g g e s t e d  th a t p e r ip h e r a l n e r v o u s  
s y s t e m  a n d  p ig m e n t a t io n  d e f e c t s  r e s u lt  f r o m  lo s s  o f  N C C s  
(S o u t h a r d -S m it h  e t  a l . ,  1 9 9 8 ;  K a p u r  1 9 9 9 ) ,  a lth o u g h  th e  
d e v e lo p m e n t a l  s ta tu s  o f  t h e s e  c e l l s  a t th e  t im e  o f  l o s s  is  
u n k n o w n . F u r th e r m o r e , r o le s  in  d e f in in g  r e g io n a l  id e n t ity  in  
th e  cr a n ia l n e u r a l c r e s t  a n d  in  g l ia l  c e l l  d if fe r e n t ia t io n  h a v e  a ls o  
b e e n  p r o p o s e d  (B o n d u r a n d  e t  a l . ,  1 9 9 8 ;  H e rb a r th  e t  a l . ,  1 9 9 8 ;  
K u h lb r o d t  e t  a l . ,  1 9 9 8 a ;  P u s c h  e t  a l . ,  1 9 9 8 ;  S o u th a r d -S m ith  e t  
a l . ,  1 9 9 8 ;  B r it s c h  e t  a l . ,  2 0 0 1 ) .
M u ta t io n s  a t th e  colourless (els) lo c u s  h a v e  b e e n  id e n t if ie d  
in  z e b r a fis h  m u t a g e n e s is  s c r e e n s  (K e ls h  e t  a l . ,  1 9 9 6 ;  M a l ic k i  
e t  a l. ,  1 9 9 6 ) .  W e  h a v e  p r e v io u s ly  c h a r a c te r is e d  th e  c r e s t  
d e r iv a t iv e  d e f e c t  d is p la y e d  b y  els m u ta n ts  (K e ls h  e t  a l . ,  2 0 0 0 a ;  
K e ls h  a n d  E is e n ,  2 0 0 0 ) ,  n o t in g  e x t e n s iv e  l o s s  o f  p ig m e n t  c e l l s  
a n d  e n te r ic  n e r v o u s  s y s t e m , to g e th e r  w ith  la r g e  r e d u c t io n s  in  
s e n s o r y  a n d  s y m p a t h e t ic  n e u r o n e s  a n d  p u ta t iv e  s a t e l l i t e  g l ia  
a n d  S c h w a n n  c e l l s .  B y  c o n tr a s t , w e  fo u n d  l i t t le  e f f e c t  o n  
e c to m e s e n c h y m a l  d e r iv a t iv e s ,  c r a n io fa c ia l  s k e le to n  a n d  fin  
m e s e n c h y m e .  B a s e d  o n  th e  s e v e r i t y  a n d  d e ta i ls  o f  th e  
p h e n o ty p e ,  w e  p r o p o s e d  th a t els fu n c t io n s  in  s p e c if ic a t io n ,  
p r o li f e r a t io n  o r  s u r v iv a l o f  a p r o g e n ito r ( s )  fo r  a ll  n o n -  
e c to m e s e n c h y m a l  c r e s t  d e r iv a t iv e s .
T h e  els p h e n o ty p e , a n d  th e  c e l l -a u to n o m y  o f  els g e n e  a c tio n  
in  p ig m e n t  c e l l  ty p e s  (K e ls h  an d  E is e n , 2 0 0 0 ) ,  s u g g e s te d  sox 10 
a s  a  c a n d id a te  g e n e .  W e  p r o v id e  an  ex p e r im e n ta l te s t  o f  th is  
h y p o th e s is . W e  rep or t th e  m a p p in g  o f  th e  els lo c u s  a n d  c lo n in g  
o f  a  ze b r a fish  sox 10 h o m o lo g u e . W e  s h o w  l in k a g e  b e tw e e n  els 
an d  soxlO, id e n t ify  soxlO  le s io n s  in  fo u r  m u ta n t a l le le s  an d  s h o w  
r e sc u e  o f  th e  els p h e n o ty p e  b y  sox 10 e x p r e ss io n . In  a d d it io n , w e  
d e s c r ib e  io n to p h o r e t ic  la b e l lin g  e x p e r im e n ts  to  e x a m in e  th e  
p r e c is e  c e l l -b io lo g ic a l  r o le  o f  cls/soxlO g e n e  fu n c t io n  in  n eu ra l 
c r e st  d e v e lo p m e n t . W e  s h o w  in  l iv e  e m b r y o s  th at N C C  c lo n e s  in  
els an d  w ild - t y p e  e m b r y o s  d iffe r e n tia te d  in to  e c to m e s e n c h y m a l  
fa te s  a fter  m ig r a t io n  to  a p p r o p r ia te  s ite s . R e m a in in g  N C C  c lo n e s  
a d o p te d  n o n -e c to m e s e n c h y m a l fa te s  in  w ild - ty p e  e m b r y o s . B y  
co n tra st, in  els e m b r y o s  d iffe r e n tia t io n  to  n o n -e c to m e s e n c h y m a l  
fa te s  w a s  ra r e ly  o b se r v e d . In stea d , m o s t  c lo n e s  fa ile d  to  m ig r a te  
a n d  u n d e r w e n t  la te  c e ll  d ea th  b y  an  a p o p to t ic  m e c h a n is m .  
F in a lly , fo r  th e  m e la n o p h o r e  fa te , w e  s h o w  d isru p te d  e x p r e ss io n  
in  els m u ta n ts  o f  g e n e s  v ita l fo r  m e la n o p h o r e  s p e c if ic a t io n  an d  
m ig r a tio n . T o g e th er , th e s e  d a ta  d e m o n str a te  a  c o m p le x  p h e n o ty p e  
in  els e m b r y o s  th at ca n  b e  e x p la in e d  b y  p r o p o s in g  th at cls/soxlO 
h a s  a  p r im a r y  r o le  in  s p e c if ic a t io n  o f  n o n -e c to m e s e n c h y m a l fa tes . 
D e f e c t s  in  c e l l  m ig r a tio n , su r v iv a l an d  d iffe r e n tia t io n  are  
th e r e fo r e  l ik e ly  to  b e  s e c o n d a r y  c o n s e q u e n c e s  o f  an  in a b ili ty  o f  
th e s e  c e l ls  to  a d o p t s p e c if ic  fa te s .
MATERIALS AND METHODS 
Fish husbandry
E m b ryos w ere  ob ta in ed  th rou gh  natural c r o sse s  and s ta g ed  acco rd in g  
to  K im m el e t  al. (K im m el e t a l., 1 9 9 5 ). W e u se d  4els a lle le s  (m618, 
t3, tw2 an d  tw ll).
M apping of c /s
els'wU h e te r o z y g o u s  fish  (T u b in g en  b ack grou n d ), w ere  cr o ssed  to  
w ild -ty p e  strain  W IK 11 to  p ro d u ce  a re feren ce  m a p p in g  cro ss .
H e tero zy g o u s  Fi w ere  in cr o ssed  an d  sep arate p o o ls  o f  E h o m o z y g o u s  
els fish  and th eir w ild -ty p e  s ib lin g s  w ere  u se d  for s im p le  se q u e n c e  
len g th  p o ly m o rp h ism  a n a ly s is  (K n ap ik  et a l., 1 9 9 6 ). L in k a g es  from  
the p o o ls  w ere  con firm ed  an d  re fin ed  b y  g e n o ty p in g  in d iv id u a l 
em b ry o s , as d escr ib ed  b y  R au ch  e t  al. (R au ch  et a l., 1 9 9 7 ).
Isolation, sequencing, phylogenetic analysis and radiation 
hybrid mapping of zebrafish soxlO
R T -PC R  w a s  p erform ed  u s in g  tota l R N A  o f  19  h p f  s ta g e  w ild -ty p e  
em b ry o s  u sin g  p u b lish e d  c o n d itio n s  an d  d eg en era te  p rim ers (Y uan  e t  
a l., 1 9 9 5 ). S e q u e n c in g  o f  re su ltin g  c lo n e s  id en tified  a r a t )  0 -like  
seq u e n c e . T h e s o x /O  c lo n e  w as e x ten d ed  b y  R A C E  P C R  u s in g  g e n e -  
sp e c ific  p rim ers (C lo n tech , S M A R T  R A C E  k it) an d  se q u e n c e d  o n  an  
A B I D N A  seq u en cer . A ll prim er s e q u e n c e s  a va ilab le  o n  req u est. T h e  
fu ll soxlO c D N A  seq u e n c e  is  ava ila b le  in  G en b an k  (A c c e s s io n  
N u m b er  A F 4 0 2 6 7 7 . T h e zeb r a fish so jc /0  h o m o lo g u e  w a s  m a p p ed  on  
th e  rad iation  h ybrid  p an e l L N 5 4  (H u k ried e  e t  a l., 1 9 9 9 ) b y  P C R  w ith  
p rim ers 5 '-A C C G T G A C A C A C T C T A C C A A G A T G A C C -3  and 5'- 
C A T G A T A A A A T T T G C A C C C T G A A A A G G -3 , w h ic h  gen era te  a 
931  bp  3' U T R  fragm ent.
For p h y lo g e n e tic  a n a ly s is  s e q u e n c e s  w ere  ex tracted  from  G en b an k  
and co d in g  s e q u e n c e s  a u to m a tica lly  ex trac ted  u s in g  G en etran s (w ith in  
G C G 9 ). T h e se  w ere  translated  and then  a lig n e d  u s in g  C lu sta lX  
(T h o m p so n  e t  a l., 19 9 7 ). T h e  n u c leo t id e  a lig n m e n ts  w ere  
recon stru cted  from  the p rotein  a lig n m e n ts  u s in g  M R T R A N S  
(w w w .h g m p .m rc .a c .u k /R eg istered /O p tio n /m rtra n s.h tm l). T re e -P u zz le  
(v  4 .0 .2 )  w a s  u se d  to con stru ct an  u n roo ted  tree b y  m a x im u m  
lik e lih o o d  (S tr im m er an d  vo n  H a e se ler , 1 9 9 6 ). It a u to m a tica lly  
a ssig n s  e s tim a tio n s  o f  sup p ort to  ea ch  internal b ran ch , figu res  for  
w h ich  are p resen ted  in the figu re . To m o d e l the su b stitu tion  p ro ce ss  
the Tam ura and N e i  (Tam ura and N e i ,  1 9 9 3 )  m o d e l w a s  e m p lo y e d  and  
all s ite s  w ere  u se d . G am m a d istrib u ted  variation  in rates o f  ev o lu tio n  
w as p erm itted  w ith  e ig h t variab le s ite s  an d  o n e  in variable. P aram eters  
w ere es tim a ted  u s in g  quartet sa m p lin g  an d  th e  n e ig h b o u r-jo in in g  tree.
Characterisation of mutant sox/0  alleles
T otal R N A  from  2 7  h p f  h o m o z y g o u s  em b ry o s o f  m u tant a ile le s  
els’"618, clstw2 and els'wl1 w a s  prepared  u s in g  T R I reagen t (S ig m a ). 
First strand c D N A  w a s  g en era ted  u s in g  random  h ex a m ers  and  
S u p erscr ip tll RT (G ib c o B R L ). F or ea c h  a lle le  fou r o v er la p p in g  RT- 
P C R  fragm en ts w ere  se q u e n c ed  to  id en tify  m u tant le s io n s . F o r ti, 
g e n o m ic  D N A  w a s  extracted  from  in d iv id u a lc /s^  m u tant e m b ry o s , a 
g e n o m ic  fragm en t en c o d in g  th e  N -term in a l o f  th e S o x lO  p rotein  w a s  
a m p lified  b y  P C R  and se q u e n c e d  c o m m e r c ia lly  (O s w e ll , 
S ou th am p ton ). T h e  t3 in sertion  seq u e n c e  is  av a ila b le  in  G en b an k  
(A c c e s s io n  N u m b er , A F 4 0 4 4 9 0 ) .
Ectopic expression in zebrafish embryos
T h e fu ll co d in g  reg ion  ofclsm6,s w a s  a m p lified  b y  R T -P C R  u sin g  
prim ers C /aI-S 21  (5 '-C C A T C G A T A C C T A C C G A A G T C A C C T G T -  
G G -3 ') and S21-Xba\ (5 '-G C T C T A G A G T T T G T G T C G A T T G T G G -  
T G C -3 '). T h e  1 6 1 5b p  fragm en t w a s  s u b c lo n ed  in to  \hd3la\IXba\ s ite  
o f  the h ea tsh o c k  v ec to r  p C S H S P  (H a lloran  e t  a l., 2 0 0 0 )  to  g en era te  
h s>soxlO(L142Q). T h e w ild  typ e sox 10 con stru ct, h s>soxl0, w a s  
gen era ted  b y  s ite -d irected  m u ta g en es is  o f  h s^soxlO(L142Q) u s in g  
Q u ik C h an ge S ite  D irected  M u ta g en es is  K it (S tra tagen e). S eq u e n c in g  
con firm ed  th e su c c e s s fu l gen era tion  o f  b oth  c lo n e s . D N A  p u rified  for  
in jec tion  u s in g  M icro co n  F ilter D e v ic e s  (M illip o r e )  w a s  d ilu ted  to a 
con cen tra tion  o f  2 5  ngp.1, w ith  0 .1%  P h en o l R ed . elsm618 o r  th eir  
w ild -ty p e  s ib lin g s  w ere  in jected  w ith  2  n l o f  e ith er  h s ^ o x /0  or  
h s>soxlO(L142Q) at the o n e -  to  tw o -c e ll  s ta g e  and in cu b a ted  at 
2 8 .5 °C . A s  appropriate, em b ry o s w ere  h e a tsh o c k e d  tw ic e  (a t 1 0 -1 3  
h p f  and 2 2 -2 4  h pf), b y  in cu b ation  at 3 7 C  for 1 hour, els em b ry o s  
w ere  sco red  for re scu e  at 4 8  h p f  u sin g  a M Z 1 2  d is se c t in g  m ic r o sc o p e  
(L e ica ). R e sc u e  w a s  d efin ed  as the p r e se n c e  o f  at le a st  o n e  
m elan op h ore o f  w ild -ty p e  m o rp h o lo g y ; th ese  are n ever  se e n  in  
u n in jected  m utant em b ry o s.
Zebrafish sox 10 mutant 4115
lontophoretic labelling and clonal analysis of single neural 
crest cells
lo n to p h o r e tic  la b e llin g  o f  in d iv id u a l neural crest c e lls  w a s  p erform ed  
u sin g  e s s e n t ia lly  the m eth o d  o f  R a ib le  et a l. (R a ib le  et a l., 1 9 9 2 ), 
ex c e p t  th at m ic ro p ip ette  tip s w ere  filled  w ith  3%  ly sin a ted  rh od am in e  
d extran  an d  3%  b io tin y la te d  d extran  (b o th  lQclO3 Afr; M o lecu la r  
P r o b e s) m ix tu re  d is s o lv e d  in 0 .2  M  KC1 and the n eed le s  b a ck filled  
w ith  0 .2  M  KC1. E m b ry o s from  h e te r o z y g o te s  forc/s  a lle le s  t3, tw2 
and tw ll  w ere  u sed ; n o  p h e n o ty p ic  d iffer en ces  b etw een  th ese  a lle le s  
w ere  s e e n , s o  w e  d o  n o t  d is tin g u ish  th em  here . Ind iv id ual N C C s  w ere  
la b e lle d  b y  in tracellu lar  in jec tio n  w ith  d y e . P rem igratory cran ia l crest  
c e l ls ,  b e tw e e n  th e  p o ster io r  e y e  an d  the anterior b oun d ary  o f  so m ite  
1, w ere  la b e lle d  in  4 - 1 4  s o m ite  (1 1 -1 6  h ou rs p o st  fertilisa tion , h pf) 
e m b ry o s , w h ile  p rem igra tory  trunk N C C s  at th e  le v e l o f  so m ite  7 w ere  
la b e lle d  in  1 6 -2 2  so m ite  (1 8 -2 0  h p f) em b ry o s . P rem igratory trunk  
N C C s  at th e le v e l o f  s o m ite  14 w ere  la b e lled  in 2 2 -2 5  so m ite  (2 0 -2 2  
h p f) e m b r y o s . E m b ry o s  w ere  reco v ered  an d  ra ised  for severa l hours  
at 2 8 .5 ° C  in em b ry o  m ed iu m  w ith  1% v /v  p en ic illin /str ep to m y c in  
so lu tio n  (G ib c o ) . E m b ry o s  w ere  rem ou n ted  and ex a m in ed  to id en tify  
th o se  w ith  o n ly  a s in g le  la b e lled  N C C ; o n ly  th ese  em b ry o s  w ere  
a n a ly sed .
L a b e lle d  c e lls  w ere  m o n ito red  u s in g  N o m a rsk i and f lu o re sc en ce  
o p tic s  o n  a B X 5 0 W I  m ic r o sc o p e  (O ly m p u s) , and d o cu m en ted  o n  a 
E c lip se  E 8 0 0  m ic r o sc o p e  (N ik o n ) u s in g  lo w  ligh t le v e l, v id e o ­
en h a n c e d  flu o r e sc e n c e  m ic ro sco p y . L a b e lled  c e lls  w ere  m on itored  
tw ic e  d a ily  for up  to  3 d a y s  u n til p ro g en y  co u ld  b e  id en tified  u sin g  
p u b lish e d  m o r p h o lo g ic a l criteria (R a ib le  and E ise n , 1994 ; R a ib le  
et a l., 1 9 9 2 ; S c h ill in g  an d  K im m el, 1 9 9 4 ). T h u s, m ela n o p h o res  
co n ta in ed  m e la n in  gran u les; x a n th o p h o res  w e r e  v is ib ly  y e l lo w  and  
a u to flu o resced  at a w a v e le n g th  n ear that o f  f lu orescein ; ir id op h ores  
c o n ta in ed  ir id escen t gran u les; d orsal root g a n g lia l n eu ro n es  w ere  
id en tified  b y  p o sit io n  ven tro la tera l to  the neural tu be co m b in ed  w ith  
a v is ib le  n eu rite; sy m p a th e tic  n eu ro n es  w ere  p o sit io n ed  ventral and  
lateral to  th e  n o toch ord  an d  sh o w e d  n eu rites; S ch w a n n  c e lls  w ere  
e lo n g a te d  and p o s it io n e d  a lo n g  ax o n a l p r o c e sse s , e .g . tr igem in al 
n erve; sa te llite  g lia  w ere  a s so c ia te d  w ith  the g a n g lio n ic  sh ea th  or 
ap p eared  to  b e w rap p ed  around n eu ron al stom ata; cran io fa c ia l 
ca r tila g e  form ed  ch arac ter istic  s ta ck s o f  v a cu o la ted  c e lls  in th e ja w  or  
g ill a rch es; fin  m e s e n c h y m e  o c c u p ie d  a p o sit io n  w ith in  th e  dorsa l fin  
fo ld  an d  s h o w e d  ch arac ter istic  a sy m m etr ic  organ isa tion  o f  p ro jectio n s  
(S m ith  e t  a l., 1 9 9 4 ). C e lls  w h ich  c o u ld  n ot b e a s s ig n e d  to an y  o f  the  
d escr ib e d  g ro u p s, o w in g  to  th eir p o sit io n  in reg io n s o f  lim ited  o p tica l 
re so lu tio n  or  la c k  o f  d is t in c tiv e  m o rp h o lo g ie s , w ere  c la ss if ie d  as  
‘u n id en tif ied ’ . In cran ia l r e g io n s, th ese  c e lls  u n d o u b ted ly  in clu d ed  
c e l ls  o f  c o n n e c t iv e  tis su e  fa tes  (S c h ill in g  and K im m el, 1 9 9 4 ).
TUNEL
T U N E L  (term in al d e o x y n u c le o t id y l tran sferase (T d T )-m ed ia ted  
d eo x y u rid in etr ip h o sp h a te  (d U T P ) n ick  en d -la b e llin g )  o f  d o u b le ­
strand D N A  fragm en ta tion  w a s  u se d  to con firm  a p o p to s is  in c e lls  w ith  
a p o p to tic  m o rp h o lo g y , els° an d  th eir w ild -ty p e  s ib lin g s  w ere  fixed  
ov ern ig h t at 4 ° C  in 4%  p ara form ald eh yd e and T U N E L  p erform ed  
u sin g  flu o re sc e in  d U T P  an d  d e v e lo p e d  u sin g  4 -N itro b lu e  tetrazo liu m  
ch lo r id e  an d  5 -B r o m o -4 -c h lo r o -3 -in d o ly l-p h o sp h a te  (B o eh r in g e r  
M a n n h e im ; R e y e s , 1 9 9 9 ).
Morpholino injections
A B  w ild -ty p e  em b ry o s  at 2 5 , 3 0  and 3 5  h p f  w ere  in jec ted  w ith  eith er  
a h igh  (1 6 .5  n g ) or lo w  (9  n g ) d o se  o f  a m orp h o lin o  d e s ig n e d  to k n o c k ­
d o w n  soxlO, as  d escr ib e d  p r e v io u s ly  (D u tton  e t  a l., 2 0 0 1 ) . E ffec ts  on  
nac/mitf e x p r e ss io n  in m e la n o b la sts  at 25  h p f  w ere  eva lu a ted  b y  
co u n tin g  n a c /m it^ e x p r e ss in g  c e l ls  in  o n e  h a lf  o f  th e  trunk in ea c h  o f  
2 0  e m b ry o s  at ea c h  d o se .
Whole-mount in situ hybridisation and antibody staining
R N A  in  situ  h yb r id isa tion  w a s  p erform ed  as d escr ib ed  b y  K e lsh  and  
E isen  (K e lsh  an d  E is e n , 2 0 0 0 ) ,  onels"1618, els'wU and els'3, th eir w ild -
typ e s ib lin g s  an d  m orp h ants. P rob es for the fo llo w in g  g e n e s  w ere  
u sed: nac/mitf (L ister  e t a l., 1 9 9 9 ) , spa/kit (P ar ich y  e t a l., 19 9 9 );  
dopachrome tautomerase(dct) (K e lsh  e t a l., 2 0 0 0 b ) ;dlx2 (A k im en k o  
et a l., 1994 ); forkhead 6 (Jkd6) (O d en th a l an d  N u e ss le in -V o lh a r d ,
19 9 8 ).
A n tib od y  sta in in g w ith  anti-H u, m A b  1 6 A 1 1 (M aru sich  et a l., 19 9 4 ), 
w as perform ed  u sin g  p erox id ase-an tip erox id ase  (V E C T A S T A D f)  
E lite  A B C  k it) and D A B  substrate.
RESULTS 
els and  a zebrafish  soxlO hom ologue  m ap to  th e  
sam e region of L inkage G roup 3
T h e  s tr o n g  p h e n o t y p ic  s im ila r ity  b e t w e e n  soxl0D°m m ic e  a n d  
els m u ta n ts  s u g g e s t e d  a  z e b r a fis h  sox 10 h o m o lo g u e  a s  a  
ca n d id a te  g e n e  fo r  els. W e  u s e d  R T -P C R  to  c lo n e  a  p a r tia l  
soxlO-l ik e  H M G  b o x  a n d  R A C E  R T -P C R  to  c lo n e  5 '  a n d  3 '  
r e g io n s .  S e q u e n c in g  th e s e  c lo n e s  r e v e a le d  an  o p e n  r e a d in g  
fr a m e  e n c o d in g  a  soxl 0 h o m o lo g u e ,  w h ic h  w e  r e fe r  to  a s  sox 10 
(F ig .  1 A ,B ) .
G e n e t ic  m a p p in g  o f  2 7 4  m e i o s e s  p la c e d  els o n  L G  3 w it h in  
a 3 .9  c M  in te r v a l b e tw e e n  m a rk ers  z 8 7 2  a n d  z l 3 3 8 7  ( F ig .  1 C ). 
T w o  o l ig o n u c le o t id e  p r im e r s  a m p lif ie d  a  9 3 1  b p  fr a g m e n t  
fr o m  z e b r a fis h , b u t n o t  fr o m  c o n tr o l  m o u s e  g e n o m ic  D N A .  
A m p l if ic a t io n  fr o m  th e  D N A s  in  th e  L N 5 4  r a d ia tio n  h y b r id  
m a p p in g  p a n e l  (H u k r ie d e  e t  a l . ,  1 9 9 9 )  w it h  t h e s e  p r im e r s  
m a p p e d  soxlO  to  L G  3 ,  O cR  fr o m  th e  m a rk er  z 8 4 9 2  ( L O D  
s c o r e = 1 7 .6 ;  F ig .  1 C ). T h e  s tr ik in g  l in k a g e  o f  els a n d  soxlO, 
to g e th e r  w ith  in  s itu  h y b r id is a t io n  e x p e r im e n t s  s h o w in g  soxl 0 
e x p r e s s io n  in  n eu r a l c r e s t  ( s e e  b e lo w ) ,  s t r o n g ly  s u p p o r te d  o u r  
h y p o th e s is  th a t els m ig h t  e n c o d e  soxlO.
soxlO is d isru p ted  in els m u tan ts
W e  u s e d  R T -P C R  t o  a m p li f y  th e  so x l0 - c o d in g  r e g io n  f r o m  2 7  
h p f  h o m o z y g o u s  m u ta n ts  o f  3 els a l l e le s .  S e q u e n c in g  th e s e  
P C R  p r o d u c ts  id e n t if ie d  s e q u e n c e  d if f e r e n c e s  fr o m  w i ld - t y p e  
c o n s is t e n t  w ith  th e m  c a u s in g  th e  m u ta n t  p h e n o t y p e  ( F ig .  
1 D ,E ) .  T w o  a l l e le s  s h o w  an  A - » T  t r a n s v e r s io n , r e s u lt in g  in  
a  p r e m a tu r e  S to p  c o d o n ;  th e  th ir d  i s  a  n o n - c o n s e r v a t iv e  
s u b s t itu t io n  ( L 1 4 2 Q )  o f  a  f u l ly - c o n s e r v e d  r e s id u e  in  th e  H M G  
d o m a in . A  fo u r th  a l l e le ,  t3, s h o w e d  h ig h ly  r e d u c e d  R N A  
e x p r e s s io n  u s in g  a  3 '  p r o b e  fo r  w h o le - m o u n t  R N A  in  s itu  
h y b r id is a t io n . P C R  fr o m  g e n o m ic  D N A  id e n t i f ie d  a  1 .5  k b  
in s e r t io n  in  a l l  t3 m u ta n ts  th a t w a s  n o t  p r e s e n t  in  w i ld  ty p e s .  
S e q u e n c in g  g e n o m ic  D N A  fr o m  t3 h o m o z y g o t e s  id e n t if i e d  a  
1 3 9 7  b p  in s e r t io n  w ith  s e q u e n c e  h o m o lo g y  to  a  t r a n s p o s o n  
f ir s t  id e n t if i e d  in  a  m u ta n t  no tail a l l e le  (d a ta  n o t  s h o w n ;  
S c h u l t e -M e r k e r  e t  a l . ,  1 9 9 4 ) .  T h e  in s e r t io n  in te r r u p ts  th e  
soxl 0 - c o d in g  s e q u e n c e  u p s tr e a m  o f  th e  H M G  d o m a in  a n d  
a d d s  e ig h t  n o v e l  a m in o  a c id s  b e f o r e  p r e m a tu r e ly  tr u n c a t in g  
th e  p r o te in  ( F ig .  I D ) .
T o  te s t  fu r th er  w h e th e r  els e n c o d e s  soxlO, w e  a t te m p te d  to  
r e s c u e  th e  els p h e n o ty p e  w ith  e c to p ic  sox 10 e x p r e s s io n  u n d e r  
h e a t  s h o c k  c o n tr o l .  W e  t o o k  a d v a n ta g e  o f  th e  c o n s is t e n t  
a b s e n c e  o f  la r g e , s t e l la t e  m e la n o p h o r e s  in  e v e r y  els e m b r y o .  
E c t o p ic  e x p r e s s io n  o f  w i ld - t y p e  soxlO  r e s c u e d  1 -4 0  
m e la n o p h o r e s  to  a  w i ld - t y p e  m o r p h o lo g y  in  4 8 %  o f  clsm618 
m u ta n ts , w h i le  e c to p ic  m u ta n t soxlO(L142Q) f a i le d  to  d o  s o  
(T a b le  1; F ig .  2 ) .  F u r th e r m o r e , w h i le  els m e la n o p h o r e s  a lw a y s  
r e m a in  d o r s a l to  th e  n eu r a l tu b e , r e s c u e d  m e la n o p h o r e s  
f r e q u e n t ly  m ig r a te d , e v e n  to  v e r y  d is ta l p o s i t io n s  (F ig .  2 ) .
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Zebrafish soxlO mutant 4117
F ig . 1 . A  zeb ra fish  sox 10 h o m o lo g u e  m a p s to  the reg ion  o f  th ec/s  
lo c u s . (A ) S e q u e n c e  c o m p a r iso n  o f  p red ic ted  zeb ra fish  S o x lO  
h o m o lo g u e  (4 4 , 4 5  an d  60%  id en tity  to  m o u se  S o x 8 , S o x 9  and  
S o x lO , re sp e c tiv e ly ) . B lo c k s  o f  id en tity  co rresp o n d in g  to all 
p r o p o se d  fim c tio n a l d o m a in s  can  b e  se e n , in c lu d in g  the H M G  
d o m a in  (red  u n d er lin e; 95%  a m in o  acid  id en tity ), N -term in a l 
sy n e r g y  d o m a in  (1 -1 0 5 ;  4 8 %  id en tity ), d im er isa tio n  d om ain  (6 6 -1 0 5 ;  
78%  id en tity ), C -term in a l tran scrip tiona l activa tion  d om ain  (3 9 5 -  
4 8 5 ;  76%  id en tity ) an d  a  d o m a in  C -term in al to  th e  H M G  d om ain  
co rresp o n d in g  to  a p u ta tive  p ro te in -p ro te in  in teraction  d o m a in  (2 3 4 -  
3 2 5 ;  64%  id en tity ; B on d u ran d  e t  a l., 2 0 0 0 ;  K u h lb rod t et a l., 1998a;  
K u h lb rod t e t a l., 1998b ; L iu  e t  a l., 1999 ; P e iran o  and W egner, 2 0 0 0 ) .
(B )  M a x im u m  lik e lih o o d  p h y lo g e n e t ic  tree o f  sub grou p  E  S o x  g en es .  
Z eb rafish  soxlO c lu ster s  w ith in  th e S o jc /O c la d e  o f  vertebrate S o x  
g e n e s . T h e  A c c e s s io n  N u m b er s  for  th e s e q u e n c e s  are as fo llo w s:  
c h ic k e n  Sox8 (A F 2 2 8 6 6 4 );  trout SoxPl (D 8 3 2 5 6 );  m o u se  S o x #
(A F 1 9 1 3 2 5 ); h u m a n S O r #  (A F 2 2 6 6 7 5 );  fr o g S o x 9 o (A B 0 3 5 8 8 7 ) ;  
a llig a to r  Sox9 (A F 1 0 6 5 7 2 );  trout S o x  9  (A B 0 0 6 4 4 8 );  ze b r a fish so x 9 a  
(A F 2 7 7 0 9 6 );  ze b r a fis h s o x 9 6  (A F 2 7 7 0 9 7 );  c h ic k e n S o x 9  
(A B 0 1 2 2 3 6 ) ;  p ig S o x 9 ( A F 0 2 9 6 9 6 ) ;  h u m a n S O T 9  (Z 4 6 6 2 9 );  
z e b r a f is h s o x /0 (A F 4 O 2 6 7 7 ) ;  c h ic k e n S o x 7 0 (A F 1 5 2 3 5 6 ) ;  m o u se  
SoxlO (A F 0 4 7 3 8 9 );  rat SoxlO 1029 ); h u m an S O W O
(N M _ 0 0 6 9 4 1 ) . (C ) M a p p in g  u s in g  the L N 5 4  p a n e l p la c e d o x /0 o n  
L G  3 in the reg ion  o f  th e c /s  lo c u s  id en tified  u sin g  m icro sa te llite  
m arkers (w e  fo u n d  fou r reco m b in a n ts  b etw een els and z l 3 3 8 7  in  2 7 4  
m e io se s ) . N o te  that z 8 4 9 2  w a s  n ot p o ly m o rp h ic  and co u ld  n o t b e  
a n a ly sed  in th e  m a p p in g  cr o ss . (D )  S ch em a tic  to  illustrate ch a n g es  in  
S o x lO  m utant p ro te in s . In els"618 a T 4 2 5 A  su b stitu tion  resu lts  in a 
n o n -c o n ser v a tiv e  ch a n g e  (L e u l4 2 G ln )  w ith in  th e H M G  d om ain  
(red ). In e l s and els'”11, a A l  1 2 6 T  su b stitu tion  in trod u ced  a S top  
co d o n  tru n catin g  the p rotein  ju s t  N -term in a l to  the tran sactivation  
d o m a in  (b lu e). In sertion  o f  a 1 .4  kb tran sp oson  at th e  s ite  in d ica ted  
b y  th e  arrow  in A  d is r u p ts j o x /0  in els'3 and in trod u ces  a C -term in al 
e x te n s io n  o f  e ig h t  n o v e l a m in o  a c id s  b efo re  prem ature tru n cation  N -  
term in al to  the H M G  d o m a in  (y e l lo w ) . (E ) C hrom atogram  traces to  
s h o w  n u c le o t id e  ch a n g e s  a ffec tin g y o x f 0 -co d in g  reg ion s in clsm6,s 
and els'™2.
sox10 ex p re ss io n  is d isru p ted  in els m u tan ts
W e u s e d  in  s itu  h y b r id is a t io n  to  e x a m in e  soxlO  e x p r e s s io n  in  
w ild - t y p e  a n d  els e m b r y o s .  In  w i ld  t y p e s ,  e x p r e s s io n  w a s  fir st  
d e te c te d  a t th e  o n e - s o m it e  s ta g e  in  c e l l s  in  th e  la te ra l n eu ra l 
p la te  (d a ta  n o t  s h o w n ) .  T h r o u g h o u t  s o m it o g e n e s i s  s ta g e s ,  
s tr o n g  soxlO  e x p r e s s io n  w a s  s e e n  in  p r e m ig r a to r y  N C C s  a n d  
e x te n d e d  p r o g r e s s iv e ly  m o r e  c a u d a lly  in  o ld e r  s ta g e s  (F ig .  3 A -  
C ,F ) . D o u b le  R N A  in  s itu  h y b r id is a t io n  s t u d ie s  s h o w  th a t  th ere  
i s  e x t e n s iv e ,  b u t  in c o m p le t e ,  o v e r la p  o f  sox JO a n d  fkd6, a  
m a rk er  e x p r e s s e d  w id e ly  in  p r e m ig r a to r y  N C C s  ( F ig .  3 0 , P )  
(O d e n th a l a n d  N u e s s le in - V o lh a r d ,  19 9 8 ) .  sox 10 e x p r e s s io n  
w a s  m a in ta in e d  in  s o m e  m ig r a t in g  N C C s  o n  th e  m e d ia l  
m ig r a t io n  p a th w a y  ( F ig .  3 C ,F ) .  B y  3 0 - 4 0  h p f  soxlO  e x p r e s s io n
Table 1. Rescue o f els phenotype using ectopic soxlO  
expression
Mean number o f
Heat Injected cls~ Rescued cls~ melanophores per 
Construct shock that survived (% rescued) rescued embryo
hs>soxl0 +  92 4 4 (4 8 ) 15
hs>soxl0 -  48 17(35)* 4.3
hs>soxlO(L142Q) +  122 0 (0 )  0
*A similar degree o f  leakiness with this promoter has been reported by 
Lister et al. (Lister et al., 1999); note that the degree o f  rescue is much less in 
the absence o f  heat shock.
o n  th e  m e d ia l  p a th w a y  i s  o r g a n is e d  in  s e g m e n t a l ly  a r r a n g e d  
c lu s te r s  a d ja c e n t  to  th e  n o to c h o r d , p r e s u m a b ly  d e v e lo p in g  
S c h w a n n  c e l l s  a s s o c ia t e d  w ith  th e  s e g m e n t a l  n e r v e s  ( F ig .  3 Q );  
soxlO  e x p r e s s io n  is  lo s t  f r o m  t h is  s i t e  b y  4 8  h p f . A lt h o u g h  
N C C s  are fo u n d  e x t e n s iv e ly  o n  th e  la te ra l p a th w a y  fr o m  2 4  h p f  
( R a ib le  e t  a l . ,  1 9 9 2 ) ,  c o u n t s  o f  soxl  ^ - e x p r e s s in g  c e l l s  s h o w  
th a t e x p r e s s io n  w a s  e s s e n t ia l ly  a b s e n t  f r o m  c e l l s  o n  th is  
p a th w a y  ( F ig .  3 M ,N ) .  T h is  d e m o n s tr a te s  th e  ra p id  
d o w n r e g u la t io n  o f  sox 10 f r o m  p ig m e n t  c e l l  p r e c u r so r s , a s  
N C C s  o n  th is  p a th w a y  fo r m  o n ly  p ig m e n t  c e l l s  (R a ib le  a n d  
E is e n ,  1 9 9 4 ) .  C o n s is t e n t  w ith  th is ,  x a n th o p h o r e s  a n d  m o s t  
p ig m e n te d  m e la n o p h o r e s  s h o w  n o  d e te c ta b le  soxlO  e x p r e s s io n  
(F ig .  3 L ) ,  a lth o u g h  s o m e  w e a k ly  e x p r e s s in g  m e la n o p h o r e s  
w e r e  n o te d  a t e a r lie r  s t a g e s  ( F ig .  3 K ) .  E x p r e s s io n  w a s  n o t  s e e n  
in  f in  m e s e n c h y m e  n o r  in  J /x 2 - e x p r e s s in g  c r a n io fa c ia l  c a r t i la g e  
p r e c u r so r s  ( F ig .  3 D ,E ) ,  a lth o u g h  d if fe r e n t ia t in g  j a w  c a r ti la g e  
s h o w s  w e a k  e x p r e s s io n  b y  6 0  h p f  (d a ta  n o t  s h o w n ) .  C e l l s  
e x p r e s s in g  soxlO  a c c u m u la te d  in  c lu s t e r s  c o r r e s p o n d in g  t o  th e  
fo r m in g  c r a n ia l g a n g l ia  a n d  e x te n d in g  a lo n g  th e  p o s te r io r  
la te ra l l in e  n e r v e  b y  2 4  h p f  ( F ig .  3 F ,H ) , in  a  p a ttern  r e m in is c e n t  
o f  Jkd6 e x p r e s s io n  (K e ls h  e t  a l . ,  2 0 0 0 a ) ,  s u g g e s t in g  th a t  soxlO 
i s  e x p r e s s e d  in  s a t e l l i t e  g l ia l  a n d  S c h w a n n  c e l l s .  C o n s is t e n t  
w ith  th is  in te r p r e ta tio n , d o u b le  la b e l l in g  w ith  a n t i-H u  a n t ib o d y  
c o n f ir m e d  th e  n o n -o v e r la p p in g  e x p r e s s io n  o f  sox 10 a n d  th is  
n e u r o n a l m a rk er  ( F ig .  3 J ) . sox 10 is  m a in ta in e d  in  d e v e lo p in g  
S c h w a n n  c e l l s  o n  th e  p o s te r io r  la te ra l l in e  n e r v e  u p  to  6 0  h p f  
(d a ta  n o t  s h o w n ) .  soxlO  e x p r e s s io n  w a s  p r o m in e n t  in  e n te r ic  
n e r v o u s  s y s t e m  p r e c u r so r s  a t 6 0  h p f  ( F ig .  3 S ) .
A t  e a r ly  s t a g e s ,  p r e m ig r a to r y  c r e s t  s h o w e d  e q u iv a le n t  
p a tte r n s  o f  soxl 0 - p o s i t iv e  c e l l s  in  w i ld - t y p e  a n d  elstwI1 a n d  
clsm6i8 m u ta n t e m b r y o s .  C o u n ts  a t 2 4 ,  3 0  a n d  3 5  h p f  r e v e a le d  
th a t a lth o u g h  in  w i ld  t y p e  soxl  ^ - e x p r e s s in g  c e l l s  w e r e  r a p id ly  
lo s t  fr o m  th e  p r e m ig r a to r y  p o s i t io n ,  t h e y  r e m a in e d  h e r e  in  
c[sm6i8 m u ta n ts ;  b y  c o n tr a s t , sox 10 e x p r e s s io n  in  m ig r a t in g  
tru n k  N C C  w a s  b r o a d ly  c o m p a r a b le  b e tw e e n  w i ld  t y p e  a n d  
c[sm6i8 m u ta n ts  (F ig .  3 M ,N ) .  A d d it io n a l ly ,  els m u ta n ts  w e r e
F ig . 2 . els p h e n o ty p e  is  r e scu ed  b y  ec to p ic  
sox 10 e x p re ss io n . W ild -ty p e  e m b ry o s  sh o w  
m an y large, s tro n g ly  p ig m en ted  
m ela n o p h o res  at 4 8  h p f  (A ; c lo se -u p  o f  anal 
reg ion  in D ) , w h ile  hs>soxlO(L142Q)- 
in jec ted  elsm6,s m u tan ts (B )  s h o w  o n ly  tiny  
m ela n ise d  sp o ts  in p o s it io n  o f  p rem igratory  
N C C s (arrow h ead s). (C ,E ,F ) B y  contrast, 
els"618 em b ry o s  in jec ted  w ith  h s ^ o x /O a n d  
h ea t-sh o c k e d , s h o w  m o s a ic  re scu e  o f  m ela n o p h o res . T h is  e m b ry o  sh o w ed  o n e  rescu ed  m ela n o p h o re  in the d orsa l stripe (*  in C ), tviw the  
ventral stripe (arrow s in C; c lo se -u p  in E ) and o n e  on  th e y o lk  sac  (F ). S c a le  bar: 12$tm  in A -C ; 7 0  p m  in  D -F .
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F ig . 3 .  E m b ry o n ic  soxlO e x p r e ss io n  in  
w ild -ty p e  an d  c / s  em b ry o s .
(A,B) soxl 0 is e x p r e ss e d  in  m o st  
cran ia l (A ; f iv e -so m ite  s ta g e )  and trunk  
(B ; 14 -s o m ite  s ta g e )  p rem igra tory  
N C C s; d o u b le  m R N A  in  s itu  
h y b r id isa tio n  w ith  fkd6 (O , p u rp le) and  
soxlO(P, g reen ) in  a  s ix - s o m ite  sta g e  
em b ry o  revea ls  e x te n s iv e  over la p , 
a lth o u g h  so m e  in d iv id u a l N C C s  lack  
soxlO (a rro w h ea d s). (C ) 1 8 -so m ite  
s ta g e  em b ry o  s h o w s  stro n g  e x p re ss io n  
in  p rem igra tory  (b la ck  arrow ) and  
m ig ra tin g  (a s ter isk ) N C C s  an d  o tic  
v e s ic le  (o ). (D ,E )  D o u b le  m R N A  in  
s itu  h y b r id isa tio n  w ith dlx2 (D , p urp le)  
an d  soxlO (E , g r e e n )  in  2 9  h p f  stage  
em b ry o s  sh o w s  a b se n c e  o (sox 10 
e x p r e ss io n  in d e v e lo p in g  b ran ch ia l 
arch es  (1 -5 ) . (F )  B y  2 4  h p f  in w ild  
ty p e s , stron g  e x p r e ss io n  is  a s so c ia ted  
w ith  cran ia l g a n g lia  (w h ite  
arrow h ead s) an d  p o ste r io r  lateral lin e  
n erv e  (b la ck  arrow h ead ; en la rg ed  in  
in se t) , o tic  v e s ic le  (o ) ,  m ig ra tin g  N C C s  
th ro u g h o u t trunk (a s te r isk s )  and in  
prem igra tory  cr e st  (arrow ). (G ) A t 2 4  
h p f  in  els m u tan ts , e x p r e ss io n  in  the  
h ead  is  c lu ster ed  (w h ite  a s ter isk s) and  
cran ia l g a n g lia  h a v e  re d u ce d  la b e llin g  
(w h ite  arrow h ead s). C e lls  e x p r e ss in g  
soxl 0 ex ten d  a lo n g  th e  p o ste r io r  lateral 
lin e  n erv e  (arrow h ead  an d  in set).
R ostra l trunk s h o w s  s o m e  m igra tin g  
c e l ls  (b la ck  a ster isk ), b utsoxlO- 
p o s it iv e  c e lls  are c lu s te r e d  dorsa l to  th e  
n eu ra l tu be (a rro w s) in  trunk and tail.
(H ,I )  C o m b in e d  soxlO in  s itu  
h yb r id isa tio n  (p u rp le ) an d  an ti-H u  
a n tib o d y  la b e llin g  (o r a n g e )  sh o w s  
stro n g  soxlO e x p r e ss io n  a s so c ia te d  
w ith  w ild -ty p e  (H ) p o ste r io r  lateral lin e  
g a n g lio n  (g ) , m u ch  re d u ce d  in els 
m u tant (I). (J) In tra n sv erse  se c t io n  o f  
w ild -ty p e  g a n g lio n  (ap p ro x im a te  
p o s it io n  in d ica ted  b y  w h ite  lin e  in  H ), 
soxlO ex p r e ss io n  is  s tron g  p erip h era lly  (n on -n eu ron a l c e l ls ) ,  but a b sen t cen tra lly  (n eu ro n es). (K ,L ) 3 6  h p f  w ild -ty p e  em b ry o s  s h o w  » le  
e x p r e ss io n  in s o m e  m e la n o p h o r e s , but n o t a ll. T h u s, w ea k  ex p r e ss io n  (arrow h ead ) is  s e e n  in  s o m e  c e lls  o f  the d orsa l stripe (K ^ it n ot in  c e lls  
on  th e  y o lk  sa c  (L ). (M ,N )  N u m b er  ofsoxlO -expressing N C C s  in  d ifferen t lo c a tio n s  (p rem igratory, pre; m igra tin g  o n  m ed ia l p a th w ay , M P; 
m igra tin g  on  lateral p a th w a y , L P ) o f  trunk and anterior ta il ( so m ite s  1 -2 0 ) at 2 4  (M ) and 3 0  h p f  (N )  in W T  and/s m utants. (Q ,R ) S eg m en ta lly  
arranged  lin e s  o f s o x /O -p o s it iv e  c e l ls  ly in g  ad jacen t to  the n o to ch o rd  (n o ), p resu m ab ly  g lia , are abundant in w ild  ty p e  (Q ) an d  o n ly  w e a k ly  
a ffec te d  in  els m u tan ts (R ) at 4 0  hpf. (S ,T )  T ran sverse  se c t io n  o f  trunk o f  6 0  h p f  w ild -ty p e  em b ry o  (S )  sh o w s  en teric  n ervou s s y ste m  e x p r e ss io n  
(a rrow h ead s) lateral to  th e  gu t (g ) , a b sen t ir c /s  m utant (T ). e ,  ey e ; m , m u sc le ; s , som ite; v s , ventral stripe m e la n o p h o res . A ll im a g e s  are lateral 
v ie w s , rostral tow ard s th e  le ft, d orsa l u p w ard s, e x c e p t  d orsa l v ie w s  o f  A ,K ,0 ,P . S ca le  bar: 20p .m  in  A ; 5 0  p m  in  B ,H -I ,K -L ; 1 2 0 p m  in C ;
7 5  p m  in D ,E ; 1 5 0  p m  in F,G ; 3 5  p m  in J; 65  p m  in 0 ,P ;  5 5  p m  in  Q ,R ; 4 5  p m  in  S,T.
d is t in g u is h a b le  f r o m  2 4  h p f  b y  th e  c lu s te r e d , n o t  s c a t te r e d ,  
d is tr ib u t io n  o f  soxl 0 - p o s i t iv e  c e l l s  in  th e  h e a d  (F ig .  3 F ,G )  a n d  
a v a r ia b le  r e d u c t io n  in  th e  n u m b e r  o f  sox l0 - p o s i t iv e  c e l l s  in  
c r a n ia l g a n g l ia  a n d  o n  c r a n ia l n e r v e s  ( F ig .  3 H ,I ) .  B y  3 5  h p f ,  
els m u ta n ts  w e r e  r e a d i ly  d is t in g u is h e d  fr o m  w i ld  t y p e s  b y  th e ir  
r e d u c e d  n u m b e r  o f  so x l0 - p o s i t iv e  c e l l s ,  c o n c e n tr a te d  in  a  
p r e m ig r a to r y  p o s i t i o n  d o r s a l to  th e  n eu r a l tu b e  o r  c lu s te r e d  
n e a r  th e  p o s t e r io r  la te r a l l in e  g a n g lia ;  p u ta t iv e  S c h w a n n  c e l l s  
w e r e  m is s in g  fr o m  th e  p o s t e r io r  la te ra l l in e  n e r v e , els m u ta n ts
s h o w e d  r e d u c e d  e x p r e s s io n  in  th e  p u ta t iv e  S c h w a n n  c e l l s  
f o u n d  a s  s e g m e n ta l  c lu s t e r s  o f  so x l0 - p o s i t iv e  c e l l s  ( F ig .  3 Q ,R ) .  
E n te r ic  n e r v o u s  s y s t e m  p r e c u r so r s  w e r e  a b se n t  at 6 0  h p f  ( F ig .  
3 T )  in  els m u ta n ts .
In  c o n tr a s t  to  th e  o th e r  m u ta n t  a l l e le s  e x a m in e d , clst3 
m u ta n ts  c o n s is t e n t ly  s h o w  h ig h ly  r e d u c e d  sox 10 tr a n s c r ip ts  
w h e n  e x a m in e d  u s in g  th e  3 '  soxlO  p r o b e  a t a ll s ta g e s .  W h e n  
e x a m in e d  u s in g  a  p r o b e  ly in g  5 '  to  th e  in s e r t io n  s it e ,  soxlO 
e x p r e s s io n  le v e l s  w e r e  c o m p a r a b le  w ith  t h o s e  in  o th e r  m u ta n t
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Table 2. Fates o f  single neural crest cells injected with lineage tracer
Fate*
Trunk (somite 14) Cranial*
Wild type co lou rless Wild type co lo u rless
Number Percentage Number Percentage Number Percentage Number Percentage
Ectomesenchymal
Cartilage - - - - 6 7 2 6
Fin mesenchyme 5 7 2 8 - - - -
Non-ectomesenchymal
P igm en t
Melanophore 26 34 - - 12 14 - -
Xanthophore 9 12 4§ 16 12 14 7§ 21
Iridophore 3 4 - - 2 2 - -
Mixed pigment 10 13 - - - - - -
N eu ra l
Cranial ganglia - - - - 9 11 - -
Dorsal root ganglia 6 8 - - - - - -
Sympathetic neuron 3 4 - - - - - -
Schwann cell 1 1 — — - - — -
Mixed neural ^ 5 7 - - - - - -
M ix e d  p ig m en t/n eu ra l  
Melanophore
+ Dorsal root ganglia 1 1 - - - - - -
Other
Died 1 1 19* 76 11 13 15* 45
Unidentified 5 7 - - 33 39 9 27
Total 75 100 25 100 85 100 33 100
♦All progeny within a single clone adopted the same fate in every case, as shown previously (Schilling and Kimmel, 1994).
*Only single injected cells that survived and were identified as NCCs in the afternoon on the day of labelling are included. The numbers represent the number
of clones whose cells adopted the indicated fates, using the criteria outlined in the Materials and Methods.
5All xanthophores identified in e ls embryos subsequently died; hence in total, 23 (92%) and 22 (66%) cells died in the somite 14 and cranial samples.
^Mixed neural fates include clones with both neuronal and glial derivatives.
a l l e le s ,  s u g g e s t i n g  th a t in s e r t io n  o f  th e  tr a n s p o s o n  d o e s  n o t  
d is r u p t  t r a n s c r ip t io n  o f  5 '  s e q u e n c e s  (d a ta  n o t  s h o w n ) .
O u ts id e  n e u r a l c r e s t ,  sox 10 e x p r e s s io n  w a s  p a r t ic u la r ly  
s tr o n g  in  o t ic  p la c o d e  a n d  o t ic  v e s i c l e ,  a n d  fr o m  11 - s o m it e  
s ta g e  o n w a r d s  (F ig .  3 C ,F ,H ) ,  w a s  d e te c te d  in  p e c to r a l f in  an d  
in  s o m e  s p in a l  c o r d  c e l l s  f r o m  3 6  h p f . E x p r e s s io n  in  th e  ear  
w a s  s ig n if ic a n t ly  w e a k e r  in  els m u ta n ts  b y  4 0  h p f  (d a ta  n o t  
s h o w n ) .
els no n -ec to m esen ch y m al neural c re s t cells die 
p rior to  differentiation
P r e v io u s  c h a r a c te r is a t io n  o f  els e m b r y o s  c a ta lo g u e d  a s tr o n g  
r e d u c t io n  in  n o n - e c t o m e s e n c h y m a l  n eu r a l c r e s t  d e r iv a t iv e s  
(K e ls h  a n d  E is e n ,  2 0 0 0 ) .  T o  a n a ly s e  th e  c e l l  b io lo g ic a l  b a s is  
f o r  lo s s  o f  t h e s e  n e u r a l c r e s t  d e r iv a t iv e s ,  w e  u s e d  io n to p h o r e t ic  
la b e l l in g  o f  s in g le  N C C s .  W e  la b e l le d  p r e m ig r a to r y  N C C s  in  
els m u ta n ts  a n d  th e ir  w i ld - t y p e  s ib l in g s  in  tw o  r e g io n s  th a t  
g e n e r a te  e c to m e s e n c h y m a l  fa te s , a n d  s c o r e d  th e m  fo r  th e  
fa t e ( s )  a d o p te d  b y  th e ir  p r o g e n y  (T a b le  2 ) .  In  w i ld - t y p e  
e m b r y o s ,  a lm o s t  a ll ( 1 4 8 /1 6 0 ;  9 3 % ) la b e l le d  c e l l s  s u r v iv e d  
th r o u g h o u t  th e  e x p e r im e n t ,  a n d  a ll m a jo r  d e r iv a t iv e s ,  b o th  
e c to m e s e n c h y m a l  a n d  n o n - e c t o m e s e n c h y m a l ,  w e r e  id e n t if ie d  
a m o n g  th e  c lo n e s .  C o n s is t e n t  w ith  o u r  p r e v io u s  a n a ly s e s ,  
la b e l le d  c e l l s  g e n e r a te d  a  s im ila r  p r o p o r t io n  o f  
e c to m e s e n c h y m a l  fa te s  in  els m u ta n ts  ( 4 /5 8 ;  7 % ) a n d  w i ld - t y p e  
s ib l in g s  ( 1 1 /1 6 0 ;  7 % ). F u r th e r m o r e , e v e n  in  els m u ta n ts , c e l l s  
in  th e s e  c l o n e s  m ig r a te d  a n d  d if fe r e n tia te d  n o r m a lly . In  w i ld -  
ty p e  e m b r y o s ,  m o s t  c e l l s  w h e r e  fa te s  w e r e  id e n t if ia b le  
( 1 1 1 /1 2 2 ;  9 1 % ) d if fe r e n t ia te d  in to  r e c o g n is a b le  n o n -
e c to m e s e n c h y m a l  d e r iv a t iv e s . B y  c o n tr a s t , m o s t  id e n t if ia b le
c lo n e s  in  els e m b r y o s  ( 4 5 /4 9 ;  9 2 % ) d ie d  la te  o n  th e  s e c o n d  d a y  
( ~ 3 5 - 4 5  h p f ) .  M o s t  s h o w e d  n o  s ig n  o f  m o r p h o lo g ic a l  
d if fe r e n tia t io n  o r  p ig m e n ta t io n  ( 3 4 /4 9 ;  6 9 % ). T h e  o n ly  
e x c e p t io n , c lo n e s  th a t d e v e lo p e d  s o m e  x a n th o p h o r e  
p ig m e n ta t io n  ( 1 1 /4 9 ;  2 2 % ), a lw a y s  h a d  a b n o r m a l m o r p h o lo g y ,  
b e in g  ra th er  r o u n d e d  a n d  b le b b e d , a n d  d ie d  s o o n  a fter  
d if fe r e n tia t io n  ( F ig .  4 N ) .  A  s e r ie s  o f  s in g le  c e l l  in j e c t io n s  in  
N C C s  at th e  a x ia l le v e l  o f  s o m it e  7  g a v e  s im ila r  r e s u lt s ,  w ith  
9 2 %  o f  els c e l l s  d y in g  b y  a r o u n d  4 8  h p f ,  in  c o n tr a s t  t o  o n ly  
2 %  in  w i ld - t y p e  s ib l in g s  (d a ta  n o t  s h o w n );  n o te  th a t a t th is  
a x ia l p o s i t io n  n o  e c to m e s e n c h y m a l  fa te s  h a v e  b e e n  r e p o r te d  
(R a ib le  a n d  E is e n ,  1 9 9 4 ) .  O u r  r e s u lt s  a re  c o n s is t e n t  w it h  th e  
s e v e r e  r e d u c t io n  in  d if fe r e n tia te d  n o n - e c t o m e s e n c h y m a l  fa te s  
in  els e m b r y o s  a n d  s u g g e s t  th a t e x t e n s iv e  N C C  d e a th  i s  
a s s o c ia t e d  w ith  th e  els p h e n o ty p e .
N on-ectom esenchym al c re s t deriva tives die by 
ap o p to s is  during a d isc re te  tim e-w indow
T h e  m o r p h o lo g ic a l  a p p e a r a n c e  o f  d y in g  c e l l s  in  o u r  c lo n a l  
a n a ly s e s  s u g g e s t e d  an  a p o p to t ic  m e c h a n is m  o f  d e a th . W e  
c o m b in e d  T U N E L  w ith  b io t in -d e te c t io n  o f  th e  la b e l le d  c l o n e  
in  e a c h  o f  f iv e  els e m b r y o s  a n d  s h o w e d  th a t th e  d y in g  c e l l s  h a d  
f r a g m e n te d  D N A  ( F ig .  4 A - C ) .  W e  c o n c lu d e  th a t m a n y  n o n -  
e c to m e s e n c h y m a l  c lo n e s  in  els e m b r y o s  d ie  b y  an  a p o p to t ic  
m e c h a n is m .
A n a ly s i s  o f  c e l l  s u r v iv a l in  o u r  c r a n ia l N C C  d a ta  s e t  s h o w s  
th a t d ea th  o f  la b e l le d  N C C s  o c c u r s  w ith in  a  r e la t iv e ly  d is c r e te  
t im e - w in d o w  (F ig .  4 L ) .  In  b o th  els a n d  w i ld - t y p e  e m b r y o s ,  
a r o u n d  10%  o f  la b e l le d  c lo n e s  h a d  d ie d  b y  th e  m o r n in g  a fte r  
in j e c t io n . In  w i ld - t y p e  e m b r y o s ,  th e  n u m b e r  o f  s u r v iv in g
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(A -C )  N C C  c lo n e s  d ie  b y  an ap optotic  
m e c h a n ism  in  els em b ry o s . L ateral 
v ie w s  o f  4 0  h p f  els em b ry o  in w h ic h  
tw o  d au gh ters o f  a s in g le  la b e lled  
N C C  con trib u ted  to  the p oster ior  
lateral lin e  g a n g lio n , ly in g  ju st  
p o ste r io r  to  the o t ic  v e s ic le  (o ) . In the  
liv e  em b ry o , b oth  c e l ls  s h o w  b leb b ed  
m o r p h o lo g y  ty p ica l o f  ap o p to tic  c e lls  
w h e n  v ie w e d  w ith  N o m a rsk i o p tics  
(A ). A fter  fixa tion  and p r o c e ss in g  for  
T U N E L  (B ) an d  d e te c t io n  o f  the  
b io tin y la ted -d ex tra n  lin ea g e-tra cer
(C ), v is ib le  T U N E L  s ig n a l o f  th ese  
c lo n a l c e l ls  in d ica te s  D N A  
fragm en ta tion  ch aracteristic  o f  
a p o p to tic  c e lls .  (D -K )  W h o le -m o u n t  
T U N E L  sh o w s  N C C  a p o p to s is  inels 
em b ry o s . L ateral v ie w s  o f  d orsa l 
sp in a l cord  (s c )  in  ta il o f  3 0  (D ,H ) , 35  
(E ,I ) , 4 0  (F,J) an d  4 5  (G ,K ) h p f  
e m b ry o s  s h o w  ap o p to tic  N C C s  
im m e d ia te ly  d orsa l to  th e sp in a l cord  
from  35  h p f  i n c /5 (arrow h ead s, D -G ),  
but n o t w ild -ty p e  (H -K ), em b ry o s .
S ca ttered  T U N E L -p o s it iv e  c e l ls  are 
p ro m in en t in d orsa l sp in a l cord  (* )  o f  
els e m b ry o s  (E -G ); th ese  are 
o c c a s io n a lly  se e n  in w ild -ty p e  
s ib lin g s  at th ese  s ta g e s  (d ata  n ot 
sh o w n ), d f, d orsa l fin . (L ) T im e-
co u r se  o f  la b e lled  s in g le  cran ia l N C C  c lo n e  su rv iva l irc/s m u tants and th eir w ild -ty p e  s ib lin g s . P e rcen tage o f  su r v iv in g  c lo n e s  is  g iv e n  at ea c h  
o f  th e  five  standard  tim e  p o in ts  w h e n  em b ry o s  w ere  ex a m in e d . T h e tim e  p o in ts  corresp on d  to ap p ro x im a te ly  16 , 3 2 ,4 0 ,  5 6  and 6$>fi 
resp ec tiv e ly . T h e  first tim e  p o in t in c lu d es  o n ly  s in g le  la b e lled  N C C s b a sed  on  ex a m in a tio n  w ith in  a few  h ours a fter  la b e l lin g e 6 te x t  for  
further d eta ils . (M ,N )  W ild -ty p e  xan th o p h o res  (arrow s) at 4 8  h p f  h ave a very  fla tten ed , th in  m o rp h o lo g y  and are o n ly  w e a k ly  coined  (M ), 
w h ile  a d y in g  els x an th op h ore (arrow ) sh o w s  ch aracteristic  ap o p to tic  m o rp h o lo g y  and con cen tra ted  y e l lo w  co lo ra tio n , w h ic h  w a s  u su a lly  
v is ib le  b y  35  h p f  (N ). S c a le  bar: 1 0 0 p m  in A -C ; 5 0  p m  in D -K ; 75  p m  in  M ,N .
c lo n e s  w a s  e s s e n t ia l ly  u n c h a n g e d  at la te r  t im e s .  H o w e v e r ,  
in  els m u ta n ts , th e  n u m b e r  o f  s u r v iv in g  c lo n e s  d r o p p e d  
p r e c ip it o u s ly  to  o n ly  4 0 %  w it h in  th e  p e r io d  o f  a ro u n d  5 - 1 0  
h o u r s  b e tw e e n  th e  tw o  o b s e r v a t io n a l  t im e -p o in t s  o n  th e  s e c o n d  
d a y  a fte r  la b e l l in g  ( e q u iv a le n t  to  ~ 4 0  h p f ) ,  b u t  th e n  r e m a in e d  
c o n s ta n t . W e  in ter p r e t  th e  e a r ly  (o v e r n ig h t  a fter  in j e c t io n )  lo s s  
o f  w i ld - t y p e  a n d  els c l o n e s  a s  r e p r e s e n t in g  d e a th  d u e  to  
d a m a g e  d u r in g  la b e l l in g .  T h e  s u b s e q u e n t  la te  l o s s  o f  c l o n e s  in  
els e m b r y o s  c o r r e s p o n d s  to  th e  t im e  o f  a p p e a r a n c e  o f  a p o p to t ic  
c e l l s  a n d  w e  a ttr ib u te  th is  to  th e  els p h e n o ty p e .
T o  e x a m in e  th e  e x te n t  t o  w h ic h  a p o p t o s is  c o n tr ib u te s  to  th e  
els p h e n o ty p e ,  w e  u s e d  w h o le - m o u n t  T U N E L  to  e x a m in e  
a p o p to s is  o f  N C C s  ( F ig .  4 D - K ) .  W e  s a w  a  n o t a b le  
c o n c e n tr a t io n  o f  a p o p to t ic  c e l l s  d o r s a l o r  d o r s o la te r a l to  th e  
n e u r a l tu b e  in  els e m b r y o s ,  b u t  n o t  in  w i ld - t y p e  c o n tr o l  
e m b r y o s .  A  t im e c o u r s e  o f  T U N E L  b e tw e e n  2 0  a n d  6 0  h p f  
in d ic a te d  th a t c e l l  d e a th  in  N C C s  b e c o m e s  a p p a r en t b y  3 5  h p f  
a n d  c o n t in u e s  to  a p p r o x im a t e ly  4 5  h p f.
els neural c re s t ce lls  fail to  m igrate before 
undergo ing  a p o p to s is
O u r  in  v iv o  c lo n a l  s tu d ie s  r e v e a le d  th a t, w h i le  w i ld - t y p e  N C C s  
m ig r a te d  e x t e n s iv e ly  o n  b o th  m e d ia l  a n d  la te ra l p a th w a y s ,  
m o s t  els N C C s  fa i le d  to  le a v e  th e  p r e m ig r a to r y  c r e s t  area . 
T h u s , e x c lu d in g  e c to m e s e n c h y m a l  d e r iv a t iv e s  ( w h ic h  a lw a y s
m ig r a te d  n o r m a lly ) ,  o n ly  2 /3 1  (6 % ) o f  c r a n ia l N C C s  a p p e a r e d  
to  m ig r a te  a w a y  fr o m  th e ir  in it ia l  p o s i t io n s .  A t  th e  le v e l  o f  
s o m ite  1 4 , a ll w i ld - t y p e  la b e l le d  c e l l s  le f t  th e  p r e m ig r a to r y  
a rea , an d  m o r e  th a n  7 5 %  m ig r a te d  a t le a s t  5 0  | i m  fr o m  th e ir  
o r ig in a l p o s i t io n . O n ly  f in  m e s e n c h y m e  c lo n e s  m ig r a te d  
n o r m a lly  in  els m u ta n ts . O f  th e  r e m a in in g  c l o n e s ,  o n ly  4 /2 3  
(1 7 % ) m ig r a te d  a w a y  fr o m  th e  p r e m ig r a to r y  cr e st;  a n o th e r  c e l l  
e x te n d e d  to w a r d s  th e  h o r iz o n ta l m y o s e p t u m , b u t m a in ta in e d  
c o n ta c t  w ith  th e  p r e m ig r a to r y  area . O f  t h e s e  f iv e  c e l l s ,  t w o  
m ig r a te d  o n  th e  la te ra l p a th w a y , b u t  u n d e r w e n t  a p o p to s is  a fte r  
m o v in g  a b o u t  h a l f  w a y  to  th e  h o r iz o n ta l  m y o s e p t u m . T h e  o th e r  
th ree  c e l l s  m ig r a te d  o n  th e  m e d ia l  p a th . In  o n e  c a s e ,  th e  c e l l  
d id  n o t  d iv id e ,  m ig r a te d  to  a  p o s i t io n  a p p r o p r ia te  fo r  a d o r s a l  
r o o t  g a n g l io n ,  th e n  d ie d  b e f o r e  o v e r t  d if fe r e n t ia t io n . T h e  o th e r  
tw o  c e l l s  d iv id e d  o n c e ;  in  e a c h  c lo n e ,  o n e  s is t e r  c e l l  r e m a in e d  
d o r s a l to  th e  n e u r a l tu b e , a n d  m a y  h a v e  b e e n  an  e x tr a m e d u l la r y  
c e l l  (K e ls h  a n d  E is e n , 2 0 0 0 ) ,  w h i l e  th e  o th e r  m ig r a te d  to  
a d o r s a l r o o t  g a n g lia l  p o s i t io n ,  b u t f a i l e d  to  u n d e r g o  
a x o n o g e n e s is ,  c o n s is t e n t  w ith  th e  im p a ir e d  to u c h  r e s p o n s e  o f  
5 d p f  la r v a e . W e  o b ta in e d  s im ila r  r e s u lt s  fo r  la b e l le d  N C C s  
fr o m  th e  r e g io n  o f  s o m it e  7  (d a ta  n o t  s h o w n ) .  T h is  d ir e c t  
o b s e r v a t io n  o f  f a i l e d  N C C  m ig r a t io n  in  els e m b r y o s  is  
c o n s is t e n t  w ith  o u r  o b s e r v a t io n  o f  d c / - e x p r e s s in g  m e la n o b la s t s  
a n d  soxl 0 - e x p r e s s in g  N C C s  c o n c e n tr a te d  d o r s a l to  th e  n e u r a l  
tu b e  in  m u ta n t  e m b r y o s  (K e ls h  e t  a l . ,  2 0 0 0 b )  ( t h is  w o r k ) .
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els m u tan ts  and  soxlO  m o rp h an ts  fail to  ex p re ss  
g e n e s  critical for m e lanophore  specification  and 
m igration
els m u ta n ts  c o m b in e  a n  e x t e n s iv e  fa ilu r e  o f  N C C  m ig r a t io n  
w it h  la te  a p o p t o t ic  d e a th  o f  n o n - e c t o m e s e n c h y m a l  d e r iv a t iv e s .  
T h r e e  r e c e n t  s tu d ie s  s u g g e s t e d  a  p o s s ib l e  m o le c u la r  g e n e t ic  
m e c h a n is m  fo r  th e s e  a s p e c t s  o f  th e  p h e n o ty p e ,  sparse (spa), a  
kit h o m o lo g u e ,  i s  c r u c ia l f o r  s u r v iv a l a n d  m ig r a t io n  o f  
m e la n o p h o r e s  a n d  m e la n o b la s t s  (P a r ic h y  e t  a l. ,  1 9 9 9 ;  K e ls h  e t  
a l . ,  2 0 0 0 b )  a n d  nacre (nac) ,  a  microphthalmia transcription 
factor  (mitf) h o m o lo g u e ,  i s  c r u c ia l fo r  m e la n o p h o r e  
s p e c i f ic a t io n  a n d  r e q u ir e d  fo r  spa  e x p r e s s io n  (L is te r  e t  a l., 
1 9 9 9 ) .  W e  u s e d  in  s itu  h y b r id is a t io n  a t 2 0 - 3 5  h p f  to  a s k  
w h e th e r  spa  o r  nac e x p r e s s io n  w a s  d is r u p te d  in  els e m b r y o s  
( F ig .  5 ) . W e  fo u n d  th a t  b o th  spa  a n d  nac e x p r e s s io n  w e r e  
a b s e n t  f r o m  N C C s ,  e v e n  a t a  t im e  w h e n  m a n y  d c r -p o s it iv e  c e l l s  
are p r e s e n t , s u g g e s t in g  th a t  th e  els m e la n o p h o r e  p h e n o ty p e  
m ig h t  r e s u lt  f r o m  l o s s  o f  nac e x p r e s s io n . B y  c o n tr a s t , spa 
e x p r e s s io n  in  in te r m e d ia te  c e l l  m a s s  a n d  nac e x p r e s s io n  in  th e  
p ig m e n te d  r e t in a l e p it h e l iu m  are  u n a f fe c te d  in  els m u ta n ts .
W e  h a v e  r e c e n t ly  s h o w n  th a t in j e c t io n  o f  soxlO  m o r p h o lin o  
o l i g o n u c l e o t id e s  p h e n o c o p ie s  th e  els m u ta n t p h e n o t y p e  
(D u t to n  e t  a l . ,  2 0 0 1 ) .  T h e  m o r p h a n t  p h e n o t y p e  v a r ie s  
d e p e n d in g  u p o n  th e  a m o u n t  o f  m o r p h o lin o  in je c te d , w ith  h ig h  
d o s e s  p h e n o c o p y in g  a l l  a s p e c t s  o f  th e  p h e n o ty p e  o f  th e  s tr o n g  
els a l l e le s .  I n je c t io n  o f  lo w e r  d o s e s  r e s u lt s  in  a  p h e n o c o p y  o f  
th e  w e a k  els a l l e le  p h e n o t y p e ,  w ith  e m b r y o s  s h o w in g  s o m e  
m e la n o p h o r e s ,  c o n c e n tr a te d  in  d o r s a l p o s i t io n s  (D u t to n  e t  a l.,  
2 0 0 1 ;  M a l ic k i  e t  a l . ,  1 9 9 6 ) .  T h e  n u m b e r  o f  nac/mitf - e x p r e s s in g  
c e l l s  in  e m b r y o s  in je c te d  w ith  a  lo w  d o s e  o f  soxlO  m o r p h o lin o  
(m e d ia n  n u m b e r = 7 8 ;  n = 2 0 )  is  s ig n if ic a n t ly  h ig h e r  th a n  in  
e m b r y o s  in je c te d  w it h  a  h ig h  d o s e  (m e d ia n  n u m b e r = 2 0 ;  n=2 0 ;  
M a n n -W h itn e y  U - t e s t ,  P < 0 .0 5 ;  F ig .  5 C ,D ) ,  c o n s is t e n t  w it h  th e  
d i f f e r e n c e s  in  m e la n o p h o r e  p h e n o t y p e .
DISCUSSION
S tu d ie s  in  m ic e  h a v e  le d  to  id e n t if ic a t io n  o f  SoxlO a s  a  k e y  
g e n e  in  h u m a n  W a a r d e n b u r g -S h a h  s y n d r o m e . W e  h a v e  s h o w n  
th a t th e  z e b r a fis h  els lo c u s  i s  a  sox 10 h o m o lo g u e  p r e d ic te d  to  
e n c o d e  a p r o te in  w ith  a ll th e  m a jo r  d o m a in s  id e n t if ie d  in  
m a m m a ls  ( F ig .  1 ). W e  h a v e  id e n t if ie d  th e  m o le c u la r  le s io n  
l ik e ly  to  c a u s e  th e  m u ta n t  p h e n o ty p e  in  4  els a l l e le s .  In  tw o  
c a s e s ,  tw2 a n d  tw l l ,  b o th  o r ig in a t in g  fr o m  th e  s a m e  
m u ta g e n is e d  m a le  (H a f f te r  e t  a l . ,  1 9 9 6 ;  K e ls h  e t  a l . ,  1 9 9 6 ) ,  th e  
l e s i o n s  are id e n t ic a l  a n d  are p r e s u m a b ly  in d e p e n d e n t  is o la t io n s  
o f  th e  s a m e  a l le le .  T h e  z e b r a fis h  L y s 3 7 6 S t o p  le s io n s  r e s e m b le  
th e  h u m a n  059 a l l e le  ( d e lG A )  in  la c k in g  th e  tr a n s a c t iv a t io n  
d o m a in , a lth o u g h  t h e y  la c k  th e  C -te r m in a l e x t e n s io n  p r e s e n t  in  
th e  h u m a n  a l le le .  In  tr a n s ie n t  tr a n s fe c t io n  a s s a y s  h u m a n  0 5 9  
m u ta n t  p r o te in  h a s  b e e n  s h o w n  to  h a v e  n o  tr a n s c r ip t io n a l  
a c t iv a t io n  (B o n d u r a n d  e t  a l . ,  2 0 0 0 ;  K u h lb r o d t  e t  a l . ,  1 9 9 8 b ;  L iu  
e t  a l . ,  1 9 9 9 ) .  T h e  m618 a l l e le  s u b s t itu te s  L e u  1 4 2  in  th e  s e c o n d  
a lp h a  h e l ix  o f  th e  H M G  d o m a in  a n d  th e r e  is  n o  s im ila r  
m a m m a lia n  m u ta t io n . T h e  t3 a l l e le  r e s u lt s  in  a  s e v e r e ly  
tr u n c a te d  p r o te in  th a t la c k s  b o th  th e  D N A - b in d in g  a n d  
tr a n s c r ip t io n a l a c t iv a t io n  d o m a in s .  It is  th u s  r e m in is c e n t  o f  th e  
h u m a n  Y 8 3 X  a l l e le  w h ic h  h a s  b e e n  p r o p o s e d  to  b e  a fu n c t io n a l  
n u l l (K u h lb r o d t  e t  a l . ,  1 9 9 8 b ;  P o t t e r f  e t  a l . ,  2 0 0 0 ) .  A l l  fo u r  
m u ta n t  a l le le s  d e s c r ib e d  h e r e  s h o w  s im ila r , s tr o n g  p h e n o t y p e s
F ig . 5 . els m u tants lack  nac and spa e x p re ss io n . L ateral v ie w s  o f  
cau d al trunk o f  25  h p f  w ild -ty p e  andels e m b ry o s  a fter in  situ  
h yb rid isa tion  w ith  nac (A ,B ) , spa (E ,F ) an d  dct (G ,H ) p rob es. 
(C ,D ) nac/mitfe x p re ss io n  is  d ecr ea se d  w e a k ly  (C ) or s tro n g ly  (D )  
after in jec tion  w ith  e ith er  a lo w  or h ig h  d o se , r e sp ec tiv e ly , oioxlO  
m orp h o lin o . n , neural tube; y, y o lk  sa c . S ca le  bar: 7 fjim .
(K e ls h  e t  a l . ,  1 9 9 6 ;  M a lic k i  e t  a l . ,  1 9 9 6 )  (d a ta  n o t  s h o w n ) .  
T h e s e  c o n s id e r a t io n s ,  c o m b in e d  w ith  th e  s im ila r ity  o f  th e s e  
p h e n o t y p e s  w it h  th e  m a x im a l m o r p h a n t  p h e n o c o p y  g e n e r a te d  
w ith  a  soxlO  m o r p h o lin o ,  le a d  u s  to  s u g g e s t  th a t t h e s e  a l l e le s  
a re a ll l ik e ly  n u l l  a l l e le s .  A n a ly s i s  o f  th e  a c t iv i t ie s  o f  th e s e  
m u ta n t p r o te in s  w i l l  b e  in te r e s t in g  to  te s t  th is  p r o p o s a l .
Z e b r a f ish  sox 10 e x p r e s s io n  i s  c o n s is t e n t  w ith  c e l l  t y p e s  
a f fe c te d  in  els m u ta n ts  a n d  s t r o n g ly  r e m in is c e n t  o f  th a t  in  
m a m m a ls . W e  h a v e  ta k en  a d v a n ta g e  o f  th e  h ig h e r  r e s o lu t io n  o f  
su c h  s tu d ie s  in  z e b r a fis h , to  d e f in e  m o r e  p r e c i s e ly  th e  e x te n t  o f  
sox 10 e x p r e s s io n  th r o u g h o u t  th e  n e u r a l c r e s t  a t d if fe r e n t  s ta g e s .  
In  w i ld  ty p e ,  e x p r e s s io n  is  e x t e n s iv e  in  p r e m ig r a to r y  n e u r a l  
cr e s t , b u t c o m p a r is o n  w ith  fkd6  e x p r e s s io n  s h o w s  th a t  a  
m in o r ity  o f  p r e m ig r a to r y  N C C s  la c k  soxlO  e x p r e s s io n .  
E x p r e s s io n  p e r s is t s  in  s o m e  m ig r a t in g  c e l l s  o n  th e  m e d ia l  
m ig r a t io n  p a th w a y , b u t i s  r a p id ly  d o w n r e g u la te d  in  
d if fe r e n t ia t in g  p ig m e n t  c e l l s .  G l ia  o f  th e  d e v e lo p in g  p e r ip h e r a l  
n e r v o u s  s y s t e m  s h o w  s tr o n g  e x p r e s s io n ,  a s  h a s  a ls o  b e e n  
d e s c r ib e d  in  m ic e  (K u h lb r o d t  e t  a l . ,  1 9 9 8 a ;  B r it s c h  e t  a l. ,  
2 0 0 1 ) .  C r e s t  c e l l s  in  fo r m in g  b r a n c h ia l a r c h e s  a n d  f in  
m e s e n c h y m e  d o  n o t  s h o w  e x p r e s s io n ,  in  a g r e e m e n t  w ith  
m o u s e ,  b u t n o t  h u m a n , e x p r e s s io n  s tu d ie s  (B o n d u r a n d  e t  a l . ,  
1 9 9 8 ;  K u h lb r o d t  e t  a l . ,  1 9 9 8 a ;  S o u th a r d -S m ith  e t  a l . ,  1 9 9 8 ) .  
L a te  e x p r e s s io n  in  cr a n ia l c a r t i la g e s  i s  in t r ig u in g , b u t  w i l l  
re q u ir e  fu r th er  s tu d y  to  e v a lu a te  i t s  r o le . In  els m u ta n ts , soxlO- 
e x p r e s s io n  in  p r e m ig r a to r y  N C C s  i s  in i t i a l ly  u n a f f e c t e d  b u t,  
u n l ik e  in  w i ld - t y p e  s ib l in g s ,  soxl  ^ - e x p r e s s in g  c e l l s  s o o n  
a c c u m u la te  in  th is  p o s i t io n .  In  th e  tru n k  soxl  ^ - e x p r e s s in g  c e l l s  
m ig r a t in g  o n  th e  m e d ia l  p a th w a y  a re  s e e n  a n d  p r e s u m a b ly  
c o n tr ib u te  to  th e  n e u r o n e s  a n d  g l ia  o f  th e  d o r s a l r o o t  g a n g l ia ,  
w h ic h  are d e te c t a b le  in  m u ta n ts  ( K e ls h  a n d  E is e n ,  2 0 0 0 )  ( th is
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s t u d y ) .  N C C s  te n d  to  b e c o m e  c lu s te r e d  in  p r e m ig r a to r y  
p o s i t io n s  in  els m u ta n ts , c o n s is t e n t  w ith  th e  o b s e r v e d  d e f e c t  in  
N C C  m ig r a t io n  r e v e a le d  b y  o u r  s in g le - c e l l  la b e l l in g  s t u d ie s .
O u t s id e  th e  n e u r a l c r e s t , soxlO  e x p r e s s io n  i s  a l s o  la r g e ly  
c o n s e r v e d .  T h u s , e x p r e s s io n  in  th e  d e v e lo p in g  in n e r  ear  
e p it h e l iu m  i s  s e e n  in  z e b r a f is h  a s  w e l l  a s  in  m a m m a ls  
(B o n d u r a n d  e t  a l . ,  1 9 9 8 ;  S o u th a r d -S m ith  e t  a l. ,  1 9 9 8 ) .  In  
z e b r a f is h ,  th is  e x p r e s s io n  is  r e m a r k a b ly  s tr o n g  a n d  p e r s is te n t  
in  w i ld  t y p e ,  b u t  i s  d o w n r e g u la t e d  in  els m u ta n ts  b y  4 0  h p f . A s  
p r o n o u n c e d  o t ic  d e f e c t s  a re  m o r p h o lo g ic a l ly  d e te c ta b le  in  els 
m u ta n ts  b y  4 8  h p f  (R . N .  K . ,  u n p u b lis h e d ) ,  w e  s u g g e s t  th a t  
soxl 0 i s  c r u c ia l fo r  d e v e lo p m e n t  o f  o t ic  e p ith e l iu m . L im ite d  
e x p r e s s io n  in  e m b r y o n ic  c e n tr a l n e r v o u s  s y s t e m  is  s e e n  in  
z e b r a f is h  a n d  m ic e  (K u h lb r o d t  e t  a l . ,  1 9 9 8 a ) ,  a lth o u g h  d e ta ile d  
s t u d ie s  w i l l  b e  r e q u ir e d  to  e s ta b lis h  th e  c e l l  t y p e s  in v o lv e d  in  
e a c h  c a s e .
O u r  s in g le  c e l l  la b e l l in g  s tu d ie s  a t th r e e  r o s tr o c a u d a l  
p o s i t io n s  m a k e  c le a r  th a t d e f e c t s  in  els m u ta n ts  a re  n o t  l im ite d  
to  o n e  a x ia l  p o s i t io n ,  b u t  in s te a d  a f f e c t  n o n - e c to m e s e n c h y m a l  
ra th er  th a n  e c to m e s e n c h y m a l  c r e s t  d e r iv a t iv e s . M o s t  N C C s  
in  els m u ta n ts  s h o w  r e s tr ic te d  m ig r a t io n  a n d  p o o r  o r  n o  
d if f e r e n t ia t io n  b e fo r e  d y in g  b y  an  a p o p t o t ic  m e c h a n is m  w ith in  
a d is c r e t e  t im e -w in d o w . W e  in te r p r e t  th e  d y in g  c e l l s  a s  
b e in g  t h o s e  th a t w o u ld  in  w i ld - t y p e  s ib l in g s  fo r m  n o n -  
e c to m e s e n c h y m a l  fa te s . T h u s ,  in  els e m b r y o s ,  N C C s  th a t  
w o u ld  n o r m a lly  y ie ld  th e s e  m is s in g  n eu ra l c r e s t  d e r iv a t iv e s  are  
p r e s e n t  in  p r e m ig r a to r y  n e u r a l c r e s t  in  n o r m a l n u m b e r s , b u t  
th e n  d ie  b e fo r e  d if f e r e n t ia t in g ,  u s u a l ly  w ith o u t  m ig r a t in g . T h is  
c o n f ir m s  a n d  e x te n d s  r e p o r ts  th a t p u ta t iv e  N C C s  a p o p to s e  
d u r in g  m ig r a t io n  in  m o u s e  soxlO  m u ta n ts  (K a p u r , 1 9 9 9 ;  
S o u th a r d -S m ith  e t  a l . ,  1 9 9 8 ) .
T h e  soxlO  e x p r e s s io n  p a ttern  in  els m u ta n ts  m a y  a p p e a r  
c o n tr a d ic to r y  to  o u r  s in g le  c e l l  la b e l  r e s u lt s , a s  th e  e x p r e s s io n  
s tu d ie s  s h o w  n o r m a l n u m b e r s  o f  soxl 0 - p o s i t iv e  N C C s  
m ig r a t in g  o n  th e  m e d ia l  p a th w a y , w h i le  th e  s in g le  c e l l  la b e l l in g  
s tu d ie s  s h o w  a  s tr o n g  m ig r a t io n  d e f e c t  in  th e  n eu r a l c r e st .  
H o w e v e r ,  o u r  d a ta  s u g g e s t  th a t soxlO  i s  e x p r e s s e d  in  a lm o s t  a ll 
p r e m ig r a to r y  c e l l s ,  b u t  is  r a p id ly  d o w n r e g u la te d  in  
e c to m e s e n c h y m a l  an d  p ig m e n t  c e l l  p r e c u r so r s  a s  th e y  start to  
m ig r a te . T h u s ,  soxlO  e x p r e s s io n  in  m ig r a t in g  c e l l s  r e f le c t s  ju s t  
th e  n e u r a l p r e c u r so r s . O u r  s tu d ie s  s h o w  th a t t h e s e  c e l l s  are  
m u c h  le s s  d e f e c t iv e  in  m ig r a t io n  in  els m u ta n ts . C o n s is t e n t  
w ith  th is ,  th e  la b e l le d  c e l l s  in  els m u ta n ts  th a t d id  m ig r a te  
n o r m a lly  a ll t o o k  th e  m e d ia l  m ig r a t io n  p a th w a y  a n d , i f  th e y  
s u r v iv e d , a d o p te d  a  p o s i t io n  c o n s is t e n t  w ith  a  d o r s a l r o o t  
g a n g l ia l  fa te . B y  c o n tr a s t , m o s t  la b e l le d  N C C  c lo n e s  g e n e r a te d  
p ig m e n t  c e l l s ,  c o n s is t e n t  w it h  fo r m e r  s tu d ie s  in  z e b r a fis h .  
T h e s e  p ig m e n t  c e l l s  a re  s e v e r e ly  d e f e c t iv e  in  m ig r a t io n , a s  
s h o w n  b y  m o le c u la r  m a r k e r s  fo r  x a n th o p h o r e  (gdh; P a r ic h y  e t  
a l., 2 0 0 0 )  a n d  m e la n o p h o r e  ( dct; F ig .  5 )  c e l l  fa te s  (M . H a w k in s  
a n d  R . N .  K .,  u n p u b l is h e d )  (K e ls h  a n d  E is e n , 2 0 0 0 ) .  F u r th er  
w o r k  w i l l  b e  r e q u ir e d  to  in v e s t ig a te  th e  s p e c i f i c a t io n  s ta tu s  o f  
th e  m ig r a t in g  n e u r a l p r e c u r so r s  in  w i ld - t y p e  a n d  m u ta n t  
e m b r y o s .
W e  h a v e  d e m o n s tr a te d  th e  c o m p le x it y  o f  N C C  d e f e c t s  in  els 
e m b r y o s ,  w it h  s u r v iv a l, m ig r a t io n  a n d  d if fe r e n tia t io n  o f  n o n -  
e c to m e s e n c h y m a l  c e l l  t y p e s  a ll a f fe c te d . F u rth er , a  s m a ll  
d e c r e a s e  in  c l o n e  s iz e  s u g g e s t s  th a t p r o li f e r a t io n  m a y  a ls o  b e  
s o m e w h a t  a f fe c te d  (K . A . D .  a n d  R . N .  K ., u n p u b lis h e d ) .  T h is  
s p e c tr u m  o f  d e f e c t s  is  n o t  r e a d i ly  c o n s is t e n t  w ith  a  p r im a r y  
fu n c t io n  fo r  w i ld - t y p e  cls/soxlO  in  N C C  s u r v iv a l, p r o li f e r a t io n
o r  d if fe r e n t ia t io n . A lt h o u g h  a  d y in g  c e l l  m ig h t  s h o w  a b n o r m a l  
m ig r a t io n  a n d  p r o li f e r a t io n , th e  t im in g  o f  a p p e a r a n c e  o f  d e f e c t s  
in  els m u ta n ts  c o n f l i c t s  w ith  c e l l  s u r v iv a l b e in g  th e  p r im a r y  
d e fe c t .  W e  c a n  fir st  d is t in g u is h  els m u ta n ts  a t 2 0  h p f  ( b y  la c k  
o f  nac/mitf e x p r e s s io n ) ,  b u t  d o  n o t  s e e  N C C  a p o p t o s i s  b y  
T U N E L  u n t i l  a r o u n d  3 5  h p f;  p r e v io u s  w o r k  in  z e b r a f is h  h a s  
s u g g e s t e d  th a t  th e  d e la y  b e t w e e n  in d u c t io n  o f  a p o p t o s is  a n d  
d e te c ta b le  m o r p h o lo g ic a l  c h a n g e s  a n d  D N A  fr a g m e n ta t io n  is  
at m o s t  3 - 4  h o u r s  ( I k e g a m i e t  a l . ,  1 9 9 9 ) .  L ik e w is e  th e  els 
m u ta n t p h e n o ty p e  c a n n o t  b e  e x p la in e d  a s  p r im a r ily  a  fa i lu r e  o f  
m ig r a t io n , w it h  s u b s e q u e n t  fa ilu r e  o f  e x p o s u r e  to  r e q u ir e d  
tr o p h ic  fa c to r s , b e c a u s e  fo r  th r e e  s u b s e t s  o f  a f f e c t e d  c e l l s  ( th r e e  
p ig m e n t  c e l l  t y p e s  in  th e  s tr ip e  d o r s a l to  th e  n e u r a l t u b e ) ,  th e  
p r e m ig r a to r y  p o s i t io n  i s  a ls o  a  f in a l lo c a t io n  a n d  h e n c e  th e  
n e c e s s a r y  tr o p h ic  fa c to r s  m u s t  b e  a v a ila b le . D e s p i t e  th is ,  in  els 
m u ta n ts  a l l  p ig m e n t  c e l l s ,  in c lu d in g  t h o s e  o f  th e  d o r s a l s tr ip e , 
fa il  to  d e v e lo p  p r o p e r ly . I n s te a d , w e  p r o p o s e  th a t th e  p r im a r y  
r o le  o f  els g e n e  fu n c t io n  is  in  s p e c i f i c a t io n  o f  n o n -  
e c to m e s e n c h y m a l  c e l l  fa te s ;  a ll o th e r  d e f e c t s  in  els m u ta n ts  
w o u ld  th e n  b e  s e c o n d a r y  e f f e c t s  o f  a  fa ilu r e  to  b e c o m e  p r o p e r ly  
s p e c if ie d .  T h u s ,  in  els m u ta n ts  N C C s  a re  u n a b le  t o  a d o p t  n o n -  
e c to m e s e n c h y m a l fa te s  a n d  s o  fa i l  to  d if fe r e n t ia te .  T h is  
d if fe r e n tia t io n  p r o c e s s  w o u ld  in c lu d e  e x p r e s s io n  o f  g r o w th  an d  
tr o p h ic  fa c to r  r e c e p to r s , a n d  h e n c e  s e c o n d a r y  d e f e c t s  m ig h t  
in c lu d e  im p a ir e d  p r o li f e r a t io n  a n d  la te r  a p o p t o s is .  O u r  
id e n t if ic a t io n  o f  th e  els g e n e  a s  a  soxlO  t r a n s c r ip t io n  fa c to r  
g e n e  is  c o n s is t e n t  w ith  th is  in te r p r e ta tio n .
I n d e e d , f o r  th e  s p e c i f i c  c a s e  o f  m e la n o p h o r e  fa te ,  d a ta  
p r e s e n te d  h e r e  a n d  e l s e w h e r e  p e r m it  u s  to  p r o p o s e  a  m o le c u la r  
m o d e l c o n s is t e n t  w it h  th is  in te r p r e ta t io n  (F ig .  6 ) .  In  b o th  
ze b r a fis h  a n d  m a m m a ls ,  N a c /M i t f  h o m o lo g u e s  h a v e  b e e n  
s h o w n  to  b e  im p o r ta n t  tr a n s c r ip t io n  fa c to r s  fo r  s p e c i f y i n g  
m e la n o p h o r e  fa te  (L is t e r  e t  a l . ,  1 9 9 9 ;  O p d e c a m p  e t  a l . ,  1 9 9 7 ;  
T a c h ib a n a  e t  a l . ,  1 9 9 6 ) .  W e  s h o w  h e r e  th a t els m u ta n ts  la c k  
e x p r e s s io n  o f  nac ( in d e e d  it  i s  th e  e a r l ie s t  d e f e c t  w e  h a v e  
id e n t if ie d ) .  T h u s ,  soxlO  is  r e q u ir e d  fo r  nac e x p r e s s io n  a n d  th u s  
fo r  m e la n o p h o r e  l in e a g e  s p e c i f i c a t io n . In  a d d it io n , in  nac 
m u ta n ts , w o e - p o s i t iv e  c e l l s  s h o w  a  fa ilu r e  to  m ig r a te  h ig h ly  
r e m in is c e n t  o f  th e  els m e la n o b la s t  p h e n o t y p e  ( L is t e r  e t  a l.,
1 9 9 9 ) .  L ik e w is e ,  in  b o th  els a n d  nac m u ta n ts , spa/kit 
e x p r e s s io n  is  lo s t  in  m e la n o b la s t s .  spa f u n c t io n  is  n e c e s s a r y  fo r  
b o th  m e la n o b la s t  m ig r a t io n  a n d  m e la n o b la s t  a n d  m e la n o p h o r e  
s u r v iv a l (K e ls h  e t  a l., 2 0 0 0 b ;  P a r ic h y  e t  a l . ,  1 9 9 9 ) .  
F u r th e r m o r e , th e  t im in g  o f  l o s s  o f  m e la n o b la s t s  in  spa m u ta n ts ,  
b e g in n in g  b e tw e e n  3 0  a n d  3 6  h p f ,  i s  c o n s is t e n t  w ith  th e  t im in g  
o f  d e c r e a s e  in  m e la n o b la s t  n u m b e r s  a n d  w ith  th e  t im in g  o f  
N C C  a p o p t o s is  in  els m u ta n ts  (K e ls h  e t  a l . ,  2 0 0 0 b ;  th is  s tu d y ) .  
H e n c e , a  s im p le  m o d e l  ca n  la r g e ly  e x p la in  th e  els m e la n o p h o r e  
p h e n o ty p e .  cls/soxlO  h a s  a k e y  r o le ,  b y  d ir e c t  o r  in d ir e c t  
a c t iv a t io n  o f  nac/mitf, in  m e la n o p h o r e  s p e c i f ic a t io n  a n d  
c o n s e q u e n t ly  els m u ta n ts  la c k  e x p r e s s io n  o f  g e n e s  a c t iv a te d  b y  
n a c , in c lu d in g  spa/kit, m e d ia t in g  s u r v iv a l a n d  m ig r a t io n , a n d  
m e la n o g e n ic  e n z y m e s ,  m e d ia t in g  p ig m e n ta t io n . In  s u p p o r t  o f  
th is  m o d e l ,  in j e c t io n  o f  soxlO  m R N A  in to  e a r ly  e m b r y o s  
r e su lts  in  e c to p ic  nac/mitf e x p r e s s io n  a n d  e x p r e s s io n  o f  nac in  
els e m b r y o s  is  s u f f ic ie n t  to  r e s c u e  m e la n o p h o r e s  ( S .  E . a n d  R . 
N . K ., u n p u b lis h e d ) .  It w i l l  b e  o f  in te r e s t  to  e x p a n d  t h is  m o d e l  
to  in c lu d e  o th e r  ta r g e ts  o f  soxlO  a n d  nac, a s  w e l l  a s  t o  e x te n d  
th is  m o d e l  to  o th e r  n o n - e c t o m e s e n c h y m a l  n e u r a l c r e s t  
d e r iv a t iv e s  a f fe c te d  in  els m u ta n ts . O u r  m o d e l  p r e d ic t s  th a t  th e  
im m e d ia te  ta r g e ts  o f  soxlO  w i l l  b e  e i th e r  m a s te r  r e g u la to r s  o f
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F ig . 6 . M o d e l o f  ro le  o f  cls/sox 10 in  m ela n o p h o re  sp e c ifica tio n . 
F orm al g e n e t ic  in teraction s b e tw e e n  s e le c te d  g e n e s  k n ow n  to  
fu n c tio n  in  zeb ra fish  m e la n o p h o re  d ev e lo p m e n t are sch em a tised . In 
els m u tan ts, fa ilu re to  a c t iv a te /ia c  ex p r e ss io n  (an d  th us to  s p e c ify  
m ela n o p h o re  fa te) re su lts  in  a b se n c e  o f  g e n e  p rod u cts cr itica l for 
m e la n o p h o re  su rv iva l, m igra tion  an d  d ifferen tia tion . For d eta ils , s e e  
m ain  text.
n e u r a l c r e s t  fa te  ( e .g .  nac)  o r  a  m u lt itu d e  o f  d iv e r s e  g e n e  
p r o d u c ts  r e q u ir e d  w ith in  s p e c i f i c  c r e s t  d e r iv a t iv e s  fo r  th e  
c e l lu la r  f u n c t io n s  o f  t r o p h ic  su p p o r t , m ig r a t io n  an d  
d if fe r e n t ia t io n . T h u s ,  it  w i l l  b e  im p o r ta n t to  id e n t ify  th e  d ir e c t  
ta r g e ts  o f  S o x lO  tr a n s c r ip t io n a l r e g u la t io n .
T h is  s p e c i f i c  m o d e l  is  l ik e ly  to  b e  a p p l ic a b le  to  m a m m a lia n  
n eu ra l c r e s t  t o o .  T h u s ,  S o x lO  d ir e c t ly  r e g u la te s  M itf e x p r e s s io n  
in  m o u s e  (B o n d u r a n d  e t  a l . ,  2 0 0 0 ;  L e e  e t  a l . ,  2 0 0 0 ;  P o t t e r f  et  
a l.,  2 0 0 0 ;  V e r a s te g u i e t  a l . ,  2 0 0 0 ) .  A lth o u g h  D c / - p o s i t iv e  
m e la n o b la s t s  a re  n o t  d e te c ta b le  in  SoxlODom m ic e ,  s o m e  
e v id e n c e  o f  im p a ir e d  o r  d e la y e d  m ig r a t io n  o f  s o m e  N C C s  h a s  
b e e n  p r e s e n te d  (S o u th a r d -S m ith  e t  a l . ,  1 9 9 8 ) .  S im ila r ly , Kit 
f u n c t io n  i s  c r i t ic a l ly  in v o lv e d  in  p r o m o t in g  m e la n o b la s t  
m ig r a t io n  a n d  s u r v iv a l ,  is  r a p id ly  lo s t  f r o m  m e la n o b la s t s  in  
M itf m u ta n ts  a n d  i s  k n o w n  to  b e  a  d ir e c t  ta rg e t  o f  M it f ,  a t  le a s t  
in  c u ltu r e d  m a s t  c e l l s  ( O p d e c a m p  e t  a l . ,  1 9 9 7 ;  W e h r le -H a lle r  
a n d  W e s to n , 1 9 9 5 ;  W e h r le -H a l le r  a n d  W e s to n , 1 9 9 7 ) .  In  SoxlO 
m u ta n t m ic e ,  Kit e x p r e s s io n  in  m e la n o b la s t s  m a y  b e  a b se n t ,  
a lth o u g h  th e  p r e s e n c e  o f  u n a f f e c t e d  c e l l s  in  th e  s k in , s u g g e s t e d  
to  b e  m a s t  c e l l s ,  m e a n s  th a t th is  r e s u lt  n e e d s  to  b e  c o n f ir m e d  
(B o n d u r a n d  e t  a l . ,  2 0 0 0 ) .
so x l0 a lo n e  c a n n o t  b e  s u f f i c ie n t  to  s p e c i f y  e a c h  o f  th e  n o n -  
e c to m e s e n c h y m a l  fa te s . W e  b e l i e v e  th a t soxlO, w h i le  c r u c ia l  
fo r  e a c h  o f  th e m , is  n o t  s u f f ic ie n t ;  in s te a d , w e  p r o p o s e  th a t  
soxlO  is  o n e  o f  a  c o m b in a t io n  o f  g e n e s  th a t to g e th e r  s p e c i f y  
n o n - e c t o m e s e n c h y m a l  fa te s  fr o m  n eu ra l c r e s t . T h is  m o d e l  
h e lp s  e x p la in  w h y  c e l l s  th a t e x p r e s s  m o le c u la r  m a r k e r s  fo r  
a f fe c te d  c e l l  t y p e s  c a n  b e  id e n t if ie d  in  els m u ta n ts  (K e ls h  a n d  
E is e n ,  2 0 0 0 ) .  F o r  e x a m p le ,  a lth o u g h  m e la n o p h o r e s  b a r e ly  
e x p r e s s  m e la n in ,  x a n t h o p h o r e s  s h o w  m u c h  p ig m e n t  in  els 
m u ta n ts . I f  a  c o m b in a t io n  o f  tr a n s c r ip t io n  fa c to r s  to g e th e r  
s p e c i f y  a  c e l l  ty p e ,  e a c h  fa c to r  m ig h t  r e g u la te  o n ly  p a r t ia l ly  
o v e r la p p in g  s u b s e t s  o f  th e  c h a r a c te r is t ic s  o f  in d iv id u a l  fa te s . In  
th e  a b s e n c e  o f  soxlO  g e n e  fu n c t io n , t h o s e  a s p e c t s  o f  
m e la n o p h o r e  a n d  x a n th o p h o r e  fa te  r e q u ir in g  soxlO  fu n c t io n  
w o u ld  b e  a f f e c t e d  ( e .g .  s y n t h e s is  o f  m e la n in  a n d  tr o p h ic  
m a c h in e r y , r e s p e c t iv e ly ) ,  w h i le  o th e r s  w o u ld  r e m a in  at le a s t  
p a r tly  u n a f f e c t e d  ( e .g .  dct e x p r e s s io n  a n d  p te r id in e  p ig m e n t  
s y n t h e s is ,  r e s p e c t iv e ly ) .  A  d ir e c t ly  a n a lo g o u s  m e c h a n is m  h a s  
b e e n  p r o p o s e d  fo r  a u t o n o m ic  n e u r o n e  s p e c if i c a t io n  fr o m  th e  
n eu r a l c r e s t ,  w ith  d if fe r e n t  g e n e s  r e g u la t in g  p a n -n e u r o n a l a n d  
s u b ty p e  s p e c i f i c  c e l l  p r o p e r t ie s  (A n d e r s o n  e t  a l . ,  1 9 9 7 ) .  F a c to r s  
th a t in te r a c t  w ith  S o x lO  to  r e g u la te  ta rg e t  g e n e s  h a v e  b e e n
d e s c r ib e d , in c lu d in g  th e  p a ir e d  b o x  tr a n s c r ip t io n  fa c to r  P a x 3  
a n d  th e  P O U -d o m a in  p r o te in  T s t - l /O c t 6 /S C I P  (B o n d u r a n d  e t  
a l . ,  2 0 0 0 ;  K u h lb r o d t  e t  a l . ,  1 9 9 8 a ) .  H o w e v e r ,  it r e m a in s  to  b e  
s e e n  w h e th e r  th e s e  c o - fa c to r s  h a v e  a n y  r o le  in  d is t in g u is h in g  
n o n - e c t o m e s e n c h y m a l  fa te s . I d e n t i f ic a t io n  o f  c o m b in a t io n s  o f  
tr a n s c r ip t io n  fa c to r s  r e q u ir e d  to  s p e c i f y  e a c h  fa te  w i l l  b e  a  
p r o m is in g  l in e  o f  fu tu r e  r e se a r c h .
O u r  s p e c if i c a t io n  m o d e l  p r e d ic t s  th a t sox 10 f u n c t io n  i s  
r e q u ir e d  o n ly  in  N C C s  fa te d  to  n o n - e c t o m e s e n c h y m a l  
d e r iv a t iv e s . Jkd6 is  e x p r e s s e d  v e r y  b r o a d ly  in  p r e m ig r a to r y  
N C C s  (O d e n th a l a n d  N u e s s le in -V o lh a r d , 1 9 9 8 )  a n d  s h o w s  
e x te n s iv e ,  b u t  in c o m p le t e ,  o v e r la p  w ith  soxlO. F u r th e r  s tu d ie s  
w il l  b e  r e q u ir e d  to  t e s t  w h e th e r  soxlO-; Jkd6+  N C C s  r e p r e s e n t  
e c to m e s e n c h y m a l  p r e c u r so r s . H o w e v e r ,  o u r  r e s u lt s  d o  s h o w  
th a t, c o n s is t e n t  w ith  o u r  m o d e l ,  e x p r e s s io n  is ,  a t le a s t ,  r a p id ly  
d o w n r e g u la te d  in  c e l l s  th a t a d o p t  e c to m e s e n c h y m a l  fa te s . In  
m a m m a ls , S oxl0 h a s  s o m e t im e s  b e e n  a s s u m e d  to  b e  a g e n e r ic  
N C C  m a rk er  (P a tty n  e t  a l . ,  1 9 9 9 ) ,  b u t o u r  r e s u lt s  s h o w  th a t, in  
f is h , o v e r la p  w ith  o th e r  N C  m a r k e r s  is  in c o m p le t e ,  e v e n  at 
p r e m ig r a to r y  s ta g e s .
In m a n y  r e s p e c ts ,  z e b r a fis h  n eu r a l c r e s t  d e v e lo p m e n t  is  
ty p ic a l  o f  n e u r a l c r e s t  d e v e lo p m e n t  in  a ll v e r te b r a te s  (R a ib le  e t  
a l.,  1 9 9 2 ) .  In  c o n tr a s t  to  m o u s e  a n d  h u m a n  SoxlO m u ta t io n s ,  
n o n e  o f  th e  f is h  sox 10 m u ta t io n s  s h o w  d o m in a n t  e f f e c t s  o n  
m e la n o p h o r e  n u m b e r  o r  p a ttern  (R . N .  K .,  u n p u b lis h e d ) .  In  
m ic e ,  e x p r e s s iv i ty  o f  th e  soxlO  h a p lo in s u f f i c ie n c y  p h e n o ty p e  
i s  d e p e n d e n t  o n  th e  g e n e t i c  b a c k g r o u n d  (L a n e  a n d  L iu , 1 9 8 4 ) .  
P r e s u m a b ly , in  th e  A B  b a c k g r o u n d  in  z e b r a fis h  h e t e r o z y g o t e s  
h a v e  s u f f ic ie n t  S o x lO  fo r  n o r m a l m e la n o p h o r e  d e v e lo p m e n t .  
N e v e r t h e le s s ,  th e  c o n s e r v e d  e x p r e s s io n  p a ttern  a n d  
h o m o z y g o u s  p h e n o ty p e s  in  th e  t w o  s p e c ie s  s u g g e s t  th a t  th e  
d e ta i le d  c e l l - b io l o g ic a l  b a s i s  fo r  th e  els p h e n o t y p e  p r o p o s e d  
h e r e  i l lu m in a t e s  a  p o s s ib l e  m e c h a n is m  b e h in d  W a a r d e n b u r g -  
S h a h  s y n d r o m e  a n d  H ir s c h s p r u n g ’s  d is e a s e ,  in  w h ic h  r e d u c e d  
S O X  1 0  fu n c t io n  m a y  r e d u c e  th e  n u m b e r  o f  m e la n o b la s t s  a n d  
e n te r ic  p r e c u r so r s  s p e c if i e d .
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We have utilized the modified antisense RNA morpho­
lino technology to effectively phenocopy zebrafish 
colourless/sox 10 icls) mutations. The els locus was 
identified in mutagenesis screens (Kelsh et a l ,  1996; 
Malicki e t al., 1996). Homozygous mutants are char­
acterized by extensive defects in nonectomesenchy- 
mal fates (neurons, glia, and pigment cells) derived 
from the neural crest (Kelsh and Eisen 2000; Kelsh et 
al., 2000a, 2000b). Additionally, els mutants have 
small otic vesicles (Whitfield et al., 1996). Zebrafish 
els mutants are models for two human neurocristopa­
thies, Hirschsprung’s disease, characterized by few or 
no enteric ganglia, and Waardenburg-Shah syndrome, 
which combines Hirschsprung’s disease with pigment 
defects. We have recently shown that the els mutant 
phenotype results from disruptions in the zebrafish 
sox lO  homologue and that soxlO  expression is first 
seen at approximately 11 h postfertilization (hpf) in 
premigratory neural crest cells (A. Pauliny and R. N. 
Kelsh, unpublished). The els mutant phenotype can 
first be detected at 21 hpf in dopachrome tautomerase 
(dct) in situ or scored visibly at 27 hpf (Kelsh e t al., 
2000a). Thus, we demonstrate that morpholino oligos 
can effectively phenocopy late embryonic phenotypes 
in zebrafish. We have characterized morphants gener­
ated using morpholino oligos designed to target the 
zebrafish sox 10  homologue. The phenotypes resulting 
from injection of these morpholinos are consistent 
with the els mutant phenotype affecting both neural 
crest derivatives and otic vesicles with an optimal 
response achieved with a dose of 16.5 ng (Fig 1 and 
Table 1). In strong mutant phenotypes, no normal 
melanophores are seen. However, even with high 
doses of morpholino, some normal melanophores are 
present, implying that the characterized strong mu­
tant alleles are likely nulls. At lower doses, all mor­
phant embryos are reminiscent of the single reported 
weak els allele, which is not presently available (Mal­
icki e t al., 1996). As most known els alleles display 
strong phenotypes, the ability to produce a graded 
series of els hypomorphs with morpholinos will be 






3 ng 10% — 19
4.5 ng 12% — 105
6 ng 21% — 105
7 ng 26% — 98
9 ng 18% 11% 104
14 ng 14% 30% 59
16.5 ng 44% 24% 218
37 ng 49% 29% 43
aWeak phenocopies had at least 25 melanophores with a mean of
67 (SD ± 25).
bStrong phenocopies had a mean of 11 (SD ± 8) but less than 25
total melanophores. One to eight cell AB wild-type embryos were 
injected with 4.6 nl of morpholino oligo diluted as recommended by 
Gene Tools, LLC and incubated at 28.5°C. Embryos with more than 
50% of wild-type pigment at 48 hpf were scored as wild type due to 
variations in embryonic development. At doses over 16.5 ng, non­
specific deformities became apparent.
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FIG. 1. soxlO knockdown embryos pheno­
copy c/s mutant phenotypes, (a, d, g, j, m) 
Uninjected wild-type embryos shown in 
comparison with embryos injected with 16.5 
ng of a morpholino oligo (5'-GCCACAGGT- 
GACTTCGGTAGGTTTA-3') designed to tar­
get the -43 to -19  region of the (b, e, h, k, 
n) soxlO sequence and (c, f, i, I, o) c/s mu­
tant embryos. A morpholino oligo (5'-AT- 
GCTGTGCTCCTCCGCCGACATCG-3') de­
signed to target the -23 to +2 region of the 
soxlO sequence gave similar phenocopies 
(data not shown). Panels show lateral views 
of (a-f) live whole-mounts, (g-i) fixed em­
bryos processed for dct (Kelsh et al., 2000b) 
in situ hybridization, or (j—o) anti-Hu mAb 
16A11 (Marusich et al., 1994) antibody 
staining, (d-f) Lateral views of the otic vesi­
cle of a (d) 72 hpf wild-type embryo with the 
reduced otic vesicle, (e) small otoliths of an 
injected sibling, and (f) c/s mutant. The dct in 
situ hybridization reveals melanoblasts in 
the anterior trunk of a (g) 22 hpf wild-type 
embryo; these are absent in an (h) injected 
sibling, and (i) c/s mutant. Anti-Hu staining 
demonstrates a significant decrease in the 
number of enteric neurons (arrows) in the 
hindgut of an (k) injected 5-day postfertiliza­
tion (dpf) embryo compared with a (j) wild- 
type sibling and similar to a (I) c/s mutant. 
Hu-positive dorsal root ganglia (arrow) in the 
tail of a (m) 5 dpf wild-type embryo are lack­
ing in an (n) injected sibling, and (o) c/s mu­
tant (e, eye; ov, otic vesicle; s, somite).
